1	Leukemia	NNP	ORGANIZATION	Leukemia	nn	2	SENT_1	[p1l819t81r940b103],
2	Research	NNP	ORGANIZATION	Research	dep	7	SENT_1	[p1l949t81r1061b103],
3	35	CD	NUMBER	35	dep	2	SENT_1	[p1l1069t82r1099b103],
4	(	NN	O	(	dep	7	SENT_1	[p1l1109t81r1162b108],
5	201	CD	NUMBER	201	num	4	SENT_1	[p1l1109t81r1162b108],
6	1	CD	NUMBER	1	num	7	SENT_1	[p1l1168t81r1191b108],
7	)	NN	O	)	dep	10	SENT_1	[p1l1168t81r1191b108],
8	1	CD	NUMBER	1	dep	7	SENT_1	[p1l1201t82r1211b102],
9	178-1	CD	NUMBER	178-1	num	10	SENT_1	[p1l1217t82r1291b103],
10	183	CD	NUMBER	183	_	0	SENT_1	[p1l1297t82r1341b103],

1	Contents	NNS	O	contents	_	0	SENT_2	[p1l779t190r915b216],
2	lists	NNS	O	list	dep	1	SENT_2	[p1l928t191r986b215],
3	available	JJ	O	available	amod	2	SENT_2	[p1l998t191r1133b216],
4	at	IN	O	at	_	0	SENT_2	[p1l1145t194r1172b216],
5	ScienceDirect	NNP	O	ScienceDirect	prep_at	3	SENT_2	[p1l1184t190r1392b216],

1	Leukemia	NNP	O	Leukemia	nn	2	SENT_3	[p1l832t288r1093b335],
2	Research	NNP	O	Research	_	0	SENT_3	[p1l1112t288r1352b335],

1	Al	NNP	O	Al	_	0	SENT_4	[p1l36t377r86b402],
2	$	$	MONEY	$	rcmod	1	SENT_4	[p1l36t377r86b402],
3	+	CC	MONEY	+	_	0	SENT_4	[p1l36t377r86b402],
4	‘	CD	NUMBER	‘	rcmod	1	SENT_4	[p1l97t380r132b402],
5	E	NN	O	e	dep	2	SENT_4	[p1l97t380r132b402],
6	’	SYM	O	’	dep	2	SENT_4	[p1l97t380r132b402],
7	-	:	O	-	_	0	SENT_4	[p1l97t380r132b402],
8	‘	NN	O	‘	dep	1	SENT_4	[p1l97t380r132b402],
9	.	.	O	.	_	0	SENT_4	[p1l142t390r211b402],

1	.	.	O	.	_	0	SENT_5	[p1l142t390r211b402],

1	~	NN	O	~	_	0	SENT_6	[p1l142t390r211b402],
2	.	.	O	.	_	0	SENT_6	[p1l142t390r211b402],

1	,4	NN	O	,4	nsubj	2	SENT_7	[p1l142t390r211b402],
2	—	NN	O	—	_	0	SENT_7	[p1l142t390r211b402],
3	;	:	O	;	_	0	SENT_7	[p1l142t390r211b402],
4	;	:	O	;	_	0	SENT_7	[p1l142t390r211b402],
5	.	.	O	.	_	0	SENT_7	[p1l223t377r252b400],

1	ELSEVIER	NNP	O	ELSEVIER	nn	3	SENT_8	[p1l12t423r248b458],
2	journal	NN	O	journal	nn	3	SENT_8	[p1l582t420r714b451],
3	homepage	NN	O	homepage	_	0	SENT_8	[p1l737t420r940b451],
4	:	:	O	:	_	0	SENT_8	[p1l737t420r940b451],
5	www	NN	O	www	dep	3	SENT_8	[p1l956t420r1588b445],
6	.	.	O	.	_	0	SENT_8	[p1l956t420r1588b445],

1	e	LS	O	e	dep	3	SENT_9	[p1l956t420r1588b445],
2	|	SYM	O	|	dep	3	SENT_9	[p1l956t420r1588b445],
3	sevier.com/locate/leukres	NNS	O	sevier.com/locate/leukres	_	0	SENT_9	[p1l956t420r1588b445],

1	Impact	NN	O	impact	dep	110	SENT_10	[p1l6t570r189b624],
2	on	IN	O	on	dep	110	SENT_10	[p1l207t580r272b613],
3	response	NN	O	response	dep	110	SENT_10	[p1l290t580r526b624],
4	and	CC	O	and	dep	110	SENT_10	[p1l545t567r640b613],
5	survival	NN	O	survival	dep	110	SENT_10	[p1l660t567r868b613],
6	of	IN	O	of	dep	110	SENT_10	[p1l888t567r942b613],
7	DNA	NN	MISC	dna	dep	110	SENT_10	[p1l955t569r1076b612],
8	repair	NN	O	repair	dep	110	SENT_10	[p1l1093t568r1251b624],
9	single	JJ	O	single	dep	110	SENT_10	[p1l1268t567r1422b624],
10	nucleotide	NN	O	nucleotide	dep	110	SENT_10	[p1l1441t567r1720b613],
11	polymorphisms	NNS	O	polymorphism	dep	110	SENT_10	[p1l6t629r423b686],
12	in	IN	O	in	dep	110	SENT_10	[p1l440t630r489b674],
13	relapsed	VBN	O	relapse	dep	110	SENT_10	[p1l508t629r731b686],
14	or	CC	O	or	dep	110	SENT_10	[p1l751t642r805b674],
15	refractory	JJ	O	refractory	dep	110	SENT_10	[p1l822t629r1086b686],
16	multiple	JJ	O	multiple	dep	110	SENT_10	[p1l1104t629r1328b686],
17	myeloma	NN	O	myeloma	dep	110	SENT_10	[p1l1347t629r1594b686],
18	patients	NNS	O	patient	dep	110	SENT_10	[p1l1613t630r1826b686],
19	treated	VBN	O	treat	dep	110	SENT_10	[p1l1845t629r2034b674],
20	With	IN	O	with	dep	110	SENT_10	[p1l6t691r128b736],
21	thalidomide	NN	O	thalidomide	dep	110	SENT_10	[p1l146t691r469b736],
22	Maria	NNP	PERSON	Maria	dep	110	SENT_10	[p1l483t700r603b737],
23	Teresa	NNP	PERSON	Teresa	dep	110	SENT_10	[p1l615t703r751b737],
24	Cibeiraa	NNP	PERSON	Cibeiraa	dep	110	SENT_10	[p1l765t701r945b742],
25	,	,	O	,	_	0	SENT_10	[p1l765t701r945b742],
26	Carlos	NNP	PERSON	Carlos	dep	110	SENT_10	[p1l960t701r1086b737],
27	Fernandez	NNP	PERSON	Fernandez	dep	110	SENT_10	[p1l1102t700r1317b737],
28	de	IN	PERSON	de	dep	110	SENT_10	[p1l1332t701r1380b737],
29	Larreaa	NNP	PERSON	Larreaa	dep	110	SENT_10	[p1l1395t702r1558b742],
30	,	,	O	,	_	0	SENT_10	[p1l1395t702r1558b742],
31	Alfons	NNP	PERSON	Alfons	dep	110	SENT_10	[p1l1572t701r1703b737],
32	Navarrob	NNP	PERSON	Navarrob	dep	110	SENT_10	[p1l1718t695r1921b742],
33	,	,	O	,	_	0	SENT_10	[p1l1718t695r1921b742],
34	Tania	NNP	PERSON	Tania	dep	110	SENT_10	[p1l1934t701r2048b737],
35	Diazb	NNP	PERSON	Diazb	dep	110	SENT_10	[p1l6t757r132b804],
36	,	,	O	,	_	0	SENT_10	[p1l6t757r132b804],
37	Dolors	NNP	PERSON	Dolors	dep	110	SENT_10	[p1l148t763r281b798],
38	Fusterb	NNP	PERSON	Fusterb	dep	110	SENT_10	[p1l297t757r461b804],
39	,	,	O	,	_	0	SENT_10	[p1l297t757r461b804],
40	Natalia	NNP	PERSON	Natalia	dep	110	SENT_10	[p1l475t763r622b798],
41	Tovara	NNP	PERSON	Tovara	dep	110	SENT_10	[p1l634t764r786b804],
42	,	,	O	,	_	0	SENT_10	[p1l634t764r786b804],
43	Laura	NNP	PERSON	Laura	dep	110	SENT_10	[p1l802t765r915b798],
44	Rosiﬁola	NNP	PERSON	Rosiﬁola	dep	110	SENT_10	[p1l930t763r1117b803],
45	,	,	O	,	_	0	SENT_10	[p1l930t763r1117b803],
46	Mariano	NNP	PERSON	Mariano	dep	110	SENT_10	[p1l1132t763r1305b798],
47	Monz	NNP	PERSON	Monz	dep	110	SENT_10	[p1l1320t757r1602b807],
48	<	JJR	O	<	dep	110	SENT_10	[p1l1320t757r1602b807],
49	’	CD	NUMBER	’	dep	110	SENT_10	[p1l1320t757r1602b807],
50	)	CD	NUMBER	)	dep	110	SENT_10	[p1l1320t757r1602b807],
51	"	``	O	"	dep	110	SENT_10	[p1l1320t757r1602b807],
52	,	,	O	,	_	0	SENT_10	[p1l1320t757r1602b807],
53	]	CD	NUMBER	]	dep	110	SENT_10	[p1l1320t757r1602b807],
54	oan	NN	O	oan	dep	110	SENT_10	[p1l1320t757r1602b807],
55	Bladé	NNP	O	Bladé	dep	110	SENT_10	[p1l1617t761r1730b798],
56	37	CD	NUMBER	37	dep	110	SENT_10	[p1l1738t764r1780b787],
57	*	CD	NUMBER	*	dep	110	SENT_10	[p1l1738t764r1780b787],
58	3	CD	NUMBER	3	dep	110	SENT_10	[p1l6t840r15b851],
59	Department	NNP	ORGANIZATION	Department	dep	110	SENT_10	[p1l22t840r169b866],
60	of	IN	ORGANIZATION	of	dep	110	SENT_10	[p1l176t838r202b866],
61	Hematology	NNP	ORGANIZATION	Hematology	dep	110	SENT_10	[p1l205t839r356b866],
62	,	,	O	,	_	0	SENT_10	[p1l205t839r356b866],
63	Hospital	NNP	ORGANIZATION	Hospital	dep	110	SENT_10	[p1l365t839r466b866],
64	Clinic	NNP	ORGANIZATION	Clinic	dep	110	SENT_10	[p1l474t838r545b864],
65	,	,	O	,	_	0	SENT_10	[p1l474t838r545b864],
66	Barcelona	NNP	ORGANIZATION	Barcelona	dep	110	SENT_10	[p1l554t839r679b864],
67	,	,	O	,	_	0	SENT_10	[p1l554t839r679b864],
68	Institut	NNP	O	Institut	dep	110	SENT_10	[p1l688t839r777b860],
69	d’Investigacions	NNPS	O	d’Investigacions	dep	110	SENT_10	[p1l784t839r976b866],
70	Biomédiques	NNP	O	Biomédiques	dep	110	SENT_10	[p1l984t838r1137b866],
71	August	NNP	DATE	August	dep	110	SENT_10	[p1l1143t840r1229b866],
72	Pi	NN	O	pi	dep	110	SENT_10	[p1l1236t839r1258b860],
73	I	PRP	O	I	dep	110	SENT_10	[p1l1266t840r1274b860],
74	Sunyer	VBP	O	sunyer	dep	110	SENT_10	[p1l1281t840r1366b866],
75	(	JJ	O	(	dep	110	SENT_10	[p1l1372t839r1494b866],
76	IDIBAPS	NN	O	idibap	dep	110	SENT_10	[p1l1372t839r1494b866],
77	)	NN	O	)	dep	110	SENT_10	[p1l1372t839r1494b866],
78	,	,	O	,	_	0	SENT_10	[p1l1372t839r1494b866],
79	University	NNP	ORGANIZATION	University	dep	110	SENT_10	[p1l1505t839r1627b866],
80	of	IN	ORGANIZATION	of	dep	110	SENT_10	[p1l1635t838r1661b866],
81	Barcelona	NNP	ORGANIZATION	Barcelona	dep	110	SENT_10	[p1l1664t839r1789b864],
82	,	,	O	,	_	0	SENT_10	[p1l1664t839r1789b864],
83	Barcelona	NNP	ORGANIZATION	Barcelona	dep	110	SENT_10	[p1l1798t839r1922b864],
84	,	,	O	,	_	0	SENT_10	[p1l1798t839r1922b864],
85	Spain	NNP	LOCATION	Spain	dep	110	SENT_10	[p1l1931t839r1997b866],
86	'	POS	O	'	_	0	SENT_10	[p1l2007t835r2016b850],
87	’	CD	NUMBER	’	dep	110	SENT_10	[p1l2007t835r2016b850],
88	Molecular	JJ	O	molecular	dep	110	SENT_10	[p1l2024t838r2146b860],
89	Oncology	NN	O	oncology	dep	110	SENT_10	[p1l6t874r117b901],
90	and	CC	O	and	dep	110	SENT_10	[p1l125t874r170b896],
91	Embryology	NNP	ORGANIZATION	Embryology	dep	110	SENT_10	[p1l178t874r322b901],
92	Laboratory	NNP	ORGANIZATION	Laboratory	dep	110	SENT_10	[p1l330t874r467b901],
93	,	,	O	,	_	0	SENT_10	[p1l330t874r467b901],
94	Human	NNP	O	Human	dep	110	SENT_10	[p1l476t876r565b896],
95	Anatomy	NNP	O	Anatomy	dep	110	SENT_10	[p1l572t875r683b901],
96	Unit	NNP	O	Unit	dep	110	SENT_10	[p1l692t875r747b899],
97	,	,	O	,	_	0	SENT_10	[p1l692t875r747b899],
98	School	NNP	ORGANIZATION	School	dep	110	SENT_10	[p1l756t874r834b896],
99	of	IN	ORGANIZATION	of	dep	110	SENT_10	[p1l842t874r868b901],
100	Medicine	NNP	ORGANIZATION	Medicine	dep	110	SENT_10	[p1l872t874r986b899],
101	,	,	O	,	_	0	SENT_10	[p1l872t874r986b899],
102	University	NNP	ORGANIZATION	University	dep	110	SENT_10	[p1l997t875r1119b901],
103	of	IN	ORGANIZATION	of	dep	110	SENT_10	[p1l1128t874r1154b901],
104	Barcelona	NNP	ORGANIZATION	Barcelona	dep	110	SENT_10	[p1l1157t874r1281b899],
105	,	,	O	,	_	0	SENT_10	[p1l1157t874r1281b899],
106	IDIBAPS	NNP	LOCATION	IDIBAPS	dep	110	SENT_10	[p1l1290t875r1391b899],
107	,	,	O	,	_	0	SENT_10	[p1l1290t875r1391b899],
108	Barcelona	NNP	ORGANIZATION	Barcelona	dep	110	SENT_10	[p1l1401t874r1525b899],
109	,	,	O	,	_	0	SENT_10	[p1l1401t874r1525b899],
110	Spain	NNP	LOCATION	Spain	_	0	SENT_10	[p1l1533t875r1600b901],

1	ARTICLE	NN	O	article	_	0	SENT_11	[p1l6t975r232b997],
2	INFO	NN	O	info	nn	3	SENT_11	[p1l277t975r401b997],
3	ABSTRACT	NN	O	abstract	dep	1	SENT_11	[p1l701t975r972b997],

1	Article	NNP	O	Article	nn	2	SENT_12	[p1l6t1055r85b1077],
2	history	NN	O	history	_	0	SENT_12	[p1l94t1055r185b1082],
3	:	:	O	:	_	0	SENT_12	[p1l94t1055r185b1082],
4	Single	JJ	O	single	amod	6	SENT_12	[p1l7t1108r92b1138],
5	nucleotide	NN	O	nucleotide	nn	6	SENT_12	[p1l99t1108r248b1132],
6	polymorphisms	NNS	O	polymorphism	dep	2	SENT_12	[p1l255t1108r478b1138],
7	(	VBP	O	(	rcmod	6	SENT_12	[p1l485t1108r576b1138],
8	SNPS	NN	O	snp	nn	9	SENT_12	[p1l485t1108r576b1138],
9	)	NN	O	)	dobj	7	SENT_12	[p1l485t1108r576b1138],
10	in	IN	O	in	_	0	SENT_12	[p1l584t1108r609b1132],
11	12	CD	NUMBER	12	num	12	SENT_12	[p1l618t1109r649b1132],
12	genes	NNS	O	gene	prep_in	7	SENT_12	[p1l656t1115r737b1138],
13	involving	VBG	O	involve	_	0	SENT_12	[p1l744t1108r877b1138],
14	multidrug	JJ	O	multidrug	amod	15	SENT_12	[p1l883t1108r1026b1138],
15	resistance	NN	O	resistance	prep_involving	12	SENT_12	[p1l1032t1108r1181b1136],
16	,	,	O	,	_	0	SENT_12	[p1l1032t1108r1181b1136],
17	drug	NN	O	drug	nn	19	SENT_12	[p1l1188t1108r1253b1138],
18	metabolic	JJ	O	metabolic	amod	19	SENT_12	[p1l1260t1108r1400b1132],
19	pathReceived	NN	O	pathreceived	appos	15	SENT_12	[p1l1406t1108r1482b1138, p1l7t1142r118b1164],
20	22	CD	DATE	22	num	21	SENT_12	[p1l127t1143r157b1163],
21	November	NNP	DATE	November	nsubj	31	SENT_12	[p1l167t1142r298b1164],
22	2010	CD	DATE	2010	num	21	SENT_12	[p1l306t1143r368b1164],
23	Received	VBN	O	receive	partmod	21	SENT_12	[p1l7t1178r118b1199],
24	in	IN	O	in	_	0	SENT_12	[p1l128t1178r151b1199],
25	revised	JJ	O	revised	amod	26	SENT_12	[p1l159t1178r250b1199],
26	form	NN	O	form	prep_in	23	SENT_12	[p1l259t1178r319b1199],
27	2	CD	DATE	2	dep	26	SENT_12	[p1l327t1179r341b1199],
28	February	NNP	DATE	February	tmod	23	SENT_12	[p1l350t1178r462b1205],
29	2011	CD	DATE	2011	num	28	SENT_12	[p1l470t1179r529b1199],
30	Accepted	JJ	O	accepted	amod	31	SENT_12	[p1l6t1213r122b1240],
31	8	CD	DATE	8	rcmod	19	SENT_12	[p1l131t1215r144b1235],
32	February	NNP	DATE	February	dobj	31	SENT_12	[p1l154t1213r266b1240],
33	201	CD	NUMBER	201	num	32	SENT_12	[p1l274t1215r317b1235],
34	1	CD	NUMBER	1	number	35	SENT_12	[p1l323t1215r333b1235],
35	Available	JJ	O	available	amod	32	SENT_12	[p1l6t1249r122b1271],
36	online	NN	O	online	prep	31	SENT_12	[p1l131t1249r209b1271],
37	23	CD	DATE	23	dep	36	SENT_12	[p1l218t1250r247b1271],
38	March	NNP	DATE	March	tmod	7	SENT_12	[p1l257t1249r337b1271],
39	2011	CD	DATE	2011	num	38	SENT_12	[p1l345t1250r404b1271],

1	ways	NNS	O	way	nn	5	SENT_13	[p1l6t1373r85b1396],
2	,	,	O	,	_	0	SENT_13	[p1l6t1373r85b1396],
3	DNA	NN	O	dna	conj_and	5	SENT_13	[p1l94t1367r159b1390],
4	repair	NN	O	repair	nn	5	SENT_13	[p1l166t1367r250b1396],
5	systems	NNS	O	system	nsubjpass	9	SENT_13	[p1l258t1370r371b1396],
6	and	CC	O	and	_	0	SENT_13	[p1l379t1366r430b1390],
7	cytokines	NNS	O	cytokine	conj_and	5	SENT_13	[p1l439t1366r573b1396],
8	were	VBD	O	be	auxpass	9	SENT_13	[p1l581t1373r652b1390],
9	examined	VBN	O	examine	dep	29	SENT_13	[p1l660t1366r800b1390],
10	in	IN	O	in	_	0	SENT_13	[p1l808t1367r835b1390],
11	28	CD	NUMBER	28	num	12	SENT_13	[p1l842t1367r876b1390],
12	patients	NNS	O	patient	prep_in	9	SENT_13	[p1l885t1367r999b1396],
13	with	IN	O	with	_	0	SENT_13	[p1l1007t1366r1072b1390],
14	relapsed/refractory	JJ	O	relapsed/refractory	amod	16	SENT_13	[p1l1080t1366r1353b1396],
15	multiple	JJ	O	multiple	amod	16	SENT_13	[p1l1361t1366r1481b1396],
16	myeloma	NN	O	myeloma	prep_with	12	SENT_13	[p1l7t1406r139b1436],
17	(	CD	NUMBER	(	num	19	SENT_13	[p1l146t1406r225b1436],
18	MM	NN	O	mm	nn	19	SENT_13	[p1l146t1406r225b1436],
19	)	NN	O	)	dobj	9	SENT_13	[p1l146t1406r225b1436],
20	treated	VBN	O	treat	partmod	19	SENT_13	[p1l232t1406r334b1430],
21	with	IN	O	with	_	0	SENT_13	[p1l341t1406r406b1430],
22	single	JJ	O	single	amod	24	SENT_13	[p1l414t1406r496b1436],
23	agent	NN	O	agent	nn	24	SENT_13	[p1l503t1410r582b1436],
24	thalidomide	NN	O	thalidomide	prep_with	20	SENT_13	[p1l588t1406r761b1430],
25	and	CC	O	and	_	0	SENT_13	[p1l768t1406r820b1430],
26	the	DT	O	the	det	27	SENT_13	[p1l827t1406r872b1430],
27	results	NNS	O	result	conj_and	24	SENT_13	[p1l880t1406r973b1430],
28	were	VBD	O	be	auxpass	29	SENT_13	[p1l981t1413r1051b1430],
29	correlated	VBN	O	correlate	_	0	SENT_13	[p1l1059t1406r1203b1430],
30	with	IN	O	with	_	0	SENT_13	[p1l1210t1406r1275b1430],
31	response	NN	O	response	prep_with	29	SENT_13	[p1l1283t1413r1416b1436],
32	,	,	O	,	_	0	SENT_13	[p1l1283t1413r1416b1436],
33	toxicity	NN	O	toxicity	prep_with	29	SENT_13	[p1l1423t1410r1481b1430, p1l7t1446r67b1476],
34	and	CC	O	and	_	0	SENT_13	[p1l77t1446r128b1470],
35	overall	JJ	O	overall	amod	36	SENT_13	[p1l139t1446r235b1470],
36	survival	NN	O	survival	prep_with	29	SENT_13	[p1l246t1446r357b1470],
37	(	CD	NUMBER	(	num	39	SENT_13	[p1l368t1446r434b1476],
38	OS	NN	O	os	nn	39	SENT_13	[p1l368t1446r434b1476],
39	)	NN	O	)	nsubjpass	29	SENT_13	[p1l368t1446r434b1476],
40	.	.	O	.	_	0	SENT_13	[p1l368t1446r434b1476],

1	The	DT	O	the	det	3	SENT_14	[p1l444t1446r495b1470],
2	response	NN	O	response	nn	3	SENT_14	[p1l506t1453r632b1476],
3	rate	NN	O	rate	nsubj	16	SENT_14	[p1l642t1449r697b1470],
4	was	VBD	O	be	cop	16	SENT_14	[p1l707t1453r761b1470],
5	higher	JJR	O	higher	advmod	16	SENT_14	[p1l773t1446r864b1476],
6	in	IN	O	in	_	0	SENT_14	[p1l874t1446r900b1470],
7	patients	NNS	O	patient	prep_in	5	SENT_14	[p1l910t1446r1024b1476],
8	with	IN	O	with	_	0	SENT_14	[p1l1034t1446r1099b1470],
9	SNPs	NNS	O	snp	prep_with	7	SENT_14	[p1l1110t1447r1178b1470],
10	in	IN	O	in	_	0	SENT_14	[p1l1189t1446r1215b1470],
11	ERCC1	NN	O	ercc1	prep_in	9	SENT_14	[p1l1225t1447r1311b1470],
12	(	CD	NUMBER	(	num	11	SENT_14	[p1l1325t1446r1481b1476],
13	rs735482	NN	O	rs735482	nn	16	SENT_14	[p1l1325t1446r1481b1476],
14	)	CD	NUMBER	)	num	16	SENT_14	[p1l1325t1446r1481b1476],
15	(	NN	O	(	nn	16	SENT_14	[p1l7t1486r33b1516],
16	p	NN	O	p	_	0	SENT_14	[p1l7t1486r33b1516],
17	=	JJ	O	=	amod	19	SENT_14	[p1l40t1496r55b1503],
18	0.006	CD	NUMBER	0.006	tmod	17	SENT_14	[p1l62t1486r158b1516],
19	)	NN	O	)	dep	16	SENT_14	[p1l62t1486r158b1516],
20	,	,	O	,	_	0	SENT_14	[p1l62t1486r158b1516],
21	ERCC5	NN	O	ercc5	conj_or	16	SENT_14	[p1l169t1487r258b1510],
22	(	CD	NUMBER	(	num	21	SENT_14	[p1l269t1486r406b1516],
23	rs17655	NN	O	rs17655	nn	26	SENT_14	[p1l269t1486r406b1516],
24	)	CD	NUMBER	)	num	26	SENT_14	[p1l269t1486r406b1516],
25	(	NN	O	(	nn	26	SENT_14	[p1l417t1486r443b1516],
26	p	NN	O	p	dep	21	SENT_14	[p1l417t1486r443b1516],
27	=	JJ	O	=	amod	26	SENT_14	[p1l451t1496r465b1503],
28	0.04	CD	NUMBER	0.04	number	29	SENT_14	[p1l473t1486r543b1516],
29	)	CD	NUMBER	)	dep	27	SENT_14	[p1l473t1486r543b1516],
30	or	CC	O	or	_	0	SENT_14	[p1l554t1493r583b1510],
31	XRCC5	CD	NUMBER	xrcc5	number	32	SENT_14	[p1l591t1487r685b1510],
32	(	CD	NUMBER	(	conj_or	16	SENT_14	[p1l696t1486r869b1516],
33	rs1051685	NN	O	rs1051685	nn	36	SENT_14	[p1l696t1486r869b1516],
34	)	CD	NUMBER	)	num	36	SENT_14	[p1l696t1486r869b1516],
35	(	NN	O	(	nn	36	SENT_14	[p1l880t1486r906b1516],
36	p	NN	O	p	dep	32	SENT_14	[p1l880t1486r906b1516],
37	=	JJ	O	=	advmod	16	SENT_14	[p1l914t1496r928b1503],
38	0.013	CD	NUMBER	0.013	num	39	SENT_14	[p1l936t1486r1031b1516],
39	)	NN	O	)	dep	37	SENT_14	[p1l936t1486r1031b1516],
40	.	.	O	.	_	0	SENT_14	[p1l936t1486r1031b1516],

1	Longer	JJR	O	longer	amod	2	SENT_15	[p1l1042t1487r1139b1516],
2	OS	NN	O	os	nsubjpass	4	SENT_15	[p1l1148t1487r1184b1510],
3	was	VBD	O	be	auxpass	4	SENT_15	[p1l1194t1493r1249b1510],
4	associated	VBN	O	associate	_	0	SENT_15	[p1l1260t1486r1406b1510],
5	with	IN	O	with	_	0	SENT_15	[p1l1416t1486r1481b1510],
6	Keywords	NNPS	O	Keywords	prep_with	4	SENT_15	[p1l6t1541r132b1568],
7	:	:	O	:	_	0	SENT_15	[p1l6t1541r132b1568],
8	Myeloma	NNP	O	Myeloma	nn	9	SENT_15	[p1l7t1577r124b1604],
9	Thalidomide	NNP	O	Thalidomide	dep	21	SENT_15	[p1l6t1613r165b1634],
10	the	DT	O	the	det	11	SENT_15	[p1l6t1684r51b1708],
11	SNP	NN	ORGANIZATION	snp	dep	9	SENT_15	[p1l65t1685r120b1708],
12	in	IN	O	in	_	0	SENT_15	[p1l134t1684r160b1708],
13	ERCC1	NN	O	ercc1	nn	15	SENT_15	[p1l175t1685r261b1708],
14	(	CD	NUMBER	(	num	15	SENT_15	[p1l279t1684r434b1714],
15	rs735482	NN	O	rs735482	prep_in	11	SENT_15	[p1l279t1684r434b1714],
16	)	CD	NUMBER	)	num	15	SENT_15	[p1l279t1684r434b1714],
17	(	NN	O	(	nn	18	SENT_15	[p1l449t1684r593b1714],
18	p	NN	O	p	dep	21	SENT_15	[p1l449t1684r593b1714],
19	=	JJ	O	=	amod	21	SENT_15	[p1l449t1684r593b1714],
20	0.005	CD	NUMBER	0.005	tmod	19	SENT_15	[p1l449t1684r593b1714],
21	)	NN	O	)	dep	31	SENT_15	[p1l449t1684r593b1714],
22	and	CC	O	and	_	0	SENT_15	[p1l607t1684r658b1708],
23	XRCC5	NN	O	xrcc5	conj_and	21	SENT_15	[p1l672t1685r765b1708],
24	(	CD	NUMBER	(	num	23	SENT_15	[p1l780t1684r954b1714],
25	rs1051685	NN	O	rs1051685	nn	28	SENT_15	[p1l780t1684r954b1714],
26	)	CD	NUMBER	)	num	28	SENT_15	[p1l780t1684r954b1714],
27	(	NN	O	(	nn	28	SENT_15	[p1l968t1684r1102b1714],
28	p	NN	O	p	dep	23	SENT_15	[p1l968t1684r1102b1714],
29	=	JJ	O	=	amod	23	SENT_15	[p1l968t1684r1102b1714],
30	0.02	CD	NUMBER	0.02	num	31	SENT_15	[p1l968t1684r1102b1714],
31	)	NN	O	)	dep	4	SENT_15	[p1l968t1684r1102b1714],
32	.	.	O	.	_	0	SENT_15	[p1l968t1684r1102b1714],

1	Finally	RB	O	finally	advmod	10	SENT_16	[p1l1116t1684r1217b1714],
2	,	,	O	,	_	0	SENT_16	[p1l1116t1684r1217b1714],
3	polymorphism	NN	O	polymorphism	nsubjpass	10	SENT_16	[p1l1232t1684r1441b1714],
4	in	IN	O	in	_	0	SENT_16	[p1l1455t1684r1481b1708],
5	GSTT1	NN	O	gstt1	nn	8	SENT_16	[p1l6t1725r91b1748],
6	(	CD	NUMBER	(	num	8	SENT_16	[p1l107t1724r226b1754],
7	rs4630	NN	O	rs4630	nn	8	SENT_16	[p1l107t1724r226b1754],
8	)	NN	O	)	prep_in	3	SENT_16	[p1l107t1724r226b1754],
9	was	VBD	O	be	auxpass	10	SENT_16	[p1l237t1731r292b1748],
10	associated	VBN	O	associate	_	0	SENT_16	[p1l304t1724r450b1748],
11	with	IN	O	with	_	0	SENT_16	[p1l461t1724r526b1748],
12	a	DT	O	a	det	14	SENT_16	[p1l538t1731r552b1748],
13	lower	JJR	O	lower	amod	14	SENT_16	[p1l564t1724r645b1748],
14	frequency	NN	O	frequency	prep_with	10	SENT_16	[p1l656t1724r798b1754],
15	of	IN	O	of	_	0	SENT_16	[p1l809t1724r838b1748],
16	thalidomide-induced	JJ	O	thalidomide-induced	amod	19	SENT_16	[p1l846t1724r1146b1748],
17	peripheral	JJ	O	peripheral	amod	19	SENT_16	[p1l1158t1724r1305b1754],
18	neuropathy	NN	O	neuropathy	nn	19	SENT_16	[p1l1317t1724r1482b1754],
19	SNP	NN	O	snp	prep_of	14	SENT_16	[p1l1492t1737r1541b1757],
20	(	CD	NUMBER	(	number	21	SENT_16	[p1l6t1764r199b1843],
21	(	CD	NUMBER	(	num	22	SENT_16	[p1l6t1764r199b1843],
22	lé3	NN	O	lé3	npadvmod	23	SENT_16	[p1l6t1764r199b1843],
23	=	JJ	O	=	amod	24	SENT_16	[p1l6t1764r199b1843],
24	020i	NNS	O	020us	nsubj	25	SENT_16	[p1l6t1764r199b1843],
25	)	VBP	O	)	rcmod	19	SENT_16	[p1l6t1764r199b1843],
26	l11	NN	O	l11	nn	28	SENT_16	[p1l6t1764r199b1843],
27	Elsevier	NNP	ORGANIZATION	Elsevier	nn	28	SENT_16	[p1l225t1797r442b1843],
28	Ltd.	NNP	ORGANIZATION	Ltd.	dobj	25	SENT_16	[p1l460t1797r557b1844],
29	.	.	O	.	_	0	SENT_16	[p1l460t1797r557b1844],

1	All	DT	O	all	det	2	SENT_17	[p1l575t1797r649b1843],
2	rights	NNS	O	rights	nsubj	3	SENT_17	[p1l670t1797r826b1855],
3	reserved	VBN	O	reserve	_	0	SENT_17	[p1l847t1797r1097b1844],
4	.	.	O	.	_	0	SENT_17	[p1l847t1797r1097b1844],

1	DNA	NN	O	dna	nn	2	SENT_18	[p1l9t1884r121b1924],
2	repair	NN	O	repair	_	0	SENT_18	[p1l136t1883r283b1935],
3	Survival	NNP	O	Survival	nn	4	SENT_18	[p1l9t1951r206b1992],
4	Response	NNP	O	Response	dep	2	SENT_18	[p1l9t2023r238b2073],

1	1	LS	NUMBER	1	_	0	SENT_19	[p1l10t2302r61b2352],
2	.	.	O	.	_	0	SENT_19	[p1l10t2302r61b2352],

1	Introduction	NN	O	introduction	_	0	SENT_20	[p1l105t2299r520b2351],

1	Thalidomide	NNP	O	Thalidomide	nsubj	4	SENT_21	[p1l103t2469r491b2521],
2	was	VBD	O	be	cop	4	SENT_21	[p1l525t2484r644b2521],
3	the	DT	O	the	det	4	SENT_21	[p1l679t2469r776b2521],
4	ﬁrst	NN	O	ﬁrst	_	0	SENT_21	[p1l811t2469r932b2521],
5	of	IN	O	of	_	0	SENT_21	[p1l966t2469r1029b2521],
6	the	DT	O	the	det	9	SENT_21	[p1l1056t2469r1153b2521],
7	so-called	JJ	O	so-called	amod	9	SENT_21	[p1l1189t2469r1462b2521],
8	new	JJ	O	new	amod	9	SENT_21	[p1l1498t2484r1628b2521],
9	drugs	NNS	O	drug	prep_of	4	SENT_21	[p1l1661t2469r1830b2534],
10	incorporated	VBN	O	incorporate	partmod	9	SENT_21	[p1l1867t2470r2048b2521, p1l10t2553r246b2617],
11	in	IN	O	in	_	0	SENT_21	[p1l277t2553r333b2604],
12	the	DT	O	the	det	13	SENT_21	[p1l362t2553r459b2604],
13	treatment	NN	O	treatment	prep_in	10	SENT_21	[p1l488t2560r798b2604],
14	of	IN	O	of	_	0	SENT_21	[p1l826t2552r890b2604],
15	multiple	JJ	O	multiple	amod	16	SENT_21	[p1l913t2553r1171b2617],
16	myeloma	NN	O	myeloma	prep_of	13	SENT_21	[p1l1202t2553r1487b2617],
17	(	CD	NUMBER	(	num	19	SENT_21	[p1l1517t2553r1688b2617],
18	MM	NN	O	mm	nn	19	SENT_21	[p1l1517t2553r1688b2617],
19	)	NN	O	)	dep	16	SENT_21	[p1l1517t2553r1688b2617],
20	[	CD	NUMBER	[	number	21	SENT_21	[p1l1721t2552r1894b2617],
21	1	CD	NUMBER	1	num	22	SENT_21	[p1l1721t2552r1894b2617],
22	—	NN	O	—	dep	19	SENT_21	[p1l1721t2552r1894b2617],
23	3	CD	NUMBER	3	num	24	SENT_21	[p1l1721t2552r1894b2617],
24	]	NN	O	]	dep	19	SENT_21	[p1l1721t2552r1894b2617],
25	.	.	O	.	_	0	SENT_21	[p1l1721t2552r1894b2617],

1	This	DT	O	this	det	2	SENT_22	[p1l1922t2553r2047b2604],
2	compound	NN	O	compound	nsubj	12	SENT_22	[p1l9t2636r337b2700],
3	was	VBD	O	be	auxpass	5	SENT_22	[p1l352t2651r471b2688],
4	initially	RB	O	initially	advmod	5	SENT_22	[p1l489t2636r724b2700],
5	used	VBN	O	use	_	0	SENT_22	[p1l739t2636r880b2688],
6	in	IN	O	in	_	0	SENT_22	[p1l897t2637r953b2687],
7	Europe	NNP	LOCATION	Europe	prep_in	5	SENT_22	[p1l970t2639r1184b2700],
8	as	IN	O	as	_	0	SENT_22	[p1l1201t2651r1260b2688],
9	a	DT	O	a	det	10	SENT_22	[p1l1277t2651r1308b2688],
10	sedative	NN	O	sedative	prep_as	5	SENT_22	[p1l1325t2636r1577b2688],
11	and	CC	O	and	_	0	SENT_22	[p1l1593t2636r1704b2688],
12	antiemetic	JJ	O	antiemetic	conj_and	5	SENT_22	[p1l1721t2637r2049b2688],
13	for	IN	O	for	_	0	SENT_22	[p1l10t2718r95b2770],
14	emesis	NN	O	emesis	nn	15	SENT_22	[p1l113t2719r321b2770],
15	gravidarum	NN	O	gravidarum	prep_for	12	SENT_22	[p1l341t2718r714b2783],
16	.	.	O	.	_	0	SENT_22	[p1l341t2718r714b2783],

1	It	PRP	O	it	nsubjpass	3	SENT_23	[p1l736t2721r778b2770],
2	was	VBD	O	be	auxpass	3	SENT_23	[p1l796t2733r915b2770],
3	withdrawn	VBN	O	withdraw	_	0	SENT_23	[p1l935t2718r1277b2770],
4	from	IN	O	from	_	0	SENT_23	[p1l1298t2718r1444b2770],
5	the	DT	O	the	det	6	SENT_23	[p1l1463t2718r1560b2770],
6	market	NN	O	market	prep_from	3	SENT_23	[p1l1582t2718r1801b2770],
7	in	IN	O	in	_	0	SENT_23	[p1l1821t2719r1877b2769],
8	1961	CD	DATE	1961	prep_in	6	SENT_23	[p1l1900t2721r2040b2770],
9	because	IN	O	because	_	0	SENT_23	[p1l9t2801r252b2853],
10	of	IN	O	of	_	0	SENT_23	[p1l282t2801r345b2853],
11	reports	NNS	O	report	prep_because_of	3	SENT_23	[p1l367t2809r585b2866],
12	of	IN	O	of	_	0	SENT_23	[p1l616t2801r679b2853],
13	congenital	JJ	O	congenital	amod	14	SENT_23	[p1l701t2801r1020b2866],
14	defects	NNS	O	defect	prep_of	11	SENT_23	[p1l1050t2801r1265b2853],
15	when	WRB	O	when	advmod	16	SENT_23	[p1l1294t2801r1466b2853],
16	taken	VBN	O	take	advcl	3	SENT_23	[p1l1494t2801r1664b2853],
17	during	IN	O	during	_	0	SENT_23	[p1l1693t2801r1896b2866],
18	gestation	NN	O	gestation	prep_during	16	SENT_23	[p1l1922t2816r2048b2866, p1l9t2885r204b2937],
19	.	.	O	.	_	0	SENT_23	[p1l1922t2816r2048b2866, p1l9t2885r204b2937],

1	It	PRP	O	it	nsubjpass	4	SENT_24	[p1l235t2888r277b2936],
2	was	VBD	O	be	auxpass	4	SENT_24	[p1l304t2899r423b2936],
3	not	RB	O	not	neg	4	SENT_24	[p1l454t2892r554b2936],
4	used	VBN	O	use	_	0	SENT_24	[p1l583t2884r724b2936],
5	to	TO	O	to	aux	6	SENT_24	[p1l754t2892r812b2936],
6	treat	VB	O	treat	xcomp	4	SENT_24	[p1l842t2892r987b2936],
7	patients	NNS	O	patient	dobj	6	SENT_24	[p1l1016t2885r1262b2949],
8	with	IN	O	with	_	0	SENT_24	[p1l1291t2884r1433b2936],
9	MM	NN	O	mm	prep_with	6	SENT_24	[p1l1462t2887r1583b2936],
10	until	IN	O	until	_	0	SENT_24	[p1l1613t2884r1754b2936],
11	14	CD	DATE	14	num	12	SENT_24	[p1l1788t2887r1859b2935],
12	years	NNS	DATE	year	prep_until	6	SENT_24	[p1l1887t2899r2047b2949],
13	ago	IN	DATE	ago	advmod	6	SENT_24	[p1l9t2982r114b3032],
14	[	CD	NUMBER	[	number	15	SENT_24	[p1l144t2967r239b3032],
15	1	CD	NUMBER	1	num	16	SENT_24	[p1l144t2967r239b3032],
16	]	NN	O	]	pobj	13	SENT_24	[p1l144t2967r239b3032],
17	.	.	O	.	_	0	SENT_24	[p1l144t2967r239b3032],

1	Thalidomide	NNP	O	Thalidomide	nsubj	2	SENT_25	[p1l264t2967r652b3019],
2	has	VBZ	O	have	_	0	SENT_25	[p1l680t2967r779b3019],
3	antiangiogenic	JJ	O	antiangiogenic	amod	6	SENT_25	[p1l807t2968r1260b3032],
4	and	CC	O	and	_	0	SENT_25	[p1l1286t2967r1397b3019],
5	immunomodulatory	JJ	O	immunomodulatory	amod	6	SENT_25	[p1l1425t2967r2050b3032],
6	activity	NN	O	activity	dobj	2	SENT_25	[p1l9t3051r237b3115],
7	[	CD	NUMBER	[	number	8	SENT_25	[p1l276t3050r425b3115],
8	4,5	CD	NUMBER	4,5	num	9	SENT_25	[p1l276t3050r425b3115],
9	]	NN	O	]	dobj	2	SENT_25	[p1l276t3050r425b3115],
10	.	.	O	.	_	0	SENT_25	[p1l276t3050r425b3115],

1	However	RB	O	however	advmod	12	SENT_26	[p1l463t3054r741b3102],
2	the	DT	O	the	det	4	SENT_26	[p1l775t3051r872b3102],
3	precise	JJ	O	precise	amod	4	SENT_26	[p1l909t3051r1125b3115],
4	mechanisms	NNS	O	mechanism	nsubjpass	12	SENT_26	[p1l1162t3051r1545b3102],
5	of	IN	O	of	_	0	SENT_26	[p1l1583t3050r1646b3102],
6	thalidomide	NN	O	thalidomide	nn	8	SENT_26	[p1l1675t3051r2048b3102],
7	antimyeloma	NN	O	antimyeloma	nn	8	SENT_26	[p1l9t3134r416b3198],
8	activity	NN	O	activity	prep_of	4	SENT_26	[p1l460t3135r689b3198],
9	are	VBP	O	be	auxpass	12	SENT_26	[p1l732t3149r825b3186],
10	not	RB	O	not	neg	12	SENT_26	[p1l870t3142r971b3186],
11	well	RB	O	well	advmod	12	SENT_26	[p1l1012t3134r1142b3186],
12	known	VBN	O	know	_	0	SENT_26	[p1l1188t3134r1398b3186],
13	and	CC	O	and	_	0	SENT_26	[p1l1442t3134r1553b3186],
14	the	DT	O	the	det	16	SENT_26	[p1l1597t3134r1694b3186],
15	individual	JJ	O	individual	amod	16	SENT_26	[p1l1740t3134r2048b3186],
16	response	NN	O	response	nsubj	22	SENT_26	[p1l10t3231r282b3281],
17	to	TO	O	to	_	0	SENT_26	[p1l321t3224r379b3268],
18	this	DT	O	this	det	19	SENT_26	[p1l418t3216r529b3268],
19	drug	NN	O	drug	prep_to	16	SENT_26	[p1l569t3216r710b3281],
20	is	VBZ	O	be	cop	22	SENT_26	[p1l748t3217r792b3268],
21	highly	RB	O	highly	advmod	22	SENT_26	[p1l833t3216r1024b3281],
22	variable	JJ	O	variable	conj_and	12	SENT_26	[p1l1060t3216r1321b3268],
23	.	.	O	.	_	0	SENT_26	[p1l1060t3216r1321b3268],

1	In	IN	O	in	_	0	SENT_27	[p1l1361t3219r1418b3267],
2	the	DT	O	the	det	4	SENT_27	[p1l1456t3216r1552b3268],
3	present	JJ	DATE	present	amod	4	SENT_27	[p1l1592t3224r1823b3281],
4	era	NN	O	era	prep_in	11	SENT_27	[p1l1860t3231r1954b3268],
5	of	IN	O	of	_	0	SENT_27	[p1l1993t3216r2056b3268],
6	emerging	VBG	O	emerge	amod	8	SENT_27	[p1l9t3300r301b3364],
7	novel	JJ	O	novel	amod	8	SENT_27	[p1l342t3299r508b3351],
8	agents	NNS	O	agent	prep_of	4	SENT_27	[p1l551t3307r764b3364],
9	,	,	O	,	_	0	SENT_27	[p1l551t3307r764b3364],
10	there	EX	O	there	expl	11	SENT_27	[p1l807t3299r967b3351],
11	is	VBZ	O	be	_	0	SENT_27	[p1l1010t3300r1054b3351],
12	a	DT	O	a	det	14	SENT_27	[p1l1098t3314r1128b3351],
13	real	JJ	O	real	amod	14	SENT_27	[p1l1172t3299r1284b3351],
14	need	NN	O	need	nsubj	11	SENT_27	[p1l1328t3299r1473b3351],
15	for	IN	O	for	_	0	SENT_27	[p1l1517t3299r1602b3351],
16	an	DT	O	a	det	18	SENT_27	[p1l1643t3314r1714b3351],
17	increased	VBN	O	increase	amod	18	SENT_27	[p1l1757t3299r2048b3351],
18	knowledge	NN	O	knowledge	prep_for	14	SENT_27	[p1l10t3382r346b3447],
19	about	IN	O	about	_	0	SENT_27	[p1l381t3382r556b3434],
20	the	DT	O	the	det	23	SENT_27	[p1l589t3382r685b3434],
21	pre	JJ	O	pre	amod	23	SENT_27	[p1l721t3390r1160b3447],
22	—	NN	O	—	nn	23	SENT_27	[p1l721t3390r1160b3447],
23	treatment	NN	O	treatment	prep_about	11	SENT_27	[p1l721t3390r1160b3447],
24	constitutive	JJ	O	constitutive	amod	26	SENT_27	[p1l1194t3383r1558b3434],
25	genetic	JJ	O	genetic	amod	26	SENT_27	[p1l1592t3383r1815b3447],
26	proﬁle	NN	O	proﬁle	tmod	11	SENT_27	[p1l1850t3382r2048b3447],
27	of	IN	O	of	_	0	SENT_27	[p1l9t3465r73b3517],
28	patients	NNS	O	patient	prep_of	26	SENT_27	[p1l95t3466r341b3530],
29	who	WP	O	who	nsubj	32	SENT_27	[p1l369t3465r502b3517],
30	will	MD	O	will	aux	32	SENT_27	[p1l530t3465r645b3517],
31	potentially	RB	O	potentially	advmod	32	SENT_27	[p1l675t3465r1009b3530],
32	beneﬁt	VB	O	beneﬁt	rcmod	26	SENT_27	[p1l1036t3465r1251b3517],
33	from	IN	O	from	_	0	SENT_27	[p1l1279t3465r1425b3517],
34	a	DT	O	a	det	36	SENT_27	[p1l1454t3480r1485b3517],
35	certain	JJ	O	certain	amod	36	SENT_27	[p1l1513t3466r1725b3517],
36	drug	NN	O	drug	prep_from	32	SENT_27	[p1l1754t3465r1909b3530],
37	.	.	O	.	_	0	SENT_27	[p1l1754t3465r1909b3530],

1	The	DT	O	the	det	2	SENT_28	[p1l1936t3465r2048b3517],
2	analysis	NN	O	analysis	nsubj	15	SENT_28	[p1l9t3549r252b3613],
3	of	IN	O	of	_	0	SENT_28	[p1l282t3548r345b3600],
4	polymorphisms	NNS	O	polymorphism	prep_of	2	SENT_28	[p1l367t3549r849b3613],
5	in	IN	O	in	_	0	SENT_28	[p1l879t3549r936b3600],
6	drug	NN	O	drug	nn	8	SENT_28	[p1l965t3549r1106b3613],
7	metabolism	NN	O	metabolism	nn	8	SENT_28	[p1l1134t3549r1497b3600],
8	pathways	NNS	O	pathway	prep_in	4	SENT_28	[p1l1527t3549r1822b3613],
9	and	CC	O	and	_	0	SENT_28	[p1l1852t3549r1962b3600],
10	in	IN	O	in	_	0	SENT_28	[p1l1993t3549r2049b3600],
11	immune	JJ	O	immune	amod	13	SENT_28	[p1l10t3633r266b3684],
12	system	NN	O	system	nn	13	SENT_28	[p1l292t3640r507b3696],
13	genes	NNS	O	gene	prep_in	4	SENT_28	[p1l531t3647r705b3696],
14	can	MD	O	can	aux	15	SENT_28	[p1l731t3647r835b3684],
15	help	VB	O	help	_	0	SENT_28	[p1l860t3632r991b3696],
16	to	TO	O	to	aux	17	SENT_28	[p1l1016t3640r1075b3684],
17	identify	VB	O	identify	xcomp	15	SENT_28	[p1l1101t3632r1339b3696],
18	patients	NNS	O	patient	dobj	17	SENT_28	[p1l1363t3633r1609b3696],
19	with	IN	O	with	_	0	SENT_28	[p1l1633t3632r1775b3684],
20	possible	JJ	O	possible	amod	23	SENT_28	[p1l1800t3632r2048b3696],
21	different	JJ	O	different	amod	23	SENT_28	[p1l9t3714r275b3766],
22	treatment	NN	O	treatment	nn	23	SENT_28	[p1l303t3722r613b3766],
23	response	NN	O	response	prep_with	17	SENT_28	[p1l642t3729r914b3779],
24	and	CC	O	and	_	0	SENT_28	[p1l944t3714r1055b3766],
25	outcome	NN	O	outcome	prep_with	17	SENT_28	[p1l1085t3722r1352b3766],
26	[	CD	NUMBER	[	number	27	SENT_28	[p1l1386t3714r1480b3779],
27	6	CD	NUMBER	6	num	28	SENT_28	[p1l1386t3714r1480b3779],
28	]	NN	O	]	dep	25	SENT_28	[p1l1386t3714r1480b3779],
29	.	.	O	.	_	0	SENT_28	[p1l1386t3714r1480b3779],

1	Single	JJ	O	single	amod	3	SENT_29	[p1l1511t3714r1695b3779],
2	nucleotide	NN	O	nucleotide	nn	3	SENT_29	[p1l1726t3714r2048b3766],
3	polymorphisms	NNS	O	polymorphism	nsubj	4	SENT_29	[p2l10t16r491b81],
4	(	VBP	O	(	_	0	SENT_29	[p2l530t16r728b80],
5	SNPs	NNS	O	snp	dobj	4	SENT_29	[p2l530t16r728b80],
6	)	CD	NUMBER	)	nsubjpass	17	SENT_29	[p2l530t16r728b80],
7	are	VBP	O	be	cop	11	SENT_29	[p2l766t31r859b68],
8	the	DT	O	the	det	11	SENT_29	[p2l897t16r994b68],
9	most	RBS	O	most	advmod	10	SENT_29	[p2l1033t24r1185b68],
10	frequent	JJ	O	frequent	amod	11	SENT_29	[p2l1222t16r1485b81],
11	type	NN	O	type	rcmod	5	SENT_29	[p2l1521t24r1655b81],
12	of	IN	O	of	_	0	SENT_29	[p2l1693t16r1756b68],
13	genomic	JJ	O	genomic	amod	14	SENT_29	[p2l1786t17r2049b81],
14	polymorphisms	NNS	O	polymorphism	prep_of	11	SENT_29	[p2l10t99r491b164],
15	and	CC	O	and	_	0	SENT_29	[p2l517t99r627b151],
16	are	VBP	O	be	auxpass	17	SENT_29	[p2l653t114r746b151],
17	involved	VBN	O	involve	rcmod	5	SENT_29	[p2l771t99r1034b151],
18	in	IN	O	in	_	0	SENT_29	[p2l1060t100r1116b151],
19	response	NN	O	response	prep_in	17	SENT_29	[p2l1141t114r1413b164],
20	to	TO	O	to	_	0	SENT_29	[p2l1438t107r1496b151],
21	chemotherapy	NN	O	chemotherapy	prep_to	17	SENT_29	[p2l1522t99r1969b164],
22	in	IN	O	in	prep	17	SENT_29	[p2l1993t100r2049b151],

1	*	NN	O	*	_	0	SENT_30	[p2l55t347r77b371],
2	Corresponding	VBG	O	correspond	partmod	1	SENT_30	[p2l106t346r468b399],
3	author	NN	O	author	dobj	2	SENT_30	[p2l490t346r655b388],
4	at	IN	O	at	prep	2	SENT_30	[p2l676t353r736b388],
5	:	:	O	:	_	0	SENT_30	[p2l676t353r736b388],
6	Servei	FW	O	servei	nn	7	SENT_30	[p2l763t347r911b388],
7	d’Hematologia	FW	O	d’hematologia	dep	1	SENT_30	[p2l935t346r1305b399],
8	,	,	O	,	_	0	SENT_30	[p2l935t346r1305b399],
9	Hospital	NNP	ORGANIZATION	Hospital	nn	12	SENT_30	[p2l1330t346r1533b399],
10	Clinic	NNP	ORGANIZATION	Clinic	nn	12	SENT_30	[p2l1557t345r1693b388],
11	de	IN	ORGANIZATION	de	amod	12	SENT_30	[p2l1716t346r1772b388],
12	Barcelona	NNP	ORGANIZATION	Barcelona	appos	7	SENT_30	[p2l1796t346r2048b395],
13	,	,	O	,	_	0	SENT_30	[p2l1796t346r2048b395],
14	Villarroel	NNP	PERSON	Villarroel	appos	7	SENT_30	[p2l7t416r236b457],
15	170	CD	NUMBER	170	num	14	SENT_30	[p2l256t418r355b464],
16	,	,	O	,	_	0	SENT_30	[p2l256t418r355b464],
17	08036	CD	NUMBER	08036	num	14	SENT_30	[p2l373t418r525b457],
18	Barcelona	NNP	ORGANIZATION	Barcelona	dep	14	SENT_30	[p2l542t416r794b464],
19	,	,	O	,	_	0	SENT_30	[p2l542t416r794b464],
20	Spain	NNP	LOCATION	Spain	appos	7	SENT_30	[p2l812t416r958b468],
21	.	.	O	.	_	0	SENT_30	[p2l812t416r958b468],

1	Tel.	NNP	O	Tel.	_	0	SENT_31	[p2l973t416r1074b458],
2	:	:	O	:	_	0	SENT_31	[p2l973t416r1074b458],
3	+34	CD	NUMBER	+34	dep	1	SENT_31	[p2l1095t418r1184b457],
4	93	CD	NUMBER	93	number	5	SENT_31	[p2l1200t418r1257b457],
5	227	CD	NUMBER	227	num	7	SENT_31	[p2l1276t418r1365b457],
6	54	CD	NUMBER	54	number	7	SENT_31	[p2l1384t418r1442b457],
7	28	CD	NUMBER	28	dep	3	SENT_31	[p2l1459t418r1533b464],
8	;	:	O	;	_	0	SENT_31	[p2l1459t418r1533b464],
9	fax	NN	O	fax	dep	1	SENT_31	[p2l9t485r96b527],
10	:	:	O	:	_	0	SENT_31	[p2l9t485r96b527],
11	+34	CD	NUMBER	+34	dep	1	SENT_31	[p2l117t487r206b527],
12	93	CD	NUMBER	93	number	13	SENT_31	[p2l222t487r279b527],
13	227	CD	NUMBER	227	num	15	SENT_31	[p2l298t487r387b526],
14	54	CD	NUMBER	54	number	15	SENT_31	[p2l406t487r464b527],
15	84	CD	NUMBER	84	dep	11	SENT_31	[p2l481t487r551b527],
16	.	.	O	.	_	0	SENT_31	[p2l481t487r551b527],

1	E-mail	NN	O	e-mail	nn	2	SENT_32	[p2l106t555r262b597],
2	address	NN	O	address	_	0	SENT_32	[p2l278t555r470b597],
3	:	:	O	:	_	0	SENT_32	[p2l278t555r470b597],
4	jblade@clinic.ub.es	NNS	O	jblade@clinic.ub.es	nsubj	5	SENT_32	[p2l483t555r952b608],
5	(	VBP	O	(	dep	2	SENT_32	[p2l970t555r1015b608],
6	J.	NNP	PERSON	J.	nn	8	SENT_32	[p2l970t555r1015b608],
7	Bladé	NNP	PERSON	Bladé	nn	8	SENT_32	[p2l1033t554r1198b607],
8	)	NN	O	)	dobj	5	SENT_32	[p2l1033t554r1198b607],
9	.	.	O	.	_	0	SENT_32	[p2l1033t554r1198b607],

1	0145-2126	CD	DURATION	0145-2126	_	0	SENT_33	[p2l9t700r323b754],
2	/	:	O	/	punct	1	SENT_33	[p2l9t700r323b754],
3	$	$	MONEY	$	nsubj	5	SENT_33	[p2l9t700r323b754],
4	—	CD	MONEY	—	num	3	SENT_33	[p2l341t727r367b731],
5	see	VBP	O	see	dep	1	SENT_33	[p2l386t714r462b743],
6	front	JJ	O	front	amod	7	SENT_33	[p2l480t702r601b743],
7	matter	NN	O	matter	dobj	5	SENT_33	[p2l617t708r783b743],
8	©	CD	NUMBER	©	num	11	SENT_33	[p2l798t705r837b743],
9	2011	CD	DATE	2011	num	11	SENT_33	[p2l854t704r969b743],
10	Elsevier	NNP	ORGANIZATION	Elsevier	nn	11	SENT_33	[p2l993t702r1185b743],
11	Ltd.	NNP	ORGANIZATION	Ltd.	dep	7	SENT_33	[p2l1201t702r1288b744],
12	.	.	O	.	_	0	SENT_33	[p2l1201t702r1288b744],

1	All	DT	O	all	det	2	SENT_34	[p2l1304t702r1369b743],
2	rights	NNS	O	rights	nsubj	3	SENT_34	[p2l1388t702r1527b754],
3	reserved	VBN	O	reserve	_	0	SENT_34	[p2l1545t702r1767b744],
4	.	.	O	.	_	0	SENT_34	[p2l1545t702r1767b744],

1	doi	FW	O	doi	_	0	SENT_35	[p2l9t771r99b813],
2	:	:	O	:	_	0	SENT_35	[p2l9t771r99b813],
3	1	CD	NUMBER	1	number	4	SENT_35	[p2l109t773r128b812],
4	0.101	CD	NUMBER	0.101	num	5	SENT_35	[p2l138t773r265b813],
5	6/j	NN	O	6/j	dep	1	SENT_35	[p2l275t771r849b823],
6	.	.	O	.	_	0	SENT_35	[p2l275t771r849b823],

1	leul	NN	O	leul	_	0	SENT_36	[p2l275t771r849b823],
2	<	JJR	O	<	dep	1	SENT_36	[p2l275t771r849b823],
3	res	CD	NUMBER	res	number	4	SENT_36	[p2l275t771r849b823],
4	.2011.02.009	CD	NUMBER	.2011.02.009	dep	2	SENT_36	[p2l275t771r849b823],

1	different	JJ	O	different	amod	2	SENT_37	[p2l54t1125r328b1178],
2	tumors	NNS	O	tumor	_	0	SENT_37	[p2l343t1133r584b1186],
3	,	,	O	,	_	0	SENT_37	[p2l343t1133r584b1186],
4	including	VBG	O	include	dep	2	SENT_37	[p2l603t1125r899b1192],
5	MM	NN	O	mm	pobj	4	SENT_37	[p2l915t1128r1055b1179],
6	.	.	O	.	_	0	SENT_37	[p2l915t1128r1055b1179],

1	The	DT	O	the	det	2	SENT_38	[p2l1071t1125r1185b1178],
2	aim	NN	O	aim	nsubj	6	SENT_38	[p2l1203t1126r1320b1178],
3	of	IN	O	of	_	0	SENT_38	[p2l1337t1125r1402b1178],
4	this	DT	O	this	det	5	SENT_38	[p2l1411t1125r1525b1178],
5	study	NN	O	study	prep_of	2	SENT_38	[p2l1545t1125r1718b1192],
6	was	VBD	O	be	_	0	SENT_38	[p2l1732t1141r1855b1178],
7	to	TO	O	to	aux	8	SENT_38	[p2l1872t1133r1933b1178],
8	examine	VB	O	examine	ccomp	6	SENT_38	[p2l1951t1141r2149b1178, p2l55t1212r148b1264],
9	SNPs	NNS	O	snp	dobj	8	SENT_38	[p2l164t1214r315b1264],
10	in	IN	O	in	_	0	SENT_38	[p2l332t1212r390b1264],
11	12	CD	NUMBER	12	num	12	SENT_38	[p2l409t1214r479b1264],
12	genes	NNS	O	gene	prep_in	8	SENT_38	[p2l495t1227r673b1278],
13	involving	VBG	O	involve	_	0	SENT_38	[p2l691t1211r985b1278],
14	multidrug	JJ	O	multidrug	amod	15	SENT_38	[p2l999t1211r1317b1278],
15	resistance	NN	O	resistance	prep_involving	12	SENT_38	[p2l1331t1212r1662b1273],
16	,	,	O	,	_	0	SENT_38	[p2l1331t1212r1662b1273],
17	drug	NN	O	drug	nn	19	SENT_38	[p2l1679t1211r1824b1278],
18	metabolic	JJ	O	metabolic	amod	19	SENT_38	[p2l1838t1211r2150b1264],
19	pathways	NNS	O	pathway	prep_involving	12	SENT_38	[p2l54t1297r374b1364],
20	,	,	O	,	_	0	SENT_38	[p2l54t1297r374b1364],
21	DNA	NN	O	dna	nn	23	SENT_38	[p2l398t1300r541b1350],
22	repair	NN	O	repair	nn	23	SENT_38	[p2l562t1298r751b1364],
23	systems	NNS	O	system	prep_involving	12	SENT_38	[p2l772t1305r1022b1364],
24	and	CC	O	and	_	0	SENT_38	[p2l1046t1297r1160b1351],
25	cytokines	NNS	O	cytokine	prep_involving	12	SENT_38	[p2l1183t1298r1498b1364],
26	,	,	O	,	_	0	SENT_38	[p2l1183t1298r1498b1364],
27	and	CC	O	and	_	0	SENT_38	[p2l1522t1297r1636b1351],
28	to	TO	O	to	aux	29	SENT_38	[p2l1659t1305r1719b1351],
29	correlate	VB	O	correlate	conj_and	8	SENT_38	[p2l1743t1297r2022b1351],
30	our	PRP$	O	we	poss	31	SENT_38	[p2l2045t1313r2152b1351],
31	ﬁndings	NNS	O	ﬁndings	dobj	29	SENT_38	[p2l55t1383r306b1450],
32	with	IN	O	with	_	0	SENT_38	[p2l327t1384r473b1437],
33	response	NN	O	response	prep_with	29	SENT_38	[p2l495t1399r790b1450],
34	,	,	O	,	_	0	SENT_38	[p2l495t1399r790b1450],
35	serum	NN	O	serum	nn	37	SENT_38	[p2l814t1399r1010b1437],
36	cytokine	NN	O	cytokine	nn	37	SENT_38	[p2l1033t1384r1301b1450],
37	levels	NNS	O	level	prep_with	29	SENT_38	[p2l1324t1384r1516b1445],
38	,	,	O	,	_	0	SENT_38	[p2l1324t1384r1516b1445],
39	toxicity	NN	O	toxicity	prep_with	29	SENT_38	[p2l1539t1384r1779b1450],
40	and	CC	O	and	_	0	SENT_38	[p2l1799t1384r1913b1437],
41	overall	JJ	O	overall	amod	42	SENT_38	[p2l1935t1384r2149b1437],
42	survival	NN	O	survival	prep_with	29	SENT_38	[p2l55t1470r302b1523],
43	(	CD	NUMBER	(	num	45	SENT_38	[p2l322t1470r454b1536],
44	OS	NN	O	os	nn	45	SENT_38	[p2l322t1470r454b1536],
45	)	NN	O	)	dep	42	SENT_38	[p2l322t1470r454b1536],
46	in	IN	O	in	_	0	SENT_38	[p2l475t1471r533b1522],
47	patients	NNS	O	patient	prep_in	29	SENT_38	[p2l553t1471r806b1536],
48	with	IN	O	with	_	0	SENT_38	[p2l825t1470r970b1523],
49	relapsed/refractory	JJ	O	relapsed/refractory	amod	50	SENT_38	[p2l990t1470r1599b1536],
50	MM	NN	O	mm	prep_with	47	SENT_38	[p2l1617t1473r1740b1522],
51	treated	VBN	O	treat	partmod	50	SENT_38	[p2l1761t1470r1986b1523],
52	with	IN	O	with	_	0	SENT_38	[p2l2005t1470r2150b1523],
53	single	JJ	O	single	amod	55	SENT_38	[p2l55t1555r237b1622],
54	agent	NN	O	agent	nn	55	SENT_38	[p2l259t1563r434b1622],
55	thalidomide	NN	O	thalidomide	prep_with	51	SENT_38	[p2l454t1555r853b1609],
56	.	.	O	.	_	0	SENT_38	[p2l454t1555r853b1609],

1	2	LS	NUMBER	2	_	0	SENT_39	[p2l53t1738r96b1779],
2	.	.	O	.	_	0	SENT_39	[p2l53t1738r96b1779],

1	Materials	NNPS	O	Materials	_	0	SENT_40	[p2l141t1736r389b1778],
2	and	CC	O	and	_	0	SENT_40	[p2l405t1736r504b1778],
3	methods	NNS	O	method	conj_and	1	SENT_40	[p2l520t1736r753b1778],

1	2.1	CD	NUMBER	2.1	_	0	SENT_41	[p2l50t1879r134b1920],
2	.	.	O	.	_	0	SENT_41	[p2l50t1879r134b1920],

1	Patients	NNS	O	patient	_	0	SENT_42	[p2l180t1878r374b1920],

1	Twenty	CD	NUMBER	twenty	num	4	SENT_43	[p2l151t2018r496b2071],
2	—	CD	NUMBER	—	num	4	SENT_43	[p2l151t2018r496b2071],
3	eight	CD	NUMBER	eight	num	4	SENT_43	[p2l151t2018r496b2071],
4	patients	NNS	O	patient	_	0	SENT_43	[p2l509t2019r712b2071],
5	(	IN	O	(	_	0	SENT_43	[p2l727t2018r905b2071],
6	13M/1	NN	O	13m/1	nn	7	SENT_43	[p2l727t2018r905b2071],
7	5F	NN	O	5f	prep_(	4	SENT_43	[p2l916t2021r987b2067],
8	;	:	O	;	_	0	SENT_43	[p2l916t2021r987b2067],
9	median	NN	O	median	nn	10	SENT_43	[p2l1006t2018r1195b2061],
10	age	NN	O	age	dep	4	SENT_43	[p2l1209t2031r1293b2071],
11	59	CD	DURATION	59	num	12	SENT_43	[p2l1308t2020r1367b2061],
12	years	NNS	NUMBER	year	nsubjpass	24	SENT_43	[p2l1381t2031r1527b2071],
13	,	,	O	,	_	0	SENT_43	[p2l1381t2031r1527b2071],
14	range	NN	O	range	appos	12	SENT_43	[p2l1543t2031r1682b2071],
15	40-82	CD	NUMBER	40-82	num	16	SENT_43	[p2l1696t2020r1852b2061],
16	years	NNS	NUMBER	year	dep	14	SENT_43	[p2l1867t2018r2020b2071],
17	)	RB	O	)	amod	14	SENT_43	[p2l1867t2018r2020b2071],
18	with	IN	O	with	_	0	SENT_43	[p2l2034t2018r2150b2061],
19	relapsed	VBN	O	relapse	prepc_with	17	SENT_43	[p2l54t2088r267b2141],
20	or	CC	O	or	_	0	SENT_43	[p2l286t2100r339b2130],
21	refractory	JJ	O	refractory	amod	22	SENT_43	[p2l357t2087r607b2141],
22	MM	NN	O	mm	appos	12	SENT_43	[p2l626t2090r725b2130],
23	were	VBD	O	be	auxpass	24	SENT_43	[p2l744t2100r870b2130],
24	treated	VBN	O	treat	rcmod	10	SENT_43	[p2l889t2087r1070b2130],
25	with	IN	O	with	_	0	SENT_43	[p2l1088t2088r1205b2130],
26	single	JJ	O	single	amod	28	SENT_43	[p2l1225t2088r1371b2141],
27	agent	NN	O	agent	nn	28	SENT_43	[p2l1390t2094r1530b2141],
28	thalidomide	NN	O	thalidomide	prep_with	24	SENT_43	[p2l1548t2087r1855b2130],
29	at	IN	O	at	_	0	SENT_43	[p2l1875t2094r1922b2130],
30	Hospital	NNP	ORGANIZATION	Hospital	nn	31	SENT_43	[p2l1941t2087r2149b2141],
31	Clinic	NNP	ORGANIZATION	Clinic	prep_at	28	SENT_43	[p2l54t2157r194b2200],
32	of	IN	ORGANIZATION	of	_	0	SENT_43	[p2l212t2158r265b2200],
33	Barcelona	NNP	ORGANIZATION	Barcelona	prep_of	31	SENT_43	[p2l278t2158r525b2200],
34	from	IN	O	from	_	0	SENT_43	[p2l545t2158r665b2200],
35	November	NNP	DATE	November	prep_from	24	SENT_43	[p2l684t2158r949b2200],
36	1999	CD	DATE	1999	num	35	SENT_43	[p2l969t2160r1090b2200],
37	to	TO	O	to	_	0	SENT_43	[p2l1110t2164r1158b2200],
38	December	NNP	DATE	December	prep_to	24	SENT_43	[p2l1179t2158r1436b2200],
39	2003	CD	DATE	2003	num	38	SENT_43	[p2l1454t2160r1590b2201],
40	.	.	O	.	_	0	SENT_43	[p2l1454t2160r1590b2201],

1	Baseline	NN	O	baseline	nn	2	SENT_44	[p2l1611t2158r1818b2200],
2	demographics	NNS	O	demographic	nsubjpass	11	SENT_44	[p2l1838t2158r2149b2211, p2l54t2229r129b2278],
3	,	,	O	,	_	0	SENT_44	[p2l1838t2158r2149b2211, p2l54t2229r129b2278],
4	clinical	JJ	O	clinical	amod	7	SENT_44	[p2l151t2228r328b2271],
5	and	CC	O	and	_	0	SENT_44	[p2l348t2228r439b2271],
6	laboratory	JJ	O	laboratory	amod	7	SENT_44	[p2l460t2228r723b2282],
7	ﬁndings	NNS	O	ﬁndings	conj_and	2	SENT_44	[p2l741t2228r943b2282],
8	and	CC	O	and	_	0	SENT_44	[p2l963t2228r1055b2271],
9	treatment	NN	O	treatment	conj_and	2	SENT_44	[p2l1074t2235r1329b2271],
10	are	VBP	O	be	auxpass	11	SENT_44	[p2l1347t2241r1424b2271],
11	summarized	VBN	O	summarize	_	0	SENT_44	[p2l1445t2228r1759b2271],
12	in	IN	O	in	_	0	SENT_44	[p2l1779t2229r1826b2270],
13	Table	NNP	O	Table	prep_in	11	SENT_44	[p2l1843t2228r1979b2271],
14	1	CD	NUMBER	1	num	13	SENT_44	[p2l2001t2231r2039b2271],
15	.	.	O	.	_	0	SENT_44	[p2l2001t2231r2039b2271],

1	The	DT	O	the	det	2	SENT_45	[p2l2058t2228r2149b2271],
2	drug	NN	O	drug	nsubjpass	17	SENT_45	[p2l54t2298r170b2351],
3	was	VBD	O	be	auxpass	5	SENT_45	[p2l193t2310r291b2340],
4	initially	RB	O	initially	advmod	5	SENT_45	[p2l317t2298r511b2351],
5	administered	VBN	O	administer	_	0	SENT_45	[p2l535t2298r870b2340],
6	at	IN	O	at	_	0	SENT_45	[p2l896t2304r943b2340],
7	a	DT	O	a	det	9	SENT_45	[p2l967t2310r992b2340],
8	nightly	JJ	SET	nightly	amod	9	SENT_45	[p2l1018t2298r1197b2351],
9	dose	NN	O	dose	prep_at	5	SENT_45	[p2l1221t2298r1335b2340],
10	of	IN	O	of	_	0	SENT_45	[p2l1360t2298r1413b2340],
11	200	CD	NUMBER	200	num	12	SENT_45	[p2l1432t2300r1524b2340],
12	mg	NN	O	mg	prep_of	9	SENT_45	[p2l1538t2310r1616b2351],
13	and	CC	O	and	_	0	SENT_45	[p2l1640t2298r1731b2340],
14	later	RB	O	later	advmod	15	SENT_45	[p2l1758t2298r1873b2340],
15	increased	VBD	O	increase	conj_and	5	SENT_45	[p2l1897t2298r2149b2347],
16	,	,	O	,	_	0	SENT_45	[p2l1897t2298r2149b2347],
17	depending	VBG	O	depend	conj_and	5	SENT_45	[p2l54t2368r322b2421],
18	on	IN	O	on	pcomp	17	SENT_45	[p2l336t2381r398b2411],
19	tolerance	NN	O	tolerance	pobj	18	SENT_45	[p2l412t2368r659b2417],
20	,	,	O	,	_	0	SENT_45	[p2l412t2368r659b2417],
21	by	IN	O	by	dep	28	SENT_45	[p2l674t2368r735b2421],
22	1	CD	NUMBER	1	number	23	SENT_45	[p2l751t2370r771b2410],
23	00-200	CD	NUMBER	00-200	num	24	SENT_45	[p2l781t2370r969b2411],
24	mg	NN	O	mg	pobj	28	SENT_45	[p2l982t2381r1060b2421],
25	every	DT	SET	every	quantmod	26	SENT_45	[p2l1074t2381r1213b2421],
26	2	CD	SET	2	num	27	SENT_45	[p2l1227t2370r1254b2410],
27	weeks	NNS	NUMBER	week	npadvmod	28	SENT_45	[p2l1269t2368r1427b2411],
28	up	IN	O	up	advmod	19	SENT_45	[p2l1443t2381r1505b2421],
29	to	TO	O	to	_	0	SENT_45	[p2l1520t2374r1568b2411],
30	a	DT	O	a	det	33	SENT_45	[p2l1584t2381r1609b2411],
31	maximum	JJ	O	maximum	amod	33	SENT_45	[p2l1625t2369r1884b2411],
32	daily	JJ	SET	daily	amod	33	SENT_45	[p2l1899t2368r2022b2421],
33	dose	NN	O	dose	prep_to	28	SENT_45	[p2l2036t2368r2149b2411],
34	of	IN	O	of	_	0	SENT_45	[p2l54t2437r106b2480],
35	800	CD	NUMBER	800	num	37	SENT_45	[p2l121t2440r213b2480],
36	mg	NN	O	mg	nn	37	SENT_45	[p2l226t2450r304b2491],
37	(	NN	O	(	prep_of	33	SENT_45	[p2l324t2438r391b2490],
38	in	IN	O	in	_	0	SENT_45	[p2l324t2438r391b2490],
39	two	CD	NUMBER	two	num	41	SENT_45	[p2l411t2444r507b2480],
40	divided	JJ	O	divided	amod	41	SENT_45	[p2l529t2437r716b2480],
41	doses	NNS	O	dose	prep_in	37	SENT_45	[p2l737t2437r909b2490],
42	)	RB	O	)	advmod	18	SENT_45	[p2l737t2437r909b2490],
43	.	.	O	.	_	0	SENT_45	[p2l737t2437r909b2490],

1	In	IN	O	in	_	0	SENT_46	[p2l931t2440r978b2480],
2	responding	VBG	O	respond	prepc_in	12	SENT_46	[p2l999t2437r1284b2491],
3	patients	NNS	O	patient	dobj	2	SENT_46	[p2l1303t2438r1519b2491],
4	,	,	O	,	_	0	SENT_46	[p2l1303t2438r1519b2491],
5	the	DT	O	the	det	6	SENT_46	[p2l1540t2437r1619b2480],
6	dose	NN	O	dose	nsubjpass	12	SENT_46	[p2l1641t2437r1755b2480],
7	of	IN	O	of	_	0	SENT_46	[p2l1776t2437r1829b2480],
8	thalidomide	NN	O	thalidomide	prep_of	6	SENT_46	[p2l1843t2437r2149b2480],
9	was	VBD	O	be	auxpass	12	SENT_46	[p2l52t2520r150b2550],
10	thereafter	RB	O	thereafter	advmod	12	SENT_46	[p2l175t2508r428b2550],
11	progressively	RB	O	progressively	advmod	12	SENT_46	[p2l451t2508r790b2561],
12	tapered	VBN	O	taper	_	0	SENT_46	[p2l812t2508r1005b2561],
13	to	TO	O	to	_	0	SENT_46	[p2l1030t2514r1078b2550],
14	a	DT	O	a	det	16	SENT_46	[p2l1103t2520r1129b2550],
15	maintenance	NN	O	maintenance	nn	16	SENT_46	[p2l1153t2509r1480b2550],
16	dose	NN	O	dose	prep_to	12	SENT_46	[p2l1506t2508r1619b2550],
17	of	IN	O	of	_	0	SENT_46	[p2l1645t2508r1697b2550],
18	100	CD	NUMBER	100	num	19	SENT_46	[p2l1718t2510r1807b2550],
19	mg/d	NN	O	mg/d	prep_of	16	SENT_46	[p2l1820t2508r1963b2561],
20	.	.	O	.	_	0	SENT_46	[p2l1820t2508r1963b2561],

1	In	IN	O	in	_	0	SENT_47	[p2l1988t2511r2035b2550],
2	one	CD	NUMBER	one	num	3	SENT_47	[p2l2060t2520r2150b2550],
3	patient	NN	O	patient	prep_in	10	SENT_47	[p2l54t2579r233b2632],
4	the	DT	O	the	det	7	SENT_47	[p2l250t2578r330b2621],
5	lowest	JJS	O	lowest	amod	7	SENT_47	[p2l349t2578r517b2621],
6	maintenance	NN	O	maintenance	nn	7	SENT_47	[p2l535t2579r862b2621],
7	dose	NN	O	dose	nsubj	10	SENT_47	[p2l881t2578r995b2621],
8	was	VBD	O	be	cop	10	SENT_47	[p2l1013t2591r1110b2621],
9	50	CD	NUMBER	50	num	10	SENT_47	[p2l1131t2581r1190b2621],
10	mg	NN	O	mg	_	0	SENT_47	[p2l1203t2591r1293b2632],
11	.	.	O	.	_	0	SENT_47	[p2l1203t2591r1293b2632],

1	Treatment	NN	O	treatment	nsubjpass	9	SENT_48	[p2l1310t2581r1576b2621],
2	with	IN	O	with	_	0	SENT_48	[p2l1593t2578r1709b2621],
3	thalidomide	NN	O	thalidomide	prep_with	1	SENT_48	[p2l1727t2578r2034b2621],
4	was	VBD	O	be	auxpass	6	SENT_48	[p2l2051t2591r2149b2621],
5	also	RB	O	also	advmod	6	SENT_48	[p2l53t2648r151b2690],
6	reduced	VBN	O	reduce	_	0	SENT_48	[p2l164t2648r367b2690],
7	or	CC	O	or	_	0	SENT_48	[p2l380t2660r432b2690],
8	even	RB	O	even	advmod	9	SENT_48	[p2l443t2660r561b2690],
9	discontinued	VBN	O	discontinue	conj_or	6	SENT_48	[p2l574t2648r901b2690],
10	as	IN	O	as	mark	11	SENT_48	[p2l914t2660r963b2690],
11	needed	VBN	O	need	advcl	9	SENT_48	[p2l977t2648r1159b2690],
12	in	IN	O	in	_	0	SENT_48	[p2l1173t2648r1219b2690],
13	the	DT	O	the	det	14	SENT_48	[p2l1231t2648r1311b2690],
14	event	NN	O	event	prep_in	11	SENT_48	[p2l1324t2654r1464b2690],
15	of	IN	O	of	_	0	SENT_48	[p2l1476t2648r1528b2690],
16	toxicity	NN	O	toxicity	prep_of	14	SENT_48	[p2l1534t2648r1736b2701],
17	.	.	O	.	_	0	SENT_48	[p2l1534t2648r1736b2701],

1	The	DT	O	the	det	3	SENT_49	[p2l1748t2648r1840b2690],
2	Ethics	NNPS	O	Ethics	nn	3	SENT_49	[p2l1853t2648r2001b2690],
3	Committee	NNP	ORGANIZATION	Committee	nsubj	9	SENT_49	[p2l2015t2650r2149b2690, p2l54t2719r217b2761],
4	of	IN	ORGANIZATION	of	_	0	SENT_49	[p2l234t2718r286b2761],
5	Hospital	NNP	ORGANIZATION	Hospital	nn	6	SENT_49	[p2l296t2718r505b2771],
6	Clinic	NNP	ORGANIZATION	Clinic	prep_of	3	SENT_49	[p2l522t2717r662b2761],
7	of	IN	ORGANIZATION	of	_	0	SENT_49	[p2l678t2718r730b2761],
8	Barcelona	NNP	ORGANIZATION	Barcelona	prep_of	6	SENT_49	[p2l740t2718r987b2761],
9	provided	VBD	O	provide	_	0	SENT_49	[p2l1004t2718r1228b2771],
10	institutional	JJ	O	institutional	amod	12	SENT_49	[p2l1245t2718r1554b2761],
11	review	NN	O	review	nn	12	SENT_49	[p2l1572t2719r1744b2761],
12	board-approval	NN	O	board-approval	dobj	9	SENT_49	[p2l1758t2718r2150b2771],
13	for	IN	O	for	_	0	SENT_49	[p2l54t2787r124b2830],
14	this	DT	O	this	det	15	SENT_49	[p2l138t2788r230b2830],
15	study	NN	O	study	prep_for	9	SENT_49	[p2l248t2788r398b2841],
16	.	.	O	.	_	0	SENT_49	[p2l248t2788r398b2841],

1	Relapse	NN	O	relapse	nsubjpass	5	SENT_50	[p2l415t2788r606b2841],
2	and	CC	O	and	_	0	SENT_50	[p2l623t2787r715b2830],
3	progression	NN	O	progression	nsubjpass	5	SENT_50	[p2l732t2788r1028b2841],
4	were	VBD	O	be	auxpass	5	SENT_50	[p2l1043t2800r1169b2830],
5	established	VBN	O	establish	_	0	SENT_50	[p2l1186t2787r1471b2830],
6	according	VBG	O	accord	_	0	SENT_50	[p2l1488t2787r1734b2841],
7	to	TO	O	to	prepc_according_to	5	SENT_50	[p2l1749t2794r1797b2830],
8	the	DT	O	the	det	12	SENT_50	[p2l1814t2788r1894b2830],
9	European	JJ	MISC	european	amod	12	SENT_50	[p2l1911t2790r2150b2841],
10	Bone	NN	MISC	bone	nn	12	SENT_50	[p2l54t2861r177b2900],
11	Marrow	NN	MISC	marrow	nn	12	SENT_50	[p2l193t2861r395b2900],
12	transplantation	NN	O	transplantation	pobj	5	SENT_50	[p2l408t2858r799b2911],
13	(	CD	NUMBER	(	num	16	SENT_50	[p2l813t2858r997b2911],
14	EBMT	NN	O	ebmt	nn	16	SENT_50	[p2l813t2858r997b2911],
15	)	NN	O	)	nn	16	SENT_50	[p2l813t2858r997b2911],
16	criteria	NNS	O	criterion	dep	12	SENT_50	[p2l1013t2859r1193b2900],
17	[	CD	NUMBER	[	number	18	SENT_50	[p2l1210t2858r1288b2911],
18	7	CD	NUMBER	7	num	19	SENT_50	[p2l1210t2858r1288b2911],
19	]	NN	O	]	dep	16	SENT_50	[p2l1210t2858r1288b2911],
20	.	.	O	.	_	0	SENT_50	[p2l1210t2858r1288b2911],

1	Response	NN	O	response	nsubjpass	6	SENT_51	[p2l1304t2861r1540b2911],
2	to	TO	O	to	_	0	SENT_51	[p2l1555t2864r1603b2900],
3	thalidomide	NN	O	thalidomide	prep_to	1	SENT_51	[p2l1618t2858r1925b2900],
4	was	VBD	O	be	auxpass	6	SENT_51	[p2l1938t2870r2037b2900],
5	also	RB	O	also	advmod	6	SENT_51	[p2l2052t2858r2149b2900],
6	evaluated	VBN	O	evaluate	_	0	SENT_51	[p2l54t2928r299b2971],
7	according	VBG	O	accord	_	0	SENT_51	[p2l316t2928r563b2982],
8	to	TO	O	to	prepc_according_to	6	SENT_51	[p2l579t2935r627b2971],
9	EBMT	NN	O	ebmt	nn	10	SENT_51	[p2l645t2931r791b2970],
10	criteria	NNS	O	criterion	pobj	6	SENT_51	[p2l806t2929r986b2971],
11	[	CD	NUMBER	[	number	12	SENT_51	[p2l1006t2928r1084b2982],
12	7	CD	NUMBER	7	num	13	SENT_51	[p2l1006t2928r1084b2982],
13	]	NN	O	]	dep	10	SENT_51	[p2l1006t2928r1084b2982],
14	.	.	O	.	_	0	SENT_51	[p2l1006t2928r1084b2982],

1	No	DT	O	no	det	2	SENT_52	[p2l1103t2931r1170b2971],
2	patient	NN	O	patient	nsubjpass	4	SENT_52	[p2l1189t2929r1368b2982],
3	was	VBD	O	be	auxpass	4	SENT_52	[p2l1383t2941r1481b2971],
4	lost	VBN	O	lose	_	0	SENT_52	[p2l1500t2928r1590b2971],
5	of	IN	O	of	_	0	SENT_52	[p2l1607t2928r1659b2971],
6	follow	VB	O	follow	prep_of	4	SENT_52	[p2l1670t2928r1930b2982],
7	—	RB	O	—	advmod	6	SENT_52	[p2l1670t2928r1930b2982],
8	up	RB	O	up	advmod	6	SENT_52	[p2l1670t2928r1930b2982],
9	.	.	O	.	_	0	SENT_52	[p2l1670t2928r1930b2982],

1	2.2	CD	NUMBER	2.2	_	0	SENT_53	[p2l50t3101r134b3142],
2	.	.	O	.	_	0	SENT_53	[p2l50t3101r134b3142],

1	Selection	NN	O	selection	_	0	SENT_54	[p2l179t3099r395b3141],
2	of	IN	O	of	_	0	SENT_54	[p2l413t3099r465b3152],
3	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_54	[p2l469t3099r844b3152],

1	The	DT	O	the	det	2	SENT_55	[p2l151t3240r243b3282],
2	genes	NNS	O	gene	nsubj	12	SENT_55	[p2l264t3252r407b3293],
3	explored	VBN	O	explore	partmod	2	SENT_55	[p2l430t3240r651b3293],
4	were	VBD	O	be	cop	12	SENT_55	[p2l671t3252r798b3282],
5	those	DT	O	those	det	12	SENT_55	[p2l819t3240r955b3282],
6	related	JJ	O	related	amod	8	SENT_55	[p2l977t3240r1152b3282],
7	to	TO	O	to	dep	8	SENT_55	[p2l1174t3246r1222b3282],
8	multidrug	JJ	O	multidrug	amod	12	SENT_55	[p2l1245t3240r1499b3293],
9	resistance	NN	O	resistance	nn	12	SENT_55	[p2l1520t3241r1772b3282],
10	(	CD	NUMBER	(	num	12	SENT_55	[p2l1794t3240r2012b3293],
11	ABCB1	NN	O	abcb1	nn	12	SENT_55	[p2l1794t3240r2012b3293],
12	)	NN	O	)	_	0	SENT_55	[p2l1794t3240r2012b3293],
13	,	,	O	,	_	0	SENT_55	[p2l1794t3240r2012b3293],
14	drug	NN	O	drug	appos	12	SENT_55	[p2l2035t3240r2151b3293],
15	metabolic	JJ	O	metabolic	amod	16	SENT_55	[p2l54t3310r304b3353],
16	pathways	NNS	O	pathway	nsubj	17	SENT_55	[p2l327t3310r570b3364],
17	(	VBP	O	(	rcmod	14	SENT_55	[p2l595t3310r780b3363],
18	NR1I2	NN	O	nr1i2	nn	24	SENT_55	[p2l595t3310r780b3363],
19	,	,	O	,	_	0	SENT_55	[p2l595t3310r780b3363],
20	GSTT1	NN	O	gstt1	dep	24	SENT_55	[p2l806t3312r976b3359],
21	,	,	O	,	_	0	SENT_55	[p2l806t3312r976b3359],
22	SULT1	NN	O	sult1	dep	24	SENT_55	[p2l1001t3312r1150b3353],
23	C2	NN	O	c2	nn	24	SENT_55	[p2l1161t3310r1255b3363],
24	)	NN	O	)	nsubj	29	SENT_55	[p2l1161t3310r1255b3363],
25	,	,	O	,	_	0	SENT_55	[p2l1161t3310r1255b3363],
26	DNA	NN	O	dna	nn	28	SENT_55	[p2l1280t3312r1396b3353],
27	repair	NN	O	repair	nn	28	SENT_55	[p2l1418t3311r1569b3364],
28	systems	NNS	O	system	appos	24	SENT_55	[p2l1592t3317r1792b3364],
29	(	VBP	O	(	ccomp	17	SENT_55	[p2l1817t3311r1951b3363],
30	XPA	NN	O	xpa	dobj	29	SENT_55	[p2l1817t3311r1951b3363],
31	,	,	O	,	_	0	SENT_55	[p2l1817t3311r1951b3363],
32	ERCC1	NN	O	ercc1	appos	30	SENT_55	[p2l1977t3313r2149b3360],
33	,	,	O	,	_	0	SENT_55	[p2l1977t3313r2149b3360],

1	MT.	NNP	O	MT.	nn	2	SENT_56	[p2l352t3440r402b3461],
2	Cibeira	NNP	O	Cibeira	_	0	SENT_56	[p2l412t3439r495b3461],
3	et	FW	O	et	nn	4	SENT_56	[p2l504t3442r527b3461],
4	al.	FW	O	al.	dep	2	SENT_56	[p2l534t3439r560b3461],
5	/	:	O	/	punct	2	SENT_56	[p2l566t3439r578b3466],
6	Leukemia	NNP	ORGANIZATION	Leukemia	nn	7	SENT_56	[p2l584t3439r700b3461],
7	Research	NNP	ORGANIZATION	Research	dep	2	SENT_56	[p2l708t3439r814b3461],
8	35	CD	NUMBER	35	number	9	SENT_56	[p2l822t3440r852b3461],
9	(	CD	NUMBER	(	num	10	SENT_56	[p2l860t3439r941b3466],
10	2011	CD	DATE	2011	dep	7	SENT_56	[p2l860t3439r941b3466],
11	)	CD	NUMBER	)	number	12	SENT_56	[p2l860t3439r941b3466],
12	1178-1183 1179	CD	DURATION	1178-1183 1179	num	10	SENT_56	[p2l1747t3440r1807b3461],[p2l952t3440r1085b3461],

1	Table	NNP	O	Table	nsubj	5	SENT_57	[p2l7t3574r153b3617],
2	1	CD	NUMBER	1	num	4	SENT_57	[p2l171t3576r195b3617],
3	Patient	NN	O	patient	nn	4	SENT_57	[p2l10t3646r191b3689],
4	characteristics	NNS	O	characteristic	dep	1	SENT_57	[p2l208t3645r580b3689],
5	(	VBP	O	(	_	0	SENT_57	[p2l599t3645r648b3699],
6	n	NN	O	n	dobj	5	SENT_57	[p2l599t3645r648b3699],
7	=	JJ	O	=	advmod	5	SENT_57	[p2l662t3663r688b3677],
8	28	CD	NUMBER	28	num	9	SENT_57	[p2l702t3645r796b3699],
9	)	NN	O	)	dep	7	SENT_57	[p2l702t3645r796b3699],
10	.	.	O	.	_	0	SENT_57	[p2l702t3645r796b3699],

1	Variable	JJ	O	variable	_	0	SENT_58	[p2l58t3768r272b3812],

1	Median	JJ	O	median	dep	107	SENT_59	[p3l61t64r254b107],
2	age	NN	O	age	dep	107	SENT_59	[p3l271t76r369b118],
3	,	,	O	,	_	0	SENT_59	[p3l271t76r369b118],
4	years	NNS	DURATION	year	dep	107	SENT_59	[p3l387t76r522b118],
5	(	VBP	O	(	dep	107	SENT_59	[p3l541t64r726b118],
6	range	NN	O	range	dep	107	SENT_59	[p3l541t64r726b118],
7	)	CD	NUMBER	)	dep	107	SENT_59	[p3l541t64r726b118],
8	59	CD	NUMBER	59	dep	107	SENT_59	[p3l1694t66r1754b107],
9	(	NN	O	(	dep	107	SENT_59	[p3l1767t64r1968b118],
10	40-82	CD	NUMBER	40-82	dep	107	SENT_59	[p3l1767t64r1968b118],
11	)	CD	NUMBER	)	dep	107	SENT_59	[p3l1767t64r1968b118],
12	Gender	NN	O	gender	dep	107	SENT_59	[p3l60t135r404b189],
13	(	NN	O	(	dep	107	SENT_59	[p3l60t135r404b189],
14	M/F	NN	O	m/f	dep	107	SENT_59	[p3l60t135r404b189],
15	)	CD	NUMBER	)	dep	107	SENT_59	[p3l60t135r404b189],
16	15/13	CD	NUMBER	15/13	dep	107	SENT_59	[p3l1696t135r1837b189],
17	Immunological	JJ	O	immunological	dep	107	SENT_59	[p3l61t205r449b260],
18	subtype	NN	O	subtype	dep	107	SENT_59	[p3l467t205r670b260],
19	(	CD	PERCENT	(	dep	107	SENT_59	[p3l689t205r761b260],
20	%	NN	PERCENT	%	dep	107	SENT_59	[p3l689t205r761b260],
21	)	CD	NUMBER	)	dep	107	SENT_59	[p3l689t205r761b260],
22	IgG	NN	O	igg	dep	107	SENT_59	[p3l61t279r144b331],
23	75	CD	NUMBER	75	dep	107	SENT_59	[p3l1694t279r1753b320],
24	IgA	NN	O	iga	dep	107	SENT_59	[p3l61t350r144b403],
25	14.3	CD	NUMBER	14.3	dep	107	SENT_59	[p3l1696t350r1798b392],
26	Light	NN	O	light	dep	107	SENT_59	[p3l61t419r189b473],
27	chains	NNS	O	chain	dep	107	SENT_59	[p3l206t419r368b462],
28	3.6	CD	NUMBER	3.6	dep	107	SENT_59	[p3l1725t421r1800b463],
29	IgD	NN	O	igd	dep	107	SENT_59	[p3l60t493r145b544],
30	3.6	CD	NUMBER	3.6	dep	107	SENT_59	[p3l1725t492r1800b534],
31	IgM	NN	O	igm	dep	107	SENT_59	[p3l61t563r157b615],
32	3.6	CD	NUMBER	3.6	dep	107	SENT_59	[p3l1725t563r1800b604],
33	Light	JJ	O	light	dep	107	SENT_59	[p3l61t632r189b686],
34	chain	NN	O	chain	dep	107	SENT_59	[p3l206t632r344b675],
35	subtype	NN	O	subtype	dep	107	SENT_59	[p3l362t632r565b686],
36	(	CD	PERCENT	(	dep	107	SENT_59	[p3l583t632r656b686],
37	%	NN	PERCENT	%	dep	107	SENT_59	[p3l583t632r656b686],
38	)	NN	O	)	dep	107	SENT_59	[p3l583t632r656b686],
39	kappa	NN	O	kappa	dep	107	SENT_59	[p3l61t703r215b758],
40	64.3	CD	NUMBER	64.3	dep	107	SENT_59	[p3l1693t705r1798b747],
41	lambda	NN	O	lambda	dep	107	SENT_59	[p3l61t775r251b818],
42	35.7	CD	NUMBER	35.7	dep	107	SENT_59	[p3l1692t777r1799b819],
43	Median	JJ	O	median	dep	107	SENT_59	[p3l60t846r254b890],
44	M	NN	O	m	dep	107	SENT_59	[p3l272t847r535b900],
45	—	NN	O	—	dep	107	SENT_59	[p3l272t847r535b900],
46	protein	NN	O	protein	dep	107	SENT_59	[p3l272t847r535b900],
47	size	NN	O	size	dep	107	SENT_59	[p3l553t847r661b896],
48	,	,	O	,	_	0	SENT_59	[p3l553t847r661b896],
49	g/L	NN	O	g/l	dep	107	SENT_59	[p3l679t846r757b900],
50	(	NN	O	(	dep	107	SENT_59	[p3l773t846r958b900],
51	range	NN	O	range	dep	107	SENT_59	[p3l773t846r958b900],
52	)	CD	NUMBER	)	dep	107	SENT_59	[p3l773t846r958b900],
53	37.5	CD	NUMBER	37.5	dep	107	SENT_59	[p3l1692t848r1799b890],
54	(	NN	O	(	dep	107	SENT_59	[p3l1818t846r1987b900],
55	7-76	CD	NUMBER	7-76	dep	107	SENT_59	[p3l1818t846r1987b900],
56	)	CD	NUMBER	)	dep	107	SENT_59	[p3l1818t846r1987b900],
57	Median	JJ	O	median	dep	107	SENT_59	[p3l61t916r254b960],
58	BM	NN	O	bm	dep	107	SENT_59	[p3l272t919r353b960],
59	plasma	NN	O	plasma	dep	107	SENT_59	[p3l372t916r556b971],
60	cells	NNS	O	cell	dep	107	SENT_59	[p3l574t916r685b960],
61	(	CD	PERCENT	(	dep	107	SENT_59	[p3l704t917r776b970],
62	%	NN	PERCENT	%	dep	107	SENT_59	[p3l704t917r776b970],
63	)	CD	NUMBER	)	dep	107	SENT_59	[p3l704t917r776b970],
64	36	CD	NUMBER	36	dep	107	SENT_59	[p3l1692t919r1754b960],
65	Extramedullary	JJ	O	extramedullary	dep	107	SENT_59	[p3l61t988r462b1042],
66	involvement	NN	O	involvement	dep	107	SENT_59	[p3l479t988r804b1031],
67	(	CD	PERCENT	(	dep	107	SENT_59	[p3l821t988r894b1042],
68	%	NN	PERCENT	%	dep	107	SENT_59	[p3l821t988r894b1042],
69	)	CD	NUMBER	)	dep	107	SENT_59	[p3l821t988r894b1042],
70	32.1	CD	NUMBER	32.1	dep	107	SENT_59	[p3l1692t990r1794b1032],
71	Median	JJ	O	median	dep	107	SENT_59	[p3l61t1059r254b1103],
72	time	NN	O	time	dep	107	SENT_59	[p3l271t1060r387b1103],
73	from	IN	O	from	dep	107	SENT_59	[p3l406t1059r529b1103],
74	diagnosis	NN	O	diagnosis	dep	107	SENT_59	[p3l546t1059r799b1114],
75	,	,	O	,	_	0	SENT_59	[p3l546t1059r799b1114],
76	years	NNS	DURATION	year	dep	107	SENT_59	[p3l816t1072r952b1114],
77	(	VBP	O	(	dep	107	SENT_59	[p3l971t1059r1155b1114],
78	range	NN	O	range	dep	107	SENT_59	[p3l971t1059r1155b1114],
79	)	CD	NUMBER	)	dep	107	SENT_59	[p3l971t1059r1155b1114],
80	2.5	CD	NUMBER	2.5	dep	107	SENT_59	[p3l1726t1061r1799b1103],
81	(	NN	O	(	dep	107	SENT_59	[p3l1819t1059r2046b1113],
82	0.5	CD	NUMBER	0.5	dep	107	SENT_59	[p3l1819t1059r2046b1113],
83	—	NN	O	—	dep	107	SENT_59	[p3l1819t1059r2046b1113],
84	5.4	CD	NUMBER	5.4	dep	107	SENT_59	[p3l1819t1059r2046b1113],
85	)	CD	NUMBER	)	dep	107	SENT_59	[p3l1819t1059r2046b1113],
86	Median	JJ	O	median	dep	107	SENT_59	[p3l61t1130r254b1173],
87	no.	NN	O	no.	dep	107	SENT_59	[p3l272t1142r346b1174],
88	of	IN	O	of	dep	107	SENT_59	[p3l365t1129r418b1173],
89	previous	JJ	O	previous	dep	107	SENT_59	[p3l430t1130r651b1184],
90	lines	NNS	O	line	dep	107	SENT_59	[p3l670t1130r788b1173],
91	of	IN	O	of	dep	107	SENT_59	[p3l807t1129r860b1173],
92	therapy	NN	O	therapy	dep	107	SENT_59	[p3l872t1130r1072b1184],
93	(	NN	O	(	dep	107	SENT_59	[p3l1089t1130r1273b1184],
94	range	NN	O	range	dep	107	SENT_59	[p3l1089t1130r1273b1184],
95	)	NN	O	)	dep	107	SENT_59	[p3l1089t1130r1273b1184],
96	2	CD	NUMBER	2	dep	107	SENT_59	[p3l1726t1130r1894b1184],
97	(	NN	O	(	dep	107	SENT_59	[p3l1726t1130r1894b1184],
98	1	CD	NUMBER	1	dep	107	SENT_59	[p3l1726t1130r1894b1184],
99	—	NN	O	—	dep	107	SENT_59	[p3l1726t1130r1894b1184],
100	4	CD	NUMBER	4	dep	107	SENT_59	[p3l1726t1130r1894b1184],
101	)	CD	NUMBER	)	dep	107	SENT_59	[p3l1726t1130r1894b1184],
102	Previous	JJ	O	previous	dep	107	SENT_59	[p3l61t1202r279b1245],
103	ASCT	NN	O	asct	dep	107	SENT_59	[p3l296t1203r429b1245],
104	(	CD	PERCENT	(	dep	107	SENT_59	[p3l445t1201r518b1255],
105	%	NN	PERCENT	%	dep	107	SENT_59	[p3l445t1201r518b1255],
106	)	CD	NUMBER	)	dep	107	SENT_59	[p3l445t1201r518b1255],
107	50	CD	NUMBER	50	_	0	SENT_59	[p3l1693t1203r1754b1245],

1	BM	NN	O	bm	_	0	SENT_60	[p3l10t1313r108b1355],
2	:	:	O	:	_	0	SENT_60	[p3l10t1313r108b1355],
3	bone	NN	O	bone	nn	4	SENT_60	[p3l130t1311r255b1354],
4	marrow	NN	O	marrow	dep	1	SENT_60	[p3l274t1323r494b1361],
5	;	:	O	;	_	0	SENT_60	[p3l274t1323r494b1361],
6	ASCT	NNP	O	ASCT	dep	4	SENT_60	[p3l514t1312r661b1355],
7	:	:	O	:	_	0	SENT_60	[p3l514t1312r661b1355],
8	autologous	JJ	O	autologous	amod	11	SENT_60	[p3l682t1311r965b1365],
9	stem	NN	O	stem	nn	11	SENT_60	[p3l985t1317r1109b1354],
10	cell	NN	O	cell	nn	11	SENT_60	[p3l1127t1311r1213b1354],
11	transplantation	NN	O	transplantation	dep	6	SENT_60	[p3l1231t1311r1630b1365],

1	ERCC2	NN	O	ercc2	nsubj	13	SENT_61	[p3l10t1521r186b1569],
2	,	,	O	,	_	0	SENT_61	[p3l10t1521r186b1569],
3	ERCC5	NN	O	ercc5	conj_and	1	SENT_61	[p3l207t1521r383b1569],
4	,	,	O	,	_	0	SENT_61	[p3l207t1521r383b1569],
5	XRCC1	NN	O	xrcc1	conj_and	1	SENT_61	[p3l403t1521r586b1569],
6	,	,	O	,	_	0	SENT_61	[p3l403t1521r586b1569],
7	XRCC5	NN	O	xrcc5	conj_and	1	SENT_61	[p3l606t1521r790b1569],
8	,	,	O	,	_	0	SENT_61	[p3l606t1521r790b1569],
9	TOP2A	NN	O	top2a	nn	10	SENT_61	[p3l808t1519r1002b1573],
10	)	NN	O	)	conj_and	1	SENT_61	[p3l808t1519r1002b1573],
11	and	CC	O	and	_	0	SENT_61	[p3l1022t1519r1115b1562],
12	cytokines	NNS	O	cytokine	conj_and	1	SENT_61	[p3l1136t1519r1380b1573],
13	(	VBP	O	(	_	0	SENT_61	[p3l1402t1519r1627b1573],
14	VEGFA	NNP	O	VEGFA	dobj	13	SENT_61	[p3l1402t1519r1627b1573],
15	)	CD	NUMBER	)	num	14	SENT_61	[p3l1402t1519r1627b1573],
16	.	.	O	.	_	0	SENT_61	[p3l1402t1519r1627b1573],

1	SNPs	NNS	O	snp	nsubjpass	3	SENT_62	[p3l1649t1521r1772b1562],
2	were	VBD	O	be	auxpass	3	SENT_62	[p3l1792t1531r1921b1562],
3	selected	VBN	O	select	ccomp	90	SENT_62	[p3l1942t1519r2150b1562],
4	as	IN	O	as	mark	5	SENT_62	[p3l9t1604r59b1635],
5	follows	VBZ	O	follow	advcl	3	SENT_62	[p3l84t1591r287b1635],
6	:	:	O	:	_	0	SENT_62	[p3l84t1591r287b1635],
7	those	DT	O	those	det	78	SENT_62	[p3l314t1591r453b1635],
8	located	JJ	O	located	amod	78	SENT_62	[p3l478t1591r663b1635],
9	in	IN	O	in	_	0	SENT_62	[p3l688t1592r735b1634],
10	exons	NNS	O	exon	prep_in	8	SENT_62	[p3l759t1604r907b1635],
11	or	CC	O	or	_	0	SENT_62	[p3l932t1604r985b1635],
12	in	IN	O	in	_	0	SENT_62	[p3l1008t1592r1055b1634],
13	UTR5	NN	O	utr5	conj_or	10	SENT_62	[p3l1078t1594r1226b1635],
14	’	CD	NUMBER	’	num	13	SENT_62	[p3l1078t1594r1226b1635],
15	or	CC	O	or	_	0	SENT_62	[p3l1253t1604r1306b1635],
16	UTR3	NN	O	utr3	nn	18	SENT_62	[p3l1328t1593r1476b1635],
17	’	NN	O	’	nn	18	SENT_62	[p3l1328t1593r1476b1635],
18	region	NN	O	region	conj_or	13	SENT_62	[p3l1503t1592r1678b1645],
19	,	,	O	,	_	0	SENT_62	[p3l1503t1592r1678b1645],
20	with	IN	O	with	_	0	SENT_62	[p3l1702t1591r1821b1635],
21	a	DT	O	a	det	22	SENT_62	[p3l1844t1604r1870b1635],
22	frequency	NN	O	frequency	prep_with	8	SENT_62	[p3l1894t1591r2152b1645],
23	of	IN	O	of	_	0	SENT_62	[p3l9t1662r63b1706],
24	the	DT	O	the	det	27	SENT_62	[p3l75t1662r156b1706],
25	less	JJR	O	less	amod	27	SENT_62	[p3l176t1662r268b1706],
26	frequent	JJ	O	frequent	amod	27	SENT_62	[p3l287t1662r509b1717],
27	allele	NN	O	allele	prep_of	22	SENT_62	[p3l526t1662r661b1706],
28	higher	JJR	O	higher	dep	61	SENT_62	[p3l681t1662r847b1717],
29	than	IN	O	than	_	0	SENT_62	[p3l864t1663r980b1706],
30	10	CD	PERCENT	10	num	31	SENT_62	[p3l1001t1665r1095b1706],
31	%	NN	PERCENT	%	prep_than	28	SENT_62	[p3l1001t1665r1095b1706],
32	in	IN	O	in	_	0	SENT_62	[p3l1114t1663r1162b1706],
33	the	DT	O	the	det	35	SENT_62	[p3l1180t1662r1261b1706],
34	general	JJ	O	general	amod	35	SENT_62	[p3l1279t1662r1469b1717],
35	population	NN	O	population	prep_in	31	SENT_62	[p3l1489t1663r1782b1717],
36	,	,	O	,	_	0	SENT_62	[p3l1489t1663r1782b1717],
37	and	CC	O	and	_	0	SENT_62	[p3l1801t1662r1894b1706],
38	validated	VBD	O	validate	conj_and	28	SENT_62	[p3l1911t1662r2150b1706],
39	polymorphisms	NNS	O	polymorphism	dobj	38	SENT_62	[p3l10t1735r414b1789],
40	associated	VBN	O	associate	partmod	39	SENT_62	[p3l438t1735r704b1778],
41	with	IN	O	with	_	0	SENT_62	[p3l726t1735r845b1778],
42	phenotypes	NNS	O	phenotype	prep_with	40	SENT_62	[p3l868t1735r1169b1789],
43	in	IN	O	in	_	0	SENT_62	[p3l1193t1736r1240b1778],
44	both	DT	O	both	det	48	SENT_62	[p3l1263t1735r1380b1778],
45	clinical	JJ	O	clinical	amod	48	SENT_62	[p3l1404t1735r1585b1778],
46	and	CC	O	and	_	0	SENT_62	[p3l1608t1735r1702b1778],
47	preclinical	JJ	O	preclinical	amod	48	SENT_62	[p3l1726t1735r1993b1789],
48	studies	NNS	O	study	prep_in	42	SENT_62	[p3l2018t1735r2150b1778, p3l10t1808r77b1851],
49	as	IN	O	as	mark	55	SENT_62	[p3l96t1820r146b1851],
50	prognostic	JJ	O	prognostic	amod	51	SENT_62	[p3l165t1808r439b1862],
51	factors	NNS	O	factor	nsubj	55	SENT_62	[p3l457t1807r628b1851],
52	in	IN	O	in	_	0	SENT_62	[p3l648t1808r696b1850],
53	hematological	JJ	O	hematological	amod	54	SENT_62	[p3l714t1807r1079b1862],
54	malignancies	NNS	O	malignancy	prep_in	51	SENT_62	[p3l1098t1807r1436b1862],
55	(	VBP	O	(	advcl	40	SENT_62	[p3l1455t1807r1558b1861],
56	i.e.	FW	O	i.e.	dobj	55	SENT_62	[p3l1455t1807r1558b1861],
57	,	,	O	,	_	0	SENT_62	[p3l1455t1807r1558b1861],
58	DNA	NN	O	dna	nn	60	SENT_62	[p3l1578t1809r1695b1850],
59	repair	NN	O	repair	nn	60	SENT_62	[p3l1712t1808r1866b1862],
60	genes	NNS	O	gene	nsubj	61	SENT_62	[p3l1882t1807r2049b1862],
61	)	VBP	O	)	rcmod	27	SENT_62	[p3l1882t1807r2049b1862],
62	[	CD	NUMBER	[	number	63	SENT_62	[p3l2071t1807r2150b1862],
63	8	CD	NUMBER	8	num	64	SENT_62	[p3l2071t1807r2150b1862],
64	]	NN	O	]	dobj	61	SENT_62	[p3l2071t1807r2150b1862],
65	,	,	O	,	_	0	SENT_62	[p3l2071t1807r2150b1862],
66	response	NN	O	response	appos	64	SENT_62	[p3l10t1891r238b1933],
67	to	TO	O	to	_	0	SENT_62	[p3l264t1885r313b1922],
68	drugs	NNS	O	drug	prep_to	66	SENT_62	[p3l340t1879r482b1933],
69	in	IN	O	in	_	0	SENT_62	[p3l509t1879r556b1922],
70	MM	NN	O	mm	prep_in	68	SENT_62	[p3l582t1881r683b1922],
71	(	CD	NUMBER	(	num	70	SENT_62	[p3l709t1879r812b1933],
72	i.e.	FW	O	i.e.	tmod	61	SENT_62	[p3l709t1879r812b1933],
73	,	,	O	,	_	0	SENT_62	[p3l709t1879r812b1933],
74	ABCB1	NN	O	abcb1	appos	72	SENT_62	[p3l836t1879r1027b1933],
75	)	CD	NUMBER	)	num	74	SENT_62	[p3l836t1879r1027b1933],
76	[	CD	NUMBER	[	number	77	SENT_62	[p3l1056t1878r1120b1933],
77	9	CD	NUMBER	9	num	78	SENT_62	[p3l1056t1878r1120b1933],
78	]	NN	O	]	dobj	5	SENT_62	[p3l1056t1878r1120b1933],
79	or	CC	O	or	_	0	SENT_62	[p3l1149t1891r1202b1922],
80	soluble	JJ	O	soluble	amod	81	SENT_62	[p3l1227t1879r1409b1922],
81	factors	NNS	O	factor	dobj	5	SENT_62	[p3l1436t1878r1608b1922],
82	related	VBN	O	relate	partmod	81	SENT_62	[p3l1635t1879r1813b1922],
83	to	TO	O	to	_	0	SENT_62	[p3l1839t1885r1888b1922],
84	MM	NN	O	mm	nn	85	SENT_62	[p3l1915t1881r2016b1922],
85	progression	NN	O	progression	prep_to	82	SENT_62	[p3l2042t1891r2150b1933, p3l8t1952r223b2005],
86	(	CD	NUMBER	(	num	85	SENT_62	[p3l241t1951r344b2005],
87	i.e.	FW	O	i.e.	dep	5	SENT_62	[p3l241t1951r344b2005],
88	,	,	O	,	_	0	SENT_62	[p3l241t1951r344b2005],
89	cytokines	NNS	O	cytokine	nsubj	90	SENT_62	[p3l363t1951r629b2005],
90	)	VBP	O	)	_	0	SENT_62	[p3l363t1951r629b2005],
91	[	CD	NUMBER	[	number	92	SENT_62	[p3l650t1951r763b2005],
92	10	CD	NUMBER	10	num	93	SENT_62	[p3l650t1951r763b2005],
93	]	NN	O	]	dobj	90	SENT_62	[p3l650t1951r763b2005],
94	.	.	O	.	_	0	SENT_62	[p3l650t1951r763b2005],

1	The	DT	O	the	det	2	SENT_63	[p3l780t1951r873b1995],
2	characteristics	NNS	O	characteristic	nsubjpass	8	SENT_63	[p3l892t1951r1264b1995],
3	of	IN	O	of	_	0	SENT_63	[p3l1284t1951r1337b1995],
4	all	DT	O	all	det	5	SENT_63	[p3l1349t1951r1408b1995],
5	SNPs	NNS	O	snp	prep_of	2	SENT_63	[p3l1427t1953r1551b1995],
6	analyzed	VBN	O	analyze	partmod	5	SENT_63	[p3l1570t1951r1798b2005],
7	are	VBP	O	be	auxpass	8	SENT_63	[p3l1817t1964r1895b1995],
8	shown	VBN	O	show	_	0	SENT_63	[p3l1915t1951r2085b1995],
9	in	IN	O	in	_	0	SENT_63	[p3l2104t1952r2151b1994],
10	Table	NNP	O	Table	prep_in	8	SENT_63	[p3l7t2023r145b2067],
11	2	CD	NUMBER	2	num	10	SENT_63	[p3l163t2026r205b2067],
12	.	.	O	.	_	0	SENT_63	[p3l163t2026r205b2067],

1	2.3	CD	NUMBER	2.3	_	0	SENT_64	[p3l6t2187r91b2229],
2	.	.	O	.	_	0	SENT_64	[p3l6t2187r91b2229],

1	Genotyping	VBG	O	genotype	_	0	SENT_65	[p3l141t2186r426b2239],

1	Genomic	JJ	O	genomic	amod	2	SENT_66	[p3l111t2330r340b2372],
2	DNA	NN	O	dna	nsubjpass	4	SENT_66	[p3l362t2331r479b2372],
3	was	VBD	O	be	auxpass	4	SENT_66	[p3l497t2341r597b2372],
4	isolated	VBN	O	isolate	_	0	SENT_66	[p3l620t2329r820b2372],
5	from	IN	O	from	_	0	SENT_66	[p3l842t2329r965b2372],
6	bone	NN	O	bone	nn	7	SENT_66	[p3l986t2329r1111b2372],
7	marrow	NN	O	marrow	prep_from	4	SENT_66	[p3l1133t2341r1339b2372],
8	aspirate	VB	O	aspirate	ccomp	4	SENT_66	[p3l1359t2329r1564b2383],
9	slides	NNS	O	slide	dobj	8	SENT_66	[p3l1586t2329r1729b2372],
10	using	VBG	O	use	partmod	9	SENT_66	[p3l1751t2330r1890b2383],
11	a	DT	O	a	det	16	SENT_66	[p3l1910t2341r1936b2372],
12	DNeasy	NNP	O	DNeasy	nn	16	SENT_66	[p3l1957t2332r2152b2383],
13	Blood	NNP	O	Blood	nn	16	SENT_66	[p3l10t2400r154b2444],
14	81	CD	NUMBER	81	num	16	SENT_66	[p3l183t2402r220b2444],
15	Tissue	NN	O	tissue	nn	16	SENT_66	[p3l246t2401r407b2444],
16	Kit	NN	O	kit	dobj	10	SENT_66	[p3l438t2401r509b2444],
17	(	CD	NUMBER	(	num	18	SENT_66	[p3l537t2400r756b2455],
18	Qiagen	NNP	ORGANIZATION	Qiagen	dep	16	SENT_66	[p3l537t2400r756b2455],
19	)	CD	NUMBER	)	num	18	SENT_66	[p3l537t2400r756b2455],
20	according	VBG	O	accord	_	0	SENT_66	[p3l786t2400r1038b2455],
21	to	TO	O	to	prepc_according_to	10	SENT_66	[p3l1066t2407r1115b2444],
22	the	DT	O	the	det	23	SENT_66	[p3l1144t2400r1226b2444],
23	manufacturer	NN	O	manufacturer	poss	25	SENT_66	[p3l1256t2400r1646b2444],
24	's	POS	O	's	_	0	SENT_66	[p3l1256t2400r1646b2444],
25	instructions	NNS	O	instruction	pobj	10	SENT_66	[p3l1676t2401r1996b2444],
26	.	.	O	.	_	0	SENT_66	[p3l1676t2401r1996b2444],

1	SNPs	NNS	O	snp	nsubjpass	3	SENT_67	[p3l2026t2402r2150b2444],
2	were	VBD	O	be	auxpass	3	SENT_67	[p3l8t2484r136b2515],
3	analyzed	VBN	O	analyze	_	0	SENT_67	[p3l156t2472r384b2526],
4	by	IN	O	by	_	0	SENT_67	[p3l403t2472r465b2526],
5	allelic	JJ	O	allelic	amod	6	SENT_67	[p3l482t2472r633b2515],
6	discrimination	NN	O	discrimination	agent	3	SENT_67	[p3l652t2472r1028b2515],
7	using	VBG	O	use	partmod	6	SENT_67	[p3l1047t2472r1186b2526],
8	TaqMan	NN	O	taqman	nn	9	SENT_67	[p3l1201t2474r1410b2526],
9	assays	NNS	O	assay	dobj	7	SENT_67	[p3l1429t2484r1589b2526],
10	in	IN	O	in	_	0	SENT_67	[p3l1610t2472r1657b2515],
11	an	DT	O	a	det	17	SENT_67	[p3l1676t2484r1736b2515],
12	ABI	NNP	MISC	ABI	nn	17	SENT_67	[p3l1753t2474r1839b2515],
13	Prism	NNP	O	Prism	nn	17	SENT_67	[p3l1859t2472r2005b2515],
14	7500	CD	NUMBER	7500	num	17	SENT_67	[p3l2025t2474r2150b2515],
15	Sequence	NN	O	sequence	nn	17	SENT_67	[p3l10t2545r253b2597],
16	Detection	NN	O	detection	nn	17	SENT_67	[p3l266t2544r514b2587],
17	system	NN	O	system	prep_in	7	SENT_67	[p3l527t2549r707b2597],
18	(	CD	NUMBER	(	num	21	SENT_67	[p3l719t2543r938b2597],
19	Applied	NNP	O	Applied	nn	21	SENT_67	[p3l719t2543r938b2597],
20	Biosystems	NNP	O	Biosystems	nn	21	SENT_67	[p3l951t2543r1260b2597],
21	)	NN	O	)	dep	17	SENT_67	[p3l951t2543r1260b2597],
22	with	IN	O	with	_	0	SENT_67	[p3l1272t2543r1390b2587],
23	minor	JJ	O	minor	amod	24	SENT_67	[p3l1403t2544r1559b2587],
24	modiﬁcations	NNS	O	modiﬁcations	prep_with	7	SENT_67	[p3l1570t2543r1921b2587],
25	as	IN	O	as	_	0	SENT_67	[p3l1934t2556r1984b2587],
26	previTable	JJ	O	previtable	prep_as	7	SENT_67	[p3l1997t2544r2150b2597, p3l7t2736r153b2779],

1	2	CD	NUMBER	2	num	2	SENT_68	[p3l170t2738r200b2779],
2	Genes	NNS	O	gene	nsubj	5	SENT_68	[p3l10t2809r164b2851],
3	and	CC	O	and	_	0	SENT_68	[p3l182t2807r275b2851],
4	polymorphisms	NNS	O	polymorphism	nsubj	5	SENT_68	[p3l294t2807r698b2862],
5	analyzed	VBN	O	analyze	_	0	SENT_68	[p3l717t2807r958b2862],
6	.	.	O	.	_	0	SENT_68	[p3l717t2807r958b2862],

1	ously	RB	O	ously	advmod	2	SENT_69	[p3l10t2879r147b2933],
2	described	VBN	O	describe	_	0	SENT_69	[p3l161t2879r409b2923],
3	[	NN	O	[	nn	5	SENT_69	[p3l427t2879r507b2933],
4	8	CD	NUMBER	8	num	5	SENT_69	[p3l427t2879r507b2933],
5	]	NN	O	]	dobj	2	SENT_69	[p3l427t2879r507b2933],
6	.	.	O	.	_	0	SENT_69	[p3l427t2879r507b2933],

1	The	DT	O	the	det	2	SENT_70	[p3l521t2879r615b2923],
2	probes	NNS	O	probe	nsubjpass	9	SENT_70	[p3l631t2879r803b2933],
3	used	VBN	O	use	partmod	2	SENT_70	[p3l819t2879r937b2923],
4	to	TO	O	to	aux	5	SENT_70	[p3l953t2885r1003b2923],
5	detect	VB	O	detect	xcomp	3	SENT_70	[p3l1019t2879r1178b2923],
6	the	DT	O	the	det	7	SENT_70	[p3l1192t2879r1274b2923],
7	SNPs	NNS	O	snp	dobj	5	SENT_70	[p3l1290t2881r1413b2923],
8	were	VBD	O	be	auxpass	9	SENT_70	[p3l1429t2892r1557b2923],
9	obtained	VBN	O	obtain	_	0	SENT_70	[p3l1573t2879r1799b2923],
10	from	IN	O	from	_	0	SENT_70	[p3l1815t2879r1938b2923],
11	Applied	NNP	O	Applied	nn	13	SENT_70	[p3l1951t2879r2151b2933],
12	Biosystems	NNP	O	Biosystems	nn	13	SENT_70	[p3l11t2951r299b3005],
13	assays	NNS	O	assay	prep_from	9	SENT_70	[p3l317t2963r478b3005],
14	on	IN	O	on	_	0	SENT_70	[p3l497t2963r560b2994],
15	demand-SNP	NN	O	demand-snp	nn	17	SENT_70	[p3l577t2950r914b2994],
16	genotyping	NN	O	genotyping	nn	17	SENT_70	[p3l930t2951r1223b3005],
17	products	NNS	O	product	prep_on	9	SENT_70	[p3l1240t2950r1479b3005],
18	.	.	O	.	_	0	SENT_70	[p3l1240t2950r1479b3005],

1	2.4	CD	NUMBER	2.4	_	0	SENT_71	[p3l7t3108r92b3150],
2	.	.	O	.	_	0	SENT_71	[p3l7t3108r92b3150],

1	Cytokines	NNS	O	cytokine	_	0	SENT_72	[p3l142t3106r379b3160],

1	Peripheral	JJ	O	peripheral	amod	3	SENT_73	[p4l112t52r377b106],
2	blood	NN	O	blood	nn	3	SENT_73	[p4l399t52r543b95],
3	samples	NNS	O	sample	nsubjpass	5	SENT_73	[p4l567t52r774b106],
4	were	VBD	O	be	auxpass	5	SENT_73	[p4l796t64r925b95],
5	collected	VBN	O	collect	conj_and	5	SENT_73	[p4l948t52r1178b95],
6	in	IN	O	in	_	0	SENT_73	[p4l1201t53r1248b95],
7	sterile	JJ	O	sterile	amod	9	SENT_73	[p4l1272t52r1430b95],
8	test	NN	O	test	nn	9	SENT_73	[p4l1452t58r1547b95],
9	tubes	NNS	O	tube	prep_in	5	SENT_73	[p4l1568t52r1707b95],
10	before	IN	O	before	_	0	SENT_73	[p4l1729t52r1892b95],
11	initiation	NN	O	initiation	prep_before	5	SENT_73	[p4l1916t53r2152b95],
12	of	IN	O	of	_	0	SENT_73	[p4l10t123r63b167],
13	therapy	NN	O	therapy	prep_of	11	SENT_73	[p4l77t123r278b178],
14	in	IN	O	in	_	0	SENT_73	[p4l298t124r345b166],
15	all	DT	O	all	det	16	SENT_73	[p4l366t123r425b167],
16	cases	NNS	O	case	prep_in	13	SENT_73	[p4l446t136r578b167],
17	and	CC	O	and	_	0	SENT_73	[p4l599t123r693b167],
18	at	IN	O	at	_	0	SENT_73	[p4l714t130r762b167],
19	the	DT	O	the	det	20	SENT_73	[p4l781t123r862b167],
20	time	NN	O	time	prep_at	5	SENT_73	[p4l883t124r1000b167],
21	of	IN	O	of	_	0	SENT_73	[p4l1021t123r1074b167],
22	best	JJS	O	best	amod	23	SENT_73	[p4l1088t123r1195b167],
23	response	NN	O	response	prep_of	20	SENT_73	[p4l1215t136r1444b178],
24	in	IN	O	in	_	0	SENT_73	[p4l1465t124r1513b166],
25	14	CD	NUMBER	14	num	26	SENT_73	[p4l1536t125r1595b166],
26	patients	NNS	O	patient	prep_in	5	SENT_73	[p4l1616t124r1836b178],
27	.	.	O	.	_	0	SENT_73	[p4l1616t124r1836b178],

1	These	DT	O	these	det	2	SENT_74	[p4l1855t123r2004b167],
2	samples	NNS	O	sample	nsubjpass	12	SENT_74	[p4l2026t136r2151b167, p4l10t194r111b248],
3	were	VBD	O	be	auxpass	4	SENT_74	[p4l132t206r261b237],
4	centrifuged	VBN	O	centrifuge	_	0	SENT_74	[p4l283t193r578b248],
5	at	IN	O	at	_	0	SENT_74	[p4l600t200r648b237],
6	2500	CD	DATE	2500	num	7	SENT_74	[p4l668t196r795b237],
7	rpm	NN	O	rpm	prep_at	4	SENT_74	[p4l808t206r914b248],
8	for	IN	O	for	_	0	SENT_74	[p4l936t193r1007b237],
9	7	CD	DURATION	7	num	10	SENT_74	[p4l1028t196r1055b237],
10	min	NN	DURATION	min	prep_for	7	SENT_74	[p4l1069t194r1169b237],
11	and	CC	O	and	_	0	SENT_74	[p4l1191t194r1283b237],
12	stored	VBD	O	store	conj_and	4	SENT_74	[p4l1306t194r1466b237],
13	at	IN	O	at	_	0	SENT_74	[p4l1489t200r1536b237],
14	—	CD	NUMBER	—	number	15	SENT_74	[p4l1559t196r1728b237],
15	20	CD	NUMBER	20	num	17	SENT_74	[p4l1559t196r1728b237],
16	°	NN	O	°	nn	17	SENT_74	[p4l1559t196r1728b237],
17	C	NN	O	c	prep_at	12	SENT_74	[p4l1559t196r1728b237],
18	until	IN	O	until	mark	21	SENT_74	[p4l1749t194r1868b237],
19	they	PRP	O	they	nsubjpass	21	SENT_74	[p4l1890t194r2004b248],
20	were	VBD	O	be	auxpass	21	SENT_74	[p4l2023t206r2151b237],
21	used	VBN	O	use	advcl	12	SENT_74	[p4l10t265r129b309],
22	to	TO	O	to	aux	23	SENT_74	[p4l153t271r202b309],
23	measure	VB	O	measure	xcomp	21	SENT_74	[p4l227t278r446b309],
24	cytokines	NNS	O	cytokine	dobj	23	SENT_74	[p4l471t265r728b319],
25	.	.	O	.	_	0	SENT_74	[p4l471t265r728b319],

1	Serum	NN	O	serum	nn	2	SENT_75	[p4l754t267r919b309],
2	concentrations	NNS	O	concentration	nsubjpass	18	SENT_75	[p4l943t266r1326b309],
3	of	IN	O	of	_	0	SENT_75	[p4l1351t265r1404b309],
4	tumor	NN	O	tumor	nn	10	SENT_75	[p4l1422t271r1583b309],
5	necrosis	NN	O	necrosis	nn	10	SENT_75	[p4l1606t266r1814b309],
6	factor	NN	O	factor	nn	10	SENT_75	[p4l1840t265r1989b309],
7	alpha	NN	O	alpha	nn	10	SENT_75	[p4l2012t265r2152b319],
8	(	CD	NUMBER	(	num	10	SENT_75	[p4l10t336r213b389],
9	TNF-oz	NN	O	tnf-oz	nn	10	SENT_75	[p4l10t336r213b389],
10	)	NN	O	)	prep_of	2	SENT_75	[p4l10t336r213b389],
11	and	CC	O	and	_	0	SENT_75	[p4l231t335r324b379],
12	interleukin	NN	O	interleukin	nn	15	SENT_75	[p4l344t335r628b379],
13	6	CD	NUMBER	6	num	15	SENT_75	[p4l647t338r675b379],
14	(	NN	O	(	nn	15	SENT_75	[p4l693t336r833b390],
15	IL-6	NN	O	il-6	conj_and	10	SENT_75	[p4l693t336r833b390],
16	)	NN	O	)	dep	15	SENT_75	[p4l693t336r833b390],
17	were	VBD	O	be	auxpass	18	SENT_75	[p4l850t348r978b379],
18	determined	VBN	O	determine	_	0	SENT_75	[p4l997t335r1297b379],
19	as	IN	O	as	_	0	SENT_75	[p4l1316t348r1366b379],
20	serum	NN	O	serum	nn	21	SENT_75	[p4l1386t348r1546b379],
21	immunoreactivity	NN	O	immunoreactivity	prep_as	18	SENT_75	[p4l1564t336r2031b390],
22	by	IN	O	by	_	0	SENT_75	[p4l2047t335r2109b390],
23	a	DT	O	a	det	25	SENT_75	[p4l2126t348r2152b379],
24	quantitative	JJ	O	quantitative	amod	25	SENT_75	[p4l10t408r323b461],
25	sandwich	NN	O	sandwich	nsubj	32	SENT_75	[p4l338t407r583b450],
26	enzyme-linked	JJ	O	enzyme-linked	amod	28	SENT_75	[p4l596t407r984b461],
27	immunosorbent	JJ	O	immunosorbent	amod	28	SENT_75	[p4l998t407r1415b450],
28	assay	NN	O	assay	dep	25	SENT_75	[p4l1427t419r1566b461],
29	(	CD	NUMBER	(	num	30	SENT_75	[p4l1578t407r1760b461],
30	ELISA	NN	ORGANIZATION	elisa	dep	25	SENT_75	[p4l1578t407r1760b461],
31	)	CD	NUMBER	)	dep	30	SENT_75	[p4l1578t407r1760b461],
32	using	VBG	O	use	agent	18	SENT_75	[p4l1773t408r1912b461],
33	kits	NNS	O	kit	dobj	32	SENT_75	[p4l1925t407r2014b450],
34	from	IN	O	from	_	0	SENT_75	[p4l2029t407r2152b450],
35	BioSource	NNP	ORGANIZATION	BioSource	prep_from	33	SENT_75	[p4l10t479r265b522],
36	(	CD	NUMBER	(	num	35	SENT_75	[p4l285t478r561b532],
37	BioSource	NNP	O	BioSource	nn	40	SENT_75	[p4l285t478r561b532],
38	TNF-or	NNP	O	TNF-or	nn	40	SENT_75	[p4l579t481r742b522],
39	EASIA	NNP	O	EASIA	nn	40	SENT_75	[p4l762t480r914b522],
40	kit	NN	O	kit	tmod	32	SENT_75	[p4l932t478r998b522],
41	and	CC	O	and	_	0	SENT_75	[p4l1017t478r1110b522],
42	BioSource	NNP	ORGANIZATION	BioSource	nn	44	SENT_75	[p4l1130t479r1385b522],
43	IL-6	NN	O	il-6	nn	44	SENT_75	[p4l1405t480r1502b522],
44	EASIA	NNP	O	EASIA	tmod	32	SENT_75	[p4l1522t480r1674b522],
45	kit	NN	O	kit	nn	46	SENT_75	[p4l1692t478r1791b532],
46	)	NN	O	)	dep	40	SENT_75	[p4l1692t478r1791b532],
47	,	,	O	,	_	0	SENT_75	[p4l1692t478r1791b532],
48	as	IN	O	as	_	0	SENT_75	[p4l1811t491r1861b522],
49	previously	RB	DATE	previously	advmod	50	SENT_75	[p4l1882t478r2153b533],
50	reported	VBN	O	report	amod	51	SENT_75	[p4l11t549r232b603],
51	[	NN	O	[	prep_as	40	SENT_75	[p4l256t548r336b603],
52	5	CD	NUMBER	5	num	53	SENT_75	[p4l256t548r336b603],
53	]	NN	O	]	dep	40	SENT_75	[p4l256t548r336b603],
54	.	.	O	.	_	0	SENT_75	[p4l256t548r336b603],

1	The	DT	O	the	det	2	SENT_76	[p4l355t549r448b592],
2	limit	NN	O	limit	nsubj	12	SENT_76	[p4l469t549r591b592],
3	of	IN	O	of	_	0	SENT_76	[p4l611t548r664b592],
4	detection	NN	O	detection	prep_of	2	SENT_76	[p4l678t549r920b592],
5	of	IN	O	of	_	0	SENT_76	[p4l941t549r994b592],
6	each	DT	O	each	det	7	SENT_76	[p4l1009t549r1126b592],
7	cytokine	NN	O	cytokine	prep_of	4	SENT_76	[p4l1146t549r1365b603],
8	in	IN	O	in	_	0	SENT_76	[p4l1387t549r1434b592],
9	serum	NN	O	serum	prep_in	7	SENT_76	[p4l1455t561r1615b592],
10	was	VBD	O	be	cop	12	SENT_76	[p4l1634t561r1734b592],
11	3	CD	NUMBER	3	num	12	SENT_76	[p4l1755t551r1782b592],
12	pg/mL	NN	O	pg/ml	_	0	SENT_76	[p4l1798t548r1961b603],
13	for	IN	O	for	_	0	SENT_76	[p4l1980t549r2051b592],
14	the	DT	O	the	det	15	SENT_76	[p4l2070t549r2151b592],
15	TNF-OL	NN	O	tnf-ol	prep_for	12	SENT_76	[p4l8t623r171b663],
16	and	CC	O	and	_	0	SENT_76	[p4l189t620r282b664],
17	2	CD	NUMBER	2	num	18	SENT_76	[p4l301t622r328b663],
18	pg/mL	NN	O	pg/ml	conj_and	12	SENT_76	[p4l342t620r506b674],
19	for	IN	O	for	_	0	SENT_76	[p4l522t620r594b664],
20	the	DT	O	the	det	21	SENT_76	[p4l609t620r691b664],
21	IL-6	NN	O	il-6	prep_for	18	SENT_76	[p4l709t622r819b664],
22	.	.	O	.	_	0	SENT_76	[p4l709t622r819b664],

1	2.5	CD	NUMBER	2.5	_	0	SENT_77	[p4l7t778r92b819],
2	.	.	O	.	_	0	SENT_77	[p4l7t778r92b819],

1	Data	NN	O	datum	nn	2	SENT_78	[p4l139t778r257b819],
2	analysis	NN	O	analysis	_	0	SENT_78	[p4l274t775r472b830],

1	Descriptive	JJ	O	descriptive	amod	3	SENT_79	[p4l112t920r403b974],
2	statistical	JJ	O	statistical	amod	3	SENT_79	[p4l427t920r672b963],
3	analysis	NN	O	analysis	nsubjpass	12	SENT_79	[p4l696t920r900b974],
4	of	IN	O	of	_	0	SENT_79	[p4l924t919r977b963],
5	the	DT	O	the	det	7	SENT_79	[p4l993t920r1075b963],
6	main	JJ	O	main	amod	7	SENT_79	[p4l1099t920r1228b963],
7	characteristics	NNS	O	characteristic	prep_of	3	SENT_79	[p4l1251t920r1623b963],
8	of	IN	O	of	_	0	SENT_79	[p4l1647t919r1700b963],
9	the	DT	O	the	det	10	SENT_79	[p4l1716t920r1798b963],
10	patients	NNS	O	patient	prep_of	7	SENT_79	[p4l1821t920r2028b974],
11	was	VBD	O	be	auxpass	12	SENT_79	[p4l2051t932r2151b963],
12	performed	VBN	O	perform	_	0	SENT_79	[p4l10t991r295b1045],
13	.	.	O	.	_	0	SENT_79	[p4l10t991r295b1045],

1	Differences	NNS	O	difference	nsubjpass	8	SENT_80	[p4l326t991r616b1035],
2	in	IN	O	in	_	0	SENT_80	[p4l646t992r694b1034],
3	toxicities	NNS	O	toxicity	prep_in	1	SENT_80	[p4l723t992r958b1035],
4	and	CC	O	and	_	0	SENT_80	[p4l988t991r1081b1035],
5	response	NN	O	response	nn	6	SENT_80	[p4l1112t1004r1341b1045],
6	rate	NN	O	rate	prep_in	1	SENT_80	[p4l1372t997r1470b1035],
7	were	VBD	O	be	auxpass	8	SENT_80	[p4l1499t1004r1627b1035],
8	assessed	VBN	O	assess	_	0	SENT_80	[p4l1658t991r1877b1035],
9	by	IN	O	by	_	0	SENT_80	[p4l1907t991r1969b1045],
10	Fisher	NNP	PERSON	Fisher	nn	12	SENT_80	[p4l1997t991r2153b1035],
11	exact	JJ	O	exact	amod	12	SENT_80	[p4l10t1068r146b1105],
12	test	NN	O	test	agent	8	SENT_80	[p4l169t1068r275b1105],
13	.	.	O	.	_	0	SENT_80	[p4l169t1068r275b1105],

1	Survival	NN	O	survival	nn	2	SENT_81	[p4l301t1062r508b1105],
2	probabilities	NNS	O	probability	nsubjpass	4	SENT_81	[p4l534t1061r856b1116],
3	were	VBD	O	be	auxpass	4	SENT_81	[p4l881t1074r1009b1105],
4	estimated	VBN	O	estimate	_	0	SENT_81	[p4l1034t1061r1289b1105],
5	using	VBG	O	use	xcomp	4	SENT_81	[p4l1314t1062r1453b1116],
6	the	DT	O	the	det	7	SENT_81	[p4l1476t1061r1557b1105],
7	I	PRP	O	I	nsubj	8	SENT_81	[p4l1583t1061r1916b1116],
8	(	VBP	O	(	ccomp	5	SENT_81	[p4l1583t1061r1916b1116],
9	aplan	NN	O	aplan	dobj	8	SENT_81	[p4l1583t1061r1916b1116],
10	.	.	O	.	_	0	SENT_81	[p4l1583t1061r1916b1116],

1	—	NN	O	—	_	0	SENT_82	[p4l1583t1061r1916b1116],
2	.	.	O	.	_	0	SENT_82	[p4l1583t1061r1916b1116],

1	Meir	NNP	PERSON	Meir	_	0	SENT_83	[p4l1583t1061r1916b1116],
2	method	NN	O	method	dep	1	SENT_83	[p4l1939t1061r2151b1105],
3	.	.	O	.	_	0	SENT_83	[p4l1939t1061r2151b1105],

1	Cytokines	NNS	O	cytokine	nn	2	SENT_84	[p4l10t1133r261b1187],
2	levels	NNS	O	level	nsubj	3	SENT_84	[p4l288t1133r432b1176],
3	were	VBD	O	be	_	0	SENT_84	[p4l457t1145r586b1176],
4	compared	VBN	O	compare	prep	3	SENT_84	[p4l612t1133r869b1187],
5	by	IN	O	by	pcomp	4	SENT_84	[p4l894t1133r956b1187],
6	either	CC	O	either	dep	5	SENT_84	[p4l980t1133r1133b1176],
7	I	PRP	O	I	conj	5	SENT_84	[p4l1157t1133r1546b1176],
8	(	VBP	O	(	rcmod	7	SENT_84	[p4l1157t1133r1546b1176],
9	ruskal	NN	O	ruskal	dobj	8	SENT_84	[p4l1157t1133r1546b1176],
10	.	.	O	.	_	0	SENT_84	[p4l1157t1133r1546b1176],

1	—	NN	O	—	_	0	SENT_85	[p4l1157t1133r1546b1176],
2	.	.	O	.	_	0	SENT_85	[p4l1157t1133r1546b1176],

1	Wallis	NNP	PERSON	Wallis	_	0	SENT_86	[p4l1157t1133r1546b1176],
2	test	NN	O	test	dep	1	SENT_86	[p4l1572t1139r1667b1176],
3	or	CC	O	or	_	0	SENT_86	[p4l1691t1145r1745b1176],
4	t-test	NN	O	t-test	dep	1	SENT_86	[p4l1770t1139r1918b1177],
5	.	.	O	.	_	0	SENT_86	[p4l1770t1139r1918b1177],

1	Survival	NN	O	survival	nn	2	SENT_87	[p4l1944t1133r2151b1176],
2	curves	NNS	O	curve	nsubjpass	4	SENT_87	[p4l10t1217r175b1248],
3	were	VBD	O	be	auxpass	4	SENT_87	[p4l191t1217r320b1248],
4	analyzed	VBN	O	analyze	dep	17	SENT_87	[p4l337t1204r565b1259],
5	by	IN	O	by	_	0	SENT_87	[p4l582t1204r644b1259],
6	the	DT	O	the	det	8	SENT_87	[p4l659t1204r740b1248],
7	log-rank	JJ	O	log-rank	amod	8	SENT_87	[p4l757t1204r976b1259],
8	test	NN	O	test	agent	4	SENT_87	[p4l990t1211r1097b1254],
9	,	,	O	,	_	0	SENT_87	[p4l990t1211r1097b1254],
10	and	CC	O	and	_	0	SENT_87	[p4l1114t1204r1207b1248],
11	the	DT	O	the	det	15	SENT_87	[p4l1224t1204r1305b1248],
12	Cox	NN	ORGANIZATION	cox	nn	15	SENT_87	[p4l1323t1206r1417b1248],
13	proportional	JJ	O	proportional	amod	15	SENT_87	[p4l1433t1204r1757b1259],
14	hazards	NNS	O	hazard	nn	15	SENT_87	[p4l1775t1204r1973b1248],
15	model	NN	O	model	agent	4	SENT_87	[p4l1991t1204r2151b1248],
16	was	VBD	O	be	auxpass	17	SENT_87	[p4l9t1287r108b1318],
17	used	VBN	O	use	_	0	SENT_87	[p4l129t1275r248b1318],
18	to	TO	O	to	aux	19	SENT_87	[p4l267t1281r316b1318],
19	estimate	VB	O	estimate	xcomp	17	SENT_87	[p4l337t1275r558b1318],
20	the	DT	O	the	det	22	SENT_87	[p4l578t1275r659b1318],
21	risk	NN	O	risk	nn	22	SENT_87	[p4l679t1275r773b1318],
22	ratio	NN	O	ratio	dobj	19	SENT_87	[p4l792t1275r910b1318],
23	of	IN	O	of	_	0	SENT_87	[p4l930t1274r983b1318],
24	events	NNS	O	event	prep_of	22	SENT_87	[p4l997t1281r1163b1318],
25	(	JJ	O	(	amod	27	SENT_87	[p4l1184t1275r1398b1329],
26	relative	JJ	O	relative	amod	27	SENT_87	[p4l1184t1275r1398b1329],
27	risk	NN	O	risk	nsubjpass	17	SENT_87	[p4l1418t1275r1523b1325],
28	,	,	O	,	_	0	SENT_87	[p4l1418t1275r1523b1325],
29	RR	NN	O	rr	nn	30	SENT_87	[p4l1544t1275r1630b1329],
30	)	NN	O	)	appos	27	SENT_87	[p4l1544t1275r1630b1329],
31	with	IN	O	with	_	0	SENT_87	[p4l1649t1275r1768b1318],
32	the	DT	O	the	det	38	SENT_87	[p4l1787t1275r1868b1318],
33	respective	JJ	O	respective	amod	38	SENT_87	[p4l1889t1275r2151b1329],
34	conﬁdence	NN	O	conﬁdence	nn	38	SENT_87	[p4l10t1346r289b1390],
35	interval	NN	O	interval	nn	38	SENT_87	[p4l314t1346r512b1390],
36	(	CD	NUMBER	(	num	38	SENT_87	[p4l536t1346r625b1400],
37	CI	NN	O	ci	nn	38	SENT_87	[p4l536t1346r625b1400],
38	)	NN	O	)	prep_with	30	SENT_87	[p4l536t1346r625b1400],
39	after	IN	O	after	_	0	SENT_87	[p4l650t1346r770b1390],
40	controlling	VBG	O	control	prepc_after	38	SENT_87	[p4l793t1346r1076b1400],
41	for	IN	O	for	_	0	SENT_87	[p4l1099t1346r1171b1390],
42	prognostic	JJ	O	prognostic	amod	43	SENT_87	[p4l1193t1347r1466b1400],
43	variables	NNS	O	variable	prep_for	40	SENT_87	[p4l1489t1346r1733b1390],
44	.	.	O	.	_	0	SENT_87	[p4l1489t1346r1733b1390],

1	Statistical	JJ	O	statistical	amod	2	SENT_88	[p4l1758t1346r2008b1390],
2	tests	NNS	O	test	nsubjpass	4	SENT_88	[p4l2032t1352r2151b1390],
3	were	VBD	O	be	auxpass	4	SENT_88	[p4l9t1429r137b1460],
4	performed	VBN	O	perform	_	0	SENT_88	[p4l163t1416r435b1471],
5	with	IN	O	with	_	0	SENT_88	[p4l460t1417r578b1460],
6	SPSS	NN	ORGANIZATION	spss	nn	7	SENT_88	[p4l604t1419r720b1460],
7	software	NN	O	software	prep_with	4	SENT_88	[p4l747t1416r970b1460],
8	15.0	CD	NUMBER	15.0	num	7	SENT_88	[p4l999t1419r1103b1460],
9	for	IN	O	for	_	0	SENT_88	[p4l1129t1416r1201b1460],
10	Windows	NNP	MISC	Windows	nn	11	SENT_88	[p4l1223t1412r1519b1460],
11	®	NNP	MISC	®	prep_for	4	SENT_88	[p4l1223t1412r1519b1460],
12	.	.	O	.	_	0	SENT_88	[p4l1223t1412r1519b1460],

1	A	DT	O	a	det	2	SENT_89	[p4l1543t1418r1580b1460],
2	value	NN	O	value	nsubjpass	8	SENT_89	[p4l1602t1416r1740b1460],
3	of	IN	O	of	_	0	SENT_89	[p4l1766t1416r1820b1460],
4	p	NN	O	p	prep_of	2	SENT_89	[p4l1835t1419r2025b1471],
5	<	JJR	O	<	dep	4	SENT_89	[p4l1835t1419r2025b1471],
6	0.05	CD	NUMBER	0.05	dep	5	SENT_89	[p4l1835t1419r2025b1471],
7	was	VBD	O	be	auxpass	8	SENT_89	[p4l2051t1429r2151b1460],
8	required	VBN	O	require	_	0	SENT_89	[p4l11t1488r229b1542],
9	for	IN	O	for	_	0	SENT_89	[p4l248t1488r320b1531],
10	statistical	JJ	O	statistical	amod	11	SENT_89	[p4l336t1488r582b1531],
11	signiﬁcance	NN	O	signiﬁcance	prep_for	8	SENT_89	[p4l601t1488r916b1542],
12	.	.	O	.	_	0	SENT_89	[p4l601t1488r916b1542],

1	3	LS	NUMBER	3	_	0	SENT_90	[p4l9t1673r65b1725],
2	.	.	O	.	_	0	SENT_90	[p4l9t1673r65b1725],

1	Results	NNS	O	result	_	0	SENT_91	[p4l111t1670r354b1724],

1	3.1	CD	NUMBER	3.1	_	0	SENT_92	[p4l7t1850r113b1902],
2	.	.	O	.	_	0	SENT_92	[p4l7t1850r113b1902],

1	Patients	NNS	O	patient	_	0	SENT_93	[p4l161t1849r409b1902],

1	All	DT	O	all	det	3	SENT_94	[p4l110t2025r196b2079],
2	28	CD	NUMBER	28	num	3	SENT_94	[p4l222t2027r297b2080],
3	patients	NNS	O	patient	nsubj	5	SENT_94	[p4l325t2025r583b2093],
4	were	VBD	O	be	cop	5	SENT_94	[p4l609t2040r769b2080],
5	evaluable	JJ	O	evaluable	_	0	SENT_94	[p4l795t2024r1101b2080],
6	for	IN	O	for	_	0	SENT_94	[p4l1128t2024r1218b2080],
7	response	NN	O	response	prep_for	5	SENT_94	[p4l1242t2040r1543b2093],
8	.	.	O	.	_	0	SENT_94	[p4l1242t2040r1543b2093],

1	The	DT	O	the	det	3	SENT_95	[p4l1567t2025r1684b2080],
2	median	JJ	O	median	amod	3	SENT_95	[p4l1711t2025r1951b2080],
3	duration	NN	O	duration	nsubj	9	SENT_95	[p4l1977t2025r2150b2080, p4l10t2115r137b2168],
4	of	IN	O	of	_	0	SENT_95	[p4l160t2114r226b2168],
5	thalidomide	NN	O	thalidomide	nn	6	SENT_95	[p4l241t2114r632b2168],
6	treatment	NN	O	treatment	prep_of	3	SENT_95	[p4l656t2122r980b2168],
7	was	VBD	O	be	cop	9	SENT_95	[p4l1000t2130r1125b2168],
8	4	CD	DURATION	4	num	9	SENT_95	[p4l1148t2117r1186b2167],
9	months	NNS	NUMBER	month	dep	19	SENT_95	[p4l1209t2114r1452b2168],
10	and	CC	O	and	_	0	SENT_95	[p4l1476t2114r1592b2168],
11	the	DT	O	the	det	13	SENT_95	[p4l1616t2114r1717b2168],
12	median	NN	O	median	nn	13	SENT_95	[p4l1741t2114r1982b2168],
13	dose	NN	O	dose	conj_and	9	SENT_95	[p4l2005t2114r2150b2168],
14	used	VBN	O	use	partmod	13	SENT_95	[p4l11t2201r159b2256],
15	was	VBD	O	be	cop	19	SENT_95	[p4l179t2217r303b2256],
16	400	CD	NUMBER	400	num	19	SENT_95	[p4l323t2204r443b2256],
17	mg/day	JJ	O	mg/day	amod	19	SENT_95	[p4l460t2201r702b2270],
18	(	NN	O	(	nn	19	SENT_95	[p4l722t2201r927b2270],
19	range	NN	O	range	_	0	SENT_95	[p4l722t2201r927b2270],
20	200-800	CD	NUMBER	200-800	num	21	SENT_95	[p4l948t2201r1271b2269],
21	)	NN	O	)	nsubj	19	SENT_95	[p4l948t2201r1271b2269],
22	.	.	O	.	_	0	SENT_95	[p4l948t2201r1271b2269],

1	Median	JJ	O	median	nsubj	2	SENT_96	[p4l1294t2201r1535b2256],
2	follow	VBP	O	follow	dep	10	SENT_96	[p4l1556t2201r1871b2270],
3	—	CD	NUMBER	—	dobj	2	SENT_96	[p4l1556t2201r1871b2270],
4	up	RP	O	up	prt	2	SENT_96	[p4l1556t2201r1871b2270],
5	for	IN	O	for	_	0	SENT_96	[p4l1893t2201r1982b2256],
6	alive	JJ	O	alive	amod	7	SENT_96	[p4l2001t2201r2150b2256],
7	patients	NNS	O	patient	prep_for	2	SENT_96	[p4l11t2291r269b2359],
8	was	VBD	O	be	cop	10	SENT_96	[p4l295t2306r420b2345],
9	103	CD	DURATION	103	num	10	SENT_96	[p4l451t2293r562b2345],
10	months	NNS	NUMBER	month	_	0	SENT_96	[p4l592t2290r835b2345],
11	(	JJ	O	(	amod	12	SENT_96	[p4l862t2290r1067b2359],
12	range	NN	O	range	nsubj	24	SENT_96	[p4l862t2290r1067b2359],
13	86-112	CD	NUMBER	86-112	num	14	SENT_96	[p4l1095t2290r1361b2358],
14	)	NN	O	)	dep	12	SENT_96	[p4l1095t2290r1361b2358],
15	and	CC	O	and	_	0	SENT_96	[p4l1387t2290r1504b2345],
16	in	IN	O	in	dep	12	SENT_96	[p4l1531t2291r1590b2345],
17	the	DT	O	the	det	19	SENT_96	[p4l1616t2290r1717b2345],
18	whole	JJ	O	whole	amod	19	SENT_96	[p4l1743t2290r1941b2345],
19	series	NN	O	series	pobj	16	SENT_96	[p4l1969t2291r2150b2345],
20	was	VBD	O	be	cop	24	SENT_96	[p4l9t2395r133b2434],
21	30.9	CD	DURATION	30.9	num	22	SENT_96	[p4l153t2382r288b2435],
22	months	NNS	NUMBER	month	tmod	23	SENT_96	[p4l309t2379r552b2434],
23	(	JJ	O	(	amod	24	SENT_96	[p4l573t2380r777b2448],
24	range	NN	O	range	attr	10	SENT_96	[p4l573t2380r777b2448],
25	3-115	CD	NUMBER	3-115	num	26	SENT_96	[p4l797t2379r1039b2448],
26	)	NN	O	)	nsubj	10	SENT_96	[p4l797t2379r1039b2448],
27	.	.	O	.	_	0	SENT_96	[p4l797t2379r1039b2448],

1	Partial	JJ	O	partial	amod	5	SENT_97	[p4l1060t2379r1265b2434],
2	response	NN	O	response	nn	5	SENT_97	[p4l1286t2395r1572b2448],
3	(	CD	NUMBER	(	num	5	SENT_97	[p4l1592t2380r1723b2448],
4	PR	NN	O	pr	nn	5	SENT_97	[p4l1592t2380r1723b2448],
5	)	NN	O	)	nsubjpass	7	SENT_97	[p4l1592t2380r1723b2448],
6	was	VBD	O	be	auxpass	7	SENT_97	[p4l1741t2395r1866b2434],
7	attained	VBN	O	attain	_	0	SENT_97	[p4l1887t2379r2150b2434],
8	in	IN	O	in	_	0	SENT_97	[p4l11t2469r70b2523],
9	17.9	CD	PERCENT	17.9	num	10	SENT_97	[p4l98t2471r274b2524],
10	%	NN	PERCENT	%	prep_in	7	SENT_97	[p4l98t2471r274b2524],
11	(	CD	NUMBER	(	number	12	SENT_97	[p4l298t2468r493b2537],
12	5/28	CD	NUMBER	5/28	num	13	SENT_97	[p4l298t2468r493b2537],
13	)	NN	O	)	dep	10	SENT_97	[p4l298t2468r493b2537],
14	and	CC	O	and	_	0	SENT_97	[p4l518t2469r635b2524],
15	minimal	JJ	O	minimal	amod	16	SENT_97	[p4l661t2469r929b2524],
16	response	NN	O	response	prep_in	7	SENT_97	[p4l955t2484r1241b2537],
17	(	CD	NUMBER	(	num	19	SENT_97	[p4l1267t2469r1423b2537],
18	MR	NN	O	mr	nn	19	SENT_97	[p4l1267t2469r1423b2537],
19	)	NN	O	)	dep	16	SENT_97	[p4l1267t2469r1423b2537],
20	in	IN	O	in	_	0	SENT_97	[p4l1449t2469r1508b2523],
21	28.6	CD	PERCENT	28.6	num	22	SENT_97	[p4l1533t2471r1712b2524],
22	%	NN	PERCENT	%	prep_in	7	SENT_97	[p4l1533t2471r1712b2524],
23	(	CD	NUMBER	(	number	24	SENT_97	[p4l1736t2468r1947b2537],
24	8/28	CD	NUMBER	8/28	num	25	SENT_97	[p4l1736t2468r1947b2537],
25	)	NN	O	)	rcmod	22	SENT_97	[p4l1736t2468r1947b2537],
26	,	,	O	,	_	0	SENT_97	[p4l1736t2468r1947b2537],
27	while	IN	O	while	advmod	25	SENT_97	[p4l1971t2468r2150b2524],

1	Pathway	NN	O	pathway	nn	4	SENT_98	[p4l32t2628r141b2655],
2	Gene	NN	O	gene	nn	4	SENT_98	[p4l421t2629r484b2650],
3	Gene	NN	O	gene	nn	4	SENT_98	[p4l658t2629r721b2650],
4	name	NN	O	name	_	0	SENT_98	[p4l730t2634r799b2650],
5	SNPs	NNS	O	snp	dep	4	SENT_98	[p4l1530t2629r1591b2650],
6	Change	NNP	O	Change	nn	9	SENT_98	[p4l1791t2628r1883b2655],
7	Type	NN	O	type	nn	9	SENT_98	[p4l2067t2629r2128b2655],
8	Multidrug	JJ	O	multidrug	amod	9	SENT_98	[p4l48t2691r244b2732],
9	resistance	NN	O	resistance	dep	5	SENT_98	[p4l257t2691r450b2724],
10	ABCB1	NN	O	abcb1	nn	12	SENT_98	[p4l643t2692r766b2724],
11	ATP-binding	JJ	O	atp-binding	amod	12	SENT_98	[p4l1008t2691r1250b2732],
12	cassette	NN	O	cassette	dep	9	SENT_98	[p4l1263t2696r1426b2729],
13	,	,	O	,	_	0	SENT_98	[p4l1263t2696r1426b2729],
14	sub-family	JJ	O	sub-family	amod	9	SENT_98	[p4l1441t2691r1649b2732],
15	B	NN	O	b	nn	18	SENT_98	[p4l1662t2693r1684b2724],
16	(	CD	NUMBER	(	num	18	SENT_98	[p4l1698t2691r1922b2732],
17	MDR/TAP	NN	O	mdr/tap	nn	18	SENT_98	[p4l1698t2691r1922b2732],
18	)	NN	O	)	tmod	14	SENT_98	[p4l1698t2691r1922b2732],
19	,	,	O	,	_	0	SENT_98	[p4l1698t2691r1922b2732],
20	member	NN	O	member	appos	18	SENT_98	[p4l1937t2691r2100b2724],
21	1	CD	NUMBER	1	num	20	SENT_98	[p4l2114t2692r2129b2724],

1	Drug	NN	O	drug	nn	3	SENT_99	[p4l48t2802r143b2841],
2	metabolism	NN	O	metabolism	nn	3	SENT_99	[p4l155t2800r384b2833],
3	NR1I2	NN	O	nr1i2	_	0	SENT_99	[p4l645t2802r761b2833],
4	Nuclear	JJ	O	nuclear	amod	6	SENT_99	[p4l1010t2801r1160b2833],
5	receptor	NN	O	receptor	nn	6	SENT_99	[p4l1172t2805r1335b2841],
6	subfamily	NN	O	subfamily	dep	3	SENT_99	[p4l1348t2800r1539b2841],
7	1	CD	NUMBER	1	dep	6	SENT_99	[p4l1553t2802r1582b2838],
8	,	,	O	,	_	0	SENT_99	[p4l1553t2802r1582b2838],
9	group	NN	O	group	appos	7	SENT_99	[p4l1596t2810r1708b2841],
10	I	CD	NUMBER	i	num	9	SENT_99	[p4l1723t2802r1742b2838],
11	,	,	O	,	_	0	SENT_99	[p4l1723t2802r1742b2838],
12	member	NN	O	member	dep	3	SENT_99	[p4l1756t2800r1920b2833],
13	2	CD	NUMBER	2	num	12	SENT_99	[p4l1932t2802r1952b2833],

1	GSTT1	NN	O	gstt1	nn	3	SENT_100	[p4l645t2911r761b2942],
2	Glutathione	NN	O	glutathione	nn	3	SENT_100	[p4l1010t2909r1239b2942],
3	S	NN	O	s	dep	11	SENT_100	[p4l1253t2909r1506b2942],
4	—	CD	NUMBER	—	num	6	SENT_100	[p4l1253t2909r1506b2942],
5	transferase	NN	O	transferase	nn	6	SENT_100	[p4l1253t2909r1506b2942],
6	theta	NN	O	theta	dep	3	SENT_100	[p4l1520t2909r1619b2942],
7	1	CD	NUMBER	1	num	8	SENT_100	[p4l1634t2911r1649b2942],
8	SULT1	NN	O	sult1	dep	11	SENT_100	[p4l645t2964r759b2996],
9	C2	NN	O	c2	nn	11	SENT_100	[p4l767t2964r813b2996],
10	Sulfotransferase	NN	O	sulfotransferase	nn	11	SENT_100	[p4l1010t2963r1322b2996],
11	family	NN	O	family	_	0	SENT_100	[p4l1336t2963r1466b3004],
12	,	,	O	,	_	0	SENT_100	[p4l1336t2963r1466b3004],
13	cytosolic	JJ	O	cytosolic	appos	11	SENT_100	[p4l1481t2963r1659b3004],
14	,	,	O	,	_	0	SENT_100	[p4l1481t2963r1659b3004],
15	1	CD	NUMBER	1	num	16	SENT_100	[p4l1676t2965r1690b2996],
16	C	NN	O	c	appos	11	SENT_100	[p4l1705t2964r1737b3001],
17	,	,	O	,	_	0	SENT_100	[p4l1705t2964r1737b3001],
18	member	NN	O	member	appos	11	SENT_100	[p4l1751t2963r1915b2996],
19	4	CD	NUMBER	4	num	18	SENT_100	[p4l1926t2964r1949b2996],

1	DNA	NN	O	dna	nn	3	SENT_101	[p4l48t3018r136b3049],
2	repair	NN	O	repair	nn	3	SENT_101	[p4l148t3018r264b3058],
3	systems	NNS	O	system	_	0	SENT_101	[p4l277t3022r430b3058],
4	XPA	NNP	ORGANIZATION	XPA	nn	6	SENT_101	[p4l644t3019r724b3049],
5	Xeroderma	NNP	ORGANIZATION	Xeroderma	nn	6	SENT_101	[p4l1008t3017r1226b3050],
6	pigmentosum	NN	O	pigmentosum	dep	3	SENT_101	[p4l1239t3018r1517b3058],
7	,	,	O	,	_	0	SENT_101	[p4l1239t3018r1517b3058],
8	complementation	NN	O	complementation	nn	13	SENT_101	[p4l1532t3017r1877b3058],
9	group	NN	O	group	nn	13	SENT_101	[p4l1889t3027r2002b3058],
10	A	NN	O	a	nn	13	SENT_101	[p4l2014t3019r2042b3049],
11	ERCC1	NN	O	ercc1	nn	13	SENT_101	[p4l645t3071r763b3103],
12	Excision	NN	O	excision	nn	13	SENT_101	[p4l1010t3070r1169b3103],
13	repair	NN	O	repair	appos	6	SENT_101	[p4l1182t3070r1298b3111],
14	cross-complementing	JJ	O	cross-complementing	amod	17	SENT_101	[p4l1310t3070r1734b3111],
15	rodent	JJ	O	rodent	amod	17	SENT_101	[p4l1747t3070r1875b3103],
16	repair	NN	O	repair	nn	17	SENT_101	[p4l1888t3070r2003b3111],
17	deﬁciency	NN	O	deﬁciency	dep	13	SENT_101	[p4l1010t3124r1215b3165],
18	,	,	O	,	_	0	SENT_101	[p4l1010t3124r1215b3165],
19	complementation	NN	O	complementation	nn	20	SENT_101	[p4l1229t3124r1574b3165],
20	group	NN	O	group	appos	6	SENT_101	[p4l1586t3134r1700b3165],
21	1	CD	NUMBER	1	dep	3	SENT_101	[p4l1715t3126r1730b3157],

1	ERCC2	NN	O	ercc2	nn	3	SENT_102	[p4l645t3179r767b3210],
2	Excision	NN	O	excision	nn	3	SENT_102	[p4l1010t3178r1169b3210],
3	repair	NN	O	repair	_	0	SENT_102	[p4l1182t3178r1298b3218],
4	cross-complementing	JJ	O	cross-complementing	amod	7	SENT_102	[p4l1310t3177r1734b3218],
5	rodent	JJ	O	rodent	amod	7	SENT_102	[p4l1747t3177r1875b3210],
6	repair	NN	O	repair	nn	7	SENT_102	[p4l1888t3178r2003b3218],
7	deﬁciency	NN	O	deﬁciency	dep	3	SENT_102	[p4l1010t3231r1215b3272],
8	,	,	O	,	_	0	SENT_102	[p4l1010t3231r1215b3272],
9	complementation	NN	O	complementation	nn	10	SENT_102	[p4l1229t3231r1574b3272],
10	group	NN	O	group	appos	7	SENT_102	[p4l1586t3240r1700b3272],
11	2	CD	NUMBER	2	dep	3	SENT_102	[p4l1713t3232r1734b3264],

1	ERCC5	NN	O	ercc5	nn	3	SENT_103	[p4l645t3287r767b3318],
2	Excision	NN	O	excision	nn	3	SENT_103	[p4l1010t3286r1169b3318],
3	repair	NN	O	repair	_	0	SENT_103	[p4l1182t3286r1298b3326],
4	cross-complementing	JJ	O	cross-complementing	amod	7	SENT_103	[p4l1310t3285r1734b3326],
5	rodent	JJ	O	rodent	amod	7	SENT_103	[p4l1747t3285r1875b3318],
6	repair	NN	O	repair	nn	7	SENT_103	[p4l1888t3286r2003b3326],
7	deﬁciency	NN	O	deﬁciency	dep	3	SENT_103	[p4l1010t3337r1215b3378],
8	,	,	O	,	_	0	SENT_103	[p4l1010t3337r1215b3378],
9	complementation	NN	O	complementation	nn	10	SENT_103	[p4l1010t3391r1355b3432],
10	group	NN	O	group	appos	7	SENT_103	[p4l1367t3401r1480b3432],
11	5	CD	NUMBER	5	dep	3	SENT_103	[p4l1494t3393r1514b3424],

1	XRCC1	NN	O	xrcc1	nsubj	2	SENT_104	[p4l644t3446r767b3477],
2	X	NN	O	x	_	0	SENT_104	[p4l1008t3446r1116b3485],
3	—	CD	NUMBER	—	num	5	SENT_104	[p4l1008t3446r1116b3485],
4	ray	NN	O	ray	nn	5	SENT_104	[p4l1008t3446r1116b3485],
5	repair	NN	O	repair	nsubj	6	SENT_104	[p4l1129t3445r1244b3485],
6	complementing	VBG	O	complement	dep	2	SENT_104	[p4l1257t3444r1564b3485],
7	defective	JJ	O	defective	amod	8	SENT_104	[p4l1576t3444r1751b3477],
8	repair	NN	O	repair	dobj	6	SENT_104	[p4l1765t3445r1881b3485],
9	in	IN	O	in	_	0	SENT_104	[p4l1893t3445r1929b3476],
10	Chinese	JJ	MISC	chinese	amod	12	SENT_104	[p4l1942t3444r2092b3477],
11	hamster	NN	O	hamster	nn	12	SENT_104	[p4l1010t3498r1170b3531],
12	cells	NNS	O	cell	prep_in	6	SENT_104	[p4l1182t3498r1265b3531],
13	1	CD	NUMBER	1	dep	12	SENT_104	[p4l1281t3500r1296b3530],

1	XRCC5	NN	O	xrcc5	nsubj	2	SENT_105	[p4l644t3553r771b3584],
2	X	NN	O	x	_	0	SENT_105	[p4l1008t3553r1116b3592],
3	—	CD	NUMBER	—	num	5	SENT_105	[p4l1008t3553r1116b3592],
4	ray	NN	O	ray	nn	5	SENT_105	[p4l1008t3553r1116b3592],
5	repair	NN	O	repair	nsubj	16	SENT_105	[p4l1129t3552r1244b3592],
6	complementing	VBG	O	complement	partmod	5	SENT_105	[p4l1257t3551r1564b3592],
7	defective	JJ	O	defective	amod	8	SENT_105	[p4l1576t3551r1751b3584],
8	repair	NN	O	repair	nsubj	15	SENT_105	[p4l1765t3552r1881b3592],
9	in	IN	O	in	_	0	SENT_105	[p4l1893t3552r1929b3583],
10	Chinese	JJ	MISC	chinese	amod	12	SENT_105	[p4l1942t3551r2092b3584],
11	hamster	NN	O	hamster	nn	12	SENT_105	[p4l1010t3604r1170b3637],
12	cells	NNS	O	cell	prep_in	8	SENT_105	[p4l1182t3604r1265b3637],
13	5	CD	NUMBER	5	number	14	SENT_105	[p4l1280t3606r1300b3637],
14	(	CD	NUMBER	(	npadvmod	15	SENT_105	[p4l1315t3604r1733b3645],
15	double-strand-break	JJ	O	double-strand-break	xcomp	6	SENT_105	[p4l1315t3604r1733b3645],
16	rejoining	VBG	O	rejoin	dep	2	SENT_105	[p4l1745t3604r1934b3645],
17	)	NN	O	)	dobj	16	SENT_105	[p4l1745t3604r1934b3645],

1	TOP2A	NN	O	top2a	nn	2	SENT_106	[p4l643t3715r774b3746],
2	Topoisomerase	NN	O	topoisomerase	_	0	SENT_106	[p4l1008t3714r1302b3754],
3	(	CD	NUMBER	(	num	5	SENT_106	[p4l1315t3713r1433b3754],
4	DNA	NN	O	dna	nn	5	SENT_106	[p4l1315t3713r1433b3754],
5	)	NN	O	)	dep	2	SENT_106	[p4l1315t3713r1433b3754],
6	II	CD	NUMBER	ii	number	7	SENT_106	[p4l1447t3715r1470b3745],
7	alpha	NN	O	alpha	amod	5	SENT_106	[p4l1484t3713r1589b3754],

1	Cytokines	NNS	O	cytokine	nsubj	2	SENT_107	[p4l48t3767r236b3808],
2	VEGFA	VBP	O	vegfa	_	0	SENT_107	[p4l643t3768r775b3800],
3	Vascular	JJ	O	vascular	amod	7	SENT_107	[p4l1008t3767r1175b3800],
4	endothelial	JJ	O	endothelial	amod	7	SENT_107	[p4l1187t3767r1405b3800],
5	growth	NN	O	growth	nn	7	SENT_107	[p4l1418t3767r1559b3808],
6	factor	NN	O	factor	nn	7	SENT_107	[p4l1573t3767r1684b3800],
7	A	NN	O	a	dobj	2	SENT_107	[p4l1695t3768r1723b3800],

1	Table	NNP	O	Table	tmod	16	SENT_108	[p5l8t166r117b199],
2	3	CD	NUMBER	3	num	1	SENT_108	[p5l129t167r152b199],
3	Summary	NNP	O	Summary	nsubj	16	SENT_108	[p5l10t221r197b260],
4	of	IN	O	of	_	0	SENT_108	[p5l210t219r249b252],
5	response	NN	O	response	nn	6	SENT_108	[p5l258t229r430b260],
6	rate	NN	O	rate	prep_of	3	SENT_108	[p5l444t224r528b257],
7	,	,	O	,	_	0	SENT_108	[p5l444t224r528b257],
8	overall	JJ	O	overall	amod	9	SENT_108	[p5l542t219r673b252],
9	survival	NN	O	survival	prep_of	3	SENT_108	[p5l687t219r839b252],
10	and	CC	O	and	_	0	SENT_108	[p5l853t219r923b252],
11	toxicities	NNS	O	toxicity	prep_of	3	SENT_108	[p5l936t220r1112b252],
12	according	VBG	O	accord	_	0	SENT_108	[p5l1126t219r1315b260],
13	to	TO	O	to	prepc_according_to	11	SENT_108	[p5l1327t224r1364b252],
14	the	DT	O	the	det	15	SENT_108	[p5l1378t219r1439b252],
15	SNP	NN	ORGANIZATION	snp	pobj	11	SENT_108	[p5l1453t221r1528b252],
16	studied	VBN	O	study	_	0	SENT_108	[p5l1541t219r1693b252],
17	.	.	O	.	_	0	SENT_108	[p5l1541t219r1693b252],

1	rs3842	NN	O	rs3842	nn	2	SENT_109	[p5l363t467r597b523],
2	—	NN	O	—	dep	16	SENT_109	[p5l1086t502r1132b506],
3	1	CD	NUMBER	1	num	4	SENT_109	[p5l1144t467r1171b523],
4	93C	NN	O	93c	dep	2	SENT_109	[p5l1185t467r1316b523],
5	>	JJR	O	>	amod	6	SENT_109	[p5l1334t477r1369b515],
6	T	NN	O	t	dep	4	SENT_109	[p5l1384t467r1427b523],
7	5	CD	NUMBER	5	number	8	SENT_109	[p5l1852t467r2058b523],
8	’	CD	NUMBER	’	num	12	SENT_109	[p5l1852t467r2058b523],
9	UTR	NN	O	utr	nn	12	SENT_109	[p5l1852t467r2058b523],
10	rs1045642	NN	O	rs1045642	nn	12	SENT_109	[p5l363t564r730b620],
11	Ile11	NN	O	ile11	nn	12	SENT_109	[p5l1085t561r1245b620],
12	45Met	NN	O	45met	dep	6	SENT_109	[p5l1257t564r1484b620],
13	Exonic	JJ	O	exonic	amod	14	SENT_109	[p5l1851t562r2081b620],
14	rs1523130	NN	O	rs1523130	dep	16	SENT_109	[p5l363t660r732b715],
15	—	CD	NUMBER	—	num	16	SENT_109	[p5l1086t660r1469b715],
16	1663T	NN	O	1663t	dep	25	SENT_109	[p5l1086t660r1469b715],
17	>	JJR	O	>	amod	18	SENT_109	[p5l1086t660r1469b715],
18	C	NN	O	c	dep	16	SENT_109	[p5l1086t660r1469b715],
19	5	CD	NUMBER	5	number	20	SENT_109	[p5l1852t660r2058b715],
20	’	CD	NUMBER	’	num	24	SENT_109	[p5l1852t660r2058b715],
21	UTR	NN	O	utr	nn	24	SENT_109	[p5l1852t660r2058b715],
22	rs1523127	NN	O	rs1523127	nn	24	SENT_109	[p5l363t758r731b815],
23	—	CD	NUMBER	—	num	24	SENT_109	[p5l1086t758r1434b815],
24	131C	NN	O	131c	dep	18	SENT_109	[p5l1086t758r1434b815],
25	>	JJR	O	>	dep	35	SENT_109	[p5l1086t758r1434b815],
26	A	DT	O	a	det	32	SENT_109	[p5l1086t758r1434b815],
27	5	CD	NUMBER	5	number	28	SENT_109	[p5l1852t759r2058b815],
28	’	CD	NUMBER	’	num	32	SENT_109	[p5l1852t759r2058b815],
29	UTR	NN	O	utr	nn	32	SENT_109	[p5l1852t759r2058b815],
30	rs4630	NN	O	rs4630	nn	32	SENT_109	[p5l363t855r599b910],
31	—	CD	NUMBER	—	num	32	SENT_109	[p5l1086t855r1316b910],
32	182C	NN	O	182c	dep	25	SENT_109	[p5l1086t855r1316b910],
33	>	JJR	O	>	amod	34	SENT_109	[p5l1334t855r1427b910],
34	T	NN	O	t	dep	32	SENT_109	[p5l1334t855r1427b910],
35	5	CD	NUMBER	5	dep	38	SENT_109	[p5l1852t855r2058b910],
36	’	CD	NUMBER	’	num	38	SENT_109	[p5l1852t855r2058b910],
37	UTR	NN	O	utr	nn	38	SENT_109	[p5l1852t855r2058b910],
38	rs	NNS	O	r	dep	45	SENT_109	[p5l363t967r421b1008],
39	1	CD	NUMBER	1	number	40	SENT_109	[p5l432t953r457b1008],
40	402467	CD	NUMBER	402467	dep	38	SENT_109	[p5l470t953r730b1008],
41	Asp5Glu	NN	O	asp5glu	nn	43	SENT_109	[p5l1081t950r1376b1023],
42	Exonic	JJ	O	exonic	amod	43	SENT_109	[p5l1851t951r2081b1008],
43	rs1800975	NN	O	rs1800975	dep	40	SENT_109	[p5l363t1050r730b1107],
44	—	CD	NUMBER	—	num	45	SENT_109	[p5l1086t1050r1233b1106],
45	4A	NN	O	4a	dep	47	SENT_109	[p5l1086t1050r1233b1106],
46	>	JJR	O	>	amod	47	SENT_109	[p5l1250t1061r1285b1099],
47	G	NN	O	g	dep	56	SENT_109	[p5l1302t1050r1351b1107],
48	5	CD	NUMBER	5	number	49	SENT_109	[p5l1853t1051r2058b1107],
49	’	CD	NUMBER	’	dep	47	SENT_109	[p5l1853t1051r2058b1107],
50	UTR	NN	O	utr	nn	54	SENT_109	[p5l1853t1051r2058b1107],
51	rs73	CD	NUMBER	rs73	num	54	SENT_109	[p5l363t1148r508b1203],
52	5482	CD	NUMBER	5482	num	54	SENT_109	[p5l518t1148r686b1203],
53	Lys259Thr	NNP	O	Lys259Thr	nn	54	SENT_109	[p5l1085t1145r1448b1218],
54	Exonic	NNP	O	Exonic	dep	49	SENT_109	[p5l1852t1145r2081b1203],
55	rs13181	NN	O	rs13181	nn	56	SENT_109	[p5l363t1345r635b1401],
56	Lys751Gln	NN	O	lys751gln	dep	59	SENT_109	[p5l1085t1341r1449b1416],
57	Exonic	JJ	O	exonic	amod	59	SENT_109	[p5l1851t1342r2081b1401],
58	rs17655	NN	O	rs17655	nn	59	SENT_109	[p5l363t1542r641b1598],
59	Asp1104His	NN	O	asp1104hi	dep	65	SENT_109	[p5l1081t1540r1499b1613],
60	Exonic	JJ	O	exonic	amod	62	SENT_109	[p5l1851t1540r2081b1598],
61	rs1047768	NN	O	rs1047768	nn	62	SENT_109	[p5l363t1738r730b1795],
62	His46His	NN	O	his46hi	dep	59	SENT_109	[p5l1084t1737r1394b1795],
63	Exonic	JJ	O	exonic	amod	65	SENT_109	[p5l1851t1737r2081b1795],
64	rs25487	NN	O	rs25487	nn	65	SENT_109	[p5l363t1837r642b1893],
65	Gln399Arg	NN	O	gln399arg	dep	70	SENT_109	[p5l1084t1833r1459b1908],
66	Exonic	JJ	O	exonic	amod	68	SENT_109	[p5l1851t1834r2081b1893],
67	rs1051677	NN	O	rs1051677	nn	68	SENT_109	[p5l363t2033r730b2090],
68	323T	NN	O	323t	dep	65	SENT_109	[p5l1082t2033r1367b2090],
69	>	JJR	O	>	amod	70	SENT_109	[p5l1082t2033r1367b2090],
70	C	NN	O	c	dep	72	SENT_109	[p5l1082t2033r1367b2090],
71	3	CD	NUMBER	3	num	72	SENT_109	[p5l1850t2033r2058b2090],
72	’	NN	O	’	dep	73	SENT_109	[p5l1850t2033r2058b2090],
73	UTR	NN	O	utr	_	0	SENT_109	[p5l1850t2033r2058b2090],

1	rs1051685	NN	O	rs1051685	nn	2	SENT_110	[p5l363t2231r730b2288],
2	451A	NN	O	451a	dep	10	SENT_110	[p5l1082t2231r1382b2288],
3	>	JJR	O	>	amod	4	SENT_110	[p5l1082t2231r1382b2288],
4	G	NN	O	g	dep	2	SENT_110	[p5l1082t2231r1382b2288],
5	3	CD	NUMBER	3	num	6	SENT_110	[p5l1850t2231r2058b2288],
6	’	NN	O	’	dep	4	SENT_110	[p5l1850t2231r2058b2288],
7	UTR	NN	O	utr	dep	10	SENT_110	[p5l1850t2231r2058b2288],
8	rs13695	CD	NUMBER	rs13695	num	7	SENT_110	[p5l363t2328r641b2384],
9	-531	CD	NUMBER	-531	num	10	SENT_110	[p5l1086t2328r1259b2384],
10	G	NN	O	g	dep	16	SENT_110	[p5l1293t2327r1461b2384],
11	>	JJR	O	>	dep	10	SENT_110	[p5l1293t2327r1461b2384],
12	A	DT	O	a	det	16	SENT_110	[p5l1293t2327r1461b2384],
13	3	CD	NUMBER	3	num	16	SENT_110	[p5l1850t2328r2058b2384],
14	’	NN	O	’	nn	16	SENT_110	[p5l1850t2328r2058b2384],
15	UTR	NN	O	utr	nn	16	SENT_110	[p5l1850t2328r2058b2384],
16	rs10434	NN	O	rs10434	dep	20	SENT_110	[p5l363t2427r644b2483],
17	—	CD	NUMBER	—	num	18	SENT_110	[p5l1086t2427r1439b2483],
18	913A	NN	O	913a	dep	16	SENT_110	[p5l1086t2427r1439b2483],
19	>	JJR	O	>	amod	20	SENT_110	[p5l1086t2427r1439b2483],
20	G	NN	O	g	dep	24	SENT_110	[p5l1086t2427r1439b2483],
21	3	CD	NUMBER	3	num	24	SENT_110	[p5l1850t2427r2058b2483],
22	’	NN	O	’	nn	24	SENT_110	[p5l1850t2427r2058b2483],
23	UTR	NN	O	utr	nn	24	SENT_110	[p5l1850t2427r2058b2483],
24	rs2010963	NN	O	rs2010963	dep	28	SENT_110	[p5l363t2525r728b2582],
25	—	CD	NUMBER	—	num	26	SENT_110	[p5l1086t2525r1271b2582],
26	94C	NN	O	94c	dep	24	SENT_110	[p5l1086t2525r1271b2582],
27	>	JJR	O	>	amod	28	SENT_110	[p5l1290t2536r1325b2574],
28	G	NN	O	g	dep	30	SENT_110	[p5l1342t2525r1391b2582],
29	3	CD	NUMBER	3	num	30	SENT_110	[p5l1850t2525r2058b2582],
30	’	NN	O	’	dep	31	SENT_110	[p5l1850t2525r2058b2582],
31	UTR	NN	O	utr	_	0	SENT_110	[p5l1850t2525r2058b2582],

1	ESL	NNP	O	ESL	_	0	SENT_111	[p5l32t2766r109b2855],
2	;	:	O	;	_	0	SENT_111	[p5l32t2766r109b2855],
3	+	CC	O	+	cc	4	SENT_111	[p5l311t2766r428b2855],
4	ZZ	NN	O	zz	nn	5	SENT_111	[p5l639t2765r815b2855],
5	‘	NN	O	‘	dep	1	SENT_111	[p5l639t2765r815b2855],
6	i	FW	O	i	nn	7	SENT_111	[p5l639t2765r815b2855],
7	‘	FW	O	‘	dep	5	SENT_111	[p5l639t2765r815b2855],
8	ZZ	NN	O	zz	dep	5	SENT_111	[p5l639t2765r815b2855],
9	'	''	O	'	_	0	SENT_111	[p5l639t2765r815b2855],
10	lZ	FW	O	lz	nn	13	SENT_111	[p5l639t2765r815b2855],
11	‘	FW	O	‘	nn	13	SENT_111	[p5l639t2765r815b2855],
12	f	FW	O	f	nn	13	SENT_111	[p5l639t2765r815b2855],
13	‘	FW	O	‘	dep	8	SENT_111	[p5l639t2765r815b2855],
14	;	:	O	;	_	0	SENT_111	[p5l639t2765r815b2855],
15	A	DT	O	a	det	16	SENT_111	[p5l639t2765r815b2855],
16	Z	NN	O	z	dep	8	SENT_111	[p5l1014t2766r1274b2860],
17	§	NN	O	§	dep	16	SENT_111	[p5l1014t2766r1274b2860],
18	;	:	O	;	_	0	SENT_111	[p5l1014t2766r1274b2860],
19	”	CD	NUMBER	”	number	20	SENT_111	[p5l1014t2766r1274b2860],
20	§	CD	NUMBER	§	dep	8	SENT_111	[p5l1014t2766r1274b2860],
21	IZZZI	NNP	O	IZZZI	dep	20	SENT_111	[p5l1014t2766r1274b2860],
22	,	,	O	,	_	0	SENT_111	[p5l1014t2766r1274b2860],
23	im6	CD	NUMBER	im6	num	24	SENT_111	[p5l1014t2766r1274b2860],
24	@k	NN	O	@k	appos	1	SENT_111	[p5l1479t2765r1698b2855],
25	+	CC	O	+	_	0	SENT_111	[p5l1479t2765r1698b2855],
26	`	``	O	`	_	0	SENT_111	[p5l1907t2765r2092b2860],
27	I	PRP	O	I	appos	1	SENT_111	[p5l1907t2765r2092b2860],
28	+	CC	O	+	_	0	SENT_111	[p5l1907t2765r2092b2860],
29	ERCC5	NN	O	ercc5	nn	31	SENT_111	[p5l32t2869r111b2890],
30	rs17655	NN	O	rs17655	nn	31	SENT_111	[p5l311t2869r412b2890],
31	CG	NN	O	cg	conj_+	27	SENT_111	[p5l640t2869r674b2890],
32	vs.	CC	O	vs.	_	0	SENT_111	[p5l682t2874r715b2890],
33	GG	NNS	O	gg	conj_vs.	27	SENT_111	[p5l724t2869r761b2890],
34	+	CC	O	+	_	0	SENT_111	[p5l767t2873r780b2886],
35	CC	NN	O	cc	conj_vs.	27	SENT_111	[p5l787t2869r818b2890],
36	78	CD	PERCENT	78	num	37	SENT_111	[p5l1014t2869r1061b2890],
37	%	NN	PERCENT	%	dep	1	SENT_111	[p5l1014t2869r1061b2890],
38	vs.	CC	O	vs.	prep	37	SENT_111	[p5l1069t2869r1117b2890],
39	3	CD	NUMBER	3	num	42	SENT_111	[p5l1069t2869r1117b2890],
40	=	JJ	O	=	amod	42	SENT_111	[p5l1180t2877r1193b2884],
41	0.04	CD	NUMBER	0.04	tmod	40	SENT_111	[p5l1199t2869r1252b2890],
42	NR	NN	O	nr	dep	38	SENT_111	[p5l1479t2869r1516b2889],
43	vs.	NN	O	v.	prep	42	SENT_111	[p5l1523t2874r1555b2890],
44	=	JJ	O	=	amod	45	SENT_111	[p5l1623t2877r1636b2884],
45	0.098	CD	NUMBER	0.098	dep	43	SENT_111	[p5l1642t2869r1710b2890],
46	N/S	NN	O	n/s	nn	48	SENT_111	[p5l1907t2868r1949b2895],
47	XRCC5	NN	O	xrcc5	nn	48	SENT_111	[p5l31t2904r114b2925],
48	rs1051685	NN	O	rs1051685	dep	1	SENT_111	[p5l311t2904r443b2925],
49	AG	NNP	O	AG	dep	48	SENT_111	[p5l639t2904r676b2925],
50	vs.	CC	O	vs.	_	0	SENT_111	[p5l684t2904r761b2925],
51	AA	NNP	O	AA	dep	48	SENT_111	[p5l684t2904r761b2925],
52	100	CD	PERCENT	100	num	53	SENT_111	[p5l1015t2904r1077b2925],
53	%	NN	PERCENT	%	dep	1	SENT_111	[p5l1015t2904r1077b2925],
54	vs.	CC	O	vs.	prep	53	SENT_111	[p5l1085t2909r1117b2925],
55	p	NN	O	p	dep	54	SENT_111	[p5l1174t2904r1282b2930],
56	=	JJ	O	=	amod	58	SENT_111	[p5l1174t2904r1282b2930],
57	0.013	CD	NUMBER	0.013	number	58	SENT_111	[p5l1174t2904r1282b2930],
58	115	CD	NUMBER	115	dep	1	SENT_111	[p5l1481t2904r1524b2925],
59	vs.	IN	O	vs.	_	0	SENT_111	[p5l1533t2909r1566b2925],
60	28p	NN	O	28p	prep_vs.	58	SENT_111	[p5l1575t2904r1705b2930],
61	=	JJ	O	=	amod	64	SENT_111	[p5l1575t2904r1705b2930],
62	0.02	CD	NUMBER	0.02	tmod	61	SENT_111	[p5l1575t2904r1705b2930],
63	N/S	NN	O	n/s	nn	64	SENT_111	[p5l1907t2903r1949b2930],
64	XRCC1	NN	O	xrcc1	dep	1	SENT_111	[p5l31t2939r112b2960],
65	rs25487	CD	NUMBER	rs25487	dep	64	SENT_111	[p5l311t2939r412b2960],
66	AG	NNP	O	AG	nn	69	SENT_111	[p5l639t2939r676b2960],
67	vs.	CC	O	vs.	_	0	SENT_111	[p5l684t2939r761b2960],
68	AA	NNP	O	AA	nn	69	SENT_111	[p5l684t2939r761b2960],
69	N/S	NNP	O	N/S	dep	1	SENT_111	[p5l1014t2938r1056b2965],
70	94	CD	NUMBER	94	num	69	SENT_111	[p5l1479t2939r1510b2960],
71	vs.	CC	O	vs.	prep	69	SENT_111	[p5l1517t2944r1550b2960],
72	21	CD	NUMBER	21	dep	71	SENT_111	[p5l1559t2939r1585b2960],
73	p	NN	O	p	dep	1	SENT_111	[p5l1596t2939r1689b2965],
74	=	JJ	O	=	dep	77	SENT_111	[p5l1596t2939r1689b2965],
75	0.06	CD	NUMBER	0.06	num	76	SENT_111	[p5l1596t2939r1689b2965],
76	N/S	NN	O	n/s	dep	74	SENT_111	[p5l1907t2938r1949b2965],
77	0.0045171	CD	NUMBER	0.0045171	num	80	SENT_111	[p5l6t2974r108b3031],
78	rs4630	NN	O	rs4630	nn	80	SENT_111	[p5l311t2974r396b2995],
79	'	''	O	'	_	0	SENT_111	[p5l639t2974r710b2995],
80	ITvs	NNS	O	itv	dep	73	SENT_111	[p5l639t2974r710b2995],
81	.	.	O	.	_	0	SENT_111	[p5l639t2974r710b2995],

1	cr	NN	O	cr	nn	3	SENT_112	[p5l719t2974r750b2995],
2	N/S	NN	O	n/s	nn	3	SENT_112	[p5l1014t2973r1056b3000],
3	N/S	NN	O	n/s	nsubj	34	SENT_112	[p5l1480t2973r1522b3000],
4	60	CD	PERCENT	60	number	5	SENT_112	[p5l1907t2974r1955b2995],
5	%	NN	PERCENT	%	amod	3	SENT_112	[p5l1907t2974r1955b2995],
6	vs.	CC	O	vs.	_	0	SENT_112	[p5l1962t2979r1995b2995],
7	23	CD	PERCENT	23	num	8	SENT_112	[p5l2004t2974r2051b2995],
8	%	NN	PERCENT	%	conj_vs.	3	SENT_112	[p5l2004t2974r2051b2995],
9	p	NN	O	p	nn	11	SENT_112	[p5l2058t2979r2093b3000],
10	=	JJ	O	=	amod	11	SENT_112	[p5l2058t2979r2093b3000],
11	SNP	NN	O	snp	dep	8	SENT_112	[p5l6t3059r62b3080],
12	:	:	O	:	_	0	SENT_112	[p5l6t3059r62b3080],
13	single	JJ	O	single	amod	15	SENT_112	[p5l73t3058r146b3085],
14	nucleotide	NN	O	nucleotide	nn	15	SENT_112	[p5l155t3058r287b3080],
15	polymorphism	NN	O	polymorphism	dep	8	SENT_112	[p5l296t3058r490b3085],
16	;	:	O	;	_	0	SENT_112	[p5l296t3058r490b3085],
17	OS	NNP	O	OS	dep	15	SENT_112	[p5l501t3059r541b3080],
18	:	:	O	:	_	0	SENT_112	[p5l501t3059r541b3080],
19	overall	JJ	O	overall	amod	21	SENT_112	[p5l551t3058r637b3080],
20	survival	NN	O	survival	nn	21	SENT_112	[p5l646t3058r745b3080],
21	(	NN	O	(	dep	8	SENT_112	[p5l754t3058r787b3085],
22	in	IN	O	in	_	0	SENT_112	[p5l754t3058r787b3085],
23	months	NNS	DURATION	month	prep_in	21	SENT_112	[p5l796t3058r909b3085],
24	)	RB	O	)	advmod	23	SENT_112	[p5l796t3058r909b3085],
25	;	:	O	;	_	0	SENT_112	[p5l796t3058r909b3085],
26	N/S	NN	O	n/s	dep	8	SENT_112	[p5l920t3058r971b3085],
27	:	:	O	:	_	0	SENT_112	[p5l920t3058r971b3085],
28	no	DT	O	no	det	29	SENT_112	[p5l982t3064r1012b3080],
29	signiﬁcant	NN	O	signiﬁcant	dep	26	SENT_112	[p5l1021t3058r1159b3085],
30	;	:	O	;	_	0	SENT_112	[p5l1021t3058r1159b3085],
31	NR	NNP	O	NR	dep	3	SENT_112	[p5l1170t3059r1213b3080],
32	:	:	O	:	_	0	SENT_112	[p5l1170t3059r1213b3080],
33	not	RB	O	not	neg	34	SENT_112	[p5l1224t3061r1265b3080],
34	reached	VBN	O	reach	_	0	SENT_112	[p5l1274t3058r1379b3080],
35	.	.	O	.	_	0	SENT_112	[p5l1274t3058r1379b3080],

1	M.T.	NNP	PERSON	M.T.	nn	2	SENT_113	[p5l1072t3161r1121b3181],
2	Cibeira	NNP	PERSON	Cibeira	_	0	SENT_113	[p5l1131t3160r1215b3181],
3	et	FW	O	et	nn	4	SENT_113	[p5l1224t3163r1247b3181],
4	al.	FW	O	al.	dep	2	SENT_113	[p5l1254t3160r1279b3181],
5	/	:	O	/	punct	2	SENT_113	[p5l1286t3160r1298b3186],
6	Leukemia	NNP	ORGANIZATION	Leukemia	nn	7	SENT_113	[p5l1304t3160r1419b3181],
7	Research	NNP	ORGANIZATION	Research	dep	2	SENT_113	[p5l1427t3160r1534b3181],
8	35	CD	NUMBER	35	number	9	SENT_113	[p5l1541t3161r1572b3181],
9	(	CD	NUMBER	(	num	10	SENT_113	[p5l1580t3160r1660b3186],
10	2011	CD	DATE	2011	dep	7	SENT_113	[p5l1580t3160r1660b3186],
11	)	CD	NUMBER	)	number	12	SENT_113	[p5l1580t3160r1660b3186],
12	1178-1183	CD	DATE	1178-1183	num	10	SENT_113	[p5l1671t3161r1805b3181],

1	ERCC1	NN	O	ercc1	_	0	SENT_114	[p6l1646t185r1840b229],
2	#	#	MONEY	#	dep	3	SENT_114	[p6l1597t253r1901b309],
3	5735432	CD	MONEY	5735432	dep	1	SENT_114	[p6l1597t253r1901b309],
4	}	CD	MONEY	}	dep	1	SENT_114	[p6l1597t253r1901b309],

1	[	NN	O	[	nn	2	SENT_115	[p6l221t345r288b382],
2	LB	NN	O	lb	_	0	SENT_115	[p6l221t345r288b382],

1	Probability	NN	O	probability	_	0	SENT_116	[p6l126t548r181b821],

1	F	NN	O	f	_	0	SENT_117	[p6l224t572r258b610],
2	-	:	O	-	_	0	SENT_117	[p6l224t572r258b610],
3	'	''	O	'	_	0	SENT_117	[p6l224t572r258b610],
4	on	IN	O	on	dep	1	SENT_117	[p6l261t572r288b612],

1	0.4	CD	NUMBER	0.4	_	0	SENT_118	[p6l224t809r288b849],
2	in	IN	O	in	dep	1	SENT_118	[p6l301t826r312b827],

1	[	NN	O	[	nn	2	SENT_119	[p6l221t1039r288b1076],
2	L2	NN	O	l2	_	0	SENT_119	[p6l221t1039r288b1076],
3	3	CD	NUMBER	3	dep	2	SENT_119	[p6l320t1044r321b1059],

1	n	NN	O	n	_	0	SENT_120	[p6l390t1380r415b1420],
2	20	CD	NUMBER	20	num	3	SENT_120	[p6l617t1380r672b1420],
3	40	CD	NUMBER	40	dep	1	SENT_120	[p6l887t1366r942b1420],
4	so	IN	O	so	advmod	7	SENT_120	[p6l1152t1380r1207b1420],
5	an	DT	O	a	quantmod	7	SENT_120	[p6l1404t1380r1459b1420],
6	160	CD	NUMBER	160	number	7	SENT_120	[p6l1649t1355r1730b1420],
7	10	CD	NUMBER	10	rcmod	3	SENT_120	[p6l1907t1353r1990b1420],

1	‘	NN	O	‘	nn	2	SENT_121	[p6l586t1441r715b1484],
2	lime	NN	O	lime	nsubj	10	SENT_121	[p6l586t1441r715b1484],
3	from	IN	O	from	_	0	SENT_121	[p6l733t1441r850b1484],
4	treatment	NN	O	treatment	prep_from	2	SENT_121	[p6l869t1441r1122b1484],
5	with	IN	O	with	_	0	SENT_121	[p6l1137t1441r1241b1484],
6	thalidomide	NN	O	thalidomide	prep_with	4	SENT_121	[p6l1262t1441r1567b1484],
7	-	:	O	-	_	0	SENT_121	[p6l1585t1441r1816b1496],
8	(	NN	O	(	nn	9	SENT_121	[p6l1585t1441r1816b1496],
9	montlhs	NNS	O	montlh	dep	4	SENT_121	[p6l1585t1441r1816b1496],
10	)	VBP	O	)	_	0	SENT_121	[p6l1585t1441r1816b1496],

1	Fig	NN	O	fig	_	0	SENT_122	[p6l10t1585r103b1639],
2	.	.	O	.	_	0	SENT_122	[p6l10t1585r103b1639],

1	1	LS	NUMBER	1	_	0	SENT_123	[p6l130t1587r172b1628],
2	.	.	O	.	_	0	SENT_123	[p6l130t1587r172b1628],

1	Overall	JJ	O	overall	amod	2	SENT_124	[p6l205t1585r388b1628],
2	survival	NN	O	survival	nsubj	7	SENT_124	[p6l414t1585r616b1628],
3	of	IN	O	of	_	0	SENT_124	[p6l642t1584r695b1628],
4	relapsed/refractory	JJ	O	relapsed/refractory	amod	6	SENT_124	[p6l715t1584r1213b1639],
5	MM	NN	O	mm	nn	6	SENT_124	[p6l1237t1587r1338b1628],
6	patients	NNS	O	patient	prep_of	2	SENT_124	[p6l1364t1585r1570b1639],
7	treated	VBN	O	treat	_	0	SENT_124	[p6l1596t1585r1780b1628],
8	with	IN	O	with	_	0	SENT_124	[p6l1805t1585r1923b1628],
9	thalidomide	NN	O	thalidomide	prep_with	7	SENT_124	[p6l1948t1585r2152b1628, p6l11t1656r139b1700],
10	according	VBG	O	accord	_	0	SENT_124	[p6l164t1656r416b1710],
11	to	TO	O	to	prepc_according_to	7	SENT_124	[p6l439t1662r488b1700],
12	ERCC1	NN	O	ercc1	pobj	7	SENT_124	[p6l514t1658r671b1700],
13	(	CD	NUMBER	(	num	14	SENT_124	[p6l702t1656r985b1710],
14	rs735482	NN	O	rs735482	dep	22	SENT_124	[p6l702t1656r985b1710],
15	)	CD	NUMBER	)	num	16	SENT_124	[p6l702t1656r985b1710],
16	genotype	NN	O	genotype	dep	14	SENT_124	[p6l1009t1662r1248b1710],
17	(	CD	NUMBER	(	num	18	SENT_124	[p6l1273t1656r1681b1710],
18	AA	NN	O	aa	dep	22	SENT_124	[p6l1273t1656r1681b1710],
19	=	JJ	O	=	amod	22	SENT_124	[p6l1273t1656r1681b1710],
20	wild	JJ	O	wild	amod	22	SENT_124	[p6l1273t1656r1681b1710],
21	—	NN	O	—	nn	22	SENT_124	[p6l1273t1656r1681b1710],
22	type	NN	O	type	dep	12	SENT_124	[p6l1273t1656r1681b1710],
23	,	,	O	,	_	0	SENT_124	[p6l1273t1656r1681b1710],
24	CC	NN	O	cc	nn	27	SENT_124	[p6l1707t1656r2151b1710],
25	=	JJ	O	=	amod	27	SENT_124	[p6l1707t1656r2151b1710],
26	homozygous	JJ	O	homozygous	amod	27	SENT_124	[p6l1707t1656r2151b1710],
27	SNP	NN	O	snp	appos	22	SENT_124	[p6l11t1730r123b1778],
28	,	,	O	,	_	0	SENT_124	[p6l11t1730r123b1778],
29	AC	NN	O	ac	nn	33	SENT_124	[p6l139t1729r210b1771],
30	=	JJ	O	=	amod	33	SENT_124	[p6l222t1746r249b1759],
31	heterozygous	JJ	O	heterozygous	amod	33	SENT_124	[p6l262t1727r608b1782],
32	SNP	NN	O	snp	nn	33	SENT_124	[p6l628t1728r760b1781],
33	)	NN	O	)	appos	22	SENT_124	[p6l628t1728r760b1781],
34	.	.	O	.	_	0	SENT_124	[p6l628t1728r760b1781],

1	3	CD	NUMBER	3	num	2	SENT_125	[p6l10t1939r44b1991],
2	(	NN	O	(	nsubj	13	SENT_125	[p6l69t1936r299b2004],
3	10.7	CD	PERCENT	10.7	num	4	SENT_125	[p6l69t1936r299b2004],
4	%	NN	PERCENT	%	dep	2	SENT_125	[p6l69t1936r299b2004],
5	)	CD	NUMBER	)	number	9	SENT_125	[p6l69t1936r299b2004],
6	and	CC	O	and	_	0	SENT_125	[p6l320t1936r436b1991],
7	12	CD	PERCENT	12	conj_and	9	SENT_125	[p6l461t1939r533b1990],
8	(	CD	PERCENT	(	number	9	SENT_125	[p6l556t1936r787b2004],
9	42.9	CD	PERCENT	42.9	num	10	SENT_125	[p6l556t1936r787b2004],
10	%	NN	PERCENT	%	dep	2	SENT_125	[p6l556t1936r787b2004],
11	)	CD	NUMBER	)	num	12	SENT_125	[p6l556t1936r787b2004],
12	patients	NNS	O	patient	dep	10	SENT_125	[p6l808t1937r1066b2005],
13	showed	VBD	O	show	_	0	SENT_125	[p6l1090t1936r1338b1991],
14	no	DT	O	no	det	17	SENT_125	[p6l1360t1952r1437b1991],
15	response	NN	O	response	nn	17	SENT_125	[p6l1459t1952r1745b2005],
16	(	CD	NUMBER	(	num	17	SENT_125	[p6l1767t1936r1909b2004],
17	NR	NN	MISC	nr	iobj	13	SENT_125	[p6l1767t1936r1909b2004],
18	)	CD	NUMBER	)	dobj	13	SENT_125	[p6l1767t1936r1909b2004],
19	or	CC	O	or	_	0	SENT_125	[p6l1931t1952r1997b1991],
20	progressive	JJ	O	progressive	amod	24	SENT_125	[p6l2017t1952r2151b2005, p6l10t2026r270b2094],
21	disease	NN	O	disease	nn	24	SENT_125	[p6l293t2025r525b2080],
22	(	NN	O	(	nn	24	SENT_125	[p6l548t2025r702b2094],
23	PD	NN	O	pd	nn	24	SENT_125	[p6l548t2025r702b2094],
24	)	NN	O	)	dobj	13	SENT_125	[p6l548t2025r702b2094],
25	,	,	O	,	_	0	SENT_125	[p6l548t2025r702b2094],
26	respectively	RB	O	respectively	advmod	13	SENT_125	[p6l726t2025r1130b2094],
27	.	.	O	.	_	0	SENT_125	[p6l726t2025r1130b2094],

1	OS	NN	O	os	nsubj	7	SENT_126	[p6l1154t2028r1235b2080],
2	at	IN	O	at	_	0	SENT_126	[p6l1259t2033r1319b2080],
3	2	CD	DURATION	2	num	4	SENT_126	[p6l1339t2028r1373b2080],
4	years	NNS	NUMBER	year	prep_at	1	SENT_126	[p6l1397t2041r1565b2094],
5	was	VBD	O	be	cop	7	SENT_126	[p6l1587t2041r1712b2080],
6	53.6	CD	PERCENT	53.6	num	7	SENT_126	[p6l1736t2028r1929b2081],
7	%	NN	PERCENT	%	_	0	SENT_126	[p6l1736t2028r1929b2081],
8	.	.	O	.	_	0	SENT_126	[p6l1736t2028r1929b2081],

1	3.2	CD	NUMBER	3.2	_	0	SENT_127	[p6l8t2216r114b2268],
2	.	.	O	.	_	0	SENT_127	[p6l8t2216r114b2268],

1	Genetic	JJ	O	genetic	amod	2	SENT_128	[p6l165t2214r395b2268],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_128	[p6l409t2213r888b2281],
3	and	CC	O	and	_	0	SENT_128	[p6l910t2213r1024b2268],
4	response	NN	O	response	nn	6	SENT_128	[p6l1046t2229r1313b2281],
5	to	TO	O	to	dep	6	SENT_128	[p6l1336t2221r1392b2268],
6	thalidomide	NN	O	thalidomide	conj_and	2	SENT_128	[p6l1417t2213r1784b2268],

1	The	DT	O	the	det	6	SENT_129	[p6l110t2391r227b2446],
2	response	NN	O	response	nn	6	SENT_129	[p6l274t2407r560b2460],
3	rate	NN	O	rate	nn	6	SENT_129	[p6l607t2399r731b2446],
4	(	CD	NUMBER	(	num	6	SENT_129	[p6l777t2391r1079b2460],
5	PR+MR	NN	O	pr+mr	nn	6	SENT_129	[p6l777t2391r1079b2460],
6	)	NN	O	)	nsubj	10	SENT_129	[p6l777t2391r1079b2460],
7	to	TO	O	to	_	0	SENT_129	[p6l1124t2399r1186b2446],
8	thalidomide	NN	O	thalidomide	prep_to	6	SENT_129	[p6l1232t2391r1624b2446],
9	was	VBD	O	be	cop	10	SENT_129	[p6l1669t2407r1793b2446],
10	higher	JJR	O	higher	_	0	SENT_129	[p6l1841t2391r2049b2460],
11	in	IN	O	in	_	0	SENT_129	[p6l2093t2392r2152b2446],
12	patients	NNS	O	patient	prep_in	10	SENT_129	[p6l12t2481r270b2549],
13	with	IN	O	with	_	0	SENT_129	[p6l311t2480r459b2535],
14	hetero	NN	O	hetero	nn	17	SENT_129	[p6l500t2480r877b2549],
15	—	CD	NUMBER	—	num	17	SENT_129	[p6l500t2480r877b2549],
16	(	NN	O	(	nn	17	SENT_129	[p6l500t2480r877b2549],
17	AC	NN	O	ac	prep_with	12	SENT_129	[p6l500t2480r877b2549],
18	)	CD	NUMBER	)	dep	17	SENT_129	[p6l500t2480r877b2549],
19	or	CC	O	or	_	0	SENT_129	[p6l919t2496r985b2535],
20	homozygous	JJ	O	homozygous	amod	24	SENT_129	[p6l1025t2480r1434b2549],
21	(	NN	O	(	nn	24	SENT_129	[p6l1476t2480r1608b2549],
22	CC	NN	O	cc	nn	24	SENT_129	[p6l1476t2480r1608b2549],
23	)	CD	NUMBER	)	num	24	SENT_129	[p6l1476t2480r1608b2549],
24	SNPs	NNS	O	snp	conj_or	17	SENT_129	[p6l1650t2483r1804b2535],
25	in	IN	O	in	_	0	SENT_129	[p6l1847t2481r1906b2535],
26	ERCC1	NN	O	ercc1	nn	29	SENT_129	[p6l1947t2483r2143b2535],
27	(	CD	NUMBER	(	num	29	SENT_129	[p6l11t2570r364b2638],
28	rs735482	NN	O	rs735482	nn	29	SENT_129	[p6l11t2570r364b2638],
29	)	NN	O	)	prep_in	24	SENT_129	[p6l11t2570r364b2638],
30	than	IN	O	than	advmod	10	SENT_129	[p6l400t2570r544b2625],
31	in	IN	O	in	_	0	SENT_129	[p6l580t2570r639b2624],
32	those	DT	O	those	prep_in	30	SENT_129	[p6l673t2570r847b2625],
33	with	IN	O	with	_	0	SENT_129	[p6l881t2570r1029b2625],
34	wild	JJ	O	wild	amod	35	SENT_129	[p6l1063t2570r1204b2625],
35	type	NN	O	type	prep_with	32	SENT_129	[p6l1239t2578r1379b2638],
36	(	CD	NUMBER	(	num	38	SENT_129	[p6l1415t2570r1555b2638],
37	AA	NN	O	aa	nn	38	SENT_129	[p6l1415t2570r1555b2638],
38	)	NN	O	)	attr	10	SENT_129	[p6l1415t2570r1555b2638],
39	(	CD	PERCENT	(	number	40	SENT_129	[p6l1591t2570r1796b2638],
40	66.7	CD	PERCENT	66.7	num	41	SENT_129	[p6l1591t2570r1796b2638],
41	%	NN	PERCENT	%	dep	38	SENT_129	[p6l1591t2570r1796b2638],
42	vs.	CC	O	vs.	_	0	SENT_129	[p6l1829t2585r1912b2625],
43	33.3	CD	PERCENT	33.3	num	44	SENT_129	[p6l1947t2572r2147b2633],
44	%	NN	PERCENT	%	attr	10	SENT_129	[p6l1947t2572r2147b2633],
45	;	:	O	;	_	0	SENT_129	[p6l1947t2572r2147b2633],
46	p	NN	O	p	dep	44	SENT_129	[p6l6t2659r329b2727],
47	=	JJ	O	=	amod	49	SENT_129	[p6l6t2659r329b2727],
48	0.006	CD	NUMBER	0.006	tmod	47	SENT_129	[p6l6t2659r329b2727],
49	)	NN	O	)	dep	46	SENT_129	[p6l6t2659r329b2727],
50	.	.	O	.	_	0	SENT_129	[p6l6t2659r329b2727],

1	Patients	NNS	O	patient	nsubj	13	SENT_130	[p6l365t2659r620b2714],
2	with	IN	O	with	_	0	SENT_130	[p6l654t2659r802b2714],
3	the	DT	O	the	det	7	SENT_130	[p6l836t2659r937b2714],
4	ERCC5	NN	O	ercc5	nn	7	SENT_130	[p6l973t2661r1175b2714],
5	(	CD	NUMBER	(	num	7	SENT_130	[p6l1212t2659r1524b2727],
6	rs17655	NN	O	rs17655	nn	7	SENT_130	[p6l1212t2659r1524b2727],
7	)	NN	O	)	nn	12	SENT_130	[p6l1212t2659r1524b2727],
8	heterozygous	JJ	O	heterozygous	amod	12	SENT_130	[p6l1559t2659r1992b2727],
9	SNP	NN	O	snp	dep	8	SENT_130	[p6l2028t2661r2153b2714],
10	(	CD	NUMBER	(	num	9	SENT_130	[p6l11t2748r150b2816],
11	CG	NN	O	cg	nn	12	SENT_130	[p6l11t2748r150b2816],
12	)	NN	O	)	prep_with	1	SENT_130	[p6l11t2748r150b2816],
13	had	VBD	O	have	_	0	SENT_130	[p6l178t2748r293b2803],
14	a	DT	O	a	det	17	SENT_130	[p6l320t2764r352b2803],
15	higher	JJR	O	higher	amod	17	SENT_130	[p6l378t2748r586b2816],
16	response	NN	O	response	nn	17	SENT_130	[p6l611t2764r896b2816],
17	rate	NN	O	rate	dobj	13	SENT_130	[p6l923t2756r1047b2803],
18	than	IN	O	than	_	0	SENT_130	[p6l1072t2748r1217b2803],
19	those	DT	O	those	prep_than	17	SENT_130	[p6l1242t2748r1415b2803],
20	with	IN	O	with	_	0	SENT_130	[p6l1440t2748r1588b2803],
21	the	DT	O	the	det	23	SENT_130	[p6l1614t2748r1715b2803],
22	homozygous	JJ	O	homozygous	amod	23	SENT_130	[p6l1742t2748r2150b2816],
23	SNP	NN	O	snp	prep_with	19	SENT_130	[p6l12t2839r137b2891],
24	(	CD	NUMBER	(	num	25	SENT_130	[p6l157t2836r303b2904],
25	GG	NNS	O	gg	dep	35	SENT_130	[p6l157t2836r303b2904],
26	)	CD	NUMBER	)	dep	25	SENT_130	[p6l157t2836r303b2904],
27	or	CC	O	or	_	0	SENT_130	[p6l324t2852r391b2891],
28	wild	JJ	O	wild	amod	29	SENT_130	[p6l408t2836r549b2891],
29	type	NN	O	type	conj_or	26	SENT_130	[p6l570t2844r710b2905],
30	(	CD	NUMBER	(	num	29	SENT_130	[p6l731t2836r864b2904],
31	CC	NN	O	cc	dep	35	SENT_130	[p6l731t2836r864b2904],
32	)	CD	PERCENT	)	num	31	SENT_130	[p6l731t2836r864b2904],
33	(	CD	PERCENT	(	number	34	SENT_130	[p6l885t2836r1090b2904],
34	77.8	CD	PERCENT	77.8	num	35	SENT_130	[p6l885t2836r1090b2904],
35	%	NN	PERCENT	%	dep	17	SENT_130	[p6l885t2836r1090b2904],
36	vs.	CC	O	vs.	prep	35	SENT_130	[p6l1108t2852r1191b2892],
37	31.6	CD	PERCENT	31.6	num	38	SENT_130	[p6l1212t2839r1407b2900],
38	%	NN	PERCENT	%	dep	36	SENT_130	[p6l1212t2839r1407b2900],
39	,	,	O	,	_	0	SENT_130	[p6l1212t2839r1407b2900],
40	p	NN	O	p	appos	38	SENT_130	[p6l1424t2852r1463b2905],
41	=	JJ	O	=	amod	43	SENT_130	[p6l1480t2859r1513b2875],
42	0.04	CD	NUMBER	0.04	tmod	41	SENT_130	[p6l1530t2836r1705b2904],
43	)	NN	O	)	dep	40	SENT_130	[p6l1530t2836r1705b2904],
44	.	.	O	.	_	0	SENT_130	[p6l1530t2836r1705b2904],

1	Patients	NNS	O	patient	nsubj	12	SENT_131	[p6l1728t2837r1983b2891],
2	with	IN	O	with	_	0	SENT_131	[p6l2004t2836r2152b2891],
3	heterozygous	JJ	O	heterozygous	amod	4	SENT_131	[p6l12t2925r444b2994],
4	XRCC5	NN	O	xrcc5	prep_with	1	SENT_131	[p6l477t2928r688b2980],
5	(	CD	NUMBER	(	num	6	SENT_131	[p6l724t2925r1118b2993],
6	rs1051685	NN	O	rs1051685	dep	4	SENT_131	[p6l724t2925r1118b2993],
7	)	CD	NUMBER	)	number	8	SENT_131	[p6l724t2925r1118b2993],
8	(	CD	NUMBER	(	num	11	SENT_131	[p6l1152t2925r1295b2993],
9	AG	NNP	O	AG	nn	11	SENT_131	[p6l1152t2925r1295b2993],
10	)	CD	NUMBER	)	num	11	SENT_131	[p6l1152t2925r1295b2993],
11	polymorphism	NN	O	polymorphism	dep	6	SENT_131	[p6l1329t2925r1804b2994],
12	showed	VBD	O	show	_	0	SENT_131	[p6l1838t2925r2086b2980],
13	a	DT	O	a	det	16	SENT_131	[p6l2120t2941r2152b2980],
14	higher	JJR	O	higher	amod	16	SENT_131	[p6l12t3014r220b3083],
15	response	NN	O	response	nn	16	SENT_131	[p6l242t3030r528b3083],
16	rate	NN	O	rate	iobj	12	SENT_131	[p6l552t3022r676b3069],
17	(	CD	PERCENT	(	number	18	SENT_131	[p6l700t3014r913b3083],
18	100	CD	PERCENT	100	num	19	SENT_131	[p6l700t3014r913b3083],
19	%	NN	PERCENT	%	dobj	12	SENT_131	[p6l700t3014r913b3083],
20	)	CD	NUMBER	)	dobj	12	SENT_131	[p6l700t3014r913b3083],
21	than	IN	O	than	_	0	SENT_131	[p6l937t3014r1082b3069],
22	those	DT	O	those	prep_than	20	SENT_131	[p6l1105t3014r1278b3069],
23	with	IN	O	with	_	0	SENT_131	[p6l1300t3014r1449b3069],
24	wild	JJ	O	wild	amod	27	SENT_131	[p6l1470t3014r1612b3069],
25	type	NN	O	type	nn	27	SENT_131	[p6l1635t3022r1775b3083],
26	(	CD	NUMBER	(	num	27	SENT_131	[p6l1800t3015r1939b3083],
27	AA	NN	O	aa	prep_with	22	SENT_131	[p6l1800t3015r1939b3083],
28	)	CD	NUMBER	)	num	29	SENT_131	[p6l1800t3015r1939b3083],
29	(	NN	O	(	dobj	12	SENT_131	[p6l1964t3014r2152b3083],
30	100	CD	PERCENT	100	number	31	SENT_131	[p6l1964t3014r2152b3083],
31	%	NN	PERCENT	%	amod	29	SENT_131	[p6l1964t3014r2152b3083],
32	vs.	CC	O	vs.	prep	12	SENT_131	[p6l9t3119r92b3159],
33	34.8	CD	PERCENT	34.8	num	34	SENT_131	[p6l119t3106r314b3167],
34	%	NN	PERCENT	%	dep	32	SENT_131	[p6l119t3106r314b3167],
35	,	,	O	,	_	0	SENT_131	[p6l119t3106r314b3167],
36	p	NN	O	p	dobj	12	SENT_131	[p6l337t3119r377b3172],
37	=	JJ	O	=	amod	36	SENT_131	[p6l394t3127r427b3143],
38	0.013	CD	NUMBER	0.013	num	39	SENT_131	[p6l444t3104r660b3172],
39	)	NN	O	)	dep	37	SENT_131	[p6l444t3104r660b3172],
40	.	.	O	.	_	0	SENT_131	[p6l444t3104r660b3172],

1	The	DT	O	the	det	3	SENT_132	[p6l686t3104r803b3159],
2	remaining	VBG	O	remain	amod	3	SENT_132	[p6l831t3104r1162b3172],
3	polymorphisms	NNS	O	polymorphism	nsubj	6	SENT_132	[p6l1188t3104r1693b3172],
4	did	VBD	O	do	aux	6	SENT_132	[p6l1722t3104r1822b3159],
5	not	RB	O	not	neg	6	SENT_132	[p6l1850t3112r1956b3159],
6	show	VB	O	show	_	0	SENT_132	[p6l1982t3104r2153b3159],
7	any	DT	O	any	det	9	SENT_132	[p6l11t3209r127b3261],
8	signiﬁcant	JJ	O	signiﬁcant	amod	9	SENT_132	[p6l148t3193r483b3261],
9	association	NN	O	association	nsubj	16	SENT_132	[p6l503t3194r861b3248],
10	with	IN	O	with	_	0	SENT_132	[p6l882t3193r1030b3248],
11	response	NN	O	response	nn	12	SENT_132	[p6l1053t3209r1339b3261],
12	rate	NN	O	rate	prep_with	9	SENT_132	[p6l1362t3201r1485b3248],
13	(	CD	NUMBER	(	num	16	SENT_132	[p6l1508t3193r1705b3261],
14	Table	NNP	O	Table	nn	16	SENT_132	[p6l1508t3193r1705b3261],
15	3	CD	NUMBER	3	num	16	SENT_132	[p6l1726t3193r1805b3261],
16	)	NN	O	)	xcomp	6	SENT_132	[p6l1726t3193r1805b3261],
17	.	.	O	.	_	0	SENT_132	[p6l1726t3193r1805b3261],

1	3.3	CD	NUMBER	3.3	_	0	SENT_133	[p6l8t3383r114b3436],
2	.	.	O	.	_	0	SENT_133	[p6l8t3383r114b3436],

1	Genetic	JJ	O	genetic	amod	2	SENT_134	[p6l165t3382r395b3435],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_134	[p6l409t3380r888b3449],
3	and	CC	O	and	_	0	SENT_134	[p6l910t3380r1024b3435],
4	overall	JJ	O	overall	amod	5	SENT_134	[p6l1046t3380r1255b3435],
5	survival	NN	O	survival	conj_and	2	SENT_134	[p6l1273t3380r1521b3435],

1	Longer	JJR	O	longer	amod	2	SENT_135	[p6l114t3562r333b3627],
2	OS	NN	O	os	nsubjpass	4	SENT_135	[p6l364t3561r446b3614],
3	was	VBD	O	be	auxpass	4	SENT_135	[p6l477t3574r602b3614],
4	associated	VBN	O	associate	_	0	SENT_135	[p6l635t3559r967b3614],
5	with	IN	O	with	_	0	SENT_135	[p6l998t3559r1147b3614],
6	the	DT	O	the	det	7	SENT_135	[p6l1178t3559r1280b3614],
7	homo	NN	O	homo	prep_with	4	SENT_135	[p6l1313t3559r1525b3614],
8	—	JJ	O	—	amod	7	SENT_135	[p6l1313t3559r1525b3614],
9	and	CC	O	and	_	0	SENT_135	[p6l1558t3558r1674b3614],
10	the	DT	O	the	det	11	SENT_135	[p6l1707t3559r1808b3614],
11	heterozygous	JJ	O	heterozygous	prep_with	4	SENT_135	[p6l1841t3559r2151b3627, p7l10t33r158b85],

1	SNP	NN	O	snp	_	0	SENT_136	[p7l182t20r307b72],
2	in	IN	O	in	_	0	SENT_136	[p7l329t18r388b71],
3	ERCC1	NN	O	ercc1	prep_in	1	SENT_136	[p7l410t20r606b72],
4	(	CD	NUMBER	(	num	3	SENT_136	[p7l637t17r990b85],
5	rs735482	NN	O	rs735482	nn	8	SENT_136	[p7l637t17r990b85],
6	)	CD	NUMBER	)	num	8	SENT_136	[p7l637t17r990b85],
7	(	NN	O	(	nn	8	SENT_136	[p7l1013t17r1124b85],
8	AC	NN	O	ac	dep	3	SENT_136	[p7l1013t17r1124b85],
9	+	CC	O	+	_	0	SENT_136	[p7l1140t29r1173b63],
10	CC	NN	O	cc	conj_+	3	SENT_136	[p7l1190t20r1271b72],
11	vs.	CC	O	vs.	prep	10	SENT_136	[p7l1290t33r1373b72],
12	AA	NN	O	aa	dep	11	SENT_136	[p7l1394t19r1504b80],
13	;	:	O	;	_	0	SENT_136	[p7l1394t19r1504b80],
14	p	NN	O	p	dep	10	SENT_136	[p7l1527t33r1566b85],
15	=	JJ	O	=	amod	14	SENT_136	[p7l1583t40r1616b56],
16	0.005	CD	NUMBER	0.005	tmod	15	SENT_136	[p7l1633t20r1827b80],
17	;	:	O	;	_	0	SENT_136	[p7l1633t20r1827b80],
18	RR	NN	O	rr	dep	10	SENT_136	[p7l1855t20r1940b71],
19	0.281	CD	NUMBER	0.281	num	18	SENT_136	[p7l1960t20r2151b80],
20	,	,	O	,	_	0	SENT_136	[p7l1960t20r2151b80],
21	IC	NN	O	ic	appos	18	SENT_136	[p7l12t108r72b160],
22	0.1	CD	NUMBER	0.1	number	23	SENT_136	[p7l88t108r173b161],
23	1	CD	NUMBER	1	dep	3	SENT_136	[p7l190t108r214b159],
24	-0.71	CD	NUMBER	-0.71	num	25	SENT_136	[p7l228t108r394b161],
25	)	NN	O	)	dep	23	SENT_136	[p7l410t105r428b173],
26	and	CC	O	and	_	0	SENT_136	[p7l445t105r561b160],
27	with	IN	O	with	_	0	SENT_136	[p7l577t105r726b160],
28	the	DT	O	the	det	30	SENT_136	[p7l741t105r843b160],
29	heterozygous	JJ	O	heterozygous	amod	30	SENT_136	[p7l861t105r1293b174],
30	SNP	NN	ORGANIZATION	snp	prep_with	36	SENT_136	[p7l1312t108r1437b160],
31	in	IN	O	in	_	0	SENT_136	[p7l1453t106r1512b159],
32	XRCC5	NN	O	xrcc5	nn	34	SENT_136	[p7l1526t108r1738b160],
33	(	CD	NUMBER	(	num	34	SENT_136	[p7l1758t105r2151b173],
34	rs1051685	NN	O	rs1051685	prep_in	30	SENT_136	[p7l1758t105r2151b173],
35	)	CD	NUMBER	)	number	36	SENT_136	[p7l1758t105r2151b173],
36	(	CD	NUMBER	(	prep_in	1	SENT_136	[p7l11t194r129b262],
37	AG	NNP	O	AG	dep	36	SENT_136	[p7l11t194r129b262],
38	vs.	CC	O	vs.	_	0	SENT_136	[p7l152t210r235b250],
39	AA	NNP	O	AA	conj_vs.	37	SENT_136	[p7l259t197r370b258],
40	;	:	O	;	_	0	SENT_136	[p7l259t197r370b258],
41	p	NN	O	p	dep	1	SENT_136	[p7l395t197r655b263],
42	=	JJ	O	=	amod	41	SENT_136	[p7l395t197r655b263],
43	0.02	CD	NUMBER	0.02	tmod	42	SENT_136	[p7l395t197r655b263],
44	;	:	O	;	_	0	SENT_136	[p7l395t197r655b263],
45	RR	NN	O	rr	dep	1	SENT_136	[p7l686t198r771b249],
46	0.21	CD	NUMBER	0.21	num	45	SENT_136	[p7l794t197r943b258],
47	,	,	O	,	_	0	SENT_136	[p7l794t197r943b258],
48	CI	NN	O	ci	appos	45	SENT_136	[p7l970t197r1028b249],
49	0.05	CD	NUMBER	0.05	num	48	SENT_136	[p7l1055t194r1354b262],
50	—	CD	NUMBER	—	num	54	SENT_136	[p7l1055t194r1354b262],
51	0.9	CD	NUMBER	0.9	num	54	SENT_136	[p7l1055t194r1354b262],
52	)	NN	O	)	nn	54	SENT_136	[p7l1055t194r1354b262],
53	(	CD	NUMBER	(	num	54	SENT_136	[p7l1379t194r1543b263],
54	Figs	NNS	O	fig	dep	48	SENT_136	[p7l1379t194r1543b263],
55	.	.	O	.	_	0	SENT_136	[p7l1379t194r1543b263],

1	1	CD	NUMBER	1	_	0	SENT_137	[p7l1573t197r1597b249],
2	and	CC	O	and	_	0	SENT_137	[p7l1631t194r1747b249],
3	2	CD	NUMBER	2	conj_and	1	SENT_137	[p7l1773t194r1851b262],
4	)	NN	O	)	dep	1	SENT_137	[p7l1773t194r1851b262],
5	.	.	O	.	_	0	SENT_137	[p7l1773t194r1851b262],

1	This	DT	O	this	det	3	SENT_138	[p7l1875t194r2007b249],
2	statistical	JJ	O	statistical	amod	3	SENT_138	[p7l2034t202r2151b249, p7l11t283r224b338],
3	signiﬁcance	NN	O	signiﬁcance	_	0	SENT_138	[p7l259t283r636b352],
4	remained	VBD	O	remain	dep	3	SENT_138	[p7l670t283r976b338],
5	when	WRB	O	when	advmod	8	SENT_138	[p7l1008t283r1189b338],
6	a	DT	O	a	det	8	SENT_138	[p7l1222t299r1254b338],
7	multivariate	JJ	O	multivariate	amod	8	SENT_138	[p7l1287t283r1683b338],
8	analysis	NN	O	analysis	advcl	4	SENT_138	[p7l1717t283r1971b352],
9	with	IN	O	with	prep	8	SENT_138	[p7l2004t283r2152b338],

1	XRCC5	NN	O	xrcc5	_	0	SENT_139	[p7l1711t582r1935b629],

1	(	NN	O	(	nn	2	SENT_140	[p7l1643t653r1748b712],
2	r51	NN	O	r51	_	0	SENT_140	[p7l1643t653r1748b712],
3	051	CD	NUMBER	051	number	4	SENT_140	[p7l1760t653r1861b700],
4	685	CD	NUMBER	685	dep	2	SENT_140	[p7l1873t653r2009b712],
5	)	NN	O	)	dep	4	SENT_140	[p7l1873t653r2009b712],

1	CI	NN	O	ci	_	0	SENT_141	[p7l295t1855r319b1892],
2	20	CD	NUMBER	20	amod	3	SENT_141	[p7l568t1855r623b1892],
3	4D	NN	O	4d	rcmod	1	SENT_141	[p7l853t1835r909b1892],
4	o	NN	O	o	prep	3	SENT_141	[p7l1143t1831r1198b1892],
5	an	DT	O	a	det	7	SENT_141	[p7l1425t1855r1478b1892],
6	100	CD	NUMBER	100	num	7	SENT_141	[p7l1708t1855r1788b1892],
7	12	CD	NUMBER	12	dep	4	SENT_141	[p7l1987t1855r2067b1892, p7l580t1950r709b1993],
8	:	:	O	:	_	0	SENT_141	[p7l1987t1855r2067b1892, p7l580t1950r709b1993],
9	'	''	O	'	_	0	SENT_141	[p7l1987t1855r2067b1892, p7l580t1950r709b1993],
10	|	NN	O	|	nn	12	SENT_141	[p7l1987t1855r2067b1892, p7l580t1950r709b1993],
11	'	''	O	'	_	0	SENT_141	[p7l1987t1855r2067b1892, p7l580t1950r709b1993],
12	Ime	NN	O	ime	dep	1	SENT_141	[p7l1987t1855r2067b1892, p7l580t1950r709b1993],

1	from	IN	O	from	dep	6	SENT_142	[p7l727t1950r844b1993],
2	treatment	NN	O	treatment	pobj	1	SENT_142	[p7l865t1950r1118b1993],
3	with	IN	O	with	_	0	SENT_142	[p7l1134t1950r1238b1993],
4	ihaliidorniéde	NN	O	ihaliidorniéde	prep_with	2	SENT_142	[p7l1257t1950r1561b1993],
5	{	CD	NUMBER	{	num	6	SENT_142	[p7l1582t1950r1812b2005],
6	mlontnas	NNS	O	mlontna	_	0	SENT_142	[p7l1582t1950r1812b2005],
7	}	IN	O	}	prep	6	SENT_142	[p7l1582t1950r1812b2005],

1	Fig	NN	O	fig	_	0	SENT_143	[p7l10t2094r103b2148],
2	.	.	O	.	_	0	SENT_143	[p7l10t2094r103b2148],

1	2	LS	NUMBER	2	_	0	SENT_144	[p7l116t2096r160b2137],
2	.	.	O	.	_	0	SENT_144	[p7l116t2096r160b2137],

1	Overall	JJ	O	overall	amod	2	SENT_145	[p7l193t2094r375b2137],
2	survival	NN	O	survival	nsubj	7	SENT_145	[p7l390t2094r592b2137],
3	of	IN	O	of	_	0	SENT_145	[p7l606t2094r659b2137],
4	relapsed/refractory	JJ	O	relapsed/refractory	amod	6	SENT_145	[p7l666t2093r1164b2148],
5	MM	NN	O	mm	nn	6	SENT_145	[p7l1176t2096r1276b2137],
6	patients	NNS	O	patient	prep_of	2	SENT_145	[p7l1290t2094r1497b2148],
7	treated	VBN	O	treat	_	0	SENT_145	[p7l1511t2094r1695b2137],
8	with	IN	O	with	_	0	SENT_145	[p7l1707t2094r1826b2137],
9	thalidomide	NN	O	thalidomide	prep_with	7	SENT_145	[p7l1839t2094r2152b2137],
10	according	VBG	O	accord	_	0	SENT_145	[p7l11t2165r263b2219],
11	to	TO	O	to	prepc_according_to	7	SENT_145	[p7l277t2171r326b2209],
12	XRCC5	NN	O	xrcc5	nn	14	SENT_145	[p7l341t2167r511b2209],
13	(	CD	NUMBER	(	num	14	SENT_145	[p7l529t2165r844b2219],
14	rs1051685	NN	O	rs1051685	pobj	7	SENT_145	[p7l529t2165r844b2219],
15	)	CD	NUMBER	)	num	16	SENT_145	[p7l529t2165r844b2219],
16	genotype	NN	O	genotype	dep	14	SENT_145	[p7l859t2171r1098b2219],
17	(	CD	NUMBER	(	num	18	SENT_145	[p7l1114t2165r1209b2219],
18	AA	NN	O	aa	dep	14	SENT_145	[p7l1114t2165r1209b2219],
19	=	JJ	O	=	amod	21	SENT_145	[p7l1219t2183r1246b2197],
20	wild	JJ	O	wild	amod	21	SENT_145	[p7l1258t2165r1371b2209],
21	type	NN	O	type	dep	18	SENT_145	[p7l1387t2171r1512b2219],
22	,	,	O	,	_	0	SENT_145	[p7l1387t2171r1512b2219],
23	AG	NNP	O	AG	appos	14	SENT_145	[p7l1527t2167r1602b2209],
24	=	JJ	O	=	amod	27	SENT_145	[p7l1615t2183r1642b2197],
25	heterozygous	JJ	O	heterozygous	amod	27	SENT_145	[p7l1655t2165r2002b2219],
26	SNP	NN	O	snp	nn	27	SENT_145	[p7l2019t2165r2151b2219],
27	)	NN	O	)	dep	23	SENT_145	[p7l2019t2165r2151b2219],
28	.	.	O	.	_	0	SENT_145	[p7l2019t2165r2151b2219],

1	number	NN	O	number	nsubjpass	9	SENT_146	[p7l13t2373r266b2427],
2	of	IN	O	of	_	0	SENT_146	[p7l286t2372r353b2427],
3	previous	JJ	O	previous	amod	5	SENT_146	[p7l368t2373r643b2440],
4	treatment	NN	O	treatment	nn	5	SENT_146	[p7l665t2381r989b2427],
5	lines	NNS	O	line	prep_of	1	SENT_146	[p7l1010t2373r1157b2427],
6	or	CC	O	or	_	0	SENT_146	[p7l1181t2388r1247b2427],
7	age	NN	O	age	conj_or	5	SENT_146	[p7l1267t2388r1373b2440],
8	was	VBD	O	be	auxpass	9	SENT_146	[p7l1394t2388r1519b2427],
9	considered	VBN	O	consider	_	0	SENT_146	[p7l1542t2373r1892b2427],
10	(	CD	NUMBER	(	num	12	SENT_146	[p7l1915t2373r2137b2440],
11	ERCC1	NN	O	ercc1	nn	12	SENT_146	[p7l1915t2373r2137b2440],
12	p	NN	O	p	dobj	9	SENT_146	[p7l7t2464r286b2528],
13	=	JJ	O	=	amod	12	SENT_146	[p7l7t2464r286b2528],
14	0.009	CD	NUMBER	0.009	tmod	13	SENT_146	[p7l7t2464r286b2528],
15	and	CC	O	and	_	0	SENT_146	[p7l321t2461r437b2515],
16	XRCC5	NN	O	xrcc5	nn	17	SENT_146	[p7l469t2464r680b2515],
17	p	NN	O	p	dobj	9	SENT_146	[p7l711t2461r992b2528],
18	=	JJ	O	=	amod	20	SENT_146	[p7l711t2461r992b2528],
19	0.04	CD	NUMBER	0.04	tmod	18	SENT_146	[p7l711t2461r992b2528],
20	)	NN	O	)	dep	17	SENT_146	[p7l711t2461r992b2528],
21	.	.	O	.	_	0	SENT_146	[p7l711t2461r992b2528],

1	A	DT	O	a	det	2	SENT_147	[p7l1024t2463r1071b2514],
2	trend	NN	O	trend	nsubjpass	9	SENT_147	[p7l1102t2461r1274b2515],
3	towards	IN	O	towards	_	0	SENT_147	[p7l1307t2461r1568b2515],
4	a	DT	O	a	det	6	SENT_147	[p7l1603t2476r1635b2515],
5	longer	JJR	O	longer	amod	6	SENT_147	[p7l1669t2461r1874b2528],
6	OS	NN	O	os	prep_towards	2	SENT_147	[p7l1905t2464r1987b2515],
7	was	VBD	O	be	auxpass	9	SENT_147	[p7l2020t2476r2144b2515],
8	also	RB	O	also	advmod	9	SENT_147	[p7l12t2548r136b2602],
9	observed	VBN	O	observe	_	0	SENT_147	[p7l158t2548r447b2602],
10	in	IN	O	in	_	0	SENT_147	[p7l469t2549r528b2602],
11	patients	NNS	O	patient	prep_in	9	SENT_147	[p7l549t2549r806b2616],
12	with	IN	O	with	_	0	SENT_147	[p7l827t2548r975b2602],
13	polymorphisms	NNS	O	polymorphism	prep_with	11	SENT_147	[p7l995t2548r1499b2616],
14	in	IN	O	in	_	0	SENT_147	[p7l1522t2549r1581b2602],
15	XRCCI	NN	O	xrccus	prep_in	13	SENT_147	[p7l1599t2551r1804b2602],
16	(	CD	NUMBER	(	num	15	SENT_147	[p7l1834t2548r2145b2615],
17	rs25487	NN	O	rs25487	nn	20	SENT_147	[p7l1834t2548r2145b2615],
18	)	CD	NUMBER	)	num	20	SENT_147	[p7l1834t2548r2145b2615],
19	(	NN	O	(	nn	20	SENT_147	[p7l12t2636r72b2704],
20	p	NN	O	p	dep	15	SENT_147	[p7l12t2636r72b2704],
21	=	JJ	O	=	amod	20	SENT_147	[p7l89t2659r122b2675],
22	0.06	CD	NUMBER	0.06	tmod	21	SENT_147	[p7l138t2636r298b2703],
23	)	CD	NUMBER	)	number	24	SENT_147	[p7l138t2636r298b2703],
24	(	CD	NUMBER	(	num	27	SENT_147	[p7l321t2636r516b2703],
25	Table	NNP	O	Table	nn	27	SENT_147	[p7l321t2636r516b2703],
26	3	CD	NUMBER	3	num	27	SENT_147	[p7l538t2636r616b2703],
27	)	NN	O	)	dep	20	SENT_147	[p7l538t2636r616b2703],
28	.	.	O	.	_	0	SENT_147	[p7l538t2636r616b2703],

1	3.4	CD	NUMBER	3.4	_	0	SENT_148	[p7l9t2838r114b2890],
2	.	.	O	.	_	0	SENT_148	[p7l9t2838r114b2890],

1	Genetic	JJ	O	genetic	amod	2	SENT_149	[p7l166t2837r394b2890],
2	polymorphisms	NNS	O	polymorphism	dep	5	SENT_149	[p7l409t2836r886b2903],
3	and	CC	O	and	_	0	SENT_149	[p7l908t2836r1021b2890],
4	toxicity	NN	O	toxicity	dep	5	SENT_149	[p7l1044t2837r1270b2903],
5	related	JJ	O	related	_	0	SENT_149	[p7l1292t2836r1504b2890],
6	to	TO	O	to	_	0	SENT_149	[p7l1527t2844r1582b2890],
7	thalidomide	NN	O	thalidomide	prep_to	5	SENT_149	[p7l1607t2835r1974b2890],

1	The	DT	O	the	det	2	SENT_150	[p7l111t3013r227b3067],
2	rate	NN	O	rate	nsubj	10	SENT_150	[p7l261t3021r384b3067],
3	of	IN	O	of	_	0	SENT_150	[p7l417t3013r484b3067],
4	neurotoxicity	NN	O	neurotoxicity	prep_of	2	SENT_150	[p7l509t3014r943b3081],
5	in	IN	O	in	_	0	SENT_150	[p7l974t3014r1033b3067],
6	this	DT	O	this	det	7	SENT_150	[p7l1065t3013r1181b3067],
7	series	NN	O	series	prep_in	4	SENT_150	[p7l1215t3014r1396b3067],
8	was	VBD	O	be	cop	10	SENT_150	[p7l1428t3029r1552b3067],
9	42.9	CD	PERCENT	42.9	num	10	SENT_150	[p7l1584t3016r1764b3068],
10	%	NN	PERCENT	%	_	0	SENT_150	[p7l1584t3016r1764b3068],
11	(	CD	NUMBER	(	number	12	SENT_150	[p7l1797t3013r1897b3080],
12	12	CD	NUMBER	12	num	10	SENT_150	[p7l1797t3013r1897b3080],
13	out	IN	O	out	_	0	SENT_150	[p7l1932t3021r2037b3067],
14	28	CD	NUMBER	28	num	15	SENT_150	[p7l2068t3016r2143b3067],
15	patients	NNS	O	patient	prep_out	10	SENT_150	[p7l12t3100r312b3168],
16	)	CD	NUMBER	)	dep	15	SENT_150	[p7l12t3100r312b3168],
17	.	.	O	.	_	0	SENT_150	[p7l12t3100r312b3168],

1	It	PRP	O	it	nsubj	3	SENT_151	[p7l333t3104r377b3154],
2	was	VBD	O	be	cop	3	SENT_151	[p7l394t3116r518b3154],
3	grade	NN	O	grade	_	0	SENT_151	[p7l537t3100r716b3168],
4	2	CD	NUMBER	2	num	3	SENT_151	[p7l736t3103r770b3154],
5	in	IN	O	in	_	0	SENT_151	[p7l792t3101r851b3154],
6	75	CD	PERCENT	75	num	7	SENT_151	[p7l872t3103r991b3154],
7	%	NN	PERCENT	%	prep_in	3	SENT_151	[p7l872t3103r991b3154],
8	and	CC	O	and	_	0	SENT_151	[p7l1010t3100r1126b3154],
9	grade	NN	O	grade	prep_in	3	SENT_151	[p7l1145t3100r1324b3168],
10	1	CD	NUMBER	1	num	9	SENT_151	[p7l1347t3103r1371b3154],
11	in	IN	O	in	_	0	SENT_151	[p7l1399t3101r1458b3154],
12	the	DT	O	the	det	15	SENT_151	[p7l1477t3100r1578b3154],
13	remaining	VBG	O	remain	amod	15	SENT_151	[p7l1599t3101r1929b3168],
14	25	CD	PERCENT	25	num	15	SENT_151	[p7l1947t3103r2068b3154],
15	%	NN	PERCENT	%	prep_in	9	SENT_151	[p7l1947t3103r2068b3154],
16	of	IN	O	of	_	0	SENT_151	[p7l2087t3100r2153b3154],
17	the	DT	O	the	det	18	SENT_151	[p7l12t3187r113b3241],
18	patients	NNS	O	patient	prep_of	15	SENT_151	[p7l130t3188r404b3255],
19	.	.	O	.	_	0	SENT_151	[p7l130t3188r404b3255],

1	This	DT	O	this	det	3	SENT_152	[p7l418t3187r549b3241],
2	adverse	JJ	O	adverse	amod	3	SENT_152	[p7l567t3187r813b3241],
3	effect	NN	O	effect	nsubj	4	SENT_152	[p7l829t3187r1007b3241],
4	led	VBD	O	lead	_	0	SENT_152	[p7l1022t3187r1116b3241],
5	to	TO	O	to	_	0	SENT_152	[p7l1132t3195r1194b3241],
6	discontinuation	NN	O	discontinuation	prep_to	4	SENT_152	[p7l1210t3187r1716b3241],
7	of	IN	O	of	_	0	SENT_152	[p7l1732t3187r1798b3241],
8	the	DT	O	the	det	9	SENT_152	[p7l1806t3187r1907b3241],
9	drug	NN	O	drug	prep_of	6	SENT_152	[p7l1924t3187r2072b3255],
10	in	IN	O	in	_	0	SENT_152	[p7l2087t3188r2146b3241],
11	50	CD	PERCENT	50	num	12	SENT_152	[p7l13t3277r133b3329],
12	%	NN	PERCENT	%	prep_in	9	SENT_152	[p7l13t3277r133b3329],
13	of	IN	O	of	_	0	SENT_152	[p7l149t3274r215b3329],
14	the	DT	O	the	det	15	SENT_152	[p7l223t3274r325b3328],
15	cases	NNS	O	case	prep_of	12	SENT_152	[p7l342t3290r506b3329],
16	and	CC	O	and	_	0	SENT_152	[p7l523t3274r639b3329],
17	dose	NN	O	dose	nn	18	SENT_152	[p7l657t3274r802b3329],
18	reduction	NN	O	reduction	prep_of	12	SENT_152	[p7l819t3274r1128b3329],
19	in	IN	O	in	_	0	SENT_152	[p7l1145t3275r1203b3328],
20	33.3	CD	PERCENT	33.3	num	21	SENT_152	[p7l1218t3277r1413b3329],
21	%	NN	PERCENT	%	prep_in	4	SENT_152	[p7l1218t3277r1413b3329],
22	.	.	O	.	_	0	SENT_152	[p7l1218t3277r1413b3329],

1	Only	RB	O	only	advmod	4	SENT_153	[p7l1431t3274r1580b3342],
2	the	DT	O	the	det	4	SENT_153	[p7l1594t3274r1695b3329],
3	heterozygous	JJ	O	heterozygous	amod	4	SENT_153	[p7l1713t3274r2144b3342],
4	polymorphism	NN	O	polymorphism	nsubj	27	SENT_153	[p7l12t3362r486b3429],
5	in	IN	O	in	_	0	SENT_153	[p7l513t3362r572b3415],
6	GSTT1	NN	O	gstt1	prep_in	4	SENT_153	[p7l599t3364r792b3416],
7	(	CD	NUMBER	(	num	6	SENT_153	[p7l828t3362r1097b3429],
8	rs4630	NN	O	rs4630	nn	11	SENT_153	[p7l828t3362r1097b3429],
9	)	CD	NUMBER	)	num	11	SENT_153	[p7l828t3362r1097b3429],
10	(	NN	O	(	nn	11	SENT_153	[p7l1125t3362r1230b3429],
11	CT	NN	O	ct	nsubjpass	16	SENT_153	[p7l1125t3362r1230b3429],
12	vs.	CC	O	vs.	prep	11	SENT_153	[p7l1253t3377r1335b3416],
13	TT	NN	O	tt	nn	14	SENT_153	[p7l1361t3362r1463b3429],
14	)	NN	O	)	dep	12	SENT_153	[p7l1361t3362r1463b3429],
15	was	VBD	O	be	auxpass	16	SENT_153	[p7l1489t3377r1613b3416],
16	associated	VBN	O	associate	rcmod	4	SENT_153	[p7l1641t3362r1972b3416],
17	with	IN	O	with	_	0	SENT_153	[p7l1998t3362r2146b3416],
18	a	DT	O	a	det	20	SENT_153	[p7l12t3464r44b3503],
19	lower	JJR	O	lower	amod	20	SENT_153	[p7l70t3449r254b3503],
20	frequency	NN	O	frequency	prep_with	16	SENT_153	[p7l278t3449r600b3516],
21	of	IN	O	of	_	0	SENT_153	[p7l624t3449r691b3503],
22	thalidomide-induced	JJ	O	thalidomide-induced	amod	26	SENT_153	[p7l708t3449r1388b3503],
23	peripheral	JJ	O	peripheral	amod	26	SENT_153	[p7l1415t3449r1746b3516],
24	neuropathy	NN	O	neuropathy	nn	26	SENT_153	[p7l1773t3449r2147b3516],
25	(	NN	O	(	nn	26	SENT_153	[p7l12t3535r72b3603],
26	p	NN	O	p	prep_of	20	SENT_153	[p7l12t3535r72b3603],
27	=	JJ	O	=	_	0	SENT_153	[p7l89t3535r314b3602],
28	0.04	CD	NUMBER	0.04	num	29	SENT_153	[p7l89t3535r314b3602],
29	)	NN	O	)	dobj	27	SENT_153	[p7l89t3535r314b3602],
30	.	.	O	.	_	0	SENT_153	[p7l89t3535r314b3602],

1	The	DT	O	the	det	2	SENT_154	[p7l340t3535r457b3589],
2	frequency	NN	O	frequency	nsubj	7	SENT_154	[p7l486t3535r808b3603],
3	of	IN	O	of	_	0	SENT_154	[p7l834t3535r901b3589],
4	neuropathy	NN	O	neuropathy	prep_of	2	SENT_154	[p7l921t3535r1295b3603],
5	was	VBD	O	be	cop	7	SENT_154	[p7l1320t3551r1444b3589],
6	23	CD	PERCENT	23	num	7	SENT_154	[p7l1473t3538r1594b3589],
7	%	NN	PERCENT	%	_	0	SENT_154	[p7l1473t3538r1594b3589],
8	(	CD	NUMBER	(	number	9	SENT_154	[p7l1622t3535r1681b3602],
9	3	CD	NUMBER	3	num	10	SENT_154	[p7l1622t3535r1681b3602],
10	patients	NNS	O	patient	attr	7	SENT_154	[p7l1713t3536r1970b3603],
11	with	IN	O	with	_	0	SENT_154	[p7l1998t3535r2146b3589],
12	grade	NN	O	grade	nn	14	SENT_154	[p7l11t3622r189b3690],
13	2	CD	NUMBER	2	num	14	SENT_154	[p7l211t3622r273b3689],
14	)	NN	O	)	prep_with	10	SENT_154	[p7l211t3622r273b3689],
15	in	IN	O	in	_	0	SENT_154	[p7l295t3623r354b3676],
16	the	DT	O	the	det	17	SENT_154	[p7l374t3622r476b3676],
17	SNP	NN	ORGANIZATION	snp	prep_in	14	SENT_154	[p7l498t3625r623b3676],
18	in	IN	O	in	_	0	SENT_154	[p7l643t3623r702b3676],
19	GSTT1	NN	O	gstt1	nn	20	SENT_154	[p7l724t3625r916b3676],
20	C/T	NN	O	c/t	prep_in	17	SENT_154	[p7l946t3622r1050b3690],
21	versus	CC	O	versus	prep	20	SENT_154	[p7l1067t3638r1272b3676],
22	60	CD	PERCENT	60	num	23	SENT_154	[p7l1295t3625r1416b3676],
23	%	NN	PERCENT	%	dep	21	SENT_154	[p7l1295t3625r1416b3676],
24	(	CD	NUMBER	(	number	25	SENT_154	[p7l1437t3622r1496b3690],
25	3	CD	NUMBER	3	num	26	SENT_154	[p7l1437t3622r1496b3690],
26	patients	NNS	O	patient	dep	20	SENT_154	[p7l1520t3623r1778b3690],
27	with	IN	O	with	_	0	SENT_154	[p7l1799t3622r1947b3676],
28	grade	NN	O	grade	prep_with	26	SENT_154	[p7l1966t3622r2145b3690],
29	1	CD	NUMBER	1	num	28	SENT_154	[p7l16t3712r40b3763],
30	and	CC	O	and	_	0	SENT_154	[p7l78t3709r194b3763],
31	6	CD	NUMBER	6	prep_in	17	SENT_154	[p7l224t3712r259b3763],
32	with	IN	O	with	_	0	SENT_154	[p7l288t3709r436b3763],
33	grade	NN	O	grade	nn	35	SENT_154	[p7l464t3709r642b3777],
34	2	CD	NUMBER	2	num	35	SENT_154	[p7l673t3709r734b3777],
35	)	NN	O	)	prep_with	31	SENT_154	[p7l673t3709r734b3777],
36	in	IN	O	in	_	0	SENT_154	[p7l765t3710r824b3763],
37	the	DT	O	the	det	39	SENT_154	[p7l852t3709r954b3764],
38	T/T	NNP	O	T/T	nn	39	SENT_154	[p7l981t3709r1085b3777],
39	genotype	NN	O	genotype	prep_in	35	SENT_154	[p7l1111t3717r1425b3777],
40	.	.	O	.	_	0	SENT_154	[p7l1111t3717r1425b3777],

1	In	IN	O	in	_	0	SENT_155	[p7l1456t3713r1516b3763],
2	this	DT	O	this	det	4	SENT_155	[p7l1545t3709r1661b3764],
3	last	JJ	O	last	amod	4	SENT_155	[p7l1692t3709r1803b3764],
4	genotype	NN	O	genotype	pobj	1	SENT_155	[p7l1831t3717r2144b3777],
5	,	,	O	,	_	0	SENT_155	[p7l1831t3717r2144b3777],

1	3	CD	NUMBER	3	num	2	SENT_156	[p8l11t19r45b70],
2	patients	NNS	O	patient	nsubj	3	SENT_156	[p8l76t17r334b84],
3	had	VBD	O	have	_	0	SENT_156	[p8l364t16r479b71],
4	to	TO	O	to	aux	5	SENT_156	[p8l507t24r568b70],
5	discontinue	VB	O	discontinue	xcomp	3	SENT_156	[p8l597t16r972b71],
6	the	DT	O	the	det	7	SENT_156	[p8l1000t16r1101b71],
7	drug	NN	O	drug	dobj	5	SENT_156	[p8l1130t16r1278b84],
8	and	CC	O	and	_	0	SENT_156	[p8l1304t16r1420b71],
9	in	IN	O	in	_	0	SENT_156	[p8l1449t17r1508b70],
10	4	CD	NUMBER	4	prep_in	13	SENT_156	[p8l1534t19r1572b70],
11	it	PRP	O	it	nsubjpass	13	SENT_156	[p8l1600t17r1644b70],
12	was	VBD	O	be	auxpass	13	SENT_156	[p8l1669t32r1793b71],
13	continued	VBN	O	continue	conj_and	3	SENT_156	[p8l1822t16r2145b71],
14	at	IN	O	at	_	0	SENT_156	[p8l12t113r71b159],
15	a	DT	O	a	det	17	SENT_156	[p8l97t120r129b159],
16	lower	JJR	O	lower	amod	17	SENT_156	[p8l155t105r340b159],
17	dose	NN	O	dose	prep_at	13	SENT_156	[p8l364t105r525b159],
18	.	.	O	.	_	0	SENT_156	[p8l364t105r525b159],

1	Neither	CC	O	neither	preconj	5	SENT_157	[p8l553t105r795b159],
2	the	DT	O	the	det	5	SENT_157	[p8l819t105r920b159],
3	duration	NN	O	duration	nn	5	SENT_157	[p8l947t105r1223b159],
4	of	IN	O	of	amod	5	SENT_157	[p8l1249t104r1315b159],
5	treatment	NN	O	treatment	nsubj	10	SENT_157	[p8l1333t113r1657b159],
6	nor	CC	O	nor	_	0	SENT_157	[p8l1683t120r1791b159],
7	maximum	JJ	O	maximum	amod	8	SENT_157	[p8l1815t105r2146b159],
8	dose	NN	O	dose	conj_nor	5	SENT_157	[p8l12t192r157b246],
9	was	VBD	O	be	cop	10	SENT_157	[p8l183t207r307b246],
10	different	JJ	O	different	_	0	SENT_157	[p8l335t192r613b246],
11	between	IN	O	between	_	0	SENT_157	[p8l638t192r916b246],
12	both	DT	O	both	det	14	SENT_157	[p8l941t192r1087b246],
13	genotype	NN	O	genotype	nn	14	SENT_157	[p8l1112t200r1410b259],
14	groups	NNS	O	group	prep_between	10	SENT_157	[p8l1436t207r1671b259],
15	.	.	O	.	_	0	SENT_157	[p8l1436t207r1671b259],

1	No	DT	O	no	det	3	SENT_158	[p8l1699t195r1785b246],
2	signiﬁcant	NN	O	signiﬁcant	nn	3	SENT_158	[p8l1813t192r2147b259],
3	relationship	NN	O	relationship	nsubjpass	5	SENT_158	[p8l13t278r398b346],
4	was	VBD	O	be	auxpass	5	SENT_158	[p8l414t294r538b332],
5	found	VBN	O	find	ccomp	17	SENT_158	[p8l557t278r742b332],
6	with	IN	O	with	_	0	SENT_158	[p8l758t278r906b332],
7	other	JJ	O	other	amod	8	SENT_158	[p8l923t278r1095b332],
8	toxicities	NNS	O	toxicity	prep_with	5	SENT_158	[p8l1109t279r1401b332],
9	(	VBP	O	(	rcmod	8	SENT_158	[p8l1420t278r1964b346],
10	gastrointestinal	JJ	O	gastrointestinal	acomp	9	SENT_158	[p8l1420t278r1964b346],
11	,	,	O	,	_	0	SENT_158	[p8l1420t278r1964b346],
12	cutaneous	JJ	O	cutaneous	dep	9	SENT_158	[p8l1982t286r2145b332, p8l13t381r216b428],
13	,	,	O	,	_	0	SENT_158	[p8l1982t286r2145b332, p8l13t381r216b428],
14	cardiac	JJ	O	cardiac	nsubj	17	SENT_158	[p8l240t365r468b419],
15	or	CC	O	or	_	0	SENT_158	[p8l490t381r556b419],
16	infections	NNS	O	infection	conj_or	14	SENT_158	[p8l577t365r916b432],
17	)	VBP	O	)	_	0	SENT_158	[p8l577t365r916b432],
18	(	CD	NUMBER	(	num	21	SENT_158	[p8l939t365r1135b432],
19	Table	NNP	O	Table	nn	21	SENT_158	[p8l939t365r1135b432],
20	3	CD	NUMBER	3	num	21	SENT_158	[p8l1156t365r1235b432],
21	)	NN	O	)	dep	17	SENT_158	[p8l1156t365r1235b432],
22	.	.	O	.	_	0	SENT_158	[p8l1156t365r1235b432],

1	3.5	CD	NUMBER	3.5	_	0	SENT_159	[p8l9t567r114b619],
2	.	.	O	.	_	0	SENT_159	[p8l9t567r114b619],

1	Genetic	JJ	O	genetic	amod	2	SENT_160	[p8l166t566r394b619],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_160	[p8l409t565r886b632],
3	and	CC	O	and	_	0	SENT_160	[p8l908t565r1021b619],
4	cytokines	NNS	O	cytokine	conj_and	2	SENT_160	[p8l1043t565r1330b632],

1	Pre-treatment	NN	O	pre-treatment	nn	4	SENT_161	[p8l114t745r571b796],
2	TNF-on	JJ	O	tnf-on	amod	4	SENT_161	[p8l585t745r789b796],
3	serum	NN	O	serum	nn	4	SENT_161	[p8l809t758r1008b796],
4	levels	NNS	O	level	nsubj	5	SENT_161	[p8l1027t742r1207b796],
5	showed	VBD	O	show	_	0	SENT_161	[p8l1227t742r1474b796],
6	a	DT	O	a	det	8	SENT_161	[p8l1493t758r1526b796],
7	signiﬁcant	JJ	O	signiﬁcant	amod	8	SENT_161	[p8l1545t742r1878b810],
8	correlation	NN	O	correlation	nsubj	20	SENT_161	[p8l1895t742r2145b796, p8l12t830r138b883],
9	with	IN	O	with	_	0	SENT_161	[p8l159t829r306b883],
10	VEFG	NN	O	vefg	nn	13	SENT_161	[p8l326t832r496b883],
11	(	CD	NUMBER	(	num	13	SENT_161	[p8l519t829r911b896],
12	rs2010963	NN	O	rs2010963	nn	13	SENT_161	[p8l519t829r911b896],
13	)	NN	O	)	prep_with	8	SENT_161	[p8l519t829r911b896],
14	and	CC	O	and	_	0	SENT_161	[p8l934t829r1050b883],
15	XPA	NN	O	xpa	conj_and	8	SENT_161	[p8l1071t831r1204b883],
16	(	CD	NUMBER	(	num	19	SENT_161	[p8l1225t829r1617b897],
17	rs1800975	NN	O	rs1800975	nn	19	SENT_161	[p8l1225t829r1617b897],
18	)	NN	O	)	nn	19	SENT_161	[p8l1225t829r1617b897],
19	polymorphisms	NNS	O	polymorphism	dep	15	SENT_161	[p8l1641t829r2144b897],
20	(	VBP	O	(	ccomp	5	SENT_161	[p8l12t917r144b984],
21	Fig	NN	O	fig	dobj	20	SENT_161	[p8l12t917r144b984],
22	.	.	O	.	_	0	SENT_161	[p8l12t917r144b984],

1	3	CD	NUMBER	3	_	0	SENT_162	[p8l171t916r249b984],
2	)	NN	O	)	dep	1	SENT_162	[p8l171t916r249b984],
3	.	.	O	.	_	0	SENT_162	[p8l171t916r249b984],

1	IL-6	NN	MISC	il-6	nn	2	SENT_163	[p8l278t919r399b971],
2	levels	NNS	O	level	nsubjpass	7	SENT_163	[p8l427t916r606b971],
3	post-treatment	JJ	O	post-treatment	amod	2	SENT_163	[p8l635t924r1126b984],
4	with	IN	O	with	_	0	SENT_163	[p8l1150t916r1298b971],
5	thalidomide	NN	O	thalidomide	prep_with	3	SENT_163	[p8l1324t916r1714b971],
6	were	VBD	O	be	auxpass	7	SENT_163	[p8l1740t932r1899b971],
7	associated	VBN	O	associate	_	0	SENT_163	[p8l1927t917r2145b971, p8l12t1004r149b1058],
8	with	IN	O	with	_	0	SENT_163	[p8l170t1004r318b1058],
9	polymorphism	NN	O	polymorphism	prep_with	7	SENT_163	[p8l341t1004r815b1071],
10	in	IN	O	in	_	0	SENT_163	[p8l838t1004r897b1057],
11	ERCC1	NN	O	ercc1	nn	13	SENT_163	[p8l920t1006r1116b1058],
12	(	CD	NUMBER	(	num	13	SENT_163	[p8l1147t1004r1498b1071],
13	rs735482	NN	O	rs735482	prep_in	7	SENT_163	[p8l1147t1004r1498b1071],
14	)	CD	NUMBER	)	number	15	SENT_163	[p8l1147t1004r1498b1071],
15	(	CD	NUMBER	(	num	16	SENT_163	[p8l1522t1004r1654b1071],
16	Fig	NN	O	fig	dep	7	SENT_163	[p8l1522t1004r1654b1071],
17	.	.	O	.	_	0	SENT_163	[p8l1522t1004r1654b1071],

1	4	CD	NUMBER	4	_	0	SENT_164	[p8l1676t1004r1755b1071],
2	)	NN	O	)	dep	1	SENT_164	[p8l1676t1004r1755b1071],
3	.	.	O	.	_	0	SENT_164	[p8l1676t1004r1755b1071],

1	In	IN	O	in	_	0	SENT_165	[p8l1780t1007r1840b1057],
2	addition	NN	O	addition	prep_in	20	SENT_165	[p8l1862t1004r2144b1066],
3	,	,	O	,	_	0	SENT_165	[p8l1862t1004r2144b1066],
4	this	DT	O	this	det	6	SENT_165	[p8l11t1091r128b1145],
5	SNP	NN	O	snp	nn	6	SENT_165	[p8l166t1094r291b1145],
6	polymorphism	NN	O	polymorphism	appos	2	SENT_165	[p8l326t1091r800b1158],
7	associated	VBN	O	associate	partmod	6	SENT_165	[p8l836t1091r1167b1145],
8	with	IN	O	with	_	0	SENT_165	[p8l1202t1091r1350b1145],
9	lower	JJR	O	lower	amod	11	SENT_165	[p8l1387t1091r1571b1145],
10	IL-6	NN	MISC	il-6	nn	11	SENT_165	[p8l1606t1094r1727b1145],
11	levels	NNS	O	level	prep_with	7	SENT_165	[p8l1764t1091r1944b1145],
12	posttreatment	NN	O	posttreatment	nn	14	SENT_165	[p8l1982t1099r2145b1158, p8l12t1186r335b1232],
13	(	CD	NUMBER	(	num	14	SENT_165	[p8l350t1178r457b1245],
14	CC	NN	O	cc	nsubj	20	SENT_165	[p8l350t1178r457b1245],
15	vs.	CC	O	vs.	prep	14	SENT_165	[p8l471t1193r554b1232],
16	AA	NN	O	aa	nn	17	SENT_165	[p8l569t1178r685b1245],
17	)	NN	O	)	dep	15	SENT_165	[p8l569t1178r685b1245],
18	was	VBD	O	be	cop	20	SENT_165	[p8l700t1193r825b1232],
19	the	DT	O	the	det	20	SENT_165	[p8l842t1178r943b1232],
20	same	JJ	O	same	_	0	SENT_165	[p8l962t1193r1126b1232],
21	that	IN	O	that	_	0	SENT_165	[p8l1142t1178r1271b1232],
22	the	DT	O	the	det	31	SENT_165	[p8l1286t1178r1387b1232],
23	one	CD	NUMBER	one	npadvmod	24	SENT_165	[p8l1405t1193r1519b1232],
24	related	JJ	O	related	amod	31	SENT_165	[p8l1537t1178r1760b1232],
25	with	IN	O	with	_	0	SENT_165	[p8l1775t1178r1923b1232],
26	higher	JJR	O	higher	amod	28	SENT_165	[p8l1940t1178r2148b1245],
27	response	NN	O	response	nn	28	SENT_165	[p8l13t1280r298b1332],
28	rate	NN	O	rate	prep_with	24	SENT_165	[p8l321t1272r444b1318],
29	and	CC	O	and	_	0	SENT_165	[p8l467t1264r582b1318],
30	longer	JJR	O	longer	conj_and	24	SENT_165	[p8l606t1264r811b1332],
31	OS	NNP	O	OS	prep_that	20	SENT_165	[p8l831t1267r929b1319],
32	.	.	O	.	_	0	SENT_165	[p8l831t1267r929b1319],

1	4	LS	NUMBER	4	_	0	SENT_166	[p8l9t1489r66b1540],
2	.	.	O	.	_	0	SENT_166	[p8l9t1489r66b1540],

1	Discussion	NN	O	discussion	_	0	SENT_167	[p8l113t1485r473b1540],

1	Thalidomide	NNP	O	Thalidomide	nn	2	SENT_168	[p8l111t1663r516b1717],
2	metabolism	NN	O	metabolism	nsubjpass	13	SENT_168	[p8l552t1663r931b1717],
3	exhibits	VBZ	O	exhibit	_	0	SENT_168	[p8l966t1663r1219b1717],
4	linear	JJ	O	linear	amod	7	SENT_168	[p8l1255t1663r1439b1717],
5	and	CC	O	and	_	0	SENT_168	[p8l1471t1663r1587b1717],
6	dose	NN	O	dose	amod	7	SENT_168	[p8l1622t1663r2147b1730],
7	—	NN	O	—	dobj	3	SENT_168	[p8l1622t1663r2147b1730],
8	dependent	JJ	O	dependent	amod	9	SENT_168	[p8l1622t1663r2147b1730],
9	pharmacokinetics	NNS	O	pharmacokinetic	dep	7	SENT_168	[p8l12t1750r584b1817],
10	and	CC	O	and	_	0	SENT_168	[p8l621t1750r736b1804],
11	is	VBZ	O	be	auxpass	13	SENT_168	[p8l773t1751r819b1804],
12	not	RB	O	not	neg	13	SENT_168	[p8l855t1758r961b1804],
13	affected	VBN	O	affect	conj_and	3	SENT_168	[p8l994t1750r1248b1804],
14	by	IN	O	by	_	0	SENT_168	[p8l1283t1750r1360b1817],
15	age	NN	O	age	nn	21	SENT_168	[p8l1393t1765r1516b1817],
16	,	,	O	,	_	0	SENT_168	[p8l1393t1765r1516b1817],
17	sex	NN	O	sex	dep	21	SENT_168	[p8l1553t1765r1670b1812],
18	,	,	O	,	_	0	SENT_168	[p8l1553t1765r1670b1812],
19	race	NN	O	race	dep	21	SENT_168	[p8l1707t1765r1853b1812],
20	,	,	O	,	_	0	SENT_168	[p8l1707t1765r1853b1812],
21	food	NN	O	food	agent	13	SENT_168	[p8l1890t1750r2045b1812],
22	,	,	O	,	_	0	SENT_168	[p8l1890t1750r2045b1812],
23	or	CC	O	or	_	0	SENT_168	[p8l2081t1765r2148b1804],
24	smoking	NN	O	smoking	nn	25	SENT_168	[p8l13t1836r287b1904],
25	status	NN	O	status	agent	13	SENT_168	[p8l329t1844r533b1891],
26	.	.	O	.	_	0	SENT_168	[p8l329t1844r533b1891],

1	Thalidomide	NNP	O	Thalidomide	nsubjpass	4	SENT_169	[p8l575t1836r980b1890],
2	is	VBZ	O	be	auxpass	4	SENT_169	[p8l1024t1837r1070b1890],
3	minimally	RB	O	minimally	advmod	4	SENT_169	[p8l1115t1836r1444b1904],
4	metabolized	VBN	O	metabolize	_	0	SENT_169	[p8l1486t1836r1883b1890],
5	by	IN	O	by	_	0	SENT_169	[p8l1926t1836r2003b1904],
6	the	DT	O	the	det	10	SENT_169	[p8l2044t1836r2145b1890],
7	cytochrome	NN	O	cytochrome	nn	10	SENT_169	[p8l12t1923r393b1991],
8	P450	NN	O	p450	nn	10	SENT_169	[p8l421t1926r577b1977],
9	isoenzyme	NN	O	isoenzyme	nn	10	SENT_169	[p8l604t1924r947b1991],
10	system	NN	O	system	agent	4	SENT_169	[p8l975t1931r1215b1991],
11	,	,	O	,	_	0	SENT_169	[p8l975t1931r1215b1991],
12	and	CC	O	and	_	0	SENT_169	[p8l1242t1923r1358b1977],
13	interactions	NNS	O	interaction	nsubj	21	SENT_169	[p8l1386t1924r1767b1977],
14	with	IN	O	with	_	0	SENT_169	[p8l1793t1923r1941b1977],
15	drugs	NNS	O	drug	prep_with	13	SENT_169	[p8l1967t1923r2144b1991],
16	metabolized	VBN	O	metabolize	partmod	15	SENT_169	[p8l13t2010r409b2065],
17	through	IN	O	through	_	0	SENT_169	[p8l440t2010r697b2078],
18	this	DT	O	this	det	19	SENT_169	[p8l727t2010r843b2065],
19	system	NN	O	system	prep_through	16	SENT_169	[p8l876t2018r1101b2078],
20	are	VBP	O	be	cop	21	SENT_169	[p8l1131t2026r1228b2065],
21	unlikely	JJ	O	unlikely	conj_and	4	SENT_169	[p8l1259t2010r1533b2078],
22	.	.	O	.	_	0	SENT_169	[p8l1259t2010r1533b2078],

1	Products	NNPS	O	Products	nsubjpass	6	SENT_170	[p8l1566t2010r1843b2065],
2	of	IN	O	of	_	0	SENT_170	[p8l1876t2010r1942b2064],
3	spontaneous	JJ	O	spontaneous	amod	4	SENT_170	[p8l1966t2026r2145b2078, p8l12t2106r262b2152],
4	hydrolysis	NN	O	hydrolysis	prep_of	1	SENT_170	[p8l289t2098r618b2165],
5	are	VBP	O	be	auxpass	6	SENT_170	[p8l644t2113r741b2152],
6	excreted	VBN	O	excrete	_	0	SENT_170	[p8l767t2098r1042b2152],
7	in	IN	O	in	_	0	SENT_170	[p8l1069t2098r1127b2151],
8	the	DT	O	the	det	9	SENT_170	[p8l1151t2098r1253b2152],
9	urine	NN	O	urine	prep_in	6	SENT_170	[p8l1278t2098r1461b2152],
10	.	.	O	.	_	0	SENT_170	[p8l1278t2098r1461b2152],

1	Most	JJS	O	most	nsubjpass	8	SENT_171	[p8l1487t2101r1646b2152],
2	of	IN	O	of	_	0	SENT_171	[p8l1670t2097r1737b2152],
3	an	DT	O	a	det	6	SENT_171	[p8l1753t2113r1828b2152],
4	absorbed	VBN	O	absorb	amod	6	SENT_171	[p8l1853t2098r2145b2152],
5	oral	JJ	O	oral	amod	6	SENT_171	[p8l12t2185r133b2239],
6	dose	NN	O	dose	prep_of	1	SENT_171	[p8l156t2185r301b2239],
7	is	VBZ	O	be	auxpass	8	SENT_171	[p8l324t2185r370b2239],
8	eliminated	VBN	O	eliminate	_	0	SENT_171	[p8l394t2185r739b2239],
9	through	IN	O	through	_	0	SENT_171	[p8l761t2185r1018b2252],
10	urine	NN	O	urine	prep_through	8	SENT_171	[p8l1040t2185r1207b2239],
11	and	CC	O	and	_	0	SENT_171	[p8l1229t2184r1345b2239],
12	feces	NNS	O	fece	conj_and	10	SENT_171	[p8l1368t2184r1525b2239],
13	[	CD	NUMBER	[	number	14	SENT_171	[p8l1551t2184r1691b2252],
14	11	CD	NUMBER	11	num	15	SENT_171	[p8l1551t2184r1691b2252],
15	]	NN	O	]	dep	12	SENT_171	[p8l1551t2184r1691b2252],
16	.	.	O	.	_	0	SENT_171	[p8l1551t2184r1691b2252],

1	Genetic	JJ	O	genetic	amod	2	SENT_172	[p8l1715t2185r1958b2239],
2	polymorphisms	NNS	O	polymorphism	nsubj	15	SENT_172	[p8l1979t2185r2145b2252, p8l13t2272r374b2339],
3	in	IN	O	in	_	0	SENT_172	[p8l417t2273r475b2325],
4	some	DT	O	some	det	5	SENT_172	[p8l517t2287r684b2326],
5	cytochromes	NNS	O	cytochrome	prep_in	2	SENT_172	[p8l725t2272r1137b2339],
6	could	MD	O	could	aux	15	SENT_172	[p8l1179t2272r1352b2326],
7	be	VB	O	be	cop	15	SENT_172	[p8l1393t2272r1466b2326],
8	responsible	JJ	O	responsible	amod	15	SENT_172	[p8l1507t2272r1875b2339],
9	for	IN	O	for	_	0	SENT_172	[p8l1916t2272r2006b2326],
10	the	DT	O	the	det	12	SENT_172	[p8l2044t2272r2145b2326],
11	antiangiogenic	JJ	O	antiangiogenic	amod	12	SENT_172	[p8l12t2359r486b2426],
12	activity	NN	O	activity	prep_for	8	SENT_172	[p8l506t2359r745b2426],
13	[	CD	NUMBER	[	number	14	SENT_172	[p8l767t2358r1004b2426],
14	12,13	CD	NUMBER	12,13	num	12	SENT_172	[p8l767t2358r1004b2426],
15	]	NN	O	]	_	0	SENT_172	[p8l767t2358r1004b2426],
16	.	.	O	.	_	0	SENT_172	[p8l767t2358r1004b2426],

1	but	CC	O	but	cc	6	SENT_173	[p8l1025t2358r1132b2412],
2	the	DT	O	the	det	3	SENT_173	[p8l1150t2358r1251b2412],
3	data	NNS	O	datum	nsubj	6	SENT_173	[p8l1272t2358r1409b2412],
4	are	VBP	O	be	cop	6	SENT_173	[p8l1429t2374r1526b2412],
5	contradictory	JJ	O	contradictory	amod	6	SENT_173	[p8l1547t2358r1983b2426],
6	[	NN	O	[	_	0	SENT_173	[p8l2005t2358r2144b2426],
7	14	CD	NUMBER	14	num	8	SENT_173	[p8l2005t2358r2144b2426],
8	]	NN	O	]	attr	6	SENT_173	[p8l2005t2358r2144b2426],
9	.	.	O	.	_	0	SENT_173	[p8l2005t2358r2144b2426],

1	In	IN	O	in	_	0	SENT_174	[p8l13t2449r72b2499],
2	our	PRP$	O	we	poss	3	SENT_174	[p8l101t2461r209b2499],
3	series	NN	O	series	prep_in	8	SENT_174	[p8l236t2446r433b2508],
4	,	,	O	,	_	0	SENT_174	[p8l236t2446r433b2508],
5	we	PRP	O	we	nsubj	8	SENT_174	[p8l461t2461r555b2499],
6	have	VBP	O	have	aux	8	SENT_174	[p8l584t2445r733b2499],
7	not	RB	O	not	neg	8	SENT_174	[p8l763t2453r867b2499],
8	observed	VBN	O	observe	_	0	SENT_174	[p8l895t2445r1185b2499],
9	any	DT	O	any	det	10	SENT_174	[p8l1214t2461r1329b2513],
10	inﬂuence	NN	O	inﬂuence	dobj	8	SENT_174	[p8l1356t2445r1650b2499],
11	in	IN	O	in	_	0	SENT_174	[p8l1680t2446r1739b2499],
12	response	NN	O	response	prep_in	10	SENT_174	[p8l1767t2461r2052b2513],
13	or	CC	O	or	_	0	SENT_174	[p8l2081t2461r2148b2499],
14	survival	NN	O	survival	conj_or	12	SENT_174	[p8l13t2532r264b2587],
15	for	IN	O	for	_	0	SENT_174	[p8l302t2532r391b2587],
16	SNPs	NNS	O	snp	prep_for	8	SENT_174	[p8l426t2535r579b2587],
17	of	IN	O	of	_	0	SENT_174	[p8l617t2532r683b2587],
18	phases	NNS	O	phase	prep_of	16	SENT_174	[p8l713t2532r927b2600],
19	I	CD	NUMBER	i	num	18	SENT_174	[p8l966t2536r981b2586],
20	and	CC	O	and	_	0	SENT_174	[p8l1019t2532r1134b2586],
21	II	CD	NUMBER	ii	conj_and	18	SENT_174	[p8l1172t2536r1209b2586],
22	drug	NN	O	drug	nn	23	SENT_174	[p8l1247t2532r1394b2600],
23	metabolism	NN	O	metabolism	dep	16	SENT_174	[p8l1430t2532r1810b2587],
24	and	CC	O	and	_	0	SENT_174	[p8l1846t2532r1962b2587],
25	drug	NN	O	drug	nn	26	SENT_174	[p8l1999t2532r2147b2600],
26	transporter	NN	O	transporter	dep	16	SENT_174	[p8l12t2628r378b2687],
27	(	CD	NUMBER	(	num	28	SENT_174	[p8l396t2620r647b2687],
28	ABCB1	NN	O	abcb1	dep	23	SENT_174	[p8l396t2620r647b2687],
29	,	,	O	,	_	0	SENT_174	[p8l396t2620r647b2687],
30	NR1I2	NN	O	nr1i2	nn	36	SENT_174	[p8l668t2622r877b2682],
31	,	,	O	,	_	0	SENT_174	[p8l668t2622r877b2682],
32	GSTT1	NN	O	gstt1	dep	36	SENT_174	[p8l898t2622r1114b2682],
33	,	,	O	,	_	0	SENT_174	[p8l898t2622r1114b2682],
34	SULT1	NN	O	sult1	dep	36	SENT_174	[p8l1135t2622r1324b2674],
35	C2	NN	O	c2	nn	36	SENT_174	[p8l1338t2620r1457b2687],
36	)	NN	O	)	appos	16	SENT_174	[p8l1338t2620r1457b2687],
37	.	.	O	.	_	0	SENT_174	[p8l1338t2620r1457b2687],

1	In	IN	O	in	_	0	SENT_175	[p8l1478t2623r1538b2673],
2	spite	NN	O	spite	_	0	SENT_175	[p8l1557t2620r1709b2687],
3	of	IN	O	of	_	0	SENT_175	[p8l1730t2619r1796b2674],
4	that	DT	O	that	prep_in_spite_of	31	SENT_175	[p8l1807t2620r1950b2682],
5	,	,	O	,	_	0	SENT_175	[p8l1807t2620r1950b2682],
6	a	DT	O	a	det	10	SENT_175	[p8l1970t2635r2002b2674],
7	SNP	NN	O	snp	nn	10	SENT_175	[p8l2022t2622r2147b2674],
8	(	CD	NUMBER	(	num	10	SENT_175	[p8l12t2707r282b2774],
9	rs4630	NN	O	rs4630	nn	10	SENT_175	[p8l12t2707r282b2774],
10	)	NN	O	)	nsubjpass	31	SENT_175	[p8l12t2707r282b2774],
11	in	IN	O	in	_	0	SENT_175	[p8l311t2708r370b2760],
12	GSTT1	NN	O	gstt1	prep_in	10	SENT_175	[p8l397t2710r614b2769],
13	,	,	O	,	_	0	SENT_175	[p8l397t2710r614b2769],
14	which	WDT	O	which	nsubjpass	16	SENT_175	[p8l641t2707r839b2761],
15	is	VBZ	O	be	auxpass	16	SENT_175	[p8l867t2708r913b2761],
16	involved	VBN	O	involve	rcmod	10	SENT_175	[p8l942t2707r1217b2761],
17	in	IN	O	in	_	0	SENT_175	[p8l1246t2708r1305b2760],
18	detoxiﬁcation	NN	O	detoxiﬁcation	prep_in	16	SENT_175	[p8l1332t2707r1778b2761],
19	of	IN	O	of	_	0	SENT_175	[p8l1805t2707r1872b2761],
20	reactive	JJ	O	reactive	amod	22	SENT_175	[p8l1892t2708r2145b2761],
21	oxygen	NN	O	oxygen	nn	22	SENT_175	[p8l12t2809r243b2861],
22	species	NNS	O	species	prep_of	18	SENT_175	[p8l270t2794r513b2861],
23	,	,	O	,	_	0	SENT_175	[p8l270t2794r513b2861],
24	cellular	JJ	O	cellular	amod	26	SENT_175	[p8l540t2793r779b2847],
25	redox	NN	O	redox	nn	26	SENT_175	[p8l804t2793r987b2847],
26	balance	NN	O	balance	prep_of	18	SENT_175	[p8l1011t2793r1254b2847],
27	and	CC	O	and	_	0	SENT_175	[p8l1281t2793r1396b2847],
28	apoptosis	NN	O	apoptosis	prep_of	18	SENT_175	[p8l1423t2794r1745b2861],
29	,	,	O	,	_	0	SENT_175	[p8l1423t2794r1745b2861],
30	was	VBD	O	be	auxpass	31	SENT_175	[p8l1770t2809r1894b2847],
31	related	VBN	O	relate	_	0	SENT_175	[p8l1922t2793r2145b2847],
32	to	TO	O	to	_	0	SENT_175	[p8l12t2888r73b2934],
33	the	DT	O	the	det	34	SENT_175	[p8l93t2880r195b2934],
34	development	NN	O	development	prep_to	31	SENT_175	[p8l216t2880r641b2948],
35	of	IN	O	of	_	0	SENT_175	[p8l660t2880r726b2934],
36	peripheral	JJ	O	peripheral	amod	37	SENT_175	[p8l739t2880r1071b2948],
37	neuropathy	NN	O	neuropathy	prep_of	34	SENT_175	[p8l1092t2880r1480b2948],
38	.	.	O	.	_	0	SENT_175	[p8l1092t2880r1480b2948],

1	Peripheral	JJ	O	peripheral	amod	2	SENT_176	[p8l1501t2880r1831b2948],
2	neuropathy	NN	O	neuropathy	nsubj	8	SENT_176	[p8l1852t2896r2145b2948, p8l12t2967r116b3035],
3	is	VBZ	O	be	cop	8	SENT_176	[p8l142t2968r189b3021],
4	the	DT	O	the	det	8	SENT_176	[p8l216t2967r317b3021],
5	most	RBS	O	most	advmod	6	SENT_176	[p8l346t2975r505b3021],
6	important	JJ	O	important	amod	8	SENT_176	[p8l531t2968r856b3035],
7	aadverse	NN	O	aadverse	nn	8	SENT_176	[p8l882t2967r1164b3021],
8	effect	NN	O	effect	_	0	SENT_176	[p8l1192t2967r1369b3021],
9	of	IN	O	of	_	0	SENT_176	[p8l1395t2967r1461b3021],
10	thalidomide	NN	O	thalidomide	nn	11	SENT_176	[p8l1480t2967r1871b3021],
11	therapy	NN	O	therapy	prep_of	8	SENT_176	[p8l1898t2967r2147b3035],
12	as	IN	O	as	mark	14	SENT_176	[p8l12t3070r74b3109],
13	it	PRP	O	it	nsubj	14	SENT_176	[p8l96t3055r139b3108],
14	occurs	VBZ	O	occur	advcl	8	SENT_176	[p8l158t3070r361b3109],
15	in	IN	O	in	_	0	SENT_176	[p8l383t3055r442b3108],
16	up	RB	O	up	quantmod	18	SENT_176	[p8l461t3070r540b3122],
17	to	TO	O	to	dep	18	SENT_176	[p8l560t3062r621b3109],
18	70	CD	PERCENT	70	num	19	SENT_176	[p8l642t3057r762b3109],
19	%	NN	PERCENT	%	prep_in	14	SENT_176	[p8l642t3057r762b3109],
20	of	IN	O	of	_	0	SENT_176	[p8l782t3054r848b3108],
21	the	DT	O	the	det	22	SENT_176	[p8l859t3054r961b3108],
22	patients	NNS	O	patient	prep_of	19	SENT_176	[p8l981t3055r1238b3122],
23	when	WRB	O	when	advmod	26	SENT_176	[p8l1257t3054r1438b3109],
24	treatment	NN	O	treatment	nsubjpass	26	SENT_176	[p8l1456t3062r1780b3109],
25	is	VBZ	O	be	auxpass	26	SENT_176	[p8l1799t3055r1845b3109],
26	given	VBN	O	give	advcl	14	SENT_176	[p8l1864t3055r2039b3122],
27	for	IN	O	for	_	0	SENT_176	[p8l2058t3054r2147b3109],
28	12	CD	DURATION	12	num	29	SENT_176	[p8l16t3144r87b3195],
29	months	NNS	NUMBER	month	prep_for	26	SENT_176	[p8l116t3142r358b3196],
30	[	RB	O	[	advmod	32	SENT_176	[p8l390t3141r529b3209],
31	15	CD	NUMBER	15	num	32	SENT_176	[p8l390t3141r529b3209],
32	]	NN	O	]	rcmod	29	SENT_176	[p8l390t3141r529b3209],
33	.	.	O	.	_	0	SENT_176	[p8l390t3141r529b3209],

1	The	DT	O	the	det	2	SENT_177	[p8l555t3142r671b3196],
2	studies	NNS	O	study	nsubj	8	SENT_177	[p8l700t3142r924b3196],
3	about	IN	O	about	_	0	SENT_177	[p8l952t3142r1135b3196],
4	SNPs	NNS	O	snp	prep_about	2	SENT_177	[p8l1161t3144r1315b3196],
5	and	CC	O	and	_	0	SENT_177	[p8l1343t3142r1459b3196],
6	thalidomide	NN	O	thalidomide	nn	7	SENT_177	[p8l1486t3142r1876b3196],
7	toxicity	NN	O	toxicity	prep_about	2	SENT_177	[p8l1903t3142r2147b3209],
8	reported	VBD	O	report	dep	11	SENT_177	[p8l13t3229r289b3296],
9	to	TO	O	to	_	0	SENT_177	[p8l313t3237r374b3283],
10	date	NN	O	date	prep_to	8	SENT_177	[p8l399t3229r535b3283],
11	were	VBD	O	be	_	0	SENT_177	[p8l558t3244r717b3283],
12	basically	RB	O	basically	advmod	11	SENT_177	[p8l741t3229r1019b3296],
13	about	IN	O	about	_	0	SENT_177	[p8l1041t3229r1224b3283],
14	thalidomide-related	JJ	O	thalidomide-related	amod	16	SENT_177	[p8l1246t3229r1894b3283],
15	thrombotic	JJ	O	thrombotic	amod	16	SENT_177	[p8l1917t3229r2145b3283, p8l11t3315r170b3369],
16	events	NNS	O	event	prep_about	11	SENT_177	[p8l184t3323r391b3369],
17	[	VBP	O	[	rcmod	16	SENT_177	[p8l411t3315r550b3383],
18	16	CD	NUMBER	16	num	19	SENT_177	[p8l411t3315r550b3383],
19	]	CD	NUMBER	]	dobj	17	SENT_177	[p8l411t3315r550b3383],
20	,	,	O	,	_	0	SENT_177	[p8l411t3315r550b3383],
21	and	CC	O	and	_	0	SENT_177	[p8l566t3315r682b3369],
22	found	VBD	O	find	rcmod	16	SENT_177	[p8l698t3315r882b3369],
23	association	NN	O	association	dobj	22	SENT_177	[p8l898t3316r1255b3369],
24	with	IN	O	with	_	0	SENT_177	[p8l1268t3315r1416b3369],
25	DNA	NN	MISC	dna	prep_with	22	SENT_177	[p8l1431t3317r1577b3369],
26	damage	NN	O	damage	nsubj	11	SENT_177	[p8l1590t3315r1855b3383],
27	,	,	O	,	_	0	SENT_177	[p8l1590t3315r1855b3383],
28	cytokine	NN	O	cytokine	nn	29	SENT_177	[p8l1871t3315r2145b3383],
29	response	NN	O	response	appos	26	SENT_177	[p8l13t3418r298b3470],
30	and	CC	O	and	_	0	SENT_177	[p8l321t3402r437b3456],
31	apoptosis	NN	O	apoptosis	appos	26	SENT_177	[p8l460t3403r782b3470],
32	.	.	O	.	_	0	SENT_177	[p8l460t3403r782b3470],

1	Thus	RB	O	thus	advmod	7	SENT_178	[p8l803t3402r973b3465],
2	,	,	O	,	_	0	SENT_178	[p8l803t3402r973b3465],
3	this	DT	O	this	nsubj	7	SENT_178	[p8l996t3402r1112b3456],
4	is	VBZ	O	be	cop	7	SENT_178	[p8l1137t3403r1183b3456],
5	the	DT	O	the	det	7	SENT_178	[p8l1207t3402r1308b3456],
6	ﬁrst	JJ	O	ﬁrst	amod	7	SENT_178	[p8l1332t3402r1459b3456],
7	association	NN	O	association	_	0	SENT_178	[p8l1481t3403r1837b3456],
8	with	IN	O	with	_	0	SENT_178	[p8l1858t3402r2006b3456],
9	this	DT	O	this	det	17	SENT_178	[p8l2028t3402r2144b3456],
10	serious	JJ	O	serious	amod	17	SENT_178	[p8l13t3490r255b3552],
11	,	,	O	,	_	0	SENT_178	[p8l13t3490r255b3552],
12	frequent	JJ	O	frequent	conj_and	10	SENT_178	[p8l274t3489r549b3557],
13	and	CC	O	and	_	0	SENT_178	[p8l565t3489r681b3543],
14	often	RB	O	often	advmod	15	SENT_178	[p8l699t3489r864b3543],
15	irreversible	JJ	O	irreversible	amod	17	SENT_178	[p8l882t3489r1247b3543],
16	adverse	JJ	O	adverse	amod	17	SENT_178	[p8l1265t3489r1511b3543],
17	effect	NN	O	effect	prep_with	7	SENT_178	[p8l1529t3489r1721b3544],
18	.	.	O	.	_	0	SENT_178	[p8l1529t3489r1721b3544],

1	Validation	NN	O	validation	nsubjpass	6	SENT_179	[p8l1737t3489r2069b3543],
2	in	IN	O	in	_	0	SENT_179	[p8l2087t3490r2146b3543],
3	larger	JJR	O	larger	amod	4	SENT_179	[p8l13t3576r200b3644],
4	series	NN	O	series	prep_in	1	SENT_179	[p8l217t3577r397b3631],
5	is	VBZ	O	be	auxpass	6	SENT_179	[p8l416t3577r462b3631],
6	warranted	VBN	O	warrant	_	0	SENT_179	[p8l479t3576r831b3639],
7	,	,	O	,	_	0	SENT_179	[p8l479t3576r831b3639],
8	particularly	RB	O	particularly	advmod	16	SENT_179	[p8l850t3576r1224b3644],
9	when	WRB	O	when	advmod	16	SENT_179	[p8l1238t3576r1419b3630],
10	this	DT	O	this	det	11	SENT_179	[p8l1436t3576r1551b3631],
11	association	NN	O	association	nsubj	16	SENT_179	[p8l1570t3577r1927b3631],
12	would	MD	O	would	aux	16	SENT_179	[p8l1943t3576r2145b3631],
13	not	RB	O	not	neg	16	SENT_179	[p8l13t3672r117b3718],
14	be	VB	O	be	cop	16	SENT_179	[p8l151t3663r224b3718],
15	statistically	RB	O	statistically	advmod	16	SENT_179	[p8l261t3664r628b3731],
16	signiﬁcant	JJ	O	signiﬁcant	ccomp	6	SENT_179	[p8l663t3663r996b3731],
17	if	IN	O	if	mark	27	SENT_179	[p8l1031t3663r1078b3717],
18	corrected	VBN	O	correct	amod	20	SENT_179	[p8l1105t3664r1408b3718],
19	P	NN	O	p	nn	20	SENT_179	[p8l1444t3667r1480b3717],
20	values	NNS	O	value	nsubjpass	27	SENT_179	[p8l1512t3664r1714b3718],
21	for	IN	O	for	_	0	SENT_179	[p8l1751t3663r1841b3718],
22	multiple	JJ	O	multiple	amod	23	SENT_179	[p8l1874t3663r2145b3731],
23	comparisons	NNS	O	comparison	prep_for	20	SENT_179	[p8l12t3752r419b3818],
24	would	MD	O	would	aux	27	SENT_179	[p8l441t3751r643b3805],
25	have	VB	O	have	aux	27	SENT_179	[p8l667t3751r815b3805],
26	been	VBN	O	be	auxpass	27	SENT_179	[p8l838t3751r991b3805],
27	done	VBN	O	do	advcl	16	SENT_179	[p8l1014t3751r1186b3806],
28	.	.	O	.	_	0	SENT_179	[p8l1014t3751r1186b3806],

1	The	DT	O	the	det	3	SENT_180	[p9l111t18r228b72],
2	response	NN	O	response	nn	3	SENT_180	[p9l262t34r547b86],
3	rate	NN	O	rate	nsubj	10	SENT_180	[p9l581t26r704b72],
4	to	TO	O	to	_	0	SENT_180	[p9l737t26r799b72],
5	thalidomide	NN	O	thalidomide	prep_to	3	SENT_180	[p9l832t18r1223b72],
6	as	IN	O	as	_	0	SENT_180	[p9l1257t34r1319b72],
7	single	JJ	O	single	amod	8	SENT_180	[p9l1354t18r1540b86],
8	agent	NN	O	agent	prep_as	5	SENT_180	[p9l1573t26r1751b86],
9	is	VBZ	O	be	cop	10	SENT_180	[p9l1784t19r1830b72],
10	low	JJ	O	low	_	0	SENT_180	[p9l1865t18r1997b73],
11	.	.	O	.	_	0	SENT_180	[p9l1865t18r1997b73],

1	The	DT	O	the	det	3	SENT_181	[p9l2028t18r2145b72],
2	best	JJS	O	best	amod	3	SENT_181	[p9l11t105r144b159],
3	responses	NNS	O	response	nsubjpass	5	SENT_181	[p9l173t121r489b173],
4	are	VBP	O	be	auxpass	5	SENT_181	[p9l520t121r617b159],
5	achieved	VBN	O	achieve	ccomp	19	SENT_181	[p9l647t105r930b159],
6	after	IN	O	after	_	0	SENT_181	[p9l961t105r1111b159],
7	a	DT	O	a	det	8	SENT_181	[p9l1138t121r1170b159],
8	median	NN	O	median	prep_after	5	SENT_181	[p9l1200t105r1440b159],
9	of	IN	O	of	_	0	SENT_181	[p9l1470t105r1536b159],
10	3	CD	DURATION	3	num	11	SENT_181	[p9l1557t108r1591b159],
11	months	NNS	NUMBER	month	prep_of	8	SENT_181	[p9l1625t105r1867b159],
12	of	IN	O	of	_	0	SENT_181	[p9l1898t105r1964b159],
13	therapy	NN	O	therapy	prep_of	11	SENT_181	[p9l1986t105r2145b159, p9l12t208r140b260],
14	,	,	O	,	_	0	SENT_181	[p9l1986t105r2145b159, p9l12t208r140b260],
15	the	DT	O	the	det	18	SENT_181	[p9l168t192r269b247],
16	median	JJ	O	median	amod	18	SENT_181	[p9l297t192r537b247],
17	response	NN	O	response	nn	18	SENT_181	[p9l565t208r849b260],
18	duration	NN	O	duration	nsubj	19	SENT_181	[p9l877t192r1152b247],
19	is	VBZ	O	be	_	0	SENT_181	[p9l1180t193r1226b247],
20	around	IN	O	around	_	0	SENT_181	[p9l1254t192r1481b247],
21	12	CD	DURATION	12	num	22	SENT_181	[p9l1512t195r1584b246],
22	months	NNS	NUMBER	month	prep_around	19	SENT_181	[p9l1614t192r1872b255],
23	,	,	O	,	_	0	SENT_181	[p9l1614t192r1872b255],
24	and	CC	O	and	_	0	SENT_181	[p9l1900t192r2016b247],
25	the	DT	O	the	det	34	SENT_181	[p9l2044t192r2145b247],
26	reported	VBN	O	report	amod	34	SENT_181	[p9l13t279r289b347],
27	2-year	JJ	DURATION	2-year	amod	28	SENT_181	[p9l321t282r529b347],
28	OS	NN	O	os	dep	26	SENT_181	[p9l559t282r641b334],
29	about	IN	O	about	_	0	SENT_181	[p9l673t279r855b334],
30	50	CD	PERCENT	50	num	31	SENT_181	[p9l886t282r1006b334],
31	%	NN	PERCENT	%	prep_about	28	SENT_181	[p9l886t282r1006b334],
32	[	CD	NUMBER	[	number	33	SENT_181	[p9l1041t279r1278b347],
33	17,18	CD	NUMBER	17,18	num	34	SENT_181	[p9l1041t279r1278b347],
34	]	NN	O	]	conj_and	22	SENT_181	[p9l1041t279r1278b347],
35	.	.	O	.	_	0	SENT_181	[p9l1041t279r1278b347],

1	It	PRP	O	it	nsubj	2	SENT_182	[p9l1311t283r1356b334],
2	is	VBZ	O	be	_	0	SENT_182	[p9l1387t280r1432b334],
3	of	IN	O	of	_	0	SENT_182	[p9l1465t279r1532b334],
4	note	NN	O	note	prep_of	2	SENT_182	[p9l1556t287r1696b334],
5	that	IN	O	that	complm	12	SENT_182	[p9l1727t279r1856b334],
6	patients	NNS	O	patient	nsubj	12	SENT_182	[p9l1887t280r2144b347],
7	with	IN	O	with	_	0	SENT_182	[p9l10t367r158b421],
8	extramedullary	JJ	O	extramedullary	amod	9	SENT_182	[p9l186t367r683b434],
9	involvement	NN	O	involvement	prep_with	6	SENT_182	[p9l710t367r1116b421],
10	do	VBP	O	do	aux	12	SENT_182	[p9l1142t367r1218b421],
11	not	RB	O	not	neg	12	SENT_182	[p9l1247t375r1352b421],
12	respond	VB	O	respond	ccomp	2	SENT_182	[p9l1379t367r1637b434],
13	to	TO	O	to	_	0	SENT_182	[p9l1665t375r1727b421],
14	single	JJ	O	single	amod	16	SENT_182	[p9l1756t366r1941b434],
15	agent	NN	O	agent	nn	16	SENT_182	[p9l1969t375r2147b434],
16	thalidomide	NN	O	thalidomide	prep_to	12	SENT_182	[p9l11t454r402b508],
17	[	CD	NUMBER	[	num	19	SENT_182	[p9l435t454r574b521],
18	19	CD	NUMBER	19	num	19	SENT_182	[p9l435t454r574b521],
19	]	NN	O	]	dobj	12	SENT_182	[p9l435t454r574b521],
20	.	.	O	.	_	0	SENT_182	[p9l435t454r574b521],

1	We	PRP	O	we	nsubj	2	SENT_183	[p9l602t457r710b508],
2	found	VBD	O	find	_	0	SENT_183	[p9l740t454r924b508],
3	a	DT	O	a	det	5	SENT_183	[p9l954t469r986b508],
4	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_183	[p9l1016t454r1349b521],
5	correlation	NN	O	correlation	dobj	2	SENT_183	[p9l1377t454r1729b508],
6	of	IN	O	of	_	0	SENT_183	[p9l1758t454r1824b508],
7	polymorM	NNP	O	polymorM	prep_of	5	SENT_183	[p9l1846t454r2145b521, p9l354t597r404b618],
8	.	.	O	.	_	0	SENT_183	[p9l1846t454r2145b521, p9l354t597r404b618],

1	T.	NNP	O	T.	_	0	SENT_184	[p9l1846t454r2145b521, p9l354t597r404b618],

1	Cibeira	NNP	O	Cibeira	_	0	SENT_185	[p9l414t596r497b618],
2	er	FW	O	er	nn	3	SENT_185	[p9l506t599r529b618],
3	al.	FW	O	al.	dep	1	SENT_185	[p9l536t596r562b618],
4	/	:	O	/	punct	1	SENT_185	[p9l568t596r580b623],
5	Leukemia	NNP	ORGANIZATION	Leukemia	nn	6	SENT_185	[p9l586t596r702b618],
6	Research	NNP	ORGANIZATION	Research	dep	1	SENT_185	[p9l710t596r816b618],
7	35	CD	NUMBER	35	number	8	SENT_185	[p9l824t597r854b618],
8	(	CD	NUMBER	(	num	9	SENT_185	[p9l862t596r943b623],
9	2011	CD	DATE	2011	dep	6	SENT_185	[p9l862t596r943b623],
10	)	CD	NUMBER	)	number	11	SENT_185	[p9l862t596r943b623],
11	1178-1183 1181	CD	DURATION	1178-1183 1181	num	9	SENT_185	[p9l1749t597r1806b618],[p9l954t597r1087b618],

1	TNF	NN	O	tnf	nsubj	5	SENT_186	[p9l25t1575r75b1729],
2	-	:	O	-	_	0	SENT_186	[p9l25t1575r75b1729],
3	or	CC	O	or	_	0	SENT_186	[p9l46t1520r79b1559],
4	levels	NNS	O	level	nsubj	5	SENT_186	[p9l29t1322r79b1505],
5	(	VBP	O	(	_	0	SENT_186	[p9l28t1053r93b1297],
6	pgImL	NN	O	pgiml	nn	7	SENT_186	[p9l28t1053r93b1297],
7	)	NN	O	)	dobj	5	SENT_186	[p9l28t1053r93b1297],

1	WT	NNP	O	WT	nn	2	SENT_187	[p9l583t2171r674b2214],
2	Het	NNP	O	Het	_	0	SENT_187	[p9l1119t2171r1207b2215],
3	SNP	NN	O	snp	dep	2	SENT_187	[p9l1642t2170r1760b2215],

1	VEFG	NN	O	vefg	_	0	SENT_188	[p9l935t2255r1118b2307],
2	(	CD	NUMBER	(	num	4	SENT_188	[p9l1163t2255r1532b2320],
3	rs2010963	NN	O	rs2010963	nn	4	SENT_188	[p9l1163t2255r1532b2320],
4	)	NN	O	)	dep	1	SENT_188	[p9l1163t2255r1532b2320],

1	TNF	NN	O	tnf	dep	5	SENT_189	[p10l101t937r151b1091],
2	-	:	O	-	_	0	SENT_189	[p10l101t937r151b1091],
3	on	IN	O	on	dep	1	SENT_189	[p10l119t879r152b919],
4	levels	NNS	O	level	pobj	3	SENT_189	[p10l101t680r152b863],
5	(	VBP	O	(	_	0	SENT_189	[p10l100t411r165b655],
6	pglmL	NN	O	pglml	nn	7	SENT_189	[p10l100t411r165b655],
7	)	NN	O	)	dobj	5	SENT_189	[p10l100t411r165b655],

1	WT	JJ	O	wt	amod	2	SENT_190	[p10l751t1559r843b1602],
2	Het	NN	O	het	_	0	SENT_190	[p10l1592t1559r1681b1603],

1	XPA	NNP	O	XPA	_	0	SENT_191	[p10l1007t1620r1147b1670],
2	(	CD	NUMBER	(	num	1	SENT_191	[p10l1169t1619r1539b1684],
3	rs1800975	CD	NUMBER	rs1800975	num	4	SENT_191	[p10l1169t1619r1539b1684],
4	)	NN	O	)	dep	1	SENT_191	[p10l1169t1619r1539b1684],

1	Fig	NN	O	fig	_	0	SENT_192	[p10l7t1715r100b1770],
2	.	.	O	.	_	0	SENT_192	[p10l7t1715r100b1770],

1	3	LS	NUMBER	3	_	0	SENT_193	[p10l129t1717r174b1759],
2	.	.	O	.	_	0	SENT_193	[p10l129t1717r174b1759],

1	TNF-or	JJ	O	tnf-or	amod	4	SENT_194	[p10l204t1718r368b1759],
2	pre-treatment	NN	O	pre-treatment	nn	4	SENT_194	[p10l399t1722r769b1770],
3	serum	NN	O	serum	nn	4	SENT_194	[p10l799t1728r959b1759],
4	levels	NNS	O	level	_	0	SENT_194	[p10l990t1715r1135b1759],
5	according	VBG	O	accord	_	0	SENT_194	[p10l1166t1715r1418b1770],
6	to	TO	O	to	prepc_according_to	4	SENT_194	[p10l1447t1722r1496b1759],
7	polymorphism	NN	O	polymorphism	pobj	4	SENT_194	[p10l1528t1715r1909b1770],
8	in	IN	O	in	_	0	SENT_194	[p10l1939t1716r1987b1758],
9	VEFG	NNP	O	VEFG	nn	11	SENT_194	[p10l2015t1717r2152b1759],
10	(	CD	NUMBER	(	num	11	SENT_194	[p10l7t1787r323b1841],
11	rs2010963	NN	O	rs2010963	prep_in	7	SENT_194	[p10l7t1787r323b1841],
12	)	CD	NUMBER	)	number	13	SENT_194	[p10l7t1787r323b1841],
13	(	CD	NUMBER	(	dep	7	SENT_194	[p10l348t1787r415b1841],
14	a	DT	O	a	det	15	SENT_194	[p10l348t1787r415b1841],
15	)	NN	O	)	dep	13	SENT_194	[p10l348t1787r415b1841],
16	and	CC	O	and	_	0	SENT_194	[p10l439t1787r533b1830],
17	XPA	NN	O	xpa	nn	19	SENT_194	[p10l556t1789r663b1830],
18	(	CD	NUMBER	(	num	19	SENT_194	[p10l686t1787r1001b1841],
19	rs1800975	NN	O	rs1800975	conj_and	7	SENT_194	[p10l686t1787r1001b1841],
20	)	CD	NUMBER	)	num	23	SENT_194	[p10l686t1787r1001b1841],
21	(	NN	O	(	nn	23	SENT_194	[p10l1026t1787r1110b1841],
22	b	NN	O	b	nn	23	SENT_194	[p10l1026t1787r1110b1841],
23	)	NN	O	)	dep	19	SENT_194	[p10l1026t1787r1110b1841],
24	.	.	O	.	_	0	SENT_194	[p10l1026t1787r1110b1841],

1	WT	NNP	O	WT	_	0	SENT_195	[p10l1133t1789r1238b1831],
2	:	:	O	:	_	0	SENT_195	[p10l1133t1789r1238b1831],
3	homozygous	JJ	O	homozygous	amod	5	SENT_195	[p10l1266t1787r1594b1841],
4	wild	JJ	O	wild	amod	5	SENT_195	[p10l1618t1787r1732b1830],
5	type	NN	O	type	dep	1	SENT_195	[p10l1756t1793r1885b1841],
6	;	:	O	;	_	0	SENT_195	[p10l1756t1793r1885b1841],
7	Het	NNP	O	Het	dep	5	SENT_195	[p10l1913t1789r2018b1831],
8	:	:	O	:	_	0	SENT_195	[p10l1913t1789r2018b1831],
9	heterozygous	JJ	O	heterozygous	amod	10	SENT_195	[p10l2047t1787r2151b1830, p10l7t1871r269b1912],
10	SNP	NN	O	snp	dep	1	SENT_195	[p10l288t1860r403b1902],
11	:	:	O	:	_	0	SENT_195	[p10l288t1860r403b1902],
12	homozygous	JJ	O	homozygous	amod	13	SENT_195	[p10l426t1858r753b1912],
13	SNP	NN	O	snp	dep	10	SENT_195	[p10l772t1860r884b1902],
14	.	.	O	.	_	0	SENT_195	[p10l772t1860r884b1902],

1	v	LS	O	v	_	0	SENT_196	[p10l38t2478r102b2495],
2	'	''	O	'	_	0	SENT_196	[p10l38t2478r102b2495],
3	\	SYM	O	\	dep	4	SENT_196	[p10l38t2478r102b2495],
4	75	CD	NUMBER	75	rcmod	1	SENT_196	[p10l151t2455r213b2499],
5	75	CD	NUMBER	75	dep	1	SENT_196	[p10l39t2499r88b2596],
6	'	''	O	'	_	0	SENT_196	[p10l39t2499r88b2596],
7	p	NN	O	p	prep	5	SENT_196	[p10l1492t2527r1670b2583],
8	=	JJ	O	=	amod	10	SENT_196	[p10l1492t2527r1670b2583],
9	0.04	CD	NUMBER	0.04	num	10	SENT_196	[p10l1492t2527r1670b2583],
10	E	NN	O	e	dep	7	SENT_196	[p10l37t2600r102b2658],
11	:	:	O	:	_	0	SENT_196	[p10l37t2600r102b2658],
12	3	CD	NUMBER	3	dep	5	SENT_196	[p10l38t2662r102b2721],
13	:	:	O	:	_	0	SENT_196	[p10l38t2662r102b2721],

1	(	NN	O	(	nn	3	SENT_197	[p10l51t2747r89b2780],
2	D	NN	O	d	nn	3	SENT_197	[p10l51t2747r89b2780],
3	E	NN	O	e	_	0	SENT_197	[p10l38t2786r89b2837],
4	50	CD	NUMBER	50	num	5	SENT_197	[p10l151t2767r212b2812],
5	>	JJR	O	>	dep	3	SENT_197	[p10l52t2839r88b2876],
6	2	CD	NUMBER	2	dep	5	SENT_197	[p10l38t2879r89b2929],

1	“	NN	O	“	_	0	SENT_198	[p10l38t2955r89b3009],
2	P	NN	O	p	dep	3	SENT_198	[p10l38t2955r89b3009],
3	=	JJ	O	=	dep	1	SENT_198	[p10l38t3014r88b3070],
4	'	''	O	'	_	0	SENT_198	[p10l38t3014r88b3070],

1	WT	JJ	O	wt	amod	2	SENT_199	[p10l745t3572r836b3616],
2	Het	NN	O	het	_	0	SENT_199	[p10l1585t3572r1673b3616],

1	ERCC1	NN	O	ercc1	_	0	SENT_200	[p10l917t3654r1133b3706],
2	(	CD	NUMBER	(	num	4	SENT_200	[p10l1166t3654r1498b3719],
3	rs735482	NN	O	rs735482	nn	4	SENT_200	[p10l1166t3654r1498b3719],
4	)	NN	O	)	dep	1	SENT_200	[p10l1166t3654r1498b3719],

1	Fig	NN	O	fig	_	0	SENT_201	[p11l7t22r100b76],
2	.	.	O	.	_	0	SENT_201	[p11l7t22r100b76],

1	4	LS	NUMBER	4	_	0	SENT_202	[p11l129t25r175b66],
2	.	.	O	.	_	0	SENT_202	[p11l129t25r175b66],

1	IL-6	NN	O	il-6	_	0	SENT_203	[p11l208t24r305b65],
2	post-treatment	JJ	O	post-treatment	amod	4	SENT_203	[p11l338t28r733b76],
3	serum	NN	O	serum	nn	4	SENT_203	[p11l764t34r924b65],
4	levels	NNS	O	level	rcmod	1	SENT_203	[p11l956t22r1100b65],
5	according	VBG	O	accord	_	0	SENT_203	[p11l1132t22r1385b76],
6	to	TO	O	to	prepc_according_to	4	SENT_203	[p11l1415t28r1464b65],
7	polymorphism	NN	O	polymorphism	pobj	4	SENT_203	[p11l1496t22r1877b76],
8	in	IN	O	in	_	0	SENT_203	[p11l1909t23r1956b65],
9	ERCC1	NN	O	ercc1	nn	12	SENT_203	[p11l1988t24r2145b65],
10	(	CD	NUMBER	(	num	12	SENT_203	[p11l7t93r303b147],
11	rs735482	NN	O	rs735482	nn	12	SENT_203	[p11l7t93r303b147],
12	)	NN	O	)	prep_in	7	SENT_203	[p11l7t93r303b147],
13	.	.	O	.	_	0	SENT_203	[p11l7t93r303b147],

1	WT	NNP	O	WT	_	0	SENT_204	[p11l319t96r424b137],
2	:	:	O	:	_	0	SENT_204	[p11l319t96r424b137],
3	homozygous	JJ	O	homozygous	amod	5	SENT_204	[p11l447t93r774b148],
4	wild	JJ	O	wild	amod	5	SENT_204	[p11l792t93r905b137],
5	type	NN	O	type	dep	1	SENT_204	[p11l923t100r1051b148],
6	;	:	O	;	_	0	SENT_204	[p11l923t100r1051b148],
7	Het	NNP	O	Het	dep	1	SENT_204	[p11l1074t96r1179b137],
8	:	:	O	:	_	0	SENT_204	[p11l1074t96r1179b137],
9	heterozygous	JJ	O	heterozygous	amod	10	SENT_204	[p11l1201t93r1548b148],
10	SNP	NN	O	snp	dep	7	SENT_204	[p11l1567t95r1679b137],
11	.	.	O	.	_	0	SENT_204	[p11l1567t95r1679b137],

1	phisms	NNS	O	phism	nsubj	9	SENT_205	[p11l9t301r237b368],
2	in	IN	O	in	_	0	SENT_205	[p11l269t301r328b354],
3	ERCC1	NN	O	ercc1	nn	8	SENT_205	[p11l358t303r577b363],
4	,	,	O	,	_	0	SENT_205	[p11l358t303r577b363],
5	XRCC5	NN	O	xrcc5	nn	8	SENT_205	[p11l606t303r817b355],
6	and	CC	O	and	_	0	SENT_205	[p11l850t301r966b355],
7	ERCC5	NN	O	ercc5	nn	8	SENT_205	[p11l997t303r1198b355],
8	genes	NNS	O	gene	prep_in	1	SENT_205	[p11l1229t316r1411b368],
9	(	VBP	O	(	dep	13	SENT_205	[p11l1443t301r1615b368],
10	DNA	NN	O	dna	nn	12	SENT_205	[p11l1443t301r1615b368],
11	repair	NN	O	repair	nn	12	SENT_205	[p11l1643t301r1835b368],
12	systems	NNS	O	system	dobj	9	SENT_205	[p11l1864t301r2146b368],
13	)	VBP	O	)	_	0	SENT_205	[p11l1864t301r2146b368],
14	with	IN	O	with	_	0	SENT_205	[p11l7t388r155b442],
15	clinical	JJ	O	clinical	amod	16	SENT_205	[p11l192t388r418b442],
16	response	NN	O	response	prep_with	13	SENT_205	[p11l455t403r741b455],
17	(	CD	NUMBER	(	num	19	SENT_205	[p11l778t388r1059b455],
18	PR/MR	NN	O	pr/mr	nn	19	SENT_205	[p11l778t388r1059b455],
19	)	NN	O	)	nsubj	13	SENT_205	[p11l778t388r1059b455],
20	.	.	O	.	_	0	SENT_205	[p11l778t388r1059b455],

1	The	DT	O	the	det	3	SENT_206	[p11l1094t388r1211b442],
2	two	CD	NUMBER	two	num	3	SENT_206	[p11l1247t396r1370b442],
3	ﬁrst	NN	O	ﬁrst	nsubjpass	6	SENT_206	[p11l1408t388r1535b442],
4	were	VBD	O	be	auxpass	6	SENT_206	[p11l1568t403r1729b442],
5	also	RB	O	also	advmod	6	SENT_206	[p11l1766t388r1890b442],
6	associated	VBN	O	associate	_	0	SENT_206	[p11l1927t389r2145b442, p11l9t474r145b528],
7	with	IN	O	with	_	0	SENT_206	[p11l168t474r317b528],
8	a	DT	O	a	det	10	SENT_206	[p11l340t490r372b528],
9	signiﬁcantly	RB	O	signiﬁcantly	advmod	10	SENT_206	[p11l397t474r792b542],
10	longer	RBR	O	longer	prep_with	6	SENT_206	[p11l814t474r1019b542],
11	05	CD	NUMBER	05	num	10	SENT_206	[p11l1042t477r1140b537],
12	,	,	O	,	_	0	SENT_206	[p11l1042t477r1140b537],
13	and	CC	O	and	_	0	SENT_206	[p11l1165t474r1281b528],
14	a	DT	O	a	det	15	SENT_206	[p11l1306t490r1338b528],
15	trend	NN	O	trend	nsubjpass	18	SENT_206	[p11l1361t474r1534b528],
16	was	VBD	O	be	auxpass	18	SENT_206	[p11l1556t490r1681b528],
17	also	RB	O	also	advmod	18	SENT_206	[p11l1706t474r1830b528],
18	observed	VBN	O	observe	conj_and	6	SENT_206	[p11l1855t474r2145b528],
19	for	IN	O	for	_	0	SENT_206	[p11l9t561r98b615],
20	XRCC1	NN	O	xrcc1	prep_for	18	SENT_206	[p11l123t564r353b616],
21	.	.	O	.	_	0	SENT_206	[p11l123t564r353b616],

1	ERCC1	NN	O	ercc1	nn	2	SENT_207	[p11l384t564r579b615],
2	protein	NN	O	protein	nsubj	3	SENT_207	[p11l617t562r851b629],
3	plays	VBZ	O	play	_	0	SENT_207	[p11l880t561r1044b629],
4	a	DT	O	a	det	6	SENT_207	[p11l1075t577r1107b615],
5	key	JJ	O	key	amod	6	SENT_207	[p11l1136t561r1248b629],
6	role	NN	O	role	dobj	3	SENT_207	[p11l1276t561r1397b615],
7	in	IN	O	in	_	0	SENT_207	[p11l1428t562r1487b615],
8	nucleotide	NN	O	nucleotide	nn	10	SENT_207	[p11l1516t561r1854b615],
9	excision	NN	O	excision	nn	10	SENT_207	[p11l1884t562r2146b615],
10	repair	NN	O	repair	prep_in	6	SENT_207	[p11l9t649r214b716],
11	.	.	O	.	_	0	SENT_207	[p11l9t649r214b716],

1	ERCCl	NN	O	erccl	nsubj	2	SENT_208	[p11l250t651r445b702],
2	dimerizes	VBZ	O	dimerize	_	0	SENT_208	[p11l488t648r801b702],
3	with	IN	O	with	_	0	SENT_208	[p11l835t648r983b702],
4	xeroderma	NN	O	xeroderma	nn	5	SENT_208	[p11l1014t648r1367b702],
5	pigmentosum	NN	O	pigmentosum	prep_with	2	SENT_208	[p11l1401t649r1849b716],
6	complementation	NN	O	complementation	nn	8	SENT_208	[p11l1882t648r2145b716, p11l9t736r343b790],
7	group	NN	O	group	nn	8	SENT_208	[p11l362t751r550b803],
8	F	NN	O	f	dep	5	SENT_208	[p11l572t739r618b798],
9	,	,	O	,	_	0	SENT_208	[p11l572t739r618b798],
10	and	CC	O	and	_	0	SENT_208	[p11l639t735r756b789],
11	this	DT	O	this	det	12	SENT_208	[p11l776t735r893b790],
12	complex	NN	O	complex	nsubjpass	14	SENT_208	[p11l915t735r1191b803],
13	is	VBZ	O	be	auxpass	14	SENT_208	[p11l1210t736r1257b790],
14	required	VBN	O	require	conj_and	2	SENT_208	[p11l1279t735r1552b803],
15	for	IN	O	for	_	0	SENT_208	[p11l1574t735r1663b789],
16	the	DT	O	the	det	17	SENT_208	[p11l1682t735r1783b790],
17	excision	NN	O	excision	prep_for	14	SENT_208	[p11l1804t736r2066b790],
18	of	IN	O	of	_	0	SENT_208	[p11l2087t735r2154b789],
19	the	DT	O	the	det	21	SENT_208	[p11l8t823r109b877],
20	damaged	JJ	O	damaged	amod	21	SENT_208	[p11l131t823r423b890],
21	DNA	NN	O	dna	prep_of	17	SENT_208	[p11l444t825r604b877],
22	.	.	O	.	_	0	SENT_208	[p11l444t825r604b877],

1	Nucleotide	NN	O	nucleotide	nn	3	SENT_209	[p11l626t822r973b877],
2	excision	NN	O	excision	nn	3	SENT_209	[p11l994t823r1256b877],
3	repair	NN	O	repair	nsubj	10	SENT_209	[p11l1277t823r1468b890],
4	is	VBZ	O	be	cop	10	SENT_209	[p11l1487t823r1534b877],
5	a	DT	O	a	det	10	SENT_209	[p11l1555t838r1587b877],
6	highly	RB	O	highly	advmod	7	SENT_209	[p11l1608t823r1809b890],
7	preserved	JJ	O	preserved	amod	10	SENT_209	[p11l1828t823r2145b890],
8	DNA	NN	O	dna	nn	10	SENT_209	[p11l9t912r155b964],
9	repair	NN	O	repair	nn	10	SENT_209	[p11l187t911r379b977],
10	pathway	NN	O	pathway	_	0	SENT_209	[p11l411t910r691b977],
11	that	WDT	O	that	dep	13	SENT_209	[p11l722t910r851b964],
12	repairs	NNS	O	repair	nn	13	SENT_209	[p11l884t911r1104b977],
13	lesions	NNS	O	lesion	rcmod	10	SENT_209	[p11l1139t910r1358b964],
14	which	WDT	O	which	nsubj	15	SENT_209	[p11l1391t910r1590b964],
15	alter	VBP	O	alter	rcmod	10	SENT_209	[p11l1623t910r1770b964],
16	the	DT	O	the	det	18	SENT_209	[p11l1801t910r1903b964],
17	helical	JJ	O	helical	amod	18	SENT_209	[p11l1937t910r2145b964],
18	structure	NN	O	structure	dobj	15	SENT_209	[p11l10t1004r301b1050],
19	of	IN	O	of	_	0	SENT_209	[p11l331t996r398b1050],
20	the	DT	O	the	det	24	SENT_209	[p11l419t996r520b1050],
21	DNA	NN	O	dna	nn	24	SENT_209	[p11l550t998r697b1050],
22	[	NN	O	[	nn	24	SENT_209	[p11l727t996r867b1064],
23	20	CD	NUMBER	20	num	24	SENT_209	[p11l727t996r867b1064],
24	]	NN	O	]	prep_of	18	SENT_209	[p11l727t996r867b1064],
25	.	.	O	.	_	0	SENT_209	[p11l727t996r867b1064],

1	The	DT	O	the	det	2	SENT_210	[p11l895t996r1011b1050],
2	functions	NNS	O	function	nsubj	6	SENT_210	[p11l1042t996r1340b1050],
3	of	IN	O	of	_	0	SENT_210	[p11l1370t996r1437b1050],
4	XRCC	NN	O	xrcc	nn	5	SENT_210	[p11l1456t999r1630b1050],
5	genes	NNS	O	gene	prep_of	2	SENT_210	[p11l1657t1012r1839b1064],
6	involved	VBN	O	involve	_	0	SENT_210	[p11l1871t996r2145b1050],
7	non-homologous	JJ	O	non-homologous	amod	8	SENT_210	[p11l9t1083r559b1151],
8	end	NN	O	end	dobj	6	SENT_210	[p11l601t1083r717b1137],
9	joining	VBG	O	join	partmod	8	SENT_210	[p11l750t1084r982b1151],
10	(	CD	NUMBER	(	num	12	SENT_210	[p11l1021t1083r1251b1151],
11	NHEJ	NN	O	nhej	nn	12	SENT_210	[p11l1021t1083r1251b1151],
12	)	NN	O	)	dobj	9	SENT_210	[p11l1021t1083r1251b1151],
13	,	,	O	,	_	0	SENT_210	[p11l1021t1083r1251b1151],
14	with	IN	O	with	_	0	SENT_210	[p11l1290t1083r1439b1137],
15	paradoxical	JJ	O	paradoxical	amod	16	SENT_210	[p11l1479t1083r1852b1151],
16	roles	NNS	O	role	prep_with	6	SENT_210	[p11l1893t1083r2045b1137],
17	in	IN	O	in	_	0	SENT_210	[p11l2087t1084r2146b1137],
18	repair	NN	O	repair	nn	19	SENT_210	[p11l9t1171r201b1238],
19	ﬁdelity	NN	O	ﬁdelity	prep_in	16	SENT_210	[p11l222t1170r449b1238],
20	and	CC	O	and	_	0	SENT_210	[p11l470t1170r587b1224],
21	telomere	NN	O	telomere	nn	22	SENT_210	[p11l609t1170r898b1225],
22	maintenance	NN	O	maintenance	prep_with	6	SENT_210	[p11l922t1171r1339b1225],
23	[	CD	NUMBER	[	number	24	SENT_210	[p11l1365t1170r1505b1238],
24	21	CD	NUMBER	21	num	25	SENT_210	[p11l1365t1170r1505b1238],
25	]	NN	O	]	dep	22	SENT_210	[p11l1365t1170r1505b1238],
26	.	.	O	.	_	0	SENT_210	[p11l1365t1170r1505b1238],

1	Concerning	VBG	O	concern	_	0	SENT_211	[p11l1529t1171r1896b1238],
2	XRCC1	NN	O	xrcc1	prep_concerning	11	SENT_211	[p11l1915t1173r2145b1233],
3	,	,	O	,	_	0	SENT_211	[p11l1915t1173r2145b1233],
4	the	DT	O	the	det	6	SENT_211	[p11l8t1257r109b1312],
5	clinical	JJ	O	clinical	amod	6	SENT_211	[p11l130t1257r356b1312],
6	effect	NN	O	effect	nsubj	11	SENT_211	[p11l376t1257r554b1312],
7	is	VBZ	O	be	cop	11	SENT_211	[p11l572t1258r619b1312],
8	probably	RB	O	probably	advmod	11	SENT_211	[p11l640t1257r926b1325],
9	not	RB	O	not	neg	11	SENT_211	[p11l944t1265r1049b1312],
10	only	RB	O	only	advmod	11	SENT_211	[p11l1067t1257r1207b1325],
11	related	JJ	O	related	_	0	SENT_211	[p11l1225t1257r1448b1312],
12	with	IN	O	with	_	0	SENT_211	[p11l1467t1257r1615b1311],
13	the	DT	O	the	det	15	SENT_211	[p11l1634t1257r1735b1312],
14	thalidomide	NN	O	thalidomide	nn	15	SENT_211	[p11l1754t1257r2145b1312],
15	activity	NN	O	activity	prep_with	11	SENT_211	[p11l9t1345r248b1412],
16	but	CC	O	but	_	0	SENT_211	[p11l266t1345r373b1399],
17	also	RB	O	also	_	0	SENT_211	[p11l392t1345r516b1399],
18	with	IN	O	with	_	0	SENT_211	[p11l535t1345r684b1399],
19	a	DT	O	a	det	20	SENT_211	[p11l704t1360r736b1399],
20	network	NN	O	network	prep_with	11	SENT_211	[p11l756t1345r1028b1399],
21	of	IN	O	of	_	0	SENT_211	[p11l1047t1344r1113b1399],
22	host	NN	O	host	nn	23	SENT_211	[p11l1126t1345r1263b1399],
23	factors	NNS	O	factor	prep_of	20	SENT_211	[p11l1282t1344r1513b1399],
24	.	.	O	.	_	0	SENT_211	[p11l1282t1344r1513b1399],

1	SN	NN	O	sn	nn	2	SENT_212	[p11l1536t1347r1619b1399],
2	P5	NN	O	p5	nsubjpass	9	SENT_212	[p11l1625t1348r1689b1399],
3	in	IN	O	in	_	0	SENT_212	[p11l1712t1345r1771b1398],
4	DNA	NN	MISC	dna	nn	6	SENT_212	[p11l1791t1347r1938b1398],
5	repair	NN	O	repair	nn	6	SENT_212	[p11l1956t1345r2148b1412],
6	genes	NNS	O	gene	prep_in	2	SENT_212	[p11l7t1447r189b1499],
7	have	VBP	O	have	aux	9	SENT_212	[p11l227t1432r375b1486],
8	been	VBN	O	be	auxpass	9	SENT_212	[p11l411t1432r565b1486],
9	reported	VBN	O	report	_	0	SENT_212	[p11l601t1432r877b1499],
10	as	IN	O	as	_	0	SENT_212	[p11l913t1447r975b1486],
11	prognostic	JJ	O	prognostic	amod	12	SENT_212	[p11l1012t1433r1353b1499],
12	factors	NNS	O	factor	prep_as	9	SENT_212	[p11l1388t1432r1602b1486],
13	in	IN	O	in	_	0	SENT_212	[p11l1640t1433r1698b1485],
14	several	JJ	O	several	amod	18	SENT_212	[p11l1735t1432r1959b1486],
15	solid	JJ	O	solid	amod	18	SENT_212	[p11l1996t1432r2145b1486],
16	[	NN	O	[	nn	18	SENT_212	[p11l12t1518r133b1586],
17	22	CD	NUMBER	22	num	18	SENT_212	[p11l12t1518r133b1586],
18	]	NN	O	]	prep_in	12	SENT_212	[p11l12t1518r133b1586],
19	and	CC	O	and	_	0	SENT_212	[p11l165t1518r281b1572],
20	hematological	JJ	O	hematological	amod	21	SENT_212	[p11l310t1518r765b1586],
21	[	NN	O	[	prep_as	9	SENT_212	[p11l797t1518r976b1586],
22	8,23	CD	NUMBER	8,23	number	23	SENT_212	[p11l797t1518r976b1586],
23	]	CD	NUMBER	]	num	25	SENT_212	[p11l797t1518r976b1586],
24	human	JJ	O	human	amod	25	SENT_212	[p11l1008t1518r1233b1572],
25	malignancies	NNS	O	malignancy	dep	21	SENT_212	[p11l1262t1518r1700b1586],
26	.	.	O	.	_	0	SENT_212	[p11l1262t1518r1700b1586],

1	In	IN	O	in	_	0	SENT_213	[p11l1730t1521r1790b1572],
2	MM	NN	O	mm	prep_in	15	SENT_213	[p11l1819t1521r1961b1581],
3	,	,	O	,	_	0	SENT_213	[p11l1819t1521r1961b1581],
4	SNPs	NNS	O	snp	nsubjpass	15	SENT_213	[p11l1990t1521r2145b1572],
5	in	IN	O	in	_	0	SENT_213	[p11l9t1606r68b1659],
6	genes	NNS	O	gene	prep_in	4	SENT_213	[p11l91t1621r273b1673],
7	involved	VBN	O	involve	partmod	6	SENT_213	[p11l298t1605r573b1659],
8	in	IN	O	in	_	0	SENT_213	[p11l598t1606r657b1659],
9	DNA	NN	MISC	dna	nn	11	SENT_213	[p11l680t1608r827b1659],
10	repair	NN	O	repair	nn	11	SENT_213	[p11l849t1606r1040b1673],
11	machinery	NN	O	machinery	prep_in	7	SENT_213	[p11l1063t1605r1406b1673],
12	have	VBP	O	have	aux	15	SENT_213	[p11l1429t1605r1578b1659],
13	also	RB	O	also	advmod	15	SENT_213	[p11l1602t1605r1726b1659],
14	been	VBN	O	be	auxpass	15	SENT_213	[p11l1749t1605r1904b1659],
15	associated	VBN	O	associate	_	0	SENT_213	[p11l1927t1606r2145b1659, p11l9t1692r145b1747],
16	with	IN	O	with	_	0	SENT_213	[p11l171t1692r319b1747],
17	longer	JJR	O	longer	amod	18	SENT_213	[p11l346t1692r551b1760],
18	time	NN	O	time	prep_with	15	SENT_213	[p11l575t1693r720b1747],
19	to	TO	O	to	_	0	SENT_213	[p11l747t1700r809b1747],
20	next	JJ	O	next	amod	23	SENT_213	[p11l837t1700r978b1746],
21	treatment	NN	O	treatment	nn	23	SENT_213	[p11l1003t1700r1327b1747],
22	(	CD	NUMBER	(	num	23	SENT_213	[p11l1353t1692r1581b1760],
23	ERCC2	NN	O	ercc2	prep_to	18	SENT_213	[p11l1353t1692r1581b1760],
24	and	CC	O	and	_	0	SENT_213	[p11l1610t1692r1726b1747],
25	XRCC3	NN	O	xrcc3	prep_with	15	SENT_213	[p11l1751t1693r1991b1760],
26	)	CD	NUMBER	)	num	25	SENT_213	[p11l1751t1693r1991b1760],
27	[	CD	NUMBER	[	number	28	SENT_213	[p11l2021t1692r2142b1760],
28	24	CD	NUMBER	24	num	29	SENT_213	[p11l2021t1692r2142b1760],
29	]	NN	O	]	dep	25	SENT_213	[p11l2021t1692r2142b1760],
30	as	RB	O	as	_	0	SENT_213	[p11l9t1795r71b1834],
31	well	RB	O	well	_	0	SENT_213	[p11l89t1780r225b1834],
32	as	IN	O	as	_	0	SENT_213	[p11l244t1795r306b1834],
33	with	IN	O	with	_	0	SENT_213	[p11l324t1780r472b1834],
34	response	NN	O	response	dep	44	SENT_213	[p11l491t1795r776b1847],
35	to	TO	O	to	_	0	SENT_213	[p11l795t1788r856b1834],
36	high	JJ	O	high	amod	41	SENT_213	[p11l876t1779r1195b1847],
37	—	NN	O	—	nn	41	SENT_213	[p11l876t1779r1195b1847],
38	dose	NN	O	dose	nn	41	SENT_213	[p11l876t1779r1195b1847],
39	therapy/autologous	JJ	O	therapy/autologous	amod	41	SENT_213	[p11l1213t1779r1844b1847],
40	stem	NN	O	stem	nn	41	SENT_213	[p11l1865t1788r2019b1834],
41	cell	NN	O	cell	prep_to	34	SENT_213	[p11l2037t1780r2145b1834],
42	transplantation	NN	O	transplantation	dep	44	SENT_213	[p11l8t1867r506b1934],
43	(	CD	NUMBER	(	num	42	SENT_213	[p11l531t1867r777b1934],
44	ERCC1	NN	O	ercc1	dep	54	SENT_213	[p11l531t1867r777b1934],
45	,	,	O	,	_	0	SENT_213	[p11l531t1867r777b1934],
46	ERCC4	NN	O	ercc4	conj_and	44	SENT_213	[p11l804t1870r1024b1929],
47	,	,	O	,	_	0	SENT_213	[p11l804t1870r1024b1929],
48	XRCC1	NN	O	xrcc1	conj_and	44	SENT_213	[p11l1048t1870r1254b1921],
49	and	CC	O	and	_	0	SENT_213	[p11l1287t1867r1403b1921],
50	XRCC2	NN	O	xrcc2	conj_and	44	SENT_213	[p11l1427t1867r1667b1934],
51	)	CD	NUMBER	)	num	52	SENT_213	[p11l1427t1867r1667b1934],
52	[	CD	NUMBER	[	dep	44	SENT_213	[p11l1696t1867r1795b1934],
53	9	CD	NUMBER	9	num	54	SENT_213	[p11l1696t1867r1795b1934],
54	]	NN	O	]	dep	15	SENT_213	[p11l1696t1867r1795b1934],
55	.	.	O	.	_	0	SENT_213	[p11l1696t1867r1795b1934],

1	Regarding	VBG	O	regard	_	0	SENT_214	[p11l1822t1867r2147b1934],
2	thalidomide	NN	O	thalidomide	nn	3	SENT_214	[p11l8t1954r399b2008],
3	treatment	NN	O	treatment	dobj	1	SENT_214	[p11l426t1962r764b2016],
4	,	,	O	,	_	0	SENT_214	[p11l426t1962r764b2016],
5	the	DT	O	the	det	7	SENT_214	[p11l791t1954r893b2008],
6	initial	JJ	O	initial	amod	7	SENT_214	[p11l921t1954r1105b2008],
7	evidence	NN	O	evidence	appos	3	SENT_214	[p11l1133t1954r1416b2008],
8	of	IN	O	of	_	0	SENT_214	[p11l1444t1954r1510b2008],
9	SNP	NN	ORGANIZATION	snp	nn	12	SENT_214	[p11l1530t1957r1655b2008],
10	and	CC	O	and	_	0	SENT_214	[p11l1680t1954r1796b2008],
11	treatment	NN	O	treatment	nn	12	SENT_214	[p11l1823t1962r2147b2008],
12	response	NN	O	response	prep_of	7	SENT_214	[p11l9t2056r294b2108],
13	comes	VBZ	O	come	dep	1	SENT_214	[p11l328t2056r529b2094],
14	from	IN	O	from	_	0	SENT_214	[p11l564t2040r716b2094],
15	the	DT	O	the	det	17	SENT_214	[p11l748t2040r849b2094],
16	cytokines	NNS	O	cytokine	nn	17	SENT_214	[p11l883t2040r1187b2108],
17	network	NN	O	network	prep_from	13	SENT_214	[p11l1221t2040r1510b2095],
18	:	:	O	:	_	0	SENT_214	[p11l1221t2040r1510b2095],
19	polymorphisms	NNS	O	polymorphism	dep	17	SENT_214	[p11l1549t2040r2053b2108],
20	in	IN	O	in	_	0	SENT_214	[p11l2087t2041r2146b2094],
21	the	DT	O	the	det	23	SENT_214	[p11l8t2127r109b2181],
22	TNF-oz	NN	O	tnf-oz	nn	23	SENT_214	[p11l129t2131r333b2181],
23	promoter	NN	O	promoter	prep_in	19	SENT_214	[p11l356t2135r662b2195],
24	(	CD	NUMBER	(	number	25	SENT_214	[p11l682t2127r877b2195],
25	-238	CD	NUMBER	-238	num	26	SENT_214	[p11l682t2127r877b2195],
26	position	NN	O	position	dobj	13	SENT_214	[p11l901t2127r1186b2195],
27	)	CD	NUMBER	)	num	26	SENT_214	[p11l901t2127r1186b2195],
28	conditioned	VBN	O	condition	partmod	26	SENT_214	[p11l1210t2127r1593b2181],
29	the	DT	O	the	det	31	SENT_214	[p11l1615t2127r1717b2181],
30	progressionfree	NN	O	progressionfree	nn	31	SENT_214	[p11l1740t2128r2145b2195, p11l9t2214r130b2269],
31	survival	NN	O	survival	dobj	28	SENT_214	[p11l152t2214r404b2269],
32	and	CC	O	and	_	0	SENT_214	[p11l425t2214r541b2269],
33	OS	NN	O	os	dobj	28	SENT_214	[p11l563t2217r645b2269],
34	in	IN	O	in	_	0	SENT_214	[p11l667t2215r726b2268],
35	patients	NNS	O	patient	prep_in	31	SENT_214	[p11l747t2215r1004b2282],
36	with	IN	O	with	_	0	SENT_214	[p11l1025t2214r1173b2268],
37	MM	NN	O	mm	prep_with	28	SENT_214	[p11l1193t2218r1336b2277],
38	,	,	O	,	_	0	SENT_214	[p11l1193t2218r1336b2277],
39	in	IN	O	in	_	0	SENT_214	[p11l1358t2215r1417b2268],
40	both	DT	O	both	det	46	SENT_214	[p11l1436t2214r1583b2269],
41	newly	RB	O	newly	advmod	42	SENT_214	[p11l1603t2214r1800b2282],
42	diagnosed	VBN	O	diagnose	amod	46	SENT_214	[p11l1819t2214r2145b2282],
43	and	CC	O	and	_	0	SENT_214	[p11l9t2302r125b2356],
44	relapsed/refractory	JJ	O	relapsed/refractory	amod	46	SENT_214	[p11l154t2301r775b2369],
45	disease	NN	O	disease	nn	46	SENT_214	[p11l802t2302r1034b2356],
46	[	NN	O	[	prep_in	28	SENT_214	[p11l1066t2301r1304b2369],
47	25,26	CD	NUMBER	25,26	num	48	SENT_214	[p11l1066t2301r1304b2369],
48	]	NN	O	]	nsubj	1	SENT_214	[p11l1066t2301r1304b2369],
49	.	.	O	.	_	0	SENT_214	[p11l1066t2301r1304b2369],

1	Thalidomide	NNP	O	Thalidomide	nsubj	2	SENT_215	[p11l1331t2302r1738b2356],
2	has	VBZ	O	have	_	0	SENT_215	[p11l1768t2302r1872b2356],
3	a	DT	O	a	det	5	SENT_215	[p11l1902t2317r1934b2356],
4	broad	JJ	O	broad	amod	5	SENT_215	[p11l1962t2302r2145b2356],
5	spectrum	NN	O	spectrum	dobj	2	SENT_215	[p11l10t2397r312b2456],
6	of	IN	O	of	_	0	SENT_215	[p11l337t2389r404b2443],
7	mechanisms	NNS	O	mechanism	prep_of	5	SENT_215	[p11l422t2389r824b2443],
8	of	IN	O	of	_	0	SENT_215	[p11l850t2389r917b2443],
9	action	NN	O	action	prep_of	7	SENT_215	[p11l934t2390r1146b2451],
10	,	,	O	,	_	0	SENT_215	[p11l934t2390r1146b2451],
11	and	CC	O	and	_	0	SENT_215	[p11l1172t2389r1288b2443],
12	direct	JJ	O	direct	amod	14	SENT_215	[p11l1315t2389r1500b2443],
13	DNA	NN	O	dna	nn	14	SENT_215	[p11l1525t2391r1672b2443],
14	damage	NN	O	damage	nsubj	16	SENT_215	[p11l1695t2389r1945b2456],
15	could	MD	O	could	aux	16	SENT_215	[p11l1971t2389r2145b2443],
16	explain	VB	O	explain	conj_and	2	SENT_215	[p11l9t2475r244b2543],
17	the	DT	O	the	det	18	SENT_215	[p11l270t2475r371b2529],
18	relation	NN	O	relation	dobj	16	SENT_215	[p11l399t2475r648b2529],
19	between	IN	O	between	_	0	SENT_215	[p11l673t2475r951b2529],
20	DNA	NN	MISC	dna	nn	22	SENT_215	[p11l978t2477r1124b2529],
21	repair	NN	O	repair	nn	22	SENT_215	[p11l1149t2476r1341b2543],
22	genes	NNS	O	gene	prep_between	18	SENT_215	[p11l1364t2491r1546b2543],
23	and	CC	O	and	_	0	SENT_215	[p11l1573t2475r1689b2529],
24	response	NN	O	response	prep_between	18	SENT_215	[p11l1717t2491r2003b2543],
25	and	CC	O	and	_	0	SENT_215	[p11l2029t2475r2145b2529],
26	05	NN	NUMBER	05	conj_and	22	SENT_215	[p11l9t2565r107b2617],
27	.	.	O	.	_	0	SENT_215	[p11l9t2565r107b2617],

1	In	IN	O	in	_	0	SENT_216	[p11l132t2565r192b2616],
2	fact	NN	O	fact	prep_in	27	SENT_216	[p11l215t2562r345b2624],
3	,	,	O	,	_	0	SENT_216	[p11l215t2562r345b2624],
4	free	JJ	O	free	amod	6	SENT_216	[p11l370t2562r491b2616],
5	radical	JJ	O	radical	amod	6	SENT_216	[p11l515t2562r1067b2616],
6	—	NN	O	—	nsubj	27	SENT_216	[p11l515t2562r1067b2616],
7	mediated	VBN	O	mediate	partmod	6	SENT_216	[p11l515t2562r1067b2616],
8	oxidative	JJ	O	oxidative	amod	10	SENT_216	[p11l1090t2562r1387b2616],
9	DNA	NN	O	dna	nn	10	SENT_216	[p11l1411t2564r1557b2616],
10	damage	NN	O	damage	nsubj	24	SENT_216	[p11l1579t2562r1829b2630],
11	may	MD	O	may	aux	12	SENT_216	[p11l1853t2578r1991b2630],
12	play	VB	O	play	ccomp	7	SENT_216	[p11l2013t2562r2148b2630],
13	a	DT	O	a	det	14	SENT_216	[p11l9t2665r41b2703],
14	role	NN	O	role	dobj	12	SENT_216	[p11l62t2649r184b2703],
15	in	IN	O	in	_	0	SENT_216	[p11l206t2650r265b2703],
16	teratogenicitiy	NN	O	teratogenicitiy	prep_in	12	SENT_216	[p11l285t2650r758b2717],
17	of	IN	O	of	_	0	SENT_216	[p11l778t2649r844b2703],
18	this	DT	O	this	det	19	SENT_216	[p11l857t2649r974b2703],
19	drug	NN	O	drug	prep_of	16	SENT_216	[p11l996t2649r1158b2717],
20	,	,	O	,	_	0	SENT_216	[p11l996t2649r1158b2717],
21	and	CC	O	and	_	0	SENT_216	[p11l1180t2649r1296b2703],
22	may	MD	O	may	aux	24	SENT_216	[p11l1318t2665r1456b2717],
23	also	RB	O	also	advmod	24	SENT_216	[p11l1475t2649r1599b2703],
24	have	VB	O	have	conj_and	12	SENT_216	[p11l1621t2649r1770b2703],
25	anti-tumor	JJ	O	anti-tumor	amod	26	SENT_216	[p11l1792t2650r2148b2703],
26	effects	NNS	O	effect	dobj	24	SENT_216	[p11l9t2736r216b2791],
27	[	VBP	O	[	_	0	SENT_216	[p11l238t2736r377b2804],
28	27	CD	NUMBER	27	num	29	SENT_216	[p11l238t2736r377b2804],
29	]	CD	NUMBER	]	dobj	27	SENT_216	[p11l238t2736r377b2804],
30	.	.	O	.	_	0	SENT_216	[p11l238t2736r377b2804],

1	Moreover	RB	O	moreover	advmod	8	SENT_217	[p11l397t2740r723b2799],
2	,	,	O	,	_	0	SENT_217	[p11l397t2740r723b2799],
3	an	DT	O	a	det	5	SENT_217	[p11l742t2752r817b2790],
4	apoptotic	JJ	O	apoptotic	amod	5	SENT_217	[p11l834t2737r1139b2804],
5	effect	NN	O	effect	nsubj	15	SENT_217	[p11l1156t2736r1334b2791],
6	was	VBD	O	be	auxpass	8	SENT_217	[p11l1348t2752r1473b2791],
7	also	RB	O	also	advmod	8	SENT_217	[p11l1491t2736r1615b2791],
8	observed	VBN	O	observe	_	0	SENT_217	[p11l1634t2736r1924b2791],
9	in	IN	O	in	_	0	SENT_217	[p11l1942t2737r2002b2790],
10	MM	NN	O	mm	nn	11	SENT_217	[p11l2019t2740r2145b2790],
11	cells	NNS	O	cell	prep_in	8	SENT_217	[p11l9t2824r164b2886],
12	,	,	O	,	_	0	SENT_217	[p11l9t2824r164b2886],
13	and	CC	O	and	_	0	SENT_217	[p11l183t2824r299b2878],
14	may	MD	O	may	aux	15	SENT_217	[p11l319t2839r456b2891],
15	correlate	VB	O	correlate	conj_and	8	SENT_217	[p11l473t2824r757b2878],
16	with	IN	O	with	_	0	SENT_217	[p11l774t2824r922b2878],
17	the	DT	O	the	det	19	SENT_217	[p11l940t2824r1041b2878],
18	clinical	JJ	O	clinical	amod	19	SENT_217	[p11l1060t2824r1286b2878],
19	observation	NN	O	observation	prep_with	15	SENT_217	[p11l1305t2824r1684b2878],
20	that	IN	O	that	complm	27	SENT_217	[p11l1701t2824r1831b2878],
21	complete	JJ	O	complete	amod	22	SENT_217	[p11l1848t2824r2145b2891],
22	response	NN	O	response	nsubjpass	27	SENT_217	[p11l9t2926r294b2978],
23	to	TO	O	to	_	0	SENT_217	[p11l323t2919r384b2965],
24	thalidomide	NN	O	thalidomide	prep_to	22	SENT_217	[p11l413t2911r804b2965],
25	is	VBZ	O	be	auxpass	27	SENT_217	[p11l833t2912r879b2965],
26	rarely	RB	O	rarely	advmod	27	SENT_217	[p11l909t2911r1097b2978],
27	observed	VBN	O	observe	ccomp	15	SENT_217	[p11l1124t2911r1414b2965],
28	[	CD	NUMBER	[	number	29	SENT_217	[p11l1447t2911r1586b2978],
29	28	CD	NUMBER	28	num	30	SENT_217	[p11l1447t2911r1586b2978],
30	]	NN	O	]	dobj	27	SENT_217	[p11l1447t2911r1586b2978],
31	.	.	O	.	_	0	SENT_217	[p11l1447t2911r1586b2978],

1	This	DT	O	this	det	2	SENT_218	[p11l1613t2911r1744b2965],
2	mechanism	NN	O	mechanism	nsubj	3	SENT_218	[p11l1775t2911r2146b2965],
3	has	VBZ	O	have	_	0	SENT_218	[p11l9t2997r113b3051],
4	a	DT	O	a	det	5	SENT_218	[p11l139t3013r171b3051],
5	link	NN	O	link	dobj	3	SENT_218	[p11l195t2997r316b3051],
6	with	IN	O	with	_	0	SENT_218	[p11l337t2997r485b3051],
7	the	DT	O	the	det	9	SENT_218	[p11l508t2997r610b3051],
8	two	CD	NUMBER	two	num	9	SENT_218	[p11l633t3005r756b3051],
9	polymorphisms	NNS	O	polymorphism	prep_with	5	SENT_218	[p11l781t2997r1286b3065],
10	in	IN	O	in	_	0	SENT_218	[p11l1312t2998r1370b3051],
11	ERCCT	NNP	O	ERCCT	prep_in	9	SENT_218	[p11l1395t3000r1591b3051],
12	and	CC	O	and	_	0	SENT_218	[p11l1623t2997r1739b3051],
13	XRCC5	NN	O	xrcc5	prep_with	5	SENT_218	[p11l1761t3000r1973b3051],
14	with	IN	O	with	_	0	SENT_218	[p11l1998t2997r2146b3051],
15	longer	JJR	O	longer	advmod	16	SENT_218	[p11l9t3084r214b3152],
16	05	CD	NUMBER	05	prep_with	13	SENT_218	[p11l236t3087r334b3139],
17	.	.	O	.	_	0	SENT_218	[p11l236t3087r334b3139],

1	Both	DT	O	both	det	2	SENT_219	[p11l359t3084r506b3138],
2	SNPs	NNS	O	snp	nsubj	4	SENT_219	[p11l530t3087r684b3138],
3	are	VBP	O	be	cop	4	SENT_219	[p11l709t3100r806b3138],
4	located	JJ	O	located	_	0	SENT_219	[p11l831t3084r1062b3138],
5	in	IN	O	in	_	0	SENT_219	[p11l1087t3085r1146b3138],
6	a	DT	O	a	det	11	SENT_219	[p11l1169t3100r1202b3138],
7	3	CD	NUMBER	3	num	11	SENT_219	[p11l1224t3086r1415b3138],
8	’	NN	O	’	nn	11	SENT_219	[p11l1224t3086r1415b3138],
9	UTR	NN	O	utr	nn	11	SENT_219	[p11l1224t3086r1415b3138],
10	gene	NN	O	gene	nn	11	SENT_219	[p11l1435t3100r1586b3152],
11	region	NN	O	region	prep_in	4	SENT_219	[p11l1611t3085r1829b3152],
12	,	,	O	,	_	0	SENT_219	[p11l1611t3085r1829b3152],
13	and	CC	O	and	_	0	SENT_219	[p11l1854t3084r1970b3138],
14	their	PRP$	O	they	poss	16	SENT_219	[p11l1994t3084r2148b3138],
15	biological	JJ	O	biological	amod	16	SENT_219	[p11l8t3171r317b3239],
16	effect	NN	O	effect	nsubj	18	SENT_219	[p11l353t3171r531b3226],
17	could	MD	O	could	aux	18	SENT_219	[p11l565t3171r739b3226],
18	affect	VB	O	affect	conj_and	4	SENT_219	[p11l774t3171r952b3226],
19	mRNA	NN	O	mrna	nn	20	SENT_219	[p11l986t3174r1191b3225],
20	stability	NN	O	stability	nsubj	23	SENT_219	[p11l1225t3171r1484b3239],
21	[	CD	NUMBER	[	number	22	SENT_219	[p11l1521t3171r1759b3239],
22	29,30	CD	NUMBER	29,30	num	23	SENT_219	[p11l1521t3171r1759b3239],
23	]	NN	O	]	xcomp	18	SENT_219	[p11l1521t3171r1759b3239],
24	.	.	O	.	_	0	SENT_219	[p11l1521t3171r1759b3239],

1	In	IN	O	in	_	0	SENT_220	[p11l1796t3175r1856b3225],
2	particular	JJ	O	particular	prep_in	10	SENT_220	[p11l1891t3172r2145b3239, p11l9t3258r106b3321],
3	,	,	O	,	_	0	SENT_220	[p11l1891t3172r2145b3239, p11l9t3258r106b3321],
4	XRCC5	NN	O	xrcc5	nsubjpass	10	SENT_220	[p11l141t3261r352b3312],
5	(	CD	NUMBER	(	num	7	SENT_220	[p11l391t3259r784b3326],
6	rs1051685	NN	O	rs1051685	nn	7	SENT_220	[p11l391t3259r784b3326],
7	)	NN	O	)	dep	4	SENT_220	[p11l391t3259r784b3326],
8	has	VBZ	O	have	aux	10	SENT_220	[p11l821t3258r926b3313],
9	been	VBN	O	be	auxpass	10	SENT_220	[p11l962t3258r1116b3313],
10	associated	VBN	O	associate	_	0	SENT_220	[p11l1152t3258r1483b3313],
11	to	TO	O	to	_	0	SENT_220	[p11l1519t3266r1581b3313],
12	susceptibility	NN	O	susceptibility	prep_to	10	SENT_220	[p11l1618t3258r2050b3326],
13	to	TO	O	to	_	0	SENT_220	[p11l2084t3266r2145b3313],
14	myeloma	NN	O	myeloma	prep_to	10	SENT_220	[p11l9t3346r324b3413],
15	,	,	O	,	_	0	SENT_220	[p11l9t3346r324b3413],
16	a	DT	O	a	det	19	SENT_220	[p11l347t3361r379b3400],
17	higher	JJR	O	higher	amod	19	SENT_220	[p11l402t3346r610b3413],
18	response	NN	O	response	nn	19	SENT_220	[p11l631t3361r916b3413],
19	rate	NN	O	rate	prep_to	10	SENT_220	[p11l940t3354r1063b3400],
20	and	CC	O	and	_	0	SENT_220	[p11l1086t3346r1202b3400],
21	thrombotic	JJ	O	thrombotic	amod	23	SENT_220	[p11l1224t3346r1586b3400],
22	events	NNS	O	event	nn	23	SENT_220	[p11l1608t3354r1815b3400],
23	incidence	NN	O	incidence	conj_and	14	SENT_220	[p11l1839t3346r2145b3400],
24	after	IN	O	after	_	0	SENT_220	[p11l9t3433r158b3487],
25	treatment	NN	O	treatment	prep_after	10	SENT_220	[p11l193t3441r531b3487],
26	.	.	O	.	_	0	SENT_220	[p11l193t3441r531b3487],

1	This	DT	O	this	det	2	SENT_221	[p11l566t3433r698b3487],
2	SNP	NN	O	snp	nsubj	4	SENT_221	[p11l737t3436r862b3487],
3	may	MD	O	may	aux	4	SENT_221	[p11l898t3448r1035b3500],
4	be	VB	O	be	_	0	SENT_221	[p11l1070t3433r1143b3487],
5	of	IN	O	of	_	0	SENT_221	[p11l1181t3433r1247b3487],
6	functional	JJ	O	functional	amod	7	SENT_221	[p11l1277t3433r1601b3487],
7	relevance	NN	O	relevance	prep_of	4	SENT_221	[p11l1640t3433r1947b3487],
8	since	IN	O	since	mark	11	SENT_221	[p11l1985t3434r2145b3487],
9	it	PRP	O	it	nsubj	11	SENT_221	[p11l9t3520r53b3573],
10	is	VBZ	O	be	cop	11	SENT_221	[p11l85t3520r131b3573],
11	located	JJ	O	located	advcl	4	SENT_221	[p11l165t3519r397b3573],
12	in	IN	O	in	_	0	SENT_221	[p11l431t3520r490b3573],
13	an	DT	O	a	det	15	SENT_221	[p11l522t3535r597b3573],
14	exonic	JJ	O	exonic	amod	15	SENT_221	[p11l630t3520r839b3573],
15	splice	NN	O	splice	prep_in	11	SENT_221	[p11l872t3519r1053b3587],
16	enhancer	NN	O	enhancer	nn	18	SENT_221	[p11l1087t3519r1386b3573],
17	(	CD	NUMBER	(	num	18	SENT_221	[p11l1416t3519r1580b3586],
18	ESE	NNP	O	ESE	tmod	11	SENT_221	[p11l1416t3519r1580b3586],
19	)	CD	NUMBER	)	num	20	SENT_221	[p11l1416t3519r1580b3586],
20	sequence	NN	O	sequence	dep	18	SENT_221	[p11l1614t3535r1927b3587],
21	.	.	O	.	_	0	SENT_221	[p11l1614t3535r1927b3587],

1	It	PRP	O	it	nsubj	8	SENT_222	[p11l1962t3522r2006b3573],
2	can	MD	O	can	aux	3	SENT_222	[p11l2037t3535r2146b3573],
3	result	VB	O	result	_	0	SENT_222	[p11l9t3606r193b3660],
4	in	IN	O	in	_	0	SENT_222	[p11l220t3607r279b3660],
5	exon	NN	O	exon	prep_in	3	SENT_222	[p11l307t3622r462b3660],
6	skipping	VBG	O	skip	partmod	5	SENT_222	[p11l491t3606r779b3674],
7	,	,	O	,	_	0	SENT_222	[p11l491t3606r779b3674],
8	lead	VB	O	lead	conj_and	3	SENT_222	[p11l809t3606r940b3660],
9	to	TO	O	to	_	0	SENT_222	[p11l968t3614r1030b3660],
10	errors	NNS	O	error	prep_to	8	SENT_222	[p11l1059t3622r1248b3660],
11	in	IN	O	in	_	0	SENT_222	[p11l1278t3607r1337b3660],
12	alternative	JJ	O	alternative	amod	14	SENT_222	[p11l1365t3606r1712b3660],
13	splicing	NN	O	splicing	nn	14	SENT_222	[p11l1742t3606r1990b3674],
14	patterns	NNS	O	pattern	prep_in	10	SENT_222	[p11l2017t3614r2145b3674, p11l8t3701r169b3748],
15	and	CC	O	and	_	0	SENT_222	[p11l198t3693r314b3747],
16	affect	VB	O	affect	conj_and	3	SENT_222	[p11l341t3693r519b3748],
17	mRNA	NN	O	mrna	nn	18	SENT_222	[p11l545t3696r750b3747],
18	stability	NN	O	stability	dobj	16	SENT_222	[p11l775t3693r1035b3761],
19	and	CC	O	and	_	0	SENT_222	[p11l1060t3693r1176b3747],
20	translation	NN	O	translation	conj_and	18	SENT_222	[p11l1204t3693r1569b3748],
21	.	.	O	.	_	0	SENT_222	[p11l1204t3693r1569b3748],

1	Any	DT	O	any	det	2	SENT_223	[p11l1594t3696r1722b3761],
2	alteration	NN	O	alteration	nsubj	7	SENT_223	[p11l1747t3693r2060b3748],
3	in	IN	O	in	_	0	SENT_223	[p11l2087t3694r2146b3747],
4	protein	NN	O	protein	nn	5	SENT_223	[p12l9t17r243b84],
5	binding	NN	O	binding	prep_in	2	SENT_223	[p12l259t17r506b84],
6	could	MD	O	could	aux	7	SENT_223	[p12l522t17r696b71],
7	affect	VB	O	affect	_	0	SENT_223	[p12l714t16r891b71],
8	the	DT	O	the	det	9	SENT_223	[p12l907t17r1008b71],
9	assembly	NN	O	assembly	dobj	7	SENT_223	[p12l1027t17r1326b84],
10	of	IN	O	of	_	0	SENT_223	[p12l1342t16r1409b71],
11	repair	NN	O	repair	nn	12	SENT_223	[p12l1419t17r1611b84],
12	complex	NN	O	complex	prep_of	9	SENT_223	[p12l1627t17r1916b84],
13	,	,	O	,	_	0	SENT_223	[p12l1627t17r1916b84],
14	resulting	VBG	O	result	partmod	7	SENT_223	[p12l1935t17r2145b71, p12l9t104r107b171],
15	in	IN	O	in	_	0	SENT_223	[p12l126t104r185b157],
16	accumulation	NN	O	accumulation	prep_in	14	SENT_223	[p12l203t104r642b158],
17	of	IN	O	of	_	0	SENT_223	[p12l661t103r727b158],
18	unprocessed	JJ	O	unprocessed	amod	21	SENT_223	[p12l738t104r1142b171],
19	DNA	NN	MISC	dna	nn	21	SENT_223	[p12l1163t106r1309b157],
20	double-strand	NN	O	double-strand	nn	21	SENT_223	[p12l1326t103r1781b158],
21	breaks	NNS	O	break	prep_of	16	SENT_223	[p12l1800t104r2009b158],
22	and	CC	O	and	_	0	SENT_223	[p12l2029t104r2145b158],
23	recruitment	NN	O	recruitment	prep_in	14	SENT_223	[p12l9t192r396b245],
24	of	IN	O	of	_	0	SENT_223	[p12l411t191r477b245],
25	the	DT	O	the	det	27	SENT_223	[p12l486t191r587b245],
26	apoptotic	JJ	O	apoptotic	amod	27	SENT_223	[p12l604t192r909b258],
27	machinery	NN	O	machinery	prep_of	23	SENT_223	[p12l926t191r1283b258],
28	.	.	O	.	_	0	SENT_223	[p12l926t191r1283b258],

1	This	DT	O	this	nsubj	6	SENT_224	[p12l1298t191r1430b245],
2	could	MD	O	could	aux	6	SENT_224	[p12l1448t191r1622b245],
3	at	IN	O	at	advmod	6	SENT_224	[p12l1639t199r1698b245],
4	least	JJS	O	least	pobj	3	SENT_224	[p12l1714t191r1863b245],
5	partially	RB	O	partially	advmod	6	SENT_224	[p12l1878t191r2148b258],
6	explain	VB	O	explain	dep	17	SENT_224	[p12l9t277r244b345],
7	the	DT	O	the	det	9	SENT_224	[p12l264t277r366b331],
8	high	JJ	O	high	amod	9	SENT_224	[p12l388t277r528b345],
9	sensitivity	NN	O	sensitivity	dobj	6	SENT_224	[p12l549t278r882b345],
10	of	IN	O	of	_	0	SENT_224	[p12l901t277r968b331],
11	myeloma	NN	O	myeloma	nn	12	SENT_224	[p12l981t277r1281b345],
12	patients	NNS	O	patient	prep_of	9	SENT_224	[p12l1302t278r1559b345],
13	to	TO	O	to	_	0	SENT_224	[p12l1581t285r1642b331],
14	DNA	NN	O	dna	prep_to	6	SENT_224	[p12l1665t279r1811b331],
15	damaging	NN	O	damaging	nn	16	SENT_224	[p12l1830t277r2147b345],
16	agents	NNS	O	agent	nsubj	17	SENT_224	[p12l9t372r215b432],
17	[	VBP	O	[	_	0	SENT_224	[p12l242t364r480b432],
18	30,31	CD	NUMBER	30,31	number	19	SENT_224	[p12l242t364r480b432],
19	]	CD	NUMBER	]	dobj	17	SENT_224	[p12l242t364r480b432],
20	.	.	O	.	_	0	SENT_224	[p12l242t364r480b432],

1	There	EX	O	there	expl	2	SENT_225	[p12l108t451r290b505],
2	is	VBZ	O	be	_	0	SENT_225	[p12l307t452r353b506],
3	scarce	JJ	O	scarce	amod	4	SENT_225	[p12l371t467r566b506],
4	information	NN	O	information	nsubj	2	SENT_225	[p12l583t451r967b506],
5	concerning	VBG	O	concern	_	0	SENT_225	[p12l982t452r1340b519],
6	cytokine	NN	O	cytokine	nn	7	SENT_225	[p12l1355t451r1628b519],
7	levels	NNS	O	level	prep_concerning	4	SENT_225	[p12l1645t451r1825b506],
8	and	CC	O	and	_	0	SENT_225	[p12l1841t451r1957b505],
9	SNPs	NNS	O	snp	prep_concerning	4	SENT_225	[p12l1974t454r2145b506],
10	.	.	O	.	_	0	SENT_225	[p12l1974t454r2145b506],

1	Previous	JJ	O	previous	amod	2	SENT_226	[p12l9t539r282b593],
2	reports	NNS	O	report	nsubj	11	SENT_226	[p12l315t547r544b606],
3	have	VBP	O	have	aux	4	SENT_226	[p12l576t539r725b593],
4	shown	VBN	O	show	_	0	SENT_226	[p12l758t538r970b593],
5	that	IN	O	that	_	0	SENT_226	[p12l1001t539r1130b593],
6	high	JJ	O	high	amod	9	SENT_226	[p12l1160t539r1300b606],
7	pretreatment	NN	O	pretreatment	nn	9	SENT_226	[p12l1331t547r1763b606],
8	TNF-oz	NN	O	tnf-oz	nn	9	SENT_226	[p12l1790t542r1994b592],
9	levels	NNS	O	level	prep_that	4	SENT_226	[p12l2026t539r2145b593, p12l9t626r92b680],
10	and	CC	O	and	_	0	SENT_226	[p12l128t626r244b680],
11	change	VB	O	change	conj_and	4	SENT_226	[p12l281t626r506b693],
12	in	IN	O	in	_	0	SENT_226	[p12l542t627r601b679],
13	IL-6	NN	O	il-6	nn	14	SENT_226	[p12l636t629r757b680],
14	level	NN	O	level	prep_in	11	SENT_226	[p12l794t626r942b680],
15	after	IN	O	after	mark	18	SENT_226	[p12l978t626r1128b680],
16	therapy	NN	O	therapy	nsubjpass	18	SENT_226	[p12l1160t626r1410b693],
17	were	VBD	O	be	auxpass	18	SENT_226	[p12l1442t641r1602b680],
18	correlated	VBN	O	correlate	advcl	11	SENT_226	[p12l1638t626r1964b680],
19	with	IN	O	with	_	0	SENT_226	[p12l1998t626r2146b680],
20	progression	NN	O	progression	prep_with	18	SENT_226	[p12l9t712r542b780],
21	—	CD	NUMBER	—	num	23	SENT_226	[p12l9t712r542b780],
22	free	JJ	O	free	amod	23	SENT_226	[p12l9t712r542b780],
23	survival	NN	O	survival	npadvmod	18	SENT_226	[p12l558t712r810b766],
24	in	IN	O	in	_	0	SENT_226	[p12l827t713r886b766],
25	patients	NNS	O	patient	prep_in	23	SENT_226	[p12l901t713r1159b780],
26	with	IN	O	with	_	0	SENT_226	[p12l1174t712r1322b766],
27	previously	RB	DATE	previously	advmod	28	SENT_226	[p12l1337t712r1675b780],
28	untreated	JJ	O	untreated	amod	32	SENT_226	[p12l1689t712r2003b766],
29	MM	NN	O	mm	nn	32	SENT_226	[p12l2019t715r2145b766],
30	[	NN	O	[	nn	32	SENT_226	[p12l12t799r152b867],
31	32	CD	NUMBER	32	num	32	SENT_226	[p12l12t799r152b867],
32	]	NN	O	]	prep_with	18	SENT_226	[p12l12t799r152b867],
33	.	.	O	.	_	0	SENT_226	[p12l12t799r152b867],

1	Patients	NNS	O	patient	nsubj	13	SENT_227	[p12l175t800r430b853],
2	homozygous	JJ	O	homozygous	amod	1	SENT_227	[p12l453t799r861b867],
3	for	IN	O	for	_	0	SENT_227	[p12l884t799r974b853],
4	the	DT	O	the	det	8	SENT_227	[p12l992t799r1094b853],
5	wild	JJ	O	wild	amod	8	SENT_227	[p12l1114t799r1255b853],
6	type	NN	O	type	nn	8	SENT_227	[p12l1277t807r1416b867],
7	G	NN	O	g	nn	8	SENT_227	[p12l1439t802r1483b853],
8	allele	NN	O	allele	prep_for	2	SENT_227	[p12l1505t799r1674b853],
9	of	IN	O	of	_	0	SENT_227	[p12l1696t799r1762b853],
10	IL6	NN	O	il6	nn	12	SENT_227	[p12l1776t802r1869b853],
11	G-174	NN	O	g-174	nn	12	SENT_227	[p12l1890t802r2087b853],
12	C	NN	O	c	prep_of	8	SENT_227	[p12l2109t802r2147b853],
13	survived	VBD	O	survive	_	0	SENT_227	[p12l10t886r283b940],
14	longer	JJR	O	longer	advmod	13	SENT_227	[p12l307t886r512b954],
15	than	IN	O	than	_	0	SENT_227	[p12l533t886r677b940],
16	variant	JJ	O	variant	amod	18	SENT_227	[p12l698t887r927b940],
17	allele	NN	O	allele	nn	18	SENT_227	[p12l949t886r1118b940],
18	carrier	NN	O	carrier	prep_than	13	SENT_227	[p12l1142t887r1354b940],
19	in	IN	O	in	_	0	SENT_227	[p12l1375t887r1435b940],
20	a	DT	O	a	det	21	SENT_227	[p12l1457t902r1490b940],
21	group	NN	O	group	prep_in	18	SENT_227	[p12l1511t902r1699b954],
22	of	IN	O	of	_	0	SENT_227	[p12l1723t886r1789b940],
23	patients	NNS	O	patient	prep_of	21	SENT_227	[p12l1805t887r2062b954],
24	in	IN	O	in	_	0	SENT_227	[p12l2087t887r2146b940],
25	interferon	NN	O	interferon	nn	26	SENT_227	[p12l9t973r333b1027],
26	maintenance	NN	O	maintenance	prep_in	13	SENT_227	[p12l354t974r771b1028],
27	[	CD	NUMBER	[	number	28	SENT_227	[p12l795t973r935b1041],
28	33	CD	NUMBER	33	num	29	SENT_227	[p12l795t973r935b1041],
29	]	NN	O	]	dep	13	SENT_227	[p12l795t973r935b1041],
30	.	.	O	.	_	0	SENT_227	[p12l795t973r935b1041],

1	Moreover	RB	O	moreover	advmod	9	SENT_228	[p12l958t977r1284b1036],
2	,	,	O	,	_	0	SENT_228	[p12l958t977r1284b1036],
3	patients	NNS	O	patient	nsubj	9	SENT_228	[p12l1307t974r1565b1041],
4	carrying	VBG	O	carry	partmod	3	SENT_228	[p12l1587t974r1853b1041],
5	the	DT	O	the	det	7	SENT_228	[p12l1872t973r1973b1028],
6	TNF238A	NN	O	tnf238a	nn	7	SENT_228	[p12l1992t977r2145b1027, p12l9t1063r176b1115],
7	allele	NN	O	allele	dobj	4	SENT_228	[p12l190t1061r359b1115],
8	had	VBD	O	have	aux	9	SENT_228	[p12l378t1061r493b1115],
9	signiﬁcant	VBN	O	signiﬁcant	_	0	SENT_228	[p12l512t1060r846b1128],
10	higher	JJR	O	higher	amod	13	SENT_228	[p12l862t1061r1070b1128],
11	pre-treatment	NN	O	pre-treatment	nn	13	SENT_228	[p12l1086t1069r1547b1128],
12	TNF-oz	NN	O	tnf-oz	nn	13	SENT_228	[p12l1560t1064r1764b1114],
13	levels	NNS	O	level	dobj	9	SENT_228	[p12l1782t1061r1961b1115],
14	and	CC	O	and	_	0	SENT_228	[p12l1980t1061r2096b1115],
15	a	DT	O	a	det	17	SENT_228	[p12l2114t1076r2146b1115],
16	longer	JJR	O	longer	amod	17	SENT_228	[p12l9t1148r214b1215],
17	progression	NN	O	progression	dobj	9	SENT_228	[p12l236t1148r768b1215],
18	—	CD	NUMBER	—	num	20	SENT_228	[p12l236t1148r768b1215],
19	free	JJ	O	free	amod	20	SENT_228	[p12l236t1148r768b1215],
20	survival	NN	O	survival	dep	17	SENT_228	[p12l793t1148r1044b1202],
21	and	CC	O	and	_	0	SENT_228	[p12l1068t1148r1184b1202],
22	OS	NN	O	os	conj_and	9	SENT_228	[p12l1208t1151r1290b1202],
23	[	CD	NUMBER	[	num	25	SENT_228	[p12l1317t1148r1457b1215],
24	25	CD	NUMBER	25	num	25	SENT_228	[p12l1317t1148r1457b1215],
25	]	NN	O	]	dobj	22	SENT_228	[p12l1317t1148r1457b1215],
26	.	.	O	.	_	0	SENT_228	[p12l1317t1148r1457b1215],

1	In	IN	O	in	_	0	SENT_229	[p12l1482t1151r1542b1201],
2	the	DT	O	the	det	4	SENT_229	[p12l1564t1148r1665b1202],
3	present	JJ	DATE	present	amod	4	SENT_229	[p12l1689t1156r1931b1215],
4	study	NN	O	study	prep_in	8	SENT_229	[p12l1954t1148r2145b1215],
5	,	,	O	,	_	0	SENT_229	[p12l1954t1148r2145b1215],
6	we	PRP	O	we	nsubj	8	SENT_229	[p12l7t1250r101b1288],
7	have	VBP	O	have	aux	8	SENT_229	[p12l133t1234r282b1288],
8	correlated	VBN	O	correlate	_	0	SENT_229	[p12l313t1234r640b1288],
9	SNPS	NNS	O	snp	dobj	8	SENT_229	[p12l671t1237r826b1288],
10	and	CC	O	and	_	0	SENT_229	[p12l858t1234r974b1288],
11	cytokine	NN	O	cytokine	nn	12	SENT_229	[p12l1005t1234r1279b1302],
12	levels	NNS	O	level	conj_and	9	SENT_229	[p12l1311t1234r1507b1297],
13	,	,	O	,	_	0	SENT_229	[p12l1311t1234r1507b1297],
14	and	CC	O	and	_	0	SENT_229	[p12l1539t1234r1655b1288],
15	pre	JJ	O	pre	amod	19	SENT_229	[p12l1687t1242r2147b1302],
16	—	NN	O	—	nn	19	SENT_229	[p12l1687t1242r2147b1302],
17	treatment	NN	O	treatment	nn	19	SENT_229	[p12l1687t1242r2147b1302],
18	TNF	NN	O	tnf	nn	19	SENT_229	[p12l6t1325r209b1375],
19	—	NN	O	—	nsubj	22	SENT_229	[p12l6t1325r209b1375],
20	a	DT	O	a	det	21	SENT_229	[p12l6t1325r209b1375],
21	levels	NNS	O	level	dep	19	SENT_229	[p12l239t1321r419b1375],
22	showed	VBD	O	show	conj_and	8	SENT_229	[p12l450t1321r698b1375],
23	a	DT	O	a	det	25	SENT_229	[p12l727t1337r759b1375],
24	signiﬁcant	JJ	O	signiﬁcant	amod	25	SENT_229	[p12l789t1321r1123b1389],
25	correlation	NN	O	correlation	dobj	22	SENT_229	[p12l1150t1321r1502b1375],
26	with	IN	O	with	_	0	SENT_229	[p12l1529t1321r1678b1375],
27	SNPS	NN	O	snp	prep_with	22	SENT_229	[p12l1706t1324r1861b1375],
28	in	IN	O	in	_	0	SENT_229	[p12l1891t1322r1950b1375],
29	VEFG	NNP	ORGANIZATION	VEFG	prep_in	22	SENT_229	[p12l1976t1324r2146b1375],
30	and	CC	O	and	_	0	SENT_229	[p12l9t1408r125b1462],
31	XPA	NNP	O	XPA	prep_in	22	SENT_229	[p12l144t1411r290b1471],
32	,	,	O	,	_	0	SENT_229	[p12l144t1411r290b1471],
33	in	IN	O	in	_	0	SENT_229	[p12l313t1409r372b1462],
34	spite	NN	O	spite	_	0	SENT_229	[p12l393t1409r546b1476],
35	of	IN	O	of	_	0	SENT_229	[p12l567t1408r634b1462],
36	no	DT	O	no	det	39	SENT_229	[p12l647t1424r724b1462],
37	signiﬁcant	JJ	O	signiﬁcant	amod	39	SENT_229	[p12l747t1408r1081b1476],
38	prognostic	JJ	O	prognostic	amod	39	SENT_229	[p12l1100t1409r1441b1476],
39	impact	NN	O	impact	prep_in_spite_of	22	SENT_229	[p12l1462t1409r1684b1476],
40	of	IN	O	of	_	0	SENT_229	[p12l1703t1408r1769b1462],
41	these	DT	O	these	det	42	SENT_229	[p12l1782t1408r1952b1462],
42	SNPs	NNS	O	snp	prep_of	39	SENT_229	[p12l1974t1411r2145b1463],
43	.	.	O	.	_	0	SENT_229	[p12l1974t1411r2145b1463],

1	Baseline	NN	O	baseline	nn	4	SENT_230	[p12l9t1495r273b1550],
2	TNF-OL	NN	O	tnf-ol	nn	4	SENT_230	[p12l297t1499r501b1549],
3	serum	NN	O	serum	nn	4	SENT_230	[p12l527t1511r727b1550],
4	levels	NNS	O	level	nsubj	7	SENT_230	[p12l753t1495r933b1550],
5	were	VBD	O	be	cop	7	SENT_230	[p12l958t1511r1118b1550],
6	signiﬁcantly	RB	O	signiﬁcantly	advmod	7	SENT_230	[p12l1145t1495r1540b1563],
7	lower	JJR	O	lower	_	0	SENT_230	[p12l1564t1495r1749b1550],
8	in	IN	O	in	_	0	SENT_230	[p12l1773t1496r1832b1549],
9	responding	VBG	O	respond	prepc_in	7	SENT_230	[p12l1858t1495r2145b1563, p12l9t1583r107b1650],
10	patients	NNS	O	patient	dobj	9	SENT_230	[p12l132t1583r390b1650],
11	and	CC	O	and	_	0	SENT_230	[p12l417t1583r532b1637],
12	in	IN	O	in	_	0	SENT_230	[p12l559t1583r618b1636],
13	those	DT	O	those	prepc_in	7	SENT_230	[p12l643t1583r816b1637],
14	without	IN	O	without	_	0	SENT_230	[p12l841t1583r1099b1637],
15	extramedullary	JJ	O	extramedullary	amod	16	SENT_230	[p12l1123t1583r1621b1650],
16	plasmacytomas	NNS	O	plasmacytoma	prep_without	13	SENT_230	[p12l1645t1583r2145b1650],
17	in	IN	O	in	_	0	SENT_230	[p12l9t1671r68b1723],
18	a	DT	O	a	det	20	SENT_230	[p12l90t1685r123b1724],
19	previous	JJ	O	previous	amod	20	SENT_230	[p12l145t1671r421b1737],
20	report	NN	O	report	prep_in	16	SENT_230	[p12l445t1678r645b1737],
21	in	IN	O	in	_	0	SENT_230	[p12l666t1671r726b1723],
22	this	DT	O	this	det	26	SENT_230	[p12l747t1670r864b1724],
23	series	NN	O	series	nn	26	SENT_230	[p12l888t1671r1069b1724],
24	[	NN	O	[	nn	26	SENT_230	[p12l1096t1670r1236b1737],
25	34	CD	NUMBER	34	num	26	SENT_230	[p12l1096t1670r1236b1737],
26	]	NN	O	]	prep_in	20	SENT_230	[p12l1096t1670r1236b1737],
27	.	.	O	.	_	0	SENT_230	[p12l1096t1670r1236b1737],

1	On	IN	O	on	_	0	SENT_231	[p12l1260t1673r1349b1724],
2	the	DT	O	the	det	4	SENT_231	[p12l1370t1670r1472b1724],
3	other	JJ	O	other	amod	4	SENT_231	[p12l1495t1670r1668b1724],
4	hand	NN	O	hand	prep_on	15	SENT_231	[p12l1689t1670r1863b1732],
5	,	,	O	,	_	0	SENT_231	[p12l1689t1670r1863b1732],
6	patients	NNS	O	patient	nsubj	15	SENT_231	[p12l1887t1671r2145b1737],
7	heterozygous	JJ	O	heterozygous	amod	6	SENT_231	[p12l9t1756r441b1824],
8	for	IN	O	for	_	0	SENT_231	[p12l465t1756r554b1810],
9	SNP	NN	ORGANIZATION	snp	prep_for	7	SENT_231	[p12l575t1759r700b1810],
10	in	IN	O	in	_	0	SENT_231	[p12l721t1757r780b1810],
11	ERCC1	NN	O	ercc1	nn	14	SENT_231	[p12l803t1759r998b1810],
12	(	CD	NUMBER	(	num	14	SENT_231	[p12l1029t1756r1381b1823],
13	rs735482	NN	O	rs735482	nn	14	SENT_231	[p12l1029t1756r1381b1823],
14	)	NN	O	)	prep_in	9	SENT_231	[p12l1029t1756r1381b1823],
15	showed	VBD	O	show	_	0	SENT_231	[p12l1405t1756r1653b1810],
16	lower	JJR	O	lower	amod	18	SENT_231	[p12l1676t1756r1861b1810],
17	IL-6	NN	MISC	il-6	nn	18	SENT_231	[p12l1881t1759r2003b1810],
18	levels	NNS	O	level	nsubj	19	SENT_231	[p12l2026t1756r2145b1810, p12l9t1843r92b1897],
19	post-treatment	JJ	O	post-treatment	xcomp	15	SENT_231	[p12l129t1851r621b1911],
20	than	IN	O	than	_	0	SENT_231	[p12l654t1843r798b1897],
21	wild-type	JJ	O	wild-type	amod	23	SENT_231	[p12l831t1843r1146b1911],
22	(	NN	O	(	nn	23	SENT_231	[p12l1181t1843r1298b1910],
23	AA	NN	O	aa	prep_than	19	SENT_231	[p12l1181t1843r1298b1910],
24	vs.	CC	O	vs.	prep	23	SENT_231	[p12l1329t1859r1411b1898],
25	CA	NNP	O	CA	nn	26	SENT_231	[p12l1447t1843r1573b1911],
26	)	NNP	O	)	dep	24	SENT_231	[p12l1447t1843r1573b1911],
27	.	.	O	.	_	0	SENT_231	[p12l1447t1843r1573b1911],

1	Individuals	NNS	O	individual	nsubj	14	SENT_232	[p12l1609t1843r1964b1897],
2	with	IN	O	with	_	0	SENT_232	[p12l1998t1843r2146b1897],
3	ERCC1	NN	O	ercc1	nn	5	SENT_232	[p12l9t1933r205b1984],
4	heterozygous	JJ	O	heterozygous	amod	5	SENT_232	[p12l231t1930r662b1998],
5	(	NN	O	(	prep_with	1	SENT_232	[p12l680t1930r816b1998],
6	CA	NNP	O	CA	dep	5	SENT_232	[p12l680t1930r816b1998],
7	)	CD	NUMBER	)	num	6	SENT_232	[p12l680t1930r816b1998],
8	or	CC	O	or	_	0	SENT_232	[p12l834t1946r900b1985],
9	homozygous	JJ	O	homozygous	amod	10	SENT_232	[p12l915t1930r1323b1998],
10	SNP	NN	O	snp	conj_or	5	SENT_232	[p12l1341t1933r1466b1985],
11	(	CD	NUMBER	(	num	13	SENT_232	[p12l1482t1930r1614b1998],
12	CC	NN	O	cc	nn	13	SENT_232	[p12l1482t1930r1614b1998],
13	)	NN	O	)	dep	10	SENT_232	[p12l1482t1930r1614b1998],
14	had	VBD	O	have	_	0	SENT_232	[p12l1632t1930r1747b1984],
15	also	RB	O	also	advmod	14	SENT_232	[p12l1764t1930r1888b1985],
16	a	DT	O	a	det	18	SENT_232	[p12l1905t1946r1938b1985],
17	better	JJR	O	better	amod	18	SENT_232	[p12l1953t1930r2148b1985],
18	response	NN	O	response	dobj	14	SENT_232	[p12l9t2033r294b2085],
19	rate	NN	O	rate	amod	18	SENT_232	[p12l314t2025r437b2072],
20	and	CC	O	and	_	0	SENT_232	[p12l456t2017r572b2072],
21	OS	NN	O	os	amod	18	SENT_232	[p12l591t2020r689b2072],
22	.	.	O	.	_	0	SENT_232	[p12l591t2020r689b2072],

1	If	IN	O	if	mark	5	SENT_233	[p12l709t2017r757b2071],
2	these	DT	O	these	det	3	SENT_233	[p12l767t2017r937b2072],
3	ﬁndings	NNS	O	ﬁndings	nsubj	5	SENT_233	[p12l956t2017r1212b2085],
4	are	VBP	O	be	cop	5	SENT_233	[p12l1232t2033r1329b2072],
5	due	JJ	O	due	csubjpass	24	SENT_233	[p12l1348t2017r1464b2072],
6	to	TO	O	to	_	0	SENT_233	[p12l1482t2025r1544b2071],
7	a	DT	O	a	det	10	SENT_233	[p12l1563t2033r1595b2071],
8	common	JJ	O	common	amod	10	SENT_233	[p12l1613t2033r1896b2072],
9	genetic	JJ	O	genetic	amod	10	SENT_233	[p12l1913t2018r2147b2085],
10	cause	NN	O	cause	prep_to	5	SENT_233	[p12l9t2120r185b2159],
11	or	CC	O	or	_	0	SENT_233	[p12l204t2120r271b2159],
12	IL-6	NN	O	il-6	nn	13	SENT_233	[p12l288t2107r409b2159],
13	levels	NNS	O	level	nsubj	16	SENT_233	[p12l429t2105r609b2159],
14	are	VBP	O	be	aux	16	SENT_233	[p12l629t2120r726b2159],
15	only	RB	O	only	advmod	16	SENT_233	[p12l746t2105r886b2172],
16	reﬂecting	VBG	O	reﬂecting	csubjpass	24	SENT_233	[p12l903t2104r1209b2172],
17	the	DT	O	the	det	18	SENT_233	[p12l1226t2104r1327b2159],
18	impact	NN	O	impact	dobj	16	SENT_233	[p12l1347t2105r1569b2172],
19	of	IN	O	of	_	0	SENT_233	[p12l1586t2104r1653b2159],
20	therapy	NN	O	therapy	prep_of	18	SENT_233	[p12l1663t2105r1914b2172],
21	should	MD	O	should	aux	24	SENT_233	[p12l1932t2105r2145b2159],
22	be	VB	O	be	auxpass	24	SENT_233	[p12l8t2192r81b2246],
23	further	RB	O	further	advmod	24	SENT_233	[p12l105t2192r332b2246],
24	investigated	VBN	O	investigate	_	0	SENT_233	[p12l352t2192r761b2259],
25	.	.	O	.	_	0	SENT_233	[p12l352t2192r761b2259],

1	1	CD	NUMBER	1	num	4	SENT_234	[p12l354t2335r364b2355],
2	182	CD	NUMBER	182	num	4	SENT_234	[p12l370t2335r414b2355],
3	M.T.	NNP	PERSON	M.T.	nn	4	SENT_234	[p12l1072t2335r1121b2355],
4	Cibeira	NNP	PERSON	Cibeira	_	0	SENT_234	[p12l1132t2334r1215b2355],
5	et	FW	O	et	nn	6	SENT_234	[p12l1224t2337r1247b2355],
6	al.	FW	O	al.	dep	4	SENT_234	[p12l1254t2334r1279b2355],
7	/	:	O	/	punct	4	SENT_234	[p12l1286t2334r1298b2360],
8	Leukemia	NNP	ORGANIZATION	Leukemia	nn	9	SENT_234	[p12l1304t2334r1419b2355],
9	Research	NNP	ORGANIZATION	Research	dep	4	SENT_234	[p12l1427t2334r1534b2355],
10	35	CD	NUMBER	35	number	11	SENT_234	[p12l1541t2335r1572b2355],
11	(	CD	NUMBER	(	num	12	SENT_234	[p12l1580t2334r1660b2360],
12	2011	CD	DATE	2011	dep	9	SENT_234	[p12l1580t2334r1660b2360],
13	)	CD	NUMBER	)	number	14	SENT_234	[p12l1580t2334r1660b2360],
14	1178-1183	CD	DATE	1178-1183	num	12	SENT_234	[p12l1671t2335r1805b2355],

1	Even	RB	O	even	advmod	20	SENT_235	[p12l113t2476r266b2528],
2	though	IN	O	though	dep	20	SENT_235	[p12l295t2473r524b2541],
3	the	DT	O	the	det	4	SENT_235	[p12l554t2473r656b2528],
4	use	NN	O	use	nsubj	20	SENT_235	[p12l686t2488r792b2528],
5	of	IN	O	of	_	0	SENT_235	[p12l823t2472r890b2528],
6	thalidomide	NN	O	thalidomide	prep_of	4	SENT_235	[p12l912t2473r1304b2528],
7	as	IN	O	as	_	0	SENT_235	[p12l1334t2488r1397b2528],
8	single	JJ	O	single	amod	9	SENT_235	[p12l1429t2473r1615b2541],
9	agent	NN	O	agent	prep_as	6	SENT_235	[p12l1646t2481r1824b2541],
10	and	CC	O	and	cc	6	SENT_235	[p12l1853t2473r1969b2528],
11	even	RB	O	even	advmod	6	SENT_235	[p12l2000t2488r2151b2528],
12	in	IN	O	in	dep	6	SENT_235	[p12l11t2563r70b2616],
13	combination	NN	O	combination	pobj	12	SENT_235	[p12l116t2562r523b2617],
14	with	IN	O	with	_	0	SENT_235	[p12l568t2562r716b2617],
15	dexamethasone	NN	O	dexamethasone	prep_with	13	SENT_235	[p12l763t2562r1273b2617],
16	is	VBZ	O	be	cop	20	SENT_235	[p12l1321t2563r1366b2617],
17	no	RB	O	no	advmod	18	SENT_235	[p12l1415t2578r1492b2617],
18	longer	RB	O	longer	advmod	20	SENT_235	[p12l1540t2562r1745b2630],
19	a	DT	O	a	det	20	SENT_235	[p12l1790t2578r1822b2617],
20	standard	NN	O	standard	advcl	45	SENT_235	[p12l1869t2562r2150b2617],
21	of	IN	O	of	_	0	SENT_235	[p12l10t2650r77b2705],
22	care	NN	O	care	prep_of	20	SENT_235	[p12l113t2666r244b2705],
23	in	IN	O	in	_	0	SENT_235	[p12l288t2651r347b2704],
24	patients	NNS	O	patient	prep_in	22	SENT_235	[p12l391t2651r649b2719],
25	with	IN	O	with	_	0	SENT_235	[p12l692t2650r840b2705],
26	MM	NN	O	mm	prep_with	24	SENT_235	[p12l884t2653r1026b2714],
27	,	,	O	,	_	0	SENT_235	[p12l884t2653r1026b2714],
28	both	CC	O	both	dep	20	SENT_235	[p12l1070t2650r1216b2705],
29	the	DT	O	the	det	30	SENT_235	[p12l1259t2650r1360b2705],
30	use	NN	O	use	conj	20	SENT_235	[p12l1405t2666r1510b2705],
31	of	IN	O	of	_	0	SENT_235	[p12l1554t2650r1621b2705],
32	thalidomide	NN	O	thalidomide	prep_of	30	SENT_235	[p12l1656t2650r2048b2705],
33	in	IN	O	in	_	0	SENT_235	[p12l2092t2651r2151b2704],
34	combination	NN	O	combination	nn	35	SENT_235	[p12l10t2739r417b2794],
35	therapy	NN	O	therapy	prep_in	32	SENT_235	[p12l461t2739r711b2808],
36	or	CC	O	or	_	0	SENT_235	[p12l754t2755r821b2794],
37	its	PRP$	O	its	poss	43	SENT_235	[p12l863t2740r936b2794],
38	more	RBR	O	more	advmod	39	SENT_235	[p12l982t2755r1148b2794],
39	powerful	JJ	O	powerful	amod	43	SENT_235	[p12l1194t2739r1484b2808],
40	analogue	NN	O	analogue	nn	43	SENT_235	[p12l1529t2739r1819b2808],
41	lenalido	NN	O	lenalido	nn	43	SENT_235	[p12l1865t2739r2150b2794],
42	—	CD	NUMBER	—	num	43	SENT_235	[p12l1865t2739r2150b2794],
43	mide	NN	O	mide	prep_of	30	SENT_235	[p12l11t2828r171b2883],
44	are	VBP	O	be	aux	45	SENT_235	[p12l204t2844r302b2883],
45	providing	VBG	O	provide	_	0	SENT_235	[p12l335t2828r647b2897],
46	a	DT	O	a	det	48	SENT_235	[p12l678t2844r711b2883],
47	progressive	JJ	O	progressive	amod	48	SENT_235	[p12l744t2829r1114b2897],
48	evidence	NN	O	evidence	dobj	45	SENT_235	[p12l1147t2828r1432b2883],
49	of	IN	O	of	_	0	SENT_235	[p12l1465t2828r1531b2883],
50	efﬁcacy	NN	O	efﬁcacy	prep_of	48	SENT_235	[p12l1557t2828r1801b2897],
51	in	IN	O	in	_	0	SENT_235	[p12l1833t2829r1892b2883],
52	several	JJ	O	several	amod	53	SENT_235	[p12l1926t2828r2150b2883],
53	settings	NNS	O	setting	prep_in	50	SENT_235	[p12l11t2918r276b2986],
54	.	.	O	.	_	0	SENT_235	[p12l11t2918r276b2986],

1	The	DT	O	the	det	2	SENT_236	[p12l314t2917r431b2972],
2	impact	NN	O	impact	nsubjpass	33	SENT_236	[p12l472t2918r694b2986],
3	of	IN	O	of	_	0	SENT_236	[p12l732t2917r798b2972],
4	pre	JJ	O	pre	amod	8	SENT_236	[p12l831t2917r1466b2986],
5	—	NN	O	—	nn	8	SENT_236	[p12l831t2917r1466b2986],
6	transplantation	NN	O	transplantation	nn	8	SENT_236	[p12l831t2917r1466b2986],
7	induction	NN	O	induction	nn	8	SENT_236	[p12l1506t2917r1813b2972],
8	regimens	NNS	O	regimen	prep_of	2	SENT_236	[p12l1853t2918r2149b2986],
9	with	IN	O	with	_	0	SENT_236	[p12l9t3007r157b3062],
10	novel	JJ	O	novel	amod	11	SENT_236	[p12l193t3007r367b3062],
11	agents	NNS	O	agent	prep_with	8	SENT_236	[p12l404t3015r611b3075],
12	including	VBG	O	include	_	0	SENT_236	[p12l648t3007r950b3075],
13	thalidomide	NN	O	thalidomide	prep_including	11	SENT_236	[p12l984t3007r1376b3062],
14	(	CD	NUMBER	(	num	13	SENT_236	[p12l1413t3007r1585b3075],
15	such	JJ	O	such	mwe	13	SENT_236	[p12l1413t3007r1585b3075],
16	in	IN	O	in	_	0	SENT_236	[p12l1621t3007r1680b3061],
17	VTD	NN	O	vtd	nn	18	SENT_236	[p12l1713t3010r1847b3061],
18	regimen	NN	O	regimen	prep_in	13	SENT_236	[p12l1885t3007r2151b3075],
19	[	CD	NUMBER	[	number	20	SENT_236	[p12l14t3096r262b3164],
20	35,36	CD	NUMBER	35,36	dep	13	SENT_236	[p12l14t3096r262b3164],
21	]	NN	O	]	dep	20	SENT_236	[p12l14t3096r262b3164],
22	)	CD	NUMBER	)	num	21	SENT_236	[p12l14t3096r262b3164],
23	or	CC	O	or	_	0	SENT_236	[p12l309t3112r375b3151],
24	lenalidomide	NN	O	lenalidomide	conj_or	13	SENT_236	[p12l418t3096r841b3151],
25	on	IN	O	on	_	0	SENT_236	[p12l887t3112r965b3151],
26	the	DT	O	the	det	30	SENT_236	[p12l1010t3096r1111b3151],
27	post	NN	O	post	nn	30	SENT_236	[p12l1157t3096r1825b3164],
28	—	NN	O	—	nn	30	SENT_236	[p12l1157t3096r1825b3164],
29	transplantation	NN	O	transplantation	nn	30	SENT_236	[p12l1157t3096r1825b3164],
30	outcome	NN	O	outcome	prep_on	24	SENT_236	[p12l1870t3104r2150b3151],
31	is	VBZ	O	be	aux	33	SENT_236	[p12l11t3185r57b3239],
32	being	VBG	O	be	auxpass	33	SENT_236	[p12l103t3184r281b3253],
33	investigated	VBN	O	investigate	_	0	SENT_236	[p12l326t3184r719b3253],
34	in	IN	O	in	_	0	SENT_236	[p12l766t3185r825b3238],
35	several	JJ	O	several	amod	37	SENT_236	[p12l871t3184r1096b3239],
36	large	JJ	O	large	amod	37	SENT_236	[p12l1143t3184r1299b3253],
37	phase	NN	O	phase	prep_in	33	SENT_236	[p12l1345t3184r1530b3253],
38	III	CD	NUMBER	iii	num	39	SENT_236	[p12l1577t3187r1636b3238],
39	trials	NNS	O	trial	dep	37	SENT_236	[p12l1682t3184r1859b3247],
40	,	,	O	,	_	0	SENT_236	[p12l1682t3184r1859b3247],
41	as	RB	O	as	_	0	SENT_236	[p12l1906t3200r1969b3239],
42	well	RB	O	well	_	0	SENT_236	[p12l2014t3184r2150b3239],
43	as	IN	O	as	_	0	SENT_236	[p12l10t3289r73b3328],
44	in	IN	O	in	_	0	SENT_236	[p12l138t3274r196b3328],
45	maintenance	NN	O	maintenance	nn	46	SENT_236	[p12l260t3274r678b3328],
46	therapy	NN	O	therapy	prep_in	48	SENT_236	[p12l741t3273r991b3342],
47	[	CD	NUMBER	[	number	48	SENT_236	[p12l1057t3273r1196b3342],
48	37	CD	NUMBER	37	prep_in	33	SENT_236	[p12l1057t3273r1196b3342],
49	]	NN	O	]	dep	48	SENT_236	[p12l1057t3273r1196b3342],
50	.	.	O	.	_	0	SENT_236	[p12l1057t3273r1196b3342],

1	For	IN	O	for	_	0	SENT_237	[p12l1261t3277r1363b3328],
2	elderly	JJ	O	elderly	amod	3	SENT_237	[p12l1425t3273r1648b3342],
3	patients	NNS	O	patient	prep_for	19	SENT_237	[p12l1710t3274r1985b3342],
4	,	,	O	,	_	0	SENT_237	[p12l1710t3274r1985b3342],
5	the	DT	O	the	det	6	SENT_237	[p12l2049t3273r2150b3328],
6	combination	NN	O	combination	appos	3	SENT_237	[p12l10t3362r417b3417],
7	of	IN	O	of	_	0	SENT_237	[p12l464t3362r530b3417],
8	“	CD	NUMBER	“	num	11	SENT_237	[p12l570t3362r727b3417],
9	old	JJ	O	old	amod	11	SENT_237	[p12l570t3362r727b3417],
10	”	NN	O	”	nn	11	SENT_237	[p12l570t3362r727b3417],
11	therapies	NNS	O	therapy	prep_of	6	SENT_237	[p12l775t3362r1074b3431],
12	with	IN	O	with	_	0	SENT_237	[p12l1120t3362r1268b3417],
13	thalidomide	NN	O	thalidomide	prep_with	11	SENT_237	[p12l1314t3362r1706b3417],
14	or	CC	O	or	_	0	SENT_237	[p12l1753t3378r1820b3417],
15	lenalido	NN	O	lenalido	prep_with	11	SENT_237	[p12l1865t3362r2150b3417],
16	—	CD	NUMBER	—	num	17	SENT_237	[p12l1865t3362r2150b3417],
17	mide	NN	O	mide	nsubj	19	SENT_237	[p12l11t3451r171b3506],
18	has	VBZ	O	have	aux	19	SENT_237	[p12l225t3451r329b3506],
19	resulted	VBN	O	result	_	0	SENT_237	[p12l384t3451r645b3506],
20	in	IN	O	in	_	0	SENT_237	[p12l699t3452r758b3506],
21	the	DT	O	the	det	24	SENT_237	[p12l810t3451r912b3506],
22	melphalan	JJ	O	melphalan	amod	24	SENT_237	[p12l966t3451r2150b3520],
23	—	NN	O	—	nn	24	SENT_237	[p12l966t3451r2150b3520],
24	prednisone	NN	O	prednisone	prep_in	19	SENT_237	[p12l966t3451r2150b3520],
25	—	CD	NUMBER	—	num	26	SENT_237	[p12l966t3451r2150b3520],
26	thalidomide	NN	O	thalidomide	dobj	19	SENT_237	[p12l966t3451r2150b3520],
27	[	CD	NUMBER	[	number	28	SENT_237	[p12l14t3540r252b3609],
28	38,39	CD	NUMBER	38,39	num	29	SENT_237	[p12l14t3540r252b3609],
29	]	NN	O	]	dep	26	SENT_237	[p12l14t3540r252b3609],
30	,	,	O	,	_	0	SENT_237	[p12l14t3540r252b3609],
31	melphalan	JJ	O	melphalan	amod	35	SENT_237	[p12l291t3540r1507b3609],
32	—	NN	O	—	nn	35	SENT_237	[p12l291t3540r1507b3609],
33	prednisone	NN	O	prednisone	nn	35	SENT_237	[p12l291t3540r1507b3609],
34	—	NN	O	—	nn	35	SENT_237	[p12l291t3540r1507b3609],
35	lenalidomide	NN	O	lenalidomide	dobj	19	SENT_237	[p12l291t3540r1507b3609],
36	[	CD	NUMBER	[	number	37	SENT_237	[p12l1548t3540r1669b3609],
37	40	CD	NUMBER	40	num	38	SENT_237	[p12l1548t3540r1669b3609],
38	]	NN	O	]	dep	35	SENT_237	[p12l1548t3540r1669b3609],
39	and	CC	O	and	_	0	SENT_237	[p12l1710t3541r1826b3596],
40	lenalido	NN	O	lenalido	nn	41	SENT_237	[p12l1865t3541r2150b3596],
41	—	NN	O	—	dobj	19	SENT_237	[p12l1865t3541r2150b3596],

1	mide/dexamethasone	JJ	O	mide/dexamethasone	amod	2	SENT_238	[p13l11t17r711b85],
2	[	NN	O	[	_	0	SENT_238	[p13l750t17r871b85],
3	41	CD	NUMBER	41	num	5	SENT_238	[p13l750t17r871b85],
4	]	NN	O	]	nn	5	SENT_238	[p13l750t17r871b85],
5	regimens	NNS	O	regimen	dep	2	SENT_238	[p13l911t18r1224b85],
6	,	,	O	,	_	0	SENT_238	[p13l911t18r1224b85],
7	which	WDT	O	which	nsubj	10	SENT_238	[p13l1258t17r1457b72],
8	are	VBP	O	be	cop	10	SENT_238	[p13l1492t33r1589b72],
9	highly	RB	O	highly	advmod	10	SENT_238	[p13l1626t17r1827b85],
10	effective	JJ	O	effective	rcmod	5	SENT_238	[p13l1861t17r2149b72],
11	.	.	O	.	_	0	SENT_238	[p13l1861t17r2149b72],

1	Moreover	RB	O	moreover	advmod	7	SENT_239	[p13l11t108r338b168],
2	,	,	O	,	_	0	SENT_239	[p13l11t108r338b168],
3	promising	JJ	O	promising	amod	4	SENT_239	[p13l357t106r685b174],
4	results	NNS	O	result	nsubjpass	7	SENT_239	[p13l702t105r915b160],
5	have	VBP	O	have	aux	7	SENT_239	[p13l934t105r1084b160],
6	been	VBN	O	be	auxpass	7	SENT_239	[p13l1101t105r1255b160],
7	reported	VBN	O	report	_	0	SENT_239	[p13l1274t105r1550b174],
8	with	IN	O	with	_	0	SENT_239	[p13l1567t105r1715b160],
9	both	DT	O	both	det	10	SENT_239	[p13l1732t105r1879b160],
10	thalidomide	NN	O	thalidomide	prep_with	7	SENT_239	[p13l1896t105r2150b160, p13l11t194r171b249],
11	and	CC	O	and	_	0	SENT_239	[p13l196t194r313b249],
12	lenalidomide	NN	O	lenalidomide	nn	13	SENT_239	[p13l339t194r762b249],
13	maintenance	NN	O	maintenance	conj_and	10	SENT_239	[p13l788t195r1205b249],
14	[	CD	NUMBER	[	number	15	SENT_239	[p13l1235t194r1374b263],
15	37	CD	NUMBER	37	num	16	SENT_239	[p13l1235t194r1374b263],
16	]	NN	O	]	dep	13	SENT_239	[p13l1235t194r1374b263],
17	.	.	O	.	_	0	SENT_239	[p13l1235t194r1374b263],

1	For	IN	O	for	_	0	SENT_240	[p13l1402t198r1503b249],
2	this	DT	O	this	det	3	SENT_240	[p13l1526t194r1643b249],
3	reason	NN	O	reason	prep_for	17	SENT_240	[p13l1670t210r1897b258],
4	,	,	O	,	_	0	SENT_240	[p13l1670t210r1897b258],
5	studies	NNS	O	study	nsubj	17	SENT_240	[p13l1924t194r2149b249],
6	on	IN	O	on	_	0	SENT_240	[p13l10t299r89b338],
7	genetic	JJ	O	genetic	amod	8	SENT_240	[p13l107t284r341b352],
8	proﬁle	NN	O	proﬁle	prep_on	5	SENT_240	[p13l360t283r568b352],
9	which	WDT	O	which	nsubj	11	SENT_240	[p13l586t283r785b338],
10	can	MD	O	can	aux	11	SENT_240	[p13l804t299r913b338],
11	predict	VB	O	predict	rcmod	8	SENT_240	[p13l933t283r1161b352],
12	the	DT	O	the	det	13	SENT_240	[p13l1179t283r1280b338],
13	risk	NN	O	risk	dobj	11	SENT_240	[p13l1300t283r1418b338],
14	of	IN	O	of	_	0	SENT_240	[p13l1436t283r1502b338],
15	side	JJ	O	side	amod	16	SENT_240	[p13l1515t283r1641b338],
16	effects	NNS	O	effect	prep_of	13	SENT_240	[p13l1661t283r1868b338],
17	and/or	VBP	O	and/or	_	0	SENT_240	[p13l1889t283r2101b352],
18	a	DT	O	a	det	20	SENT_240	[p13l2119t299r2151b338],
19	different	JJ	O	different	amod	20	SENT_240	[p13l10t372r290b428],
20	likelihood	NN	O	likelihood	nsubjpass	37	SENT_240	[p13l309t372r629b428],
21	of	IN	O	of	_	0	SENT_240	[p13l650t372r716b428],
22	response	NN	O	response	prep_of	20	SENT_240	[p13l729t388r1015b441],
23	or	CC	O	or	_	0	SENT_240	[p13l1035t388r1102b428],
24	longer	JJR	O	longer	amod	25	SENT_240	[p13l1120t373r1325b441],
25	survival	NN	O	survival	conj_or	20	SENT_240	[p13l1344t373r1596b428],
26	for	IN	O	for	_	0	SENT_240	[p13l1618t372r1707b428],
27	patients	NNS	O	patient	prep_for	25	SENT_240	[p13l1725t373r1983b441],
28	with	IN	O	with	_	0	SENT_240	[p13l2003t373r2151b428],
29	MM	NN	O	mm	prep_with	27	SENT_240	[p13l11t465r137b515],
30	treated	VBN	O	treat	partmod	29	SENT_240	[p13l164t462r394b516],
31	with	IN	O	with	_	0	SENT_240	[p13l420t462r569b516],
32	thalidomide	NN	O	thalidomide	prep_with	30	SENT_240	[p13l595t462r987b516],
33	or	CC	O	or	_	0	SENT_240	[p13l1015t478r1081b516],
34	lenalidomide	NN	O	lenalidomide	prep_with	30	SENT_240	[p13l1107t462r1530b516],
35	should	MD	O	should	aux	37	SENT_240	[p13l1558t462r1772b516],
36	be	VB	O	be	auxpass	37	SENT_240	[p13l1800t462r1873b516],
37	encouraged	VBN	O	encourage	ccomp	17	SENT_240	[p13l1901t478r2150b516, p13l10t550r175b618],
38	.	.	O	.	_	0	SENT_240	[p13l1901t478r2150b516, p13l10t550r175b618],

1	In	IN	O	in	_	0	SENT_241	[p13l113t641r172b693],
2	conclusion	NN	O	conclusion	prep_in	11	SENT_241	[p13l197t638r558b701],
3	,	,	O	,	_	0	SENT_241	[p13l197t638r558b701],
4	SNPs	NNS	O	snp	nsubjpass	11	SENT_241	[p13l584t641r739b693],
5	in	IN	O	in	_	0	SENT_241	[p13l766t639r825b692],
6	ERCC1	NN	O	ercc1	prep_in	4	SENT_241	[p13l850t641r1046b693],
7	and	CC	O	and	_	0	SENT_241	[p13l1079t638r1196b693],
8	XRCC5	NN	O	xrcc5	prep_in	4	SENT_241	[p13l1219t641r1431b693],
9	were	VBD	O	be	auxpass	11	SENT_241	[p13l1457t654r1618b693],
10	strongly	RB	O	strongly	advmod	11	SENT_241	[p13l1644t638r1908b707],
11	associated	VBN	O	associate	_	0	SENT_241	[p13l1932t639r2150b693, p13l10t727r147b782],
12	with	IN	O	with	_	0	SENT_241	[p13l177t727r325b782],
13	a	DT	O	a	det	16	SENT_241	[p13l356t743r388b782],
14	higher	JJR	O	higher	amod	16	SENT_241	[p13l419t727r627b796],
15	response	NN	O	response	nn	16	SENT_241	[p13l656t743r942b796],
16	rate	NN	O	rate	prep_with	11	SENT_241	[p13l974t735r1097b782],
17	and	CC	O	and	_	0	SENT_241	[p13l1128t727r1244b782],
18	longer	JJR	O	longer	conj_and	16	SENT_241	[p13l1276t727r1482b796],
19	OS	NNP	O	OS	tmod	11	SENT_241	[p13l1510t730r1592b782],
20	in	IN	O	in	_	0	SENT_241	[p13l1625t728r1683b782],
21	patients	NNS	O	patient	prep_in	11	SENT_241	[p13l1714t728r1972b796],
22	with	IN	O	with	_	0	SENT_241	[p13l2003t727r2151b782],
23	relapsed/refractory	JJ	O	relapsed/refractory	amod	24	SENT_241	[p13l11t816r632b885],
24	MM	NN	O	mm	prep_with	21	SENT_241	[p13l658t820r784b871],
25	treated	VBN	O	treat	partmod	24	SENT_241	[p13l811t816r1041b871],
26	with	IN	O	with	_	0	SENT_241	[p13l1067t816r1215b871],
27	thalidomide	NN	O	thalidomide	prep_with	25	SENT_241	[p13l1241t816r1649b872],
28	.	.	O	.	_	0	SENT_241	[p13l1241t816r1649b872],

1	SNPS	NNS	O	snp	nsubjpass	6	SENT_242	[p13l1677t819r1832b871],
2	in	IN	O	in	_	0	SENT_242	[p13l1860t817r1919b871],
3	ERCC5	NN	O	ercc5	prep_in	1	SENT_242	[p13l1946t819r2148b871],
4	were	VBD	O	be	auxpass	6	SENT_242	[p13l9t921r169b961],
5	also	RB	O	also	advmod	6	SENT_242	[p13l188t906r313b961],
6	associated	VBN	O	associate	_	0	SENT_242	[p13l332t905r664b961],
7	with	IN	O	with	_	0	SENT_242	[p13l682t906r830b961],
8	greater	JJR	O	greater	amod	10	SENT_242	[p13l848t914r1080b974],
9	response	NN	O	response	nn	10	SENT_242	[p13l1097t921r1383b974],
10	rate	NN	O	rate	prep_with	6	SENT_242	[p13l1403t914r1542b961],
11	.	.	O	.	_	0	SENT_242	[p13l1403t914r1542b961],

1	Our	PRP$	O	we	poss	2	SENT_243	[p13l1563t908r1682b961],
2	ﬁndings	NNS	O	ﬁndings	nsubj	5	SENT_243	[p13l1699t905r1956b974],
3	could	MD	O	could	aux	5	SENT_243	[p13l1976t905r2150b961],
4	be	VB	O	be	cop	5	SENT_243	[p13l10t995r83b1050],
5	useful	JJ	O	useful	_	0	SENT_243	[p13l104t995r297b1050],
6	to	TO	O	to	aux	7	SENT_243	[p13l317t1003r379b1050],
7	identify	VB	O	identify	xcomp	5	SENT_243	[p13l401t995r650b1063],
8	patients	NNS	O	patient	dobj	7	SENT_243	[p13l669t996r927b1063],
9	with	IN	O	with	_	0	SENT_243	[p13l947t995r1096b1050],
10	MM	NN	O	mm	prep_with	7	SENT_243	[p13l1116t998r1242b1049],
11	who	WP	O	who	nsubj	14	SENT_243	[p13l1262t995r1402b1050],
12	are	VBP	O	be	cop	14	SENT_243	[p13l1423t1011r1521b1050],
13	more	RBR	O	more	advmod	14	SENT_243	[p13l1542t1011r1708b1050],
14	likely	JJ	O	likely	rcmod	10	SENT_243	[p13l1729t995r1905b1063],
15	to	TO	O	to	_	0	SENT_243	[p13l1923t1003r1984b1050],
16	beneﬁt	JJ	O	beneﬁt	amod	21	SENT_243	[p13l2005t995r2150b1050, p13l10t1083r115b1138],
17	from	IN	O	from	_	0	SENT_243	[p13l136t1083r289b1138],
18	thalidomide	NN	O	thalidomide	nn	19	SENT_243	[p13l311t1083r920b1138],
19	—	NN	O	—	prep_from	16	SENT_243	[p13l311t1083r920b1138],
20	based	VBN	O	base	partmod	19	SENT_243	[p13l311t1083r920b1138],
21	therapies	NNS	O	therapy	prep_to	14	SENT_243	[p13l942t1083r1258b1152],
22	.	.	O	.	_	0	SENT_243	[p13l942t1083r1258b1152],

1	Conﬂict	NN	O	conﬂict	_	0	SENT_244	[p13l9t1284r272b1339],
2	of	IN	O	of	_	0	SENT_244	[p13l291t1284r363b1339],
3	interest	NN	O	interest	prep_of	1	SENT_244	[p13l378t1285r643b1339],

1	L.R.	NNP	PERSON	L.R.	nsubj	4	SENT_245	[p13l113t1465r218b1518],
2	and	CC	O	and	_	0	SENT_245	[p13l257t1462r373b1517],
3	M.T.C.	NNP	O	M.T.C.	conj_and	1	SENT_245	[p13l411t1465r602b1518],
4	received	VBD	O	receive	_	0	SENT_245	[p13l641t1462r911b1517],
5	honoraria	NN	O	honorarium	dobj	4	SENT_245	[p13l949t1462r1262b1517],
6	for	IN	O	for	mark	7	SENT_245	[p13l1299t1462r1389b1517],
7	lectures	VBZ	O	lecture	advcl	4	SENT_245	[p13l1424t1462r1676b1517],
8	and	CC	O	and	_	0	SENT_245	[p13l1714t1462r1831b1517],
9	Advisory	NNP	O	Advisory	nn	10	SENT_245	[p13l1865t1462r2152b1531],
10	Boards	NNS	O	board	advcl	4	SENT_245	[p13l11t1551r226b1606],
11	from	IN	O	from	_	0	SENT_245	[p13l251t1551r404b1606],
12	]	CD	NUMBER	]	num	13	SENT_245	[p13l418t1551r857b1620],
13	anssen	NN	O	anssen	prep_from	10	SENT_245	[p13l418t1551r857b1620],
14	.	.	O	.	_	0	SENT_245	[p13l418t1551r857b1620],

1	—	NN	O	—	_	0	SENT_246	[p13l418t1551r857b1620],
2	.	.	O	.	_	0	SENT_246	[p13l418t1551r857b1620],

1	Cilag	NNP	LOCATION	Cilag	_	0	SENT_247	[p13l418t1551r857b1620],
2	and	CC	O	and	_	0	SENT_247	[p13l878t1551r994b1606],
3	Celgene	NNP	ORGANIZATION	Celgene	conj_and	1	SENT_247	[p13l1018t1551r1289b1620],
4	;	:	O	;	_	0	SENT_247	[p13l1018t1551r1289b1620],
5	]	CD	NUMBER	]	dep	1	SENT_247	[p13l1309t1555r1409b1620],
6	.	.	O	.	_	0	SENT_247	[p13l1309t1555r1409b1620],

1	B.	NNP	O	B.	nsubj	2	SENT_248	[p13l1309t1555r1409b1620],
2	received	VBD	O	receive	_	0	SENT_248	[p13l1433t1551r1703b1606],
3	honoraria	NN	O	honorarium	dobj	2	SENT_248	[p13l1727t1551r2040b1606],
4	for	IN	O	for	mark	5	SENT_248	[p13l2064t1551r2153b1606],
5	lectures	VBZ	O	lecture	advcl	2	SENT_248	[p13l11t1640r263b1695],
6	and	CC	O	and	_	0	SENT_248	[p13l281t1640r397b1695],
7	Advisory	NNP	O	Advisory	nn	8	SENT_248	[p13l412t1640r699b1709],
8	Boards	NNS	O	board	conj_and	5	SENT_248	[p13l715t1640r930b1695],
9	as	RB	O	as	_	0	SENT_248	[p13l948t1656r1010b1695],
10	well	RB	O	well	_	0	SENT_248	[p13l1027t1640r1163b1695],
11	as	IN	O	as	_	0	SENT_248	[p13l1181t1656r1243b1695],
12	grant	NN	O	grant	nn	13	SENT_248	[p13l1259t1648r1430b1709],
13	support	NN	O	support	conj_and	5	SENT_248	[p13l1447t1648r1697b1709],
14	from	IN	O	from	_	0	SENT_248	[p13l1713t1640r2150b1709],
15	]	CD	NUMBER	]	num	18	SENT_248	[p13l1713t1640r2150b1709],
16	anssen	NN	O	anssen	nn	18	SENT_248	[p13l1713t1640r2150b1709],
17	—	NN	O	—	nn	18	SENT_248	[p13l1713t1640r2150b1709],
18	Cilag	NN	O	cilag	prep_from	8	SENT_248	[p13l11t1730r167b1798],
19	and	CC	O	and	_	0	SENT_248	[p13l185t1730r301b1785],
20	Ce1gene	NN	O	ce1gene	prep_from	8	SENT_248	[p13l321t1730r692b1798],
21	.	.	O	.	_	0	SENT_248	[p13l321t1730r692b1798],

1	All	DT	O	all	det	3	SENT_249	[p13l321t1730r692b1798],
2	other	JJ	O	other	amod	3	SENT_249	[p13l712t1730r884b1785],
3	authors	NNS	O	author	nsubj	4	SENT_249	[p13l901t1730r1144b1785],
4	declare	VBP	O	declare	_	0	SENT_249	[p13l1165t1730r1397b1785],
5	no	DT	O	no	det	8	SENT_249	[p13l1417t1745r1494b1785],
6	competing	VBG	O	compete	amod	8	SENT_249	[p13l1514t1730r1858b1798],
7	ﬁnancial	JJ	O	ﬁnancial	amod	8	SENT_249	[p13l1877t1729r2150b1785],
8	interests	NNS	O	interest	dep	4	SENT_249	[p13l11t1820r304b1874],
9	.	.	O	.	_	0	SENT_249	[p13l11t1820r304b1874],

1	Acknowledgments	NNS	O	acknowledgment	_	0	SENT_250	[p13l7t2019r642b2088],

1	This	DT	O	this	det	2	SENT_251	[p13l109t2198r241b2253],
2	work	NN	O	work	nsubjpass	5	SENT_251	[p13l308t2198r476b2253],
3	has	VBZ	O	have	aux	5	SENT_251	[p13l541t2198r646b2253],
4	been	VBN	O	be	auxpass	5	SENT_251	[p13l713t2198r868b2253],
5	supported	VBN	O	support	_	0	SENT_251	[p13l935t2198r1262b2266],
6	in	IN	O	in	_	0	SENT_251	[p13l1330t2199r1389b2252],
7	part	NN	O	part	prep_in	5	SENT_251	[p13l1456t2206r1587b2266],
8	by	IN	O	by	_	0	SENT_251	[p13l1652t2198r1729b2266],
9	grants	NNS	O	grant	agent	5	SENT_251	[p13l1793t2206r1993b2266],
10	RD	NN	O	rd	prep	9	SENT_251	[p13l2062t2201r2150b2252],
11	2006/0020/O05	NN	O	2006/0020/o05	dep	10	SENT_251	[p13l10t2286r520b2355],
12	,	,	O	,	_	0	SENT_251	[p13l10t2286r520b2355],
13	FISO8/0147	NN	O	fiso8/0147	dep	10	SENT_251	[p13l538t2286r896b2355],
14	and	CC	O	and	_	0	SENT_251	[p13l915t2286r1031b2341],
15	CMO7/00108	NN	O	cmo7/00108	dep	10	SENT_251	[p13l1049t2286r1461b2355],
16	from	IN	O	from	_	0	SENT_251	[p13l1480t2286r1633b2341],
17	Fondo	NNP	ORGANIZATION	Fondo	prep_from	5	SENT_251	[p13l1651t2286r1846b2341],
18	de	IN	ORGANIZATION	de	_	0	SENT_251	[p13l1863t2286r1937b2341],
19	Investigaciones	NNP	ORGANIZATION	Investigaciones	nn	24	SENT_251	[p13l1955t2289r2150b2341, p13l10t2376r334b2444],
20	Sanitarias	NNP	ORGANIZATION	Sanitarias	nn	24	SENT_251	[p13l356t2376r668b2430],
21	de	FW	ORGANIZATION	de	nn	24	SENT_251	[p13l690t2375r764b2430],
22	la	FW	ORGANIZATION	la	nn	24	SENT_251	[p13l786t2375r838b2430],
23	Seguridad	NNP	ORGANIZATION	Seguridad	nn	24	SENT_251	[p13l859t2375r1180b2444],
24	Social	NNP	ORGANIZATION	Social	prep_de	17	SENT_251	[p13l1201t2375r1402b2439],
25	,	,	O	,	_	0	SENT_251	[p13l1201t2375r1402b2439],
26	and	CC	O	and	_	0	SENT_251	[p13l1423t2375r1539b2430],
27	“	NN	O	“	nn	31	SENT_251	[p13l1561t2378r1758b2444],
28	josep	NN	O	josep	nn	31	SENT_251	[p13l1561t2378r1758b2444],
29	Font	NNP	O	Font	nn	31	SENT_251	[p13l1780t2378r1949b2430],
30	”	NNP	O	”	nn	31	SENT_251	[p13l1780t2378r1949b2430],
31	Grant	NNP	O	Grant	conj_and	17	SENT_251	[p13l1971t2378r2152b2430],
32	from	IN	O	from	_	0	SENT_251	[p13l11t2464r164b2519],
33	Hospital	NNP	ORGANIZATION	Hospital	nn	36	SENT_251	[p13l187t2464r452b2533],
34	Clinic	NNP	ORGANIZATION	Clinic	nn	36	SENT_251	[p13l476t2463r654b2519],
35	de	IN	ORGANIZATION	de	amod	36	SENT_251	[p13l676t2464r750b2519],
36	Barcelona	NNP	ORGANIZATION	Barcelona	prep_from	31	SENT_251	[p13l773t2464r1103b2520],
37	.	.	O	.	_	0	SENT_251	[p13l773t2464r1103b2520],

1	Contributions	NNS	O	contribution	_	0	SENT_252	[p13l113t2554r547b2609],
2	.	.	O	.	_	0	SENT_252	[p13l113t2554r547b2609],

1	M.T.C.	NNP	O	M.T.C.	nsubj	5	SENT_253	[p13l585t2556r776b2609],
2	and	CC	O	and	_	0	SENT_253	[p13l814t2554r930b2609],
3	C.	NNP	PERSON	C.	nn	4	SENT_253	[p13l967t2556r1020b2609],
4	F.d.L.	NNP	PERSON	F.d.L.	conj_and	1	SENT_253	[p13l1058t2554r1214b2609],
5	contributed	VBD	O	contribute	_	0	SENT_253	[p13l1252t2554r1628b2609],
6	equally	RB	O	equally	advmod	5	SENT_253	[p13l1666t2554r1901b2622],
7	to	TO	O	to	_	0	SENT_253	[p13l1935t2562r1997b2609],
8	this	DT	O	this	det	9	SENT_253	[p13l2033t2554r2149b2609],
9	work	NN	O	work	prep_to	5	SENT_253	[p13l9t2643r190b2698],
10	.	.	O	.	_	0	SENT_253	[p13l9t2643r190b2698],

1	M.T.C.	NNP	O	M.T.C.	_	0	SENT_254	[p13l218t2645r426b2706],
2	,	,	O	,	_	0	SENT_254	[p13l218t2645r426b2706],
3	C.F.d.L.	NNP	O	C.F.d.L.	appos	1	SENT_254	[p13l454t2643r670b2698],
4	and	CC	O	and	_	0	SENT_254	[p13l698t2643r814b2698],
5	]	NNP	O	]	appos	1	SENT_254	[p13l833t2646r933b2711],
6	.	.	O	.	_	0	SENT_254	[p13l833t2646r933b2711],

1	B.	NNP	O	B.	nsubj	2	SENT_255	[p13l833t2646r933b2711],
2	designed	VBD	O	design	_	0	SENT_255	[p13l961t2643r1248b2711],
3	the	DT	O	the	det	4	SENT_255	[p13l1275t2643r1376b2698],
4	research	NN	O	research	nsubj	17	SENT_255	[p13l1404t2643r1692b2706],
5	,	,	O	,	_	0	SENT_255	[p13l1404t2643r1692b2706],
6	collected	VBN	O	collect	partmod	4	SENT_255	[p13l1719t2643r2007b2698],
7	and	CC	O	and	_	0	SENT_255	[p13l2034t2643r2150b2698],
8	analyzed	VBN	O	analyze	partmod	4	SENT_255	[p13l10t2732r295b2800],
9	data	NNS	O	datum	dobj	6	SENT_255	[p13l321t2732r474b2795],
10	,	,	O	,	_	0	SENT_255	[p13l321t2732r474b2795],
11	performed	VBN	O	perform	partmod	4	SENT_255	[p13l500t2732r840b2800],
12	statistical	JJ	O	statistical	amod	13	SENT_255	[p13l867t2732r1174b2787],
13	analysis	NN	O	analysis	dobj	6	SENT_255	[p13l1199t2732r1471b2800],
14	,	,	O	,	_	0	SENT_255	[p13l1199t2732r1471b2800],
15	wrote	VBD	O	write	ccomp	2	SENT_255	[p13l1495t2740r1685b2787],
16	and	CC	O	and	_	0	SENT_255	[p13l1711t2732r1827b2787],
17	reviewed	VBD	O	review	ccomp	2	SENT_255	[p13l1853t2732r2150b2787],
18	the	DT	O	the	det	19	SENT_255	[p13l10t2820r111b2875],
19	paper	NN	O	paper	dobj	17	SENT_255	[p13l146t2836r348b2889],
20	;	:	O	;	_	0	SENT_255	[p13l146t2836r348b2889],
21	L.R.	NNP	PERSON	L.R.	nsubj	24	SENT_255	[p13l387t2823r493b2876],
22	and	CC	O	and	_	0	SENT_255	[p13l528t2820r644b2875],
23	N.T.	NNP	PERSON	N.T.	conj_and	21	SENT_255	[p13l679t2823r797b2876],
24	treated	VBD	O	treat	parataxis	2	SENT_255	[p13l832t2820r1062b2875],
25	the	DT	O	the	det	26	SENT_255	[p13l1096t2820r1197b2875],
26	patients	NNS	O	patient	dobj	24	SENT_255	[p13l1232t2821r1506b2889],
27	,	,	O	,	_	0	SENT_255	[p13l1232t2821r1506b2889],
28	collected	VBN	O	collect	dep	26	SENT_255	[p13l1542t2820r1829b2875],
29	data	NNS	O	datum	dobj	28	SENT_255	[p13l1863t2820r2001b2875],
30	and	CC	O	and	_	0	SENT_255	[p13l2034t2820r2150b2875],
31	reviewed	VBN	O	review	conj_and	28	SENT_255	[p13l11t2909r308b2964],
32	the	DT	O	the	det	33	SENT_255	[p13l328t2909r430b2964],
33	paper	NN	O	paper	dobj	31	SENT_255	[p13l451t2925r653b2978],
34	;	:	O	;	_	0	SENT_255	[p13l451t2925r653b2978],
35	A.N.	NNP	PERSON	A.N.	nsubj	42	SENT_255	[p13l675t2912r820b2973],
36	,	,	O	,	_	0	SENT_255	[p13l675t2912r820b2973],
37	T.D.	NNP	LOCATION	T.D.	nsubj	42	SENT_255	[p13l839t2913r975b2973],
38	,	,	O	,	_	0	SENT_255	[p13l839t2913r975b2973],
39	D.F.	NNP	PERSON	D.F.	nsubj	42	SENT_255	[p13l997t2913r1111b2965],
40	and	CC	O	and	_	0	SENT_255	[p13l1132t2909r1248b2964],
41	M.M.	NNP	PERSON	M.M.	nsubj	42	SENT_255	[p13l1270t2913r1428b2965],
42	performed	VBD	O	perform	parataxis	2	SENT_255	[p13l1450t2909r1790b2978],
43	the	DT	O	the	det	44	SENT_255	[p13l1810t2909r1912b2964],
44	assays	NNS	O	assay	dobj	42	SENT_255	[p13l1932t2925r2150b2978],
45	,	,	O	,	_	0	SENT_255	[p13l1932t2925r2150b2978],
46	reviewed	VBN	O	review	partmod	44	SENT_255	[p13l11t2998r308b3053],
47	and	CC	O	and	_	0	SENT_255	[p13l331t2998r447b3053],
48	approved	VBN	O	approve	partmod	44	SENT_255	[p13l470t2998r772b3067],
49	the	DT	O	the	det	50	SENT_255	[p13l795t2998r896b3053],
50	paper	NN	O	paper	dobj	46	SENT_255	[p13l920t3014r1118b3067],
51	.	.	O	.	_	0	SENT_255	[p13l920t3014r1118b3067],

1	References	NNS	O	reference	_	0	SENT_256	[p13l9t3200r378b3254],

1	[	NN	O	[	nn	5	SENT_257	[p14l39t63r104b118],
2	1	CD	NUMBER	1	num	5	SENT_257	[p14l39t63r104b118],
3	]	CD	NUMBER	]	num	5	SENT_257	[p14l39t63r104b118],
4	Palumbo	NNP	PERSON	Palumbo	nn	5	SENT_257	[p14l139t63r363b107],
5	A	NNP	O	A	_	0	SENT_257	[p14l379t65r428b114],
6	,	,	O	,	_	0	SENT_257	[p14l379t65r428b114],
7	Facon	NNP	ORGANIZATION	Facon	nn	8	SENT_257	[p14l447t66r594b107],
8	T	NN	ORGANIZATION	t	appos	5	SENT_257	[p14l609t66r652b114],
9	,	,	O	,	_	0	SENT_257	[p14l609t66r652b114],
10	Sonneveld	JJ	ORGANIZATION	sonneveld	amod	11	SENT_257	[p14l670t63r937b107],
11	P	NN	ORGANIZATION	p	appos	8	SENT_257	[p14l955t66r996b114],
12	,	,	O	,	_	0	SENT_257	[p14l955t66r996b114],
13	Bladé	NNP	PERSON	Bladé	nn	14	SENT_257	[p14l1015t62r1154b107],
14	J	NNP	PERSON	J	appos	8	SENT_257	[p14l1165t66r1198b118],
15	,	,	O	,	_	0	SENT_257	[p14l1165t66r1198b118],
16	Ofﬁdani	NNP	O	Ofﬁdani	nn	17	SENT_257	[p14l1217t63r1421b107],
17	M	NN	O	m	appos	8	SENT_257	[p14l1440t66r1501b114],
18	,	,	O	,	_	0	SENT_257	[p14l1440t66r1501b114],
19	Gay	NNS	O	gay	nn	20	SENT_257	[p14l1519t66r1617b118],
20	F	NN	O	f	appos	8	SENT_257	[p14l1634t66r1671b114],
21	,	,	O	,	_	0	SENT_257	[p14l1634t66r1671b114],
22	et	FW	O	et	nn	23	SENT_257	[p14l1689t70r1738b107],
23	al.	FW	O	al.	appos	8	SENT_257	[p14l1754t63r1809b107],
24	.	.	O	.	_	0	SENT_257	[p14l1754t63r1809b107],

1	Thalidomide	NNP	O	Thalidomide	_	0	SENT_258	[p14l1825t63r2151b107],
2	for	IN	O	for	_	0	SENT_258	[p14l139t130r210b173],
3	treatment	NN	O	treatment	prep_for	1	SENT_258	[p14l226t136r486b173],
4	of	IN	O	of	_	0	SENT_258	[p14l503t130r556b173],
5	multiple	JJ	O	multiple	amod	6	SENT_258	[p14l568t130r785b184],
6	myeloma	NN	O	myeloma	prep_of	3	SENT_258	[p14l804t130r1059b184],
7	:	:	O	:	_	0	SENT_258	[p14l804t130r1059b184],
8	10	CD	DATE	10	num	9	SENT_258	[p14l1084t132r1143b173],
9	years	NNS	DATE	year	dep	1	SENT_258	[p14l1159t142r1295b184],
10	later	RB	DATE	later	advmod	9	SENT_258	[p14l1314t130r1442b174],
11	.	.	O	.	_	0	SENT_258	[p14l1314t130r1442b174],

1	Blood	NN	O	blood	_	0	SENT_259	[p14l1462t130r1606b173],
2	2008	CD	DATE	2008	num	1	SENT_259	[p14l1624t132r1797b180],
3	;	:	O	;	_	0	SENT_259	[p14l1624t132r1797b180],
4	1	CD	NUMBER	1	number	5	SENT_259	[p14l1624t132r1797b180],
5	11:3968	CD	NUMBER	11:3968	dep	1	SENT_259	[p14l1810t132r2131b174],
6	—	NN	O	—	dep	5	SENT_259	[p14l1810t132r2131b174],
7	77	CD	NUMBER	77	num	6	SENT_259	[p14l1810t132r2131b174],
8	.	.	O	.	_	0	SENT_259	[p14l1810t132r2131b174],

1	[	NN	O	[	_	0	SENT_260	[p14l39t196r104b251],
2	2	CD	NUMBER	2	number	3	SENT_260	[p14l39t196r104b251],
3	]	CD	NUMBER	]	num	5	SENT_260	[p14l39t196r104b251],
4	Bladé	NN	O	bladé	nn	5	SENT_260	[p14l139t195r278b240],
5	J	NN	O	j	dep	1	SENT_260	[p14l291t199r324b251],
6	,	,	O	,	_	0	SENT_260	[p14l291t199r324b251],
7	Rosifiol	NNP	PERSON	Rosifiol	nn	8	SENT_260	[p14l344t196r532b240],
8	L.	NNP	O	L.	appos	5	SENT_260	[p14l552t199r589b240],
9	Advances	NNS	O	advance	dep	1	SENT_260	[p14l607t196r851b240],
10	in	IN	O	in	_	0	SENT_260	[p14l872t197r920b239],
11	therapy	NN	O	therapy	prep_in	9	SENT_260	[p14l938t196r1139b251],
12	of	IN	O	of	_	0	SENT_260	[p14l1157t196r1210b240],
13	multiple	JJ	O	multiple	amod	14	SENT_260	[p14l1223t196r1441b251],
14	myeloma	NN	O	myeloma	prep_of	11	SENT_260	[p14l1461t196r1713b251],
15	.	.	O	.	_	0	SENT_260	[p14l1461t196r1713b251],

1	Curr	NNP	O	Curr	nn	3	SENT_261	[p14l1733t198r1845b240],
2	Opin	NNP	O	Opin	nn	3	SENT_261	[p14l1863t197r1985b251],
3	Oncol	NNP	O	Oncol	_	0	SENT_261	[p14l2004t196r2151b240],

1	[	NN	O	[	nn	4	SENT_262	[p14l39t328r104b382],
2	3	CD	NUMBER	3	num	4	SENT_262	[p14l39t328r104b382],
3	]	NN	O	]	nn	4	SENT_262	[p14l39t328r104b382],
4	Blade	NN	O	blade	_	0	SENT_262	[p14l139t327r278b372],
5	J	NN	O	j	dep	4	SENT_262	[p14l288t331r321b382],
6	,	,	O	,	_	0	SENT_262	[p14l288t331r321b382],
7	Esteve	NNP	PERSON	Esteve	nn	8	SENT_262	[p14l339t331r503b372],
8	J	NNP	PERSON	J	appos	5	SENT_262	[p14l513t331r546b382],
9	,	,	O	,	_	0	SENT_262	[p14l513t331r546b382],
10	Rosiﬁol	NNP	PERSON	Rosiﬁol	nn	11	SENT_262	[p14l564t328r752b372],
11	L	NNP	PERSON	L	appos	5	SENT_262	[p14l769t331r805b378],
12	,	,	O	,	_	0	SENT_262	[p14l769t331r805b378],
13	Perales	NNP	PERSON	Perales	nn	14	SENT_262	[p14l823t328r1004b372],
14	M	NNP	O	M	appos	5	SENT_262	[p14l1022t331r1083b378],
15	,	,	O	,	_	0	SENT_262	[p14l1022t331r1083b378],
16	Montoto	NNP	LOCATION	Montoto	nn	17	SENT_262	[p14l1101t331r1322b372],
17	S	NNP	LOCATION	S	appos	5	SENT_262	[p14l1339t330r1377b378],
18	,	,	O	,	_	0	SENT_262	[p14l1339t330r1377b378],
19	Tuset	NNP	O	Tuset	nn	20	SENT_262	[p14l1392t331r1533b372],
20	M	NNP	O	M	appos	5	SENT_262	[p14l1549t331r1610b378],
21	,	,	O	,	_	0	SENT_262	[p14l1549t331r1610b378],
22	et	FW	O	et	nn	23	SENT_262	[p14l1628t334r1676b372],
23	al.	FW	O	al.	appos	5	SENT_262	[p14l1691t328r1746b372],
24	.	.	O	.	_	0	SENT_262	[p14l1691t328r1746b372],

1	Thalidomide	NNP	O	Thalidomide	_	0	SENT_263	[p14l1761t328r2087b372],
2	in	IN	O	in	_	0	SENT_263	[p14l2104t329r2151b371],
3	refractory	JJ	O	refractory	prep_in	1	SENT_263	[p14l139t393r395b448],
4	and	CC	O	and	_	0	SENT_263	[p14l411t393r504b437],
5	relapsing	JJ	O	relapsing	amod	7	SENT_263	[p14l523t394r760b448],
6	multiple	JJ	O	multiple	amod	7	SENT_263	[p14l777t393r994b448],
7	myeloma	NN	O	myeloma	prep_in	1	SENT_263	[p14l1013t393r1265b448],
8	.	.	O	.	_	0	SENT_263	[p14l1013t393r1265b448],

1	Semin	NNP	O	Semin	nn	2	SENT_264	[p14l1284t394r1444b437],
2	Oncol	NNP	O	Oncol	_	0	SENT_264	[p14l1461t393r1608b437],
3	2001	CD	DATE	2001	num	2	SENT_264	[p14l1626t396r1746b437],
4	;	:	O	;	_	0	SENT_264	[p14l1761t396r2067b444],
5	28:588	CD	NUMBER	28:588	number	6	SENT_264	[p14l1761t396r2067b444],
6	—	CD	NUMBER	—	dep	2	SENT_264	[p14l1761t396r2067b444],
7	92	CD	NUMBER	92	dep	6	SENT_264	[p14l1761t396r2067b444],
8	.	.	O	.	_	0	SENT_264	[p14l1761t396r2067b444],

1	[	NN	O	[	dep	5	SENT_265	[p14l39t460r104b514],
2	4	CD	NUMBER	4	num	1	SENT_265	[p14l39t460r104b514],
3	]	CD	NUMBER	]	num	4	SENT_265	[p14l39t460r104b514],
4	Mitsiades	NNS	O	mitsiade	dep	1	SENT_265	[p14l139t460r385b503],
5	N	NN	O	n	_	0	SENT_265	[p14l409t463r460b510],
6	,	,	O	,	_	0	SENT_265	[p14l409t463r460b510],
7	Mitsiades	NNP	O	Mitsiades	nn	8	SENT_265	[p14l485t460r731b503],
8	CS	NNP	O	CS	appos	5	SENT_265	[p14l755t462r827b510],
9	,	,	O	,	_	0	SENT_265	[p14l755t462r827b510],
10	Poulaki	NNP	O	Poulaki	nn	11	SENT_265	[p14l852t460r1040b503],
11	V	NNP	O	V	appos	5	SENT_265	[p14l1062t463r1110b510],
12	,	,	O	,	_	0	SENT_265	[p14l1062t463r1110b510],
13	Chauhan	NNP	PERSON	Chauhan	nn	14	SENT_265	[p14l1136t460r1361b503],
14	D	NNP	O	D	appos	5	SENT_265	[p14l1385t463r1434b510],
15	,	,	O	,	_	0	SENT_265	[p14l1385t463r1434b510],
16	Richardson	NNP	PERSON	Richardson	nn	17	SENT_265	[p14l1459t460r1746b503],
17	PG	NNP	O	PG	appos	5	SENT_265	[p14l1770t462r1850b510],
18	,	,	O	,	_	0	SENT_265	[p14l1770t462r1850b510],
19	Hideshima	NNP	LOCATION	Hideshima	nn	20	SENT_265	[p14l1874t460r2151b503],
20	T	NN	O	t	appos	5	SENT_265	[p14l136t529r178b576],
21	,	,	O	,	_	0	SENT_265	[p14l136t529r178b576],
22	et	FW	O	et	nn	23	SENT_265	[p14l215t533r263b570],
23	al.	FW	O	al.	appos	5	SENT_265	[p14l297t526r352b570],
24	.	.	O	.	_	0	SENT_265	[p14l297t526r352b570],

1	Apoptotic	JJ	O	apoptotic	amod	2	SENT_266	[p14l386t527r641b581],
2	signaling	NN	O	signaling	nsubj	3	SENT_266	[p14l676t526r908b581],
3	induced	VBN	O	induce	_	0	SENT_266	[p14l942t526r1147b570],
4	by	IN	O	by	_	0	SENT_266	[p14l1183t526r1244b581],
5	immunomodulatory	JJ	O	immunomodulatory	amod	7	SENT_266	[p14l1279t526r1804b581],
6	thalidomide	NN	O	thalidomide	nn	7	SENT_266	[p14l1838t526r2151b570],
7	analogs	NNS	O	analog	prep_by	3	SENT_266	[p14l138t592r331b646],
8	in	IN	O	in	_	0	SENT_266	[p14l361t592r408b635],
9	human	JJ	O	human	amod	12	SENT_266	[p14l437t592r617b635],
10	multiple	JJ	O	multiple	amod	12	SENT_266	[p14l646t592r863b646],
11	myeloma	NN	O	myeloma	nn	12	SENT_266	[p14l892t592r1132b646],
12	cells	NNS	O	cell	prep_in	7	SENT_266	[p14l1160t592r1288b636],
13	:	:	O	:	_	0	SENT_266	[p14l1160t592r1288b636],
14	therapeutic	JJ	O	therapeutic	amod	15	SENT_266	[p14l1320t592r1617b646],
15	implications	NNS	O	implication	dep	7	SENT_266	[p14l1646t592r1977b646],
16	.	.	O	.	_	0	SENT_266	[p14l1646t592r1977b646],

1	Blood	NN	O	blood	_	0	SENT_267	[p14l2006t592r2151b635],
2	2002	CD	DATE	2002	num	1	SENT_267	[p14l138t660r612b708],
3	;	:	O	;	_	0	SENT_267	[p14l138t660r612b708],
4	99:4525	CD	NUMBER	99:4525	number	5	SENT_267	[p14l138t660r612b708],
5	—	CD	NUMBER	—	dep	1	SENT_267	[p14l138t660r612b708],
6	30	CD	NUMBER	30	dep	5	SENT_267	[p14l138t660r612b708],
7	.	.	O	.	_	0	SENT_267	[p14l138t660r612b708],

1	[	NN	O	[	nn	5	SENT_268	[p14l39t723r104b778],
2	5	CD	NUMBER	5	num	5	SENT_268	[p14l39t723r104b778],
3	]	CD	NUMBER	]	num	5	SENT_268	[p14l39t723r104b778],
4	Cibeira	NNP	O	Cibeira	nn	5	SENT_268	[p14l139t723r318b767],
5	MT	NNP	O	MT	_	0	SENT_268	[p14l344t726r436b774],
6	,	,	O	,	_	0	SENT_268	[p14l344t726r436b774],
7	Rozman	NNP	PERSON	Rozman	nn	8	SENT_268	[p14l463t726r671b767],
8	M	NNP	O	M	appos	5	SENT_268	[p14l697t726r758b774],
9	,	,	O	,	_	0	SENT_268	[p14l697t726r758b774],
10	Segarra	NNP	PERSON	Segarra	nn	11	SENT_268	[p14l785t726r976b778],
11	M	NNP	O	M	appos	8	SENT_268	[p14l1002t726r1063b774],
12	,	,	O	,	_	0	SENT_268	[p14l1002t726r1063b774],
13	Lozano	NNP	PERSON	Lozano	nn	14	SENT_268	[p14l1090t726r1270b767],
14	E	NNP	PERSON	E	appos	8	SENT_268	[p14l1296t726r1337b774],
15	,	,	O	,	_	0	SENT_268	[p14l1296t726r1337b774],
16	Rosiﬁol	NNP	PERSON	Rosiﬁol	nn	17	SENT_268	[p14l1364t723r1551b767],
17	L	NNP	PERSON	L	appos	8	SENT_268	[p14l1578t726r1615b774],
18	,	,	O	,	_	0	SENT_268	[p14l1578t726r1615b774],
19	Cid	NNP	O	Cid	nn	20	SENT_268	[p14l1641t723r1722b767],
20	MC	NNP	O	MC	appos	8	SENT_268	[p14l1748t726r1843b774],
21	,	,	O	,	_	0	SENT_268	[p14l1748t726r1843b774],
22	et	FW	O	et	nn	23	SENT_268	[p14l1870t730r1919b767],
23	al.	FW	O	al.	appos	8	SENT_268	[p14l1943t723r1998b767],
24	.	.	O	.	_	0	SENT_268	[p14l1943t723r1998b767],

1	Bone	NN	O	bone	nn	3	SENT_269	[p14l2025t726r2151b767],
2	marrow	NN	O	marrow	nn	3	SENT_269	[p14l139t803r345b834],
3	angiogenesis	NN	O	angiogenesis	nsubj	10	SENT_269	[p14l357t791r688b844],
4	and	CC	O	and	_	0	SENT_269	[p14l702t790r795b834],
5	angiogenic	JJ	O	angiogenic	amod	6	SENT_269	[p14l810t791r1089b844],
6	factors	NNS	O	factor	nsubj	10	SENT_269	[p14l1102t790r1274b834],
7	in	IN	O	in	_	0	SENT_269	[p14l1289t791r1337b833],
8	multiple	JJ	O	multiple	amod	9	SENT_269	[p14l1350t790r1568b844],
9	myeloma	NN	O	myeloma	prep_in	6	SENT_269	[p14l1583t790r1822b844],
10	treated	VBN	O	treat	_	0	SENT_269	[p14l1836t790r2020b834],
11	with	IN	O	with	_	0	SENT_269	[p14l2033t790r2151b834],
12	novel	JJ	O	novel	amod	13	SENT_269	[p14l139t855r278b899],
13	agents	NNS	O	agent	prep_with	10	SENT_269	[p14l296t862r475b910],
14	.	.	O	.	_	0	SENT_269	[p14l296t862r475b910],

1	Cytokine	NN	O	cytokine	_	0	SENT_270	[p14l494t855r720b910],
2	2008	CD	DATE	2008	num	1	SENT_270	[p14l739t858r944b906],
3	;	:	O	;	_	0	SENT_270	[p14l739t858r944b906],
4	41	CD	NUMBER	41	number	5	SENT_270	[p14l739t858r944b906],
5	1244-53	CD	NUMBER	1244-53	dep	1	SENT_270	[p14l959t858r1180b899],
6	.	.	O	.	_	0	SENT_270	[p14l959t858r1180b899],

1	[	NN	O	[	nn	4	SENT_271	[p14l39t922r104b976],
2	6	CD	NUMBER	6	num	4	SENT_271	[p14l39t922r104b976],
3	]	NN	O	]	nn	4	SENT_271	[p14l39t922r104b976],
4	Monzé	NN	O	monzé	_	0	SENT_271	[p14l139t921r313b965],
5	M	NN	O	m	dep	4	SENT_271	[p14l329t925r391b972],
6	,	,	O	,	_	0	SENT_271	[p14l329t925r391b972],
7	Navarro	NNP	PERSON	Navarro	nn	8	SENT_271	[p14l407t925r612b965],
8	A	NNP	O	A	appos	4	SENT_271	[p14l625t924r673b972],
9	,	,	O	,	_	0	SENT_271	[p14l625t924r673b972],
10	Ferrer	NNP	PERSON	Ferrer	nn	11	SENT_271	[p14l689t925r845b965],
11	G	NNP	PERSON	G	appos	8	SENT_271	[p14l858t924r907b972],
12	,	,	O	,	_	0	SENT_271	[p14l858t924r907b972],
13	Artells	NNP	O	Artells	nn	15	SENT_271	[p14l921t922r1088b965],
14	R.	NNP	O	R.	nn	15	SENT_271	[p14l1105t925r1148b966],
15	Pharmacogenomics	NNP	O	Pharmacogenomics	appos	8	SENT_271	[p14l1164t922r1684b976],
16	:	:	O	:	_	0	SENT_271	[p14l1164t922r1684b976],
17	a	DT	O	a	det	18	SENT_271	[p14l1703t934r1729b965],
18	tool	NN	O	tool	dep	15	SENT_271	[p14l1743t922r1842b965],
19	for	IN	O	for	_	0	SENT_271	[p14l1858t922r1929b965],
20	improving	VBG	O	improve	prep_for	18	SENT_271	[p14l1943t923r2151b976, p14l139t989r218b1043],

1	cancer	NN	O	cancer	_	0	SENT_272	[p14l234t1001r403b1032],
2	chemotherapy	NN	O	chemotherapy	dep	1	SENT_272	[p14l419t988r806b1043],
3	.	.	O	.	_	0	SENT_272	[p14l419t988r806b1043],

1	Clin	NNP	O	Clin	nn	3	SENT_273	[p14l825t988r923b1032],
2	Transl	NNP	O	Transl	nn	3	SENT_273	[p14l938t988r1097b1032],
3	Oncol	NNP	O	Oncol	_	0	SENT_273	[p14l1115t988r1262b1032],
4	2008	CD	DATE	2008	num	3	SENT_273	[p14l1280t990r1423b1039],
5	;	:	O	;	_	0	SENT_273	[p14l1280t990r1423b1039],
6	1	CD	NUMBER	1	number	7	SENT_273	[p14l1434t991r1453b1031],
7	0:628	CD	NUMBER	0:628	num	8	SENT_273	[p14l1464t990r1673b1032],
8	—	NN	O	—	dep	3	SENT_273	[p14l1464t990r1673b1032],
9	3	CD	NUMBER	3	number	10	SENT_273	[p14l1464t990r1673b1032],
10	7	CD	NUMBER	7	amod	8	SENT_273	[p14l1681t991r1721b1032],
11	.	.	O	.	_	0	SENT_273	[p14l1681t991r1721b1032],

1	[	NN	O	[	nn	5	SENT_274	[p14l39t1053r104b1108],
2	7	CD	NUMBER	7	num	5	SENT_274	[p14l39t1053r104b1108],
3	]	CD	NUMBER	]	num	5	SENT_274	[p14l39t1053r104b1108],
4	Blade	NNP	O	Blade	nn	5	SENT_274	[p14l139t1052r278b1097],
5	J	NNP	O	J	_	0	SENT_274	[p14l292t1056r325b1108],
6	,	,	O	,	_	0	SENT_274	[p14l292t1056r325b1108],
7	Samson	NNP	PERSON	Samson	nn	8	SENT_274	[p14l347t1056r546b1097],
8	D	NNP	O	D	appos	5	SENT_274	[p14l567t1056r616b1104],
9	,	,	O	,	_	0	SENT_274	[p14l567t1056r616b1104],
10	Reece	NNP	ORGANIZATION	Reece	nn	11	SENT_274	[p14l637t1056r784b1097],
11	D	NNP	ORGANIZATION	D	appos	8	SENT_274	[p14l806t1056r855b1104],
12	,	,	O	,	_	0	SENT_274	[p14l806t1056r855b1104],
13	Apperley	NNP	O	Apperley	nn	14	SENT_274	[p14l874t1054r1109b1108],
14	J	NNP	O	J	appos	8	SENT_274	[p14l1122t1056r1154b1108],
15	,	,	O	,	_	0	SENT_274	[p14l1122t1056r1154b1108],
16	Bjorkstrand	NNP	O	Bjorkstrand	nn	17	SENT_274	[p14l1177t1054r1477b1108],
17	B	NNP	O	B	appos	8	SENT_274	[p14l1498t1056r1540b1104],
18	,	,	O	,	_	0	SENT_274	[p14l1498t1056r1540b1104],
19	Gahrton	NNP	O	Gahrton	nn	20	SENT_274	[p14l1562t1054r1772b1097],
20	G	NNP	O	G	appos	8	SENT_274	[p14l1793t1056r1841b1104],
21	,	,	O	,	_	0	SENT_274	[p14l1793t1056r1841b1104],
22	et	FW	O	et	nn	23	SENT_274	[p14l1863t1060r1911b1097],
23	al.	FW	O	al.	appos	8	SENT_274	[p14l1930t1054r1985b1098],
24	.	.	O	.	_	0	SENT_274	[p14l1930t1054r1985b1098],

1	Criteria	NNS	O	criterion	_	0	SENT_275	[p14l2007t1054r2151b1097, p14l139t1121r204b1164],
2	for	IN	O	for	_	0	SENT_275	[p14l225t1120r297b1164],
3	evaluating	VBG	O	evaluate	prepc_for	1	SENT_275	[p14l316t1120r586b1174],
4	disease	NN	O	disease	nn	5	SENT_275	[p14l605t1120r791b1164],
5	response	NN	O	response	dobj	3	SENT_275	[p14l812t1133r1041b1174],
6	and	CC	O	and	_	0	SENT_275	[p14l1062t1120r1155b1164],
7	progression	NN	O	progression	conj_and	5	SENT_275	[p14l1176t1121r1479b1174],
8	in	IN	O	in	_	0	SENT_275	[p14l1499t1121r1547b1163],
9	patients	NNS	O	patient	prep_in	5	SENT_275	[p14l1567t1121r1774b1174],
10	with	IN	O	with	_	0	SENT_275	[p14l1794t1120r1913b1164],
11	multiple	JJ	O	multiple	amod	12	SENT_275	[p14l1934t1120r2151b1174],
12	myeloma	NN	O	myeloma	prep_with	1	SENT_275	[p14l139t1185r379b1240],
13	treated	VBN	O	treat	partmod	1	SENT_275	[p14l395t1185r579b1229],
14	by	IN	O	by	_	0	SENT_275	[p14l595t1185r657b1240],
15	high-dose	JJ	O	high-dose	amod	16	SENT_275	[p14l673t1185r928b1240],
16	therapy	NN	O	therapy	agent	13	SENT_275	[p14l945t1185r1146b1240],
17	and	CC	O	and	_	0	SENT_275	[p14l1161t1185r1254b1229],
18	haemopoietic	JJ	O	haemopoietic	amod	21	SENT_275	[p14l1271t1185r1623b1240],
19	stem	NN	O	stem	nn	21	SENT_275	[p14l1640t1192r1764b1229],
20	cell	NN	O	cell	nn	21	SENT_275	[p14l1781t1185r1867b1229],
21	transplantation	NN	O	transplantation	agent	13	SENT_275	[p14l1884t1185r2151b1240, p14l138t1253r302b1296],
22	.	.	O	.	_	0	SENT_275	[p14l1884t1185r2151b1240, p14l138t1253r302b1296],

1	Myeloma	NN	O	myeloma	_	0	SENT_276	[p14l326t1252r567b1306],
2	Subcommittee	NNP	O	Subcommittee	dep	1	SENT_276	[p14l590t1252r964b1295],
3	of	IN	O	of	_	0	SENT_276	[p14l988t1252r1042b1295],
4	the	DT	O	the	det	5	SENT_276	[p14l1058t1252r1139b1295],
5	EBMT	NN	O	ebmt	prep_of	2	SENT_276	[p14l1163t1255r1322b1296],
6	.	.	O	.	_	0	SENT_276	[p14l1163t1255r1322b1296],

1	European	NNP	O	European	nn	2	SENT_277	[p14l1346t1254r1590b1306],
2	Group	NNP	O	Group	_	0	SENT_277	[p14l1614t1254r1772b1306],
3	for	IN	O	for	_	0	SENT_277	[p14l1796t1252r1868b1295],
4	Blood	NNP	O	Blood	prep_for	2	SENT_277	[p14l1890t1252r2034b1295],
5	and	CC	O	and	_	0	SENT_277	[p14l2058t1252r2151b1295],
6	Marrow	NNP	O	Marrow	nn	7	SENT_277	[p14l139t1321r345b1362],
7	Transplant	NN	O	transplant	conj_and	4	SENT_277	[p14l359t1318r649b1373],
8	.	.	O	.	_	0	SENT_277	[p14l359t1318r649b1373],

1	BrJ	NN	O	brj	nn	2	SENT_278	[p14l668t1321r753b1373],
2	Haematol	NN	O	haematol	_	0	SENT_278	[p14l771t1318r1020b1362],
3	1998	CD	DATE	1998	dep	2	SENT_278	[p14l1041t1320r1181b1368],
4	;	:	O	;	_	0	SENT_278	[p14l1041t1320r1181b1368],
5	1	CD	NUMBER	1	number	6	SENT_278	[p14l1192t1321r1212b1361],
6	02:11	CD	TIME	02:11	dep	2	SENT_278	[p14l1222t1320r1362b1362],
7	1	CD	NUMBER	1	num	8	SENT_278	[p14l1375t1321r1395b1361],
8	5-23	CD	NUMBER	5-23	dep	6	SENT_278	[p14l1406t1320r1545b1362],
9	.	.	O	.	_	0	SENT_278	[p14l1406t1320r1545b1362],

1	[	NN	O	[	nn	4	SENT_279	[p14l39t1384r103b1438],
2	8	CD	NUMBER	8	num	4	SENT_279	[p14l39t1384r103b1438],
3	]	NN	O	]	nn	4	SENT_279	[p14l39t1384r103b1438],
4	Monzo	NN	O	monzo	_	0	SENT_279	[p14l138t1383r313b1428],
5	M	NN	O	m	dep	4	SENT_279	[p14l358t1387r419b1434],
6	,	,	O	,	_	0	SENT_279	[p14l358t1387r419b1434],
7	Brunet	NNP	PERSON	Brunet	nn	8	SENT_279	[p14l464t1387r638b1428],
8	S	NNP	O	S	appos	5	SENT_279	[p14l680t1386r719b1434],
9	,	,	O	,	_	0	SENT_279	[p14l680t1386r719b1434],
10	Urbano-Ispizua	NNP	O	Urbano-Ispizua	nn	11	SENT_279	[p14l763t1384r1160b1438],
11	A	NNP	O	A	appos	5	SENT_279	[p14l1201t1386r1250b1434],
12	,	,	O	,	_	0	SENT_279	[p14l1201t1386r1250b1434],
13	Navarro	NNP	PERSON	Navarro	nn	14	SENT_279	[p14l1295t1387r1499b1428],
14	A	NNP	O	A	appos	5	SENT_279	[p14l1542t1386r1590b1434],
15	,	,	O	,	_	0	SENT_279	[p14l1542t1386r1590b1434],
16	Perea	NNP	PERSON	Perea	nn	17	SENT_279	[p14l1635t1387r1775b1428],
17	G	NNP	PERSON	G	appos	5	SENT_279	[p14l1819t1386r1867b1434],
18	,	,	O	,	_	0	SENT_279	[p14l1819t1386r1867b1434],
19	Esteve	NNP	PERSON	Esteve	nn	20	SENT_279	[p14l1913t1387r2076b1428],
20	J	NNP	PERSON	J	appos	5	SENT_279	[p14l2114t1387r2147b1438],
21	,	,	O	,	_	0	SENT_279	[p14l2114t1387r2147b1438],
22	et	FW	O	et	nn	23	SENT_279	[p14l138t1456r186b1493],
23	al.	FW	O	al.	appos	5	SENT_279	[p14l213t1450r268b1493],
24	.	.	O	.	_	0	SENT_279	[p14l213t1450r268b1493],

1	CETLAM	NNP	O	CETLAM	_	0	SENT_280	[p14l297t1451r521b1493],
2	.	.	O	.	_	0	SENT_280	[p14l297t1451r521b1493],

1	Genomic	JJ	O	genomic	amod	2	SENT_281	[p14l550t1450r779b1493],
2	polymorphisms	NNS	O	polymorphism	nsubj	3	SENT_281	[p14l807t1449r1211b1504],
3	provide	VBP	O	provide	_	0	SENT_281	[p14l1240t1449r1436b1504],
4	prognostic	JJ	O	prognostic	amod	5	SENT_281	[p14l1465t1450r1737b1504],
5	information	NN	O	information	dobj	3	SENT_281	[p14l1766t1449r2072b1493],
6	in	IN	O	in	_	0	SENT_281	[p14l2101t1450r2148b1493],
7	intermediate-risk	JJ	O	intermediate-risk	amod	10	SENT_281	[p14l138t1516r593b1559],
8	acute	JJ	O	acute	amod	10	SENT_281	[p14l610t1522r746b1559],
9	myeloblastic	JJ	O	myeloblastic	amod	10	SENT_281	[p14l765t1516r1092b1570],
10	leukemia	NN	O	leukemia	prep_in	5	SENT_281	[p14l1110t1516r1358b1560],
11	.	.	O	.	_	0	SENT_281	[p14l1110t1516r1358b1560],

1	Blood	NN	O	blood	_	0	SENT_282	[p14l1377t1516r1522b1559],
2	2006	CD	DATE	2006	num	1	SENT_282	[p14l1540t1518r2013b1566],
3	;	:	O	;	_	0	SENT_282	[p14l1540t1518r2013b1566],
4	107:4871	CD	NUMBER	107:4871	number	5	SENT_282	[p14l1540t1518r2013b1566],
5	—	CD	NUMBER	—	dep	1	SENT_282	[p14l1540t1518r2013b1566],
6	9	CD	NUMBER	9	dep	5	SENT_282	[p14l1540t1518r2013b1566],
7	.	.	O	.	_	0	SENT_282	[p14l1540t1518r2013b1566],

1	[	NN	O	[	nn	4	SENT_283	[p14l39t1582r103b1637],
2	9	CD	NUMBER	9	num	4	SENT_283	[p14l39t1582r103b1637],
3	]	NN	O	]	nn	4	SENT_283	[p14l39t1582r103b1637],
4	Dumontet	NN	O	dumontet	_	0	SENT_283	[p14l138t1585r400b1626],
5	C	NN	O	c	dep	4	SENT_283	[p14l421t1584r463b1632],
6	,	,	O	,	_	0	SENT_283	[p14l421t1584r463b1632],
7	Landi	NNP	PERSON	Landi	nn	8	SENT_283	[p14l486t1582r623b1626],
8	S	NNP	O	S	appos	5	SENT_283	[p14l646t1584r684b1632],
9	,	,	O	,	_	0	SENT_283	[p14l646t1584r684b1632],
10	Reiman	NNP	ORGANIZATION	Reiman	nn	11	SENT_283	[p14l706t1583r900b1626],
11	T	NN	ORGANIZATION	t	appos	5	SENT_283	[p14l919t1585r961b1632],
12	,	,	O	,	_	0	SENT_283	[p14l919t1585r961b1632],
13	Perry	NNP	ORGANIZATION	Perry	nn	14	SENT_283	[p14l984t1585r1120b1637],
14	T	NN	ORGANIZATION	t	appos	5	SENT_283	[p14l1138t1585r1180b1632],
15	,	,	O	,	_	0	SENT_283	[p14l1138t1585r1180b1632],
16	Plesa	NNP	PERSON	Plesa	nn	17	SENT_283	[p14l1203t1582r1332b1626],
17	A	NNP	O	A	appos	5	SENT_283	[p14l1351t1584r1399b1632],
18	,	,	O	,	_	0	SENT_283	[p14l1351t1584r1399b1632],
19	Bellini	NNP	PERSON	Bellini	appos	5	SENT_283	[p14l1421t1582r1583b1626],
20	I	PRP	O	I	dep	19	SENT_283	[p14l1605t1585r1631b1632],
21	,	,	O	,	_	0	SENT_283	[p14l1605t1585r1631b1632],
22	et	FW	O	et	nn	23	SENT_283	[p14l1653t1589r1701b1626],
23	al.	FW	O	al.	appos	5	SENT_283	[p14l1722t1582r1776b1626],
24	.	.	O	.	_	0	SENT_283	[p14l1722t1582r1776b1626],

1	Genetic	JJ	O	genetic	amod	2	SENT_284	[p14l1799t1583r1994b1626],
2	polymorphisms	NNS	O	polymorphism	nsubj	3	SENT_284	[p14l2015t1582r2147b1637, p14l138t1648r428b1702],
3	associated	VBN	O	associate	_	0	SENT_284	[p14l449t1648r715b1691],
4	with	IN	O	with	_	0	SENT_284	[p14l734t1648r853b1691],
5	outcome	NN	O	outcome	nsubj	10	SENT_284	[p14l873t1654r1097b1691],
6	in	IN	O	in	_	0	SENT_284	[p14l1119t1648r1166b1691],
7	multiple	JJ	O	multiple	amod	9	SENT_284	[p14l1186t1648r1403b1702],
8	myeloma	NN	O	myeloma	nn	9	SENT_284	[p14l1425t1648r1665b1702],
9	patients	NNS	O	patient	prep_in	5	SENT_284	[p14l1685t1648r1891b1702],
10	receiving	VBG	O	receive	prepc_with	3	SENT_284	[p14l1913t1648r2149b1702],
11	high-dose	JJ	O	high-dose	amod	12	SENT_284	[p14l138t1714r393b1768],
12	melphalan	NN	O	melphalan	dobj	10	SENT_284	[p14l412t1714r697b1768],
13	.	.	O	.	_	0	SENT_284	[p14l412t1714r697b1768],

1	Bone	NN	O	bone	nn	3	SENT_285	[p14l716t1717r841b1758],
2	Marrow	NN	O	marrow	nn	3	SENT_285	[p14l860t1717r1066b1758],
3	Transplant	NN	O	transplant	_	0	SENT_285	[p14l1080t1714r1358b1768],
4	2010	CD	DATE	2010	dep	3	SENT_285	[p14l1375t1716r1848b1764],
5	;	:	O	;	_	0	SENT_285	[p14l1375t1716r1848b1764],
6	45:1316	CD	NUMBER	45:1316	number	7	SENT_285	[p14l1375t1716r1848b1764],
7	—	CD	NUMBER	—	dep	3	SENT_285	[p14l1375t1716r1848b1764],
8	24	CD	NUMBER	24	dep	7	SENT_285	[p14l1375t1716r1848b1764],
9	.	.	O	.	_	0	SENT_285	[p14l1375t1716r1848b1764],

1	[	NN	O	[	nn	5	SENT_286	[p14l7t1779r103b1834],
2	10	CD	NUMBER	10	num	5	SENT_286	[p14l7t1779r103b1834],
3	]	CD	NUMBER	]	num	5	SENT_286	[p14l7t1779r103b1834],
4	Vacca	NNP	PERSON	Vacca	nn	5	SENT_286	[p14l136t1782r285b1823],
5	A	NNP	O	A	_	0	SENT_286	[p14l298t1781r346b1830],
6	,	,	O	,	_	0	SENT_286	[p14l298t1781r346b1830],
7	Scavelli	NNP	O	Scavelli	nn	8	SENT_286	[p14l363t1779r556b1823],
8	C	NNP	O	C	appos	5	SENT_286	[p14l573t1782r615b1830],
9	,	,	O	,	_	0	SENT_286	[p14l573t1782r615b1830],
10	Montefusco	NNP	PERSON	Montefusco	nn	11	SENT_286	[p14l632t1779r934b1823],
11	V	NNP	O	V	appos	8	SENT_286	[p14l949t1782r997b1830],
12	,	,	O	,	_	0	SENT_286	[p14l949t1782r997b1830],
13	Di	NNP	PERSON	Di	nn	15	SENT_286	[p14l1014t1780r1067b1823],
14	Pietro	NNP	PERSON	Pietro	nn	15	SENT_286	[p14l1084t1780r1234b1823],
15	G	NNP	PERSON	G	appos	8	SENT_286	[p14l1251t1782r1299b1830],
16	,	,	O	,	_	0	SENT_286	[p14l1251t1782r1299b1830],
17	Neri	NNP	PERSON	Neri	nn	18	SENT_286	[p14l1316t1780r1423b1823],
18	A	NNP	O	A	appos	8	SENT_286	[p14l1437t1781r1485b1830],
19	,	,	O	,	_	0	SENT_286	[p14l1437t1781r1485b1830],
20	Mattioli	NNP	PERSON	Mattioli	nn	21	SENT_286	[p14l1502t1779r1705b1823],
21	M	NNP	O	M	appos	8	SENT_286	[p14l1722t1782r1782b1830],
22	,	,	O	,	_	0	SENT_286	[p14l1722t1782r1782b1830],
23	et	FW	O	et	nn	24	SENT_286	[p14l1799t1786r1848b1823],
24	al.	FW	O	al.	appos	8	SENT_286	[p14l1862t1779r1917b1823],
25	.	.	O	.	_	0	SENT_286	[p14l1862t1779r1917b1823],

1	Thalidomide	NNP	O	Thalidomide	nsubj	2	SENT_287	[p14l1932t1779r2147b1823, p14l138t1846r267b1890],
2	downregulates	VBZ	O	downregulate	_	0	SENT_287	[p14l294t1846r677b1900],
3	angiogenic	JJ	O	angiogenic	amod	4	SENT_287	[p14l706t1847r984b1900],
4	genes	NNS	O	gene	dobj	2	SENT_287	[p14l1010t1859r1156b1900],
5	in	IN	O	in	prep	4	SENT_287	[p14l1184t1847r1232b1889],
6	bone	NN	O	bone	dep	9	SENT_287	[p14l1258t1846r1383b1890],
7	marrow	NN	O	marrow	dep	6	SENT_287	[p14l1411t1859r1617b1890],
8	endothelial	JJ	O	endothelial	amod	9	SENT_287	[p14l1643t1846r1933b1890],
9	cells	NNS	O	cell	dep	5	SENT_287	[p14l1962t1846r2072b1890],
10	of	IN	O	of	_	0	SENT_287	[p14l2101t1846r2154b1890],
11	patients	NNS	O	patient	prep_of	9	SENT_287	[p14l138t1912r344b1966],
12	with	IN	O	with	_	0	SENT_287	[p14l362t1911r480b1955],
13	active	JJ	O	active	amod	15	SENT_287	[p14l498t1912r649b1955],
14	multiple	JJ	O	multiple	amod	15	SENT_287	[p14l667t1911r884b1966],
15	myeloma	NN	O	myeloma	prep_with	11	SENT_287	[p14l903t1911r1187b1966],
16	.	.	O	.	_	0	SENT_287	[p14l903t1911r1187b1966],
17	]	SYM	O	]	dep	4	SENT_287	[p14l903t1911r1187b1966],

1	Clin	NNP	O	Clin	nn	2	SENT_288	[p14l1205t1912r1304b1955],
2	Oncol	NNP	O	Oncol	_	0	SENT_288	[p14l1321t1911r1467b1955],
3	2005	CD	DATE	2005	num	2	SENT_288	[p14l1486t1914r1959b1962],
4	;	:	O	;	_	0	SENT_288	[p14l1486t1914r1959b1962],
5	23:5334	CD	NUMBER	23:5334	number	6	SENT_288	[p14l1486t1914r1959b1962],
6	—	CD	NUMBER	—	dep	2	SENT_288	[p14l1486t1914r1959b1962],
7	46	CD	NUMBER	46	dep	6	SENT_288	[p14l1486t1914r1959b1962],
8	.	.	O	.	_	0	SENT_288	[p14l1486t1914r1959b1962],

1	[	NN	O	[	nn	5	SENT_289	[p14l6t1978r103b2032],
2	11	CD	NUMBER	11	num	5	SENT_289	[p14l6t1978r103b2032],
3	]	CD	NUMBER	]	num	5	SENT_289	[p14l6t1978r103b2032],
4	Teo	NNP	PERSON	Teo	nn	5	SENT_289	[p14l136t1981r227b2021],
5	SK	NNP	PERSON	SK	_	0	SENT_289	[p14l276t1980r350b2028],
6	,	,	O	,	_	0	SENT_289	[p14l276t1980r350b2028],
7	Colburn	NNP	ORGANIZATION	Colburn	nn	8	SENT_289	[p14l399t1978r602b2021],
8	WA	NNP	ORGANIZATION	WA	appos	5	SENT_289	[p14l648t1980r755b2028],
9	,	,	O	,	_	0	SENT_289	[p14l648t1980r755b2028],
10	Tracewell	NNP	O	Tracewell	nn	11	SENT_289	[p14l802t1978r1052b2021],
11	WG	NNP	O	WG	appos	8	SENT_289	[p14l1098t1980r1208b2028],
12	,	,	O	,	_	0	SENT_289	[p14l1098t1980r1208b2028],
13	Kook	NNP	LOCATION	Kook	nn	14	SENT_289	[p14l1257t1978r1386b2021],
14	KA	NN	LOCATION	ka	appos	8	SENT_289	[p14l1433t1980r1515b2028],
15	,	,	O	,	_	0	SENT_289	[p14l1433t1980r1515b2028],
16	Stirling	NNP	ORGANIZATION	Stirling	nn	17	SENT_289	[p14l1565t1978r1751b2032],
17	DI	NNP	ORGANIZATION	DI	appos	8	SENT_289	[p14l1798t1981r1865b2028],
18	,	,	O	,	_	0	SENT_289	[p14l1798t1981r1865b2028],
19	Jaworsky	NNP	PERSON	Jaworsky	nn	20	SENT_289	[p14l1907t1978r2149b2032],
20	MS	NN	O	m	appos	8	SENT_289	[p14l138t2046r229b2094],
21	,	,	O	,	_	0	SENT_289	[p14l138t2046r229b2094],
22	et	FW	O	et	nn	23	SENT_289	[p14l268t2051r316b2088],
23	al.	FW	O	al.	appos	8	SENT_289	[p14l353t2044r408b2088],
24	.	.	O	.	_	0	SENT_289	[p14l353t2044r408b2088],

1	Clinical	JJ	O	clinical	amod	2	SENT_290	[p14l448t2044r636b2088],
2	pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_290	[p14l674t2044r1133b2099],
3	of	IN	O	of	_	0	SENT_290	[p14l1173t2044r1226b2088],
4	thalidomide	NN	O	thalidomide	prep_of	2	SENT_290	[p14l1258t2044r1583b2088],
5	.	.	O	.	_	0	SENT_290	[p14l1258t2044r1583b2088],

1	Clin	NNP	O	Clin	nn	2	SENT_291	[p14l1623t2044r1721b2088],
2	Pharmacokinet	NNP	O	Pharmacokinet	_	0	SENT_291	[p14l1759t2044r2149b2088],
3	2004	CD	DATE	2004	num	2	SENT_291	[p14l138t2112r578b2160],
4	;	:	O	;	_	0	SENT_291	[p14l138t2112r578b2160],
5	43:311	CD	NUMBER	43:311	number	6	SENT_291	[p14l138t2112r578b2160],
6	—	CD	NUMBER	—	dep	2	SENT_291	[p14l138t2112r578b2160],
7	27	CD	NUMBER	27	dep	6	SENT_291	[p14l138t2112r578b2160],
8	.	.	O	.	_	0	SENT_291	[p14l138t2112r578b2160],

1	[	NN	O	[	_	0	SENT_292	[p14l6t2176r103b2230],
2	12	CD	NUMBER	12	num	1	SENT_292	[p14l6t2176r103b2230],
3	]	CD	NUMBER	]	num	5	SENT_292	[p14l6t2176r103b2230],
4	Ando	NNP	O	Ando	nn	5	SENT_292	[p14l136t2176r271b2220],
5	Y	NN	O	y	dep	1	SENT_292	[p14l287t2179r332b2226],
6	,	,	O	,	_	0	SENT_292	[p14l287t2179r332b2226],
7	Price	NNP	O	Price	nn	8	SENT_292	[p14l351t2177r475b2220],
8	DK	NNP	O	DK	appos	5	SENT_292	[p14l493t2179r578b2226],
9	,	,	O	,	_	0	SENT_292	[p14l493t2179r578b2226],
10	Dahut	NNP	O	Dahut	nn	11	SENT_292	[p14l597t2176r753b2220],
11	WL	NNP	O	WL	appos	5	SENT_292	[p14l767t2179r865b2226],
12	,	,	O	,	_	0	SENT_292	[p14l767t2179r865b2226],
13	Cox	NNP	ORGANIZATION	Cox	nn	14	SENT_292	[p14l883t2178r978b2220],
14	MC	NNP	ORGANIZATION	MC	appos	5	SENT_292	[p14l994t2178r1089b2226],
15	,	,	O	,	_	0	SENT_292	[p14l994t2178r1089b2226],
16	Reed	NNP	ORGANIZATION	Reed	nn	17	SENT_292	[p14l1108t2176r1231b2220],
17	E	NNP	ORGANIZATION	E	appos	5	SENT_292	[p14l1249t2179r1290b2226],
18	,	,	O	,	_	0	SENT_292	[p14l1249t2179r1290b2226],
19	Figg	NNP	PERSON	Figg	nn	20	SENT_292	[p14l1308t2177r1412b2230],
20	WD	NNP	O	WD	appos	5	SENT_292	[p14l1426t2179r1536b2220],
21	.	.	O	.	_	0	SENT_292	[p14l1426t2179r1536b2220],

1	Pharmacogenetic	JJ	MISC	pharmacogenetic	amod	2	SENT_293	[p14l1555t2176r2000b2230],
2	associations	NNS	O	association	_	0	SENT_293	[p14l2017t2189r2147b2220, p14l138t2242r336b2285],
3	of	IN	O	of	_	0	SENT_293	[p14l356t2241r410b2285],
4	CYP2C19	NN	O	cyp2c19	nn	5	SENT_293	[p14l423t2244r651b2285],
5	genotype	NN	O	genotype	prep_of	2	SENT_293	[p14l670t2248r909b2296],
6	with	IN	O	with	prep	2	SENT_293	[p14l928t2241r1046b2285],
7	in	FW	O	in	dep	6	SENT_293	[p14l1066t2242r1113b2285],
8	vivo	FW	O	vivo	nn	9	SENT_293	[p14l1131t2242r1239b2285],
9	metabolisms	NNS	O	metabolism	pobj	7	SENT_293	[p14l1259t2241r1588b2285],
10	and	CC	O	and	_	0	SENT_293	[p14l1608t2241r1701b2285],
11	pharmacological	JJ	O	pharmacological	amod	12	SENT_293	[p14l1721t2241r2147b2296],
12	effects	NNS	O	effect	dep	6	SENT_293	[p14l138t2308r304b2351],
13	of	IN	O	of	_	0	SENT_293	[p14l322t2308r375b2351],
14	thalidomide	NN	O	thalidomide	prep_of	12	SENT_293	[p14l387t2308r712b2352],
15	.	.	O	.	_	0	SENT_293	[p14l387t2308r712b2352],

1	Cancer	NNP	O	Cancer	nn	3	SENT_294	[p14l731t2310r906b2351],
2	Biol	NNP	O	Biol	nn	3	SENT_294	[p14l923t2308r1018b2351],
3	Ther	NNP	O	Ther	_	0	SENT_294	[p14l1035t2308r1153b2351],
4	2002	CD	DATE	2002	num	3	SENT_294	[p14l1169t2310r1577b2358],
5	;	:	O	;	_	0	SENT_294	[p14l1169t2310r1577b2358],
6	1:669	CD	NUMBER	1:669	number	7	SENT_294	[p14l1169t2310r1577b2358],
7	—	CD	NUMBER	—	dep	3	SENT_294	[p14l1169t2310r1577b2358],
8	73	CD	NUMBER	73	dep	7	SENT_294	[p14l1169t2310r1577b2358],
9	.	.	O	.	_	0	SENT_294	[p14l1169t2310r1577b2358],

1	[	RB	O	[	advmod	2	SENT_295	[p14l7t2374r103b2429],
2	13	CD	NUMBER	13	_	0	SENT_295	[p14l7t2374r103b2429],
3	]	CD	NUMBER	]	num	5	SENT_295	[p14l7t2374r103b2429],
4	Li	NNP	PERSON	Li	nn	5	SENT_295	[p14l138t2375r179b2417],
5	Y	NN	PERSON	y	dep	2	SENT_295	[p14l198t2377r244b2424],
6	,	,	O	,	_	0	SENT_295	[p14l198t2377r244b2424],
7	Hou	NNP	PERSON	Hou	nn	8	SENT_295	[p14l266t2377r370b2418],
8	J	NNP	PERSON	J	appos	5	SENT_295	[p14l385t2377r418b2429],
9	,	,	O	,	_	0	SENT_295	[p14l385t2377r418b2429],
10	Jiang	NNP	PERSON	Jiang	nn	11	SENT_295	[p14l433t2375r566b2429],
11	H	NNP	PERSON	H	appos	5	SENT_295	[p14l586t2377r636b2424],
12	,	,	O	,	_	0	SENT_295	[p14l586t2377r636b2424],
13	Wang	NNP	PERSON	Wang	nn	14	SENT_295	[p14l656t2377r808b2429],
14	D	NNP	PERSON	D	appos	5	SENT_295	[p14l829t2377r878b2424],
15	,	,	O	,	_	0	SENT_295	[p14l829t2377r878b2424],
16	Fu	NNP	O	Fu	nn	17	SENT_295	[p14l900t2377r959b2418],
17	W	NNP	O	W	appos	5	SENT_295	[p14l978t2377r1047b2424],
18	,	,	O	,	_	0	SENT_295	[p14l978t2377r1047b2424],
19	Yuan	NNP	O	Yuan	nn	20	SENT_295	[p14l1067t2377r1198b2418],
20	Z	NNP	O	Z	appos	5	SENT_295	[p14l1218t2377r1259b2424],
21	,	,	O	,	_	0	SENT_295	[p14l1218t2377r1259b2424],
22	et	FW	O	et	nn	23	SENT_295	[p14l1281t2381r1330b2418],
23	al.	FW	O	al.	appos	5	SENT_295	[p14l1350t2374r1404b2418],
24	.	.	O	.	_	0	SENT_295	[p14l1350t2374r1404b2418],

1	Polymorphisms	NNS	O	polymorphism	nsubjpass	6	SENT_296	[p14l1426t2374r1828b2429],
2	of	IN	O	of	_	0	SENT_296	[p14l1850t2374r1904b2418],
3	CYP2C19	NN	O	cyp2c19	nn	4	SENT_296	[p14l1919t2376r2147b2418],
4	gene	NN	O	gene	prep_of	1	SENT_296	[p14l137t2452r258b2494],
5	are	VBP	O	be	auxpass	6	SENT_296	[p14l271t2452r349b2483],
6	associated	VBN	O	associate	_	0	SENT_296	[p14l362t2440r628b2483],
7	with	IN	O	with	_	0	SENT_296	[p14l640t2440r758b2483],
8	the	DT	O	the	det	9	SENT_296	[p14l771t2440r852b2483],
9	efﬁcacy	NN	O	efﬁcacy	prep_with	6	SENT_296	[p14l866t2439r1061b2494],
10	of	IN	O	of	_	0	SENT_296	[p14l1073t2439r1126b2483],
11	thalidomide	NN	O	thalidomide	prep_of	9	SENT_296	[p14l1132t2440r1445b2483],
12	based	VBN	O	base	partmod	11	SENT_296	[p14l1458t2440r1605b2483],
13	regimens	NNS	O	regimen	dobj	12	SENT_296	[p14l1619t2440r1856b2494],
14	in	IN	O	in	_	0	SENT_296	[p14l1870t2440r1917b2483],
15	multiple	JJ	O	multiple	amod	16	SENT_296	[p14l1930t2440r2147b2494],
16	myeloma	NN	O	myeloma	prep_in	13	SENT_296	[p14l138t2506r390b2560],
17	.	.	O	.	_	0	SENT_296	[p14l138t2506r390b2560],

1	Haematologica	NNP	O	Haematologica	_	0	SENT_297	[p14l409t2506r794b2560],
2	2007	CD	DATE	2007	num	1	SENT_297	[p14l811t2508r1252b2556],
3	;	:	O	;	_	0	SENT_297	[p14l811t2508r1252b2556],
4	92:1246	CD	NUMBER	92:1246	number	5	SENT_297	[p14l811t2508r1252b2556],
5	—	CD	NUMBER	—	dep	1	SENT_297	[p14l811t2508r1252b2556],
6	9	CD	NUMBER	9	dep	5	SENT_297	[p14l811t2508r1252b2556],
7	.	.	O	.	_	0	SENT_297	[p14l811t2508r1252b2556],

1	[	RB	O	[	dep	5	SENT_298	[p14l7t2571r103b2626],
2	14	CD	NUMBER	14	num	5	SENT_298	[p14l7t2571r103b2626],
3	]	CD	NUMBER	]	num	5	SENT_298	[p14l7t2571r103b2626],
4	Mileshkin	NNP	O	Mileshkin	nn	5	SENT_298	[p14l138t2572r392b2615],
5	L	NNP	O	L	_	0	SENT_298	[p14l418t2574r454b2622],
6	,	,	O	,	_	0	SENT_298	[p14l418t2574r454b2622],
7	Stark	NNP	O	Stark	nn	8	SENT_298	[p14l480t2572r612b2615],
8	R	NNP	O	R	appos	5	SENT_298	[p14l635t2574r678b2622],
9	,	,	O	,	_	0	SENT_298	[p14l635t2574r678b2622],
10	Day	NNP	DURATION	Day	nn	11	SENT_298	[p14l704t2574r802b2626],
11	B	NNP	O	B	appos	5	SENT_298	[p14l826t2574r868b2622],
12	,	,	O	,	_	0	SENT_298	[p14l826t2574r868b2622],
13	Seymour	NNP	PERSON	Seymour	nn	14	SENT_298	[p14l894t2574r1124b2626],
14	JF	NNP	PERSON	JF	appos	11	SENT_298	[p14l1140t2574r1202b2626],
15	,	,	O	,	_	0	SENT_298	[p14l1140t2574r1202b2626],
16	Zeldis	NNP	O	Zeldis	nn	17	SENT_298	[p14l1226t2572r1377b2615],
17	JB	NNP	O	JB	appos	11	SENT_298	[p14l1396t2574r1462b2626],
18	,	,	O	,	_	0	SENT_298	[p14l1396t2574r1462b2626],
19	Prince	NNP	O	Prince	nn	20	SENT_298	[p14l1489t2572r1647b2615],
20	HM	NNS	O	hm	appos	11	SENT_298	[p14l1672t2574r1776b2616],
21	.	.	O	.	_	0	SENT_298	[p14l1672t2574r1776b2616],

1	Development	NN	O	development	_	0	SENT_299	[p14l1801t2572r2149b2626],
2	of	IN	O	of	_	0	SENT_299	[p14l138t2638r191b2682],
3	neuropathy	NN	O	neuropathy	prep_of	1	SENT_299	[p14l208t2638r508b2692],
4	in	IN	O	in	_	0	SENT_299	[p14l530t2639r577b2681],
5	patients	NNS	O	patient	prep_in	3	SENT_299	[p14l600t2639r806b2692],
6	with	IN	O	with	_	0	SENT_299	[p14l828t2638r947b2682],
7	myeloma	NN	O	myeloma	prep_with	5	SENT_299	[p14l970t2638r1210b2692],
8	treated	VBN	O	treat	partmod	7	SENT_299	[p14l1232t2638r1415b2682],
9	with	IN	O	with	_	0	SENT_299	[p14l1438t2638r1556b2682],
10	thalidomide	NN	O	thalidomide	prep_with	8	SENT_299	[p14l1578t2638r1907b2682],
11	:	:	O	:	_	0	SENT_299	[p14l1578t2638r1907b2682],
12	patterns	NNS	O	pattern	dep	1	SENT_299	[p14l1934t2644r2147b2692],
13	of	IN	O	of	_	0	SENT_299	[p14l138t2703r191b2747],
14	occurrence	NN	O	occurrence	prep_of	12	SENT_299	[p14l218t2716r501b2747],
15	and	CC	O	and	_	0	SENT_299	[p14l533t2703r626b2747],
16	the	DT	O	the	det	17	SENT_299	[p14l659t2704r740b2747],
17	role	NN	O	role	dep	1	SENT_299	[p14l773t2703r871b2747],
18	of	IN	O	of	_	0	SENT_299	[p14l904t2703r957b2747],
19	electrophysiologic	JJ	O	electrophysiologic	amod	20	SENT_299	[p14l983t2703r1456b2758],
20	monitoring	NN	O	monitoring	prep_of	17	SENT_299	[p14l1489t2704r1790b2758],
21	.	.	O	.	_	0	SENT_299	[p14l1489t2704r1790b2758],

1	J	NNP	O	J	nn	3	SENT_300	[p14l1817t2706r1837b2758],
2	Clin	NNP	O	Clin	nn	3	SENT_300	[p14l1870t2703r1969b2747],
3	Oncol	NNP	O	Oncol	_	0	SENT_300	[p14l2001t2703r2147b2747],
4	2006	CD	DATE	2006	num	3	SENT_300	[p14l138t2772r611b2820],
5	;	:	O	;	_	0	SENT_300	[p14l138t2772r611b2820],
6	24:4507	CD	NUMBER	24:4507	number	7	SENT_300	[p14l138t2772r611b2820],
7	—	CD	NUMBER	—	dep	3	SENT_300	[p14l138t2772r611b2820],
8	14	CD	NUMBER	14	dep	7	SENT_300	[p14l138t2772r611b2820],
9	.	.	O	.	_	0	SENT_300	[p14l138t2772r611b2820],

1	[	RB	O	[	dep	5	SENT_301	[p14l6t2836r103b2891],
2	15	CD	NUMBER	15	num	5	SENT_301	[p14l6t2836r103b2891],
3	]	CD	NUMBER	]	num	5	SENT_301	[p14l6t2836r103b2891],
4	Vangsted	NNP	O	Vangsted	nn	5	SENT_301	[p14l136t2836r375b2891],
5	AJ	NNP	O	AJ	_	0	SENT_301	[p14l400t2838r466b2891],
6	,	,	O	,	_	0	SENT_301	[p14l400t2838r466b2891],
7	Soeby	NNP	LOCATION	Soeby	nn	8	SENT_301	[p14l495t2836r647b2891],
8	K	NNP	LOCATION	K	appos	5	SENT_301	[p14l674t2839r718b2887],
9	,	,	O	,	_	0	SENT_301	[p14l674t2839r718b2887],
10	Klausen	NNP	ORGANIZATION	Klausen	nn	11	SENT_301	[p14l747t2836r949b2880],
11	TW	NNP	ORGANIZATION	TW	appos	5	SENT_301	[p14l974t2839r1075b2887],
12	,	,	O	,	_	0	SENT_301	[p14l974t2839r1075b2887],
13	Abildgaard	NNP	ORGANIZATION	Abildgaard	nn	14	SENT_301	[p14l1101t2836r1383b2891],
14	N	NNP	ORGANIZATION	N	appos	5	SENT_301	[p14l1411t2839r1460b2887],
15	,	,	O	,	_	0	SENT_301	[p14l1411t2839r1460b2887],
16	Andersen	NNP	ORGANIZATION	Andersen	nn	17	SENT_301	[p14l1487t2836r1732b2880],
17	NF	NN	ORGANIZATION	nf	appos	5	SENT_301	[p14l1760t2839r1838b2887],
18	,	,	O	,	_	0	SENT_301	[p14l1760t2839r1838b2887],
19	Gimsing	VBG	O	gimse	amod	20	SENT_301	[p14l1867t2837r2080b2891],
20	P	NN	O	p	appos	5	SENT_301	[p14l2107t2839r2147b2886],
21	,	,	O	,	_	0	SENT_301	[p14l2107t2839r2147b2886],
22	et	FW	O	et	nn	23	SENT_301	[p14l138t2908r186b2945],
23	al.	FW	O	al.	appos	20	SENT_301	[p14l202t2902r257b2946],
24	.	.	O	.	_	0	SENT_301	[p14l202t2902r257b2946],

1	No	DT	O	no	det	2	SENT_302	[p14l275t2904r344b2945],
2	inﬂuence	NN	O	inﬂuence	_	0	SENT_302	[p14l362t2901r598b2945],
3	of	IN	O	of	_	0	SENT_302	[p14l615t2901r668b2945],
4	the	DT	O	the	det	6	SENT_302	[p14l679t2902r760b2945],
5	polymorphisms	NNS	O	polymorphism	nn	6	SENT_302	[p14l778t2902r1182b2956],
6	CYP2C19	NN	O	cyp2c19	prep_of	2	SENT_302	[p14l1200t2904r1428b2945],
7	and	CC	O	and	_	0	SENT_302	[p14l1446t2902r1539b2945],
8	CYP2D6	NN	O	cyp2d6	prep_of	2	SENT_302	[p14l1556t2904r1759b2945],
9	on	IN	O	on	_	0	SENT_302	[p14l1776t2914r1839b2945],
10	the	DT	O	the	det	11	SENT_302	[p14l1855t2902r1936b2945],
11	efﬁcacy	NN	O	efﬁcacy	prep_on	2	SENT_302	[p14l1954t2901r2149b2956],
12	of	IN	O	of	_	0	SENT_302	[p14l138t2968r191b3012],
13	cyclophosphamide	NN	O	cyclophosphamide	prep_of	11	SENT_302	[p14l205t2968r702b3022],
14	,	,	O	,	_	0	SENT_302	[p14l205t2968r702b3022],
15	thalidomide	NN	O	thalidomide	prep_of	11	SENT_302	[p14l722t2968r1048b3018],
16	,	,	O	,	_	0	SENT_302	[p14l722t2968r1048b3018],
17	and	CC	O	and	_	0	SENT_302	[p14l1069t2968r1161b3012],
18	bortezomib	NN	O	bortezomib	prep_of	11	SENT_302	[p14l1181t2968r1479b3012],
19	in	IN	O	in	_	0	SENT_302	[p14l1499t2969r1546b3011],
20	patients	NNS	O	patient	prep_in	13	SENT_302	[p14l1566t2969r1772b3022],
21	with	IN	O	with	_	0	SENT_302	[p14l1792t2968r1910b3012],
22	Multiple	JJ	O	multiple	amod	23	SENT_302	[p14l1930t2968r2147b3022],
23	Myeloma	NN	O	myeloma	prep_with	20	SENT_302	[p14l138t3033r390b3088],
24	.	.	O	.	_	0	SENT_302	[p14l138t3033r390b3088],

1	BMC	NNP	O	BMC	nn	2	SENT_303	[p14l409t3036r527b3077],
2	Cancer	NNP	O	Cancer	_	0	SENT_303	[p14l544t3036r719b3077],
3	2010	CD	DATE	2010	num	2	SENT_303	[p14l735t3036r1078b3084],
4	;	:	O	;	_	0	SENT_303	[p14l735t3036r1078b3084],
5	10:404	CD	NUMBER	10:404	dep	2	SENT_303	[p14l735t3036r1078b3084],
6	.	.	O	.	_	0	SENT_303	[p14l735t3036r1078b3084],

1	[	RB	O	[	dep	5	SENT_304	[p14l6t3100r103b3154],
2	16	CD	NUMBER	16	num	5	SENT_304	[p14l6t3100r103b3154],
3	]	CD	NUMBER	]	num	5	SENT_304	[p14l6t3100r103b3154],
4	Johnson	NNP	LOCATION	Johnson	nn	5	SENT_304	[p14l131t3100r344b3154],
5	DC	NNP	LOCATION	DC	_	0	SENT_304	[p14l361t3102r444b3150],
6	,	,	O	,	_	0	SENT_304	[p14l361t3102r444b3150],
7	Corthals	NNP	O	Corthals	nn	8	SENT_304	[p14l463t3100r674b3143],
8	S	NNP	O	S	appos	5	SENT_304	[p14l692t3102r730b3150],
9	,	,	O	,	_	0	SENT_304	[p14l692t3102r730b3150],
10	Ramos	NNP	PERSON	Ramos	nn	11	SENT_304	[p14l749t3103r918b3143],
11	C	NNP	O	C	appos	5	SENT_304	[p14l936t3102r979b3150],
12	,	,	O	,	_	0	SENT_304	[p14l936t3102r979b3150],
13	Hoering	NNP	O	Hoering	nn	14	SENT_304	[p14l997t3101r1203b3154],
14	A	NNP	O	A	appos	11	SENT_304	[p14l1218t3102r1265b3150],
15	,	,	O	,	_	0	SENT_304	[p14l1218t3102r1265b3150],
16	Cocks	NNP	ORGANIZATION	Cocks	nn	17	SENT_304	[p14l1284t3100r1429b3143],
17	K	NNP	ORGANIZATION	K	appos	11	SENT_304	[p14l1448t3103r1492b3150],
18	,	,	O	,	_	0	SENT_304	[p14l1448t3103r1492b3150],
19	Dickens	NNP	ORGANIZATION	Dickens	nn	20	SENT_304	[p14l1511t3100r1711b3143],
20	NJ	NNP	ORGANIZATION	NJ	appos	11	SENT_304	[p14l1730t3103r1797b3154],
21	,	,	O	,	_	0	SENT_304	[p14l1730t3103r1797b3154],
22	et	FW	O	et	nn	23	SENT_304	[p14l1816t3106r1864b3143],
23	al.	FW	O	al.	appos	11	SENT_304	[p14l1880t3100r1935b3144],
24	.	.	O	.	_	0	SENT_304	[p14l1880t3100r1935b3144],

1	Genetic	JJ	O	genetic	amod	2	SENT_305	[p14l1953t3101r2148b3143],
2	associations	NNS	O	association	nsubj	5	SENT_305	[p14l138t3167r448b3210],
3	with	IN	O	with	_	0	SENT_305	[p14l460t3166r578b3210],
4	thalidomide	NN	O	thalidomide	prep_with	2	SENT_305	[p14l591t3166r903b3210],
5	mediated	VBD	O	mediate	_	0	SENT_305	[p14l917t3166r1159b3210],
6	venous	JJ	O	venous	amod	8	SENT_305	[p14l1171t3179r1353b3210],
7	thrombotic	JJ	O	thrombotic	amod	8	SENT_305	[p14l1366t3166r1656b3210],
8	events	NNS	O	event	dobj	5	SENT_305	[p14l1668t3173r1834b3210],
9	in	IN	O	in	_	0	SENT_305	[p14l1848t3167r1896b3209],
10	myeloma	NN	O	myeloma	prep_in	5	SENT_305	[p14l1909t3166r2148b3221],
11	identiﬁed	VBN	O	identiﬁed	partmod	10	SENT_305	[p14l138t3231r385b3275],
12	using	VBG	O	use	xcomp	11	SENT_305	[p14l403t3232r541b3286],
13	targeted	VBN	O	target	dep	12	SENT_305	[p14l558t3232r772b3286],
14	genotyping	NN	O	genotyping	dobj	13	SENT_305	[p14l789t3232r1093b3286],
15	.	.	O	.	_	0	SENT_305	[p14l789t3232r1093b3286],

1	Blood	NN	O	blood	_	0	SENT_306	[p14l1112t3232r1256b3275],
2	2008	CD	DATE	2008	num	1	SENT_306	[p14l1275t3234r1780b3282],
3	;	:	O	;	_	0	SENT_306	[p14l1275t3234r1780b3282],
4	112:4924	CD	NUMBER	112:4924	number	5	SENT_306	[p14l1275t3234r1780b3282],
5	—	CD	NUMBER	—	dep	1	SENT_306	[p14l1275t3234r1780b3282],
6	34	CD	NUMBER	34	dep	5	SENT_306	[p14l1275t3234r1780b3282],
7	.	.	O	.	_	0	SENT_306	[p14l1275t3234r1780b3282],

1	[	NN	O	[	_	0	SENT_307	[p14l7t3298r103b3353],
2	17	CD	NUMBER	17	num	1	SENT_307	[p14l7t3298r103b3353],
3	]	CD	NUMBER	]	num	5	SENT_307	[p14l7t3298r103b3353],
4	Barlogie	NN	PERSON	barlogie	nn	5	SENT_307	[p14l138t3298r346b3353],
5	B	NN	PERSON	b	dep	1	SENT_307	[p14l381t3301r423b3349],
6	,	,	O	,	_	0	SENT_307	[p14l381t3301r423b3349],
7	Desikan	NN	PERSON	desikan	nn	8	SENT_307	[p14l458t3298r661b3342],
8	R	NN	PERSON	r	appos	5	SENT_307	[p14l695t3301r739b3348],
9	,	,	O	,	_	0	SENT_307	[p14l695t3301r739b3348],
10	Eddlemon	NNP	ORGANIZATION	Eddlemon	nn	11	SENT_307	[p14l773t3298r1034b3342],
11	P	NN	ORGANIZATION	p	appos	5	SENT_307	[p14l1068t3301r1108b3348],
12	,	,	O	,	_	0	SENT_307	[p14l1068t3301r1108b3348],
13	Spencer	NNP	PERSON	Spencer	nn	14	SENT_307	[p14l1143t3300r1348b3353],
14	T	NN	PERSON	t	appos	5	SENT_307	[p14l1377t3301r1420b3349],
15	,	,	O	,	_	0	SENT_307	[p14l1377t3301r1420b3349],
16	Zeldis	NNP	ORGANIZATION	Zeldis	nn	17	SENT_307	[p14l1454t3298r1604b3342],
17	J	NNP	ORGANIZATION	J	appos	5	SENT_307	[p14l1632t3301r1665b3353],
18	,	,	O	,	_	0	SENT_307	[p14l1632t3301r1665b3353],
19	Munshi	NNP	PERSON	Munshi	nn	20	SENT_307	[p14l1700t3298r1892b3342],
20	N	NNP	O	N	appos	5	SENT_307	[p14l1927t3301r1977b3349],
21	,	,	O	,	_	0	SENT_307	[p14l1927t3301r1977b3349],
22	et	FW	O	et	nn	23	SENT_307	[p14l2012t3305r2060b3342],
23	al.	FW	O	al.	appos	5	SENT_307	[p14l2092t3298r2147b3342],
24	.	.	O	.	_	0	SENT_307	[p14l2092t3298r2147b3342],

1	Extended	JJ	O	extended	amod	2	SENT_308	[p14l138t3364r379b3407],
2	survival	NN	O	survival	_	0	SENT_308	[p14l400t3364r601b3407],
3	in	IN	O	in	_	0	SENT_308	[p14l622t3364r669b3407],
4	advanced	JJ	O	advanced	amod	8	SENT_308	[p14l689t3364r932b3407],
5	and	CC	O	and	_	0	SENT_308	[p14l952t3364r1045b3407],
6	refractory	JJ	O	refractory	amod	8	SENT_308	[p14l1066t3363r1321b3418],
7	multiple	JJ	O	multiple	amod	8	SENT_308	[p14l1340t3364r1557b3418],
8	myeloma	NN	O	myeloma	prep_in	2	SENT_308	[p14l1578t3364r1817b3418],
9	after	IN	O	after	_	0	SENT_308	[p14l1837t3363r1957b3407],
10	singleagent	JJ	O	singleagent	amod	11	SENT_308	[p14l1975t3364r2147b3418, p14l138t3436r280b3484],
11	thalidomide	NN	O	thalidomide	prep_after	8	SENT_308	[p14l292t3430r621b3474],
12	:	:	O	:	_	0	SENT_308	[p14l292t3430r621b3474],
13	identiﬁcation	NN	O	identiﬁcation	dep	2	SENT_308	[p14l640t3430r984b3474],
14	of	IN	O	of	_	0	SENT_308	[p14l998t3430r1051b3474],
15	prognostic	JJ	O	prognostic	amod	16	SENT_308	[p14l1059t3431r1332b3484],
16	factors	NNS	O	factor	prep_of	13	SENT_308	[p14l1345t3430r1517b3474],
17	in	IN	O	in	_	0	SENT_308	[p14l1532t3431r1580b3473],
18	a	DT	O	a	det	21	SENT_308	[p14l1593t3443r1619b3474],
19	phase	NN	O	phase	nn	21	SENT_308	[p14l1633t3430r1780b3484],
20	2	CD	NUMBER	2	num	21	SENT_308	[p14l1795t3432r1822b3473],
21	study	NN	O	study	prep_in	16	SENT_308	[p14l1838t3430r1980b3484],
22	of	IN	O	of	_	0	SENT_308	[p14l1993t3430r2046b3474],
23	1	CD	NUMBER	1	number	24	SENT_308	[p14l2056t3432r2076b3473],
24	69	CD	NUMBER	69	num	25	SENT_308	[p14l2086t3432r2147b3474],
25	patients	NNS	O	patient	prep_of	21	SENT_308	[p14l138t3496r358b3550],
26	.	.	O	.	_	0	SENT_308	[p14l138t3496r358b3550],

1	Blood	NN	O	blood	_	0	SENT_309	[p14l377t3495r521b3539],
2	2001	CD	DATE	2001	num	1	SENT_309	[p14l539t3498r659b3539],
3	;	:	O	;	_	0	SENT_309	[p14l674t3498r947b3546],
4	98:492	CD	NUMBER	98:492	number	5	SENT_309	[p14l674t3498r947b3546],
5	—	CD	NUMBER	—	dep	1	SENT_309	[p14l674t3498r947b3546],
6	4	CD	NUMBER	4	dep	5	SENT_309	[p14l674t3498r947b3546],
7	.	.	O	.	_	0	SENT_309	[p14l674t3498r947b3546],

1	[	NN	O	[	nn	5	SENT_310	[p14l6t3562r103b3616],
2	18	CD	NUMBER	18	num	5	SENT_310	[p14l6t3562r103b3616],
3	]	CD	NUMBER	]	num	5	SENT_310	[p14l6t3562r103b3616],
4	Cibeira	NNP	O	Cibeira	nn	5	SENT_310	[p14l138t3562r317b3605],
5	MT	NNP	O	MT	nsubj	22	SENT_310	[p14l342t3564r435b3612],
6	,	,	O	,	_	0	SENT_310	[p14l342t3564r435b3612],
7	Rosiﬁol	NNP	ORGANIZATION	Rosiﬁol	nn	8	SENT_310	[p14l461t3562r649b3605],
8	L	NNP	ORGANIZATION	L	appos	5	SENT_310	[p14l675t3565r711b3612],
9	,	,	O	,	_	0	SENT_310	[p14l675t3565r711b3612],
10	Ramiro	NNP	PERSON	Ramiro	nn	11	SENT_310	[p14l738t3563r922b3605],
11	L	NNP	PERSON	L	appos	5	SENT_310	[p14l948t3565r984b3612],
12	,	,	O	,	_	0	SENT_310	[p14l948t3565r984b3612],
13	Esteve	NNP	PERSON	Esteve	nn	14	SENT_310	[p14l1011t3565r1174b3605],
14	J	NNP	PERSON	J	appos	5	SENT_310	[p14l1193t3565r1226b3616],
15	,	,	O	,	_	0	SENT_310	[p14l1193t3565r1226b3616],
16	Torrebadell	NNP	O	Torrebadell	nn	17	SENT_310	[p14l1250t3562r1546b3605],
17	M	NNP	O	M	appos	5	SENT_310	[p14l1573t3565r1634b3612],
18	,	,	O	,	_	0	SENT_310	[p14l1573t3565r1634b3612],
19	Bladé	NNP	O	Bladé	nn	20	SENT_310	[p14l1660t3561r1799b3605],
20	J.	NNP	O	J.	appos	5	SENT_310	[p14l1818t3565r1851b3616],
21	Long-term	JJ	O	long-term	amod	22	SENT_310	[p14l1877t3565r2148b3616],
22	results	NNS	O	result	_	0	SENT_310	[p14l138t3628r308b3672],
23	of	IN	O	of	_	0	SENT_310	[p14l342t3628r395b3672],
24	thalidomide	NN	O	thalidomide	prep_of	22	SENT_310	[p14l421t3628r734b3672],
25	in	IN	O	in	_	0	SENT_310	[p14l767t3629r814b3671],
26	refractory	JJ	O	refractory	prep_in	22	SENT_310	[p14l846t3628r1102b3683],
27	and	CC	O	and	_	0	SENT_310	[p14l1133t3628r1226b3672],
28	relapsed	VBD	O	relapse	conj_and	22	SENT_310	[p14l1259t3628r1476b3683],
29	multiple	JJ	O	multiple	amod	30	SENT_310	[p14l1509t3628r1726b3683],
30	myeloma	NN	O	myeloma	dobj	28	SENT_310	[p14l1759t3628r1999b3683],
31	with	IN	O	with	_	0	SENT_310	[p14l2030t3628r2148b3672],
32	emphasis	NN	O	emphasis	prep_with	28	SENT_310	[p14l138t3694r380b3748],
33	on	IN	O	on	_	0	SENT_310	[p14l399t3706r461b3737],
34	response	NN	O	response	nn	35	SENT_310	[p14l479t3706r708b3748],
35	duration	NN	O	duration	prep_on	28	SENT_310	[p14l726t3694r959b3738],
36	.	.	O	.	_	0	SENT_310	[p14l726t3694r959b3738],

1	Eur	NNP	MISC	Eur	nn	3	SENT_311	[p14l978t3696r1094b3748],
2	]	NNP	O	]	nn	3	SENT_311	[p14l978t3696r1094b3748],
3	Haematol	NNP	O	Haematol	_	0	SENT_311	[p14l1113t3694r1361b3737],
4	2006	CD	DATE	2006	num	3	SENT_311	[p14l1379t3696r1819b3744],
5	;	:	O	;	_	0	SENT_311	[p14l1379t3696r1819b3744],
6	77:486	CD	NUMBER	77:486	number	7	SENT_311	[p14l1379t3696r1819b3744],
7	—	CD	NUMBER	—	dep	3	SENT_311	[p14l1379t3696r1819b3744],
8	92	CD	NUMBER	92	dep	7	SENT_311	[p14l1379t3696r1819b3744],
9	.	.	O	.	_	0	SENT_311	[p14l1379t3696r1819b3744],

1	[	NN	O	[	nn	4	SENT_312	[p14l6t3760r103b3814],
2	19	CD	NUMBER	19	num	4	SENT_312	[p14l6t3760r103b3814],
3	]	NN	O	]	nn	4	SENT_312	[p14l6t3760r103b3814],
4	Rosiﬁol	NN	ORGANIZATION	rosiﬁol	_	0	SENT_312	[p14l138t3760r326b3804],
5	L	NN	ORGANIZATION	l	dep	4	SENT_312	[p14l363t3763r399b3810],
6	,	,	O	,	_	0	SENT_312	[p14l363t3763r399b3810],
7	Cibeira	NNP	O	Cibeira	nn	8	SENT_312	[p14l437t3760r615b3804],
8	MT	NNP	O	MT	appos	5	SENT_312	[p14l652t3763r744b3810],
9	,	,	O	,	_	0	SENT_312	[p14l652t3763r744b3810],
10	Bladé	NNP	PERSON	Bladé	nn	11	SENT_312	[p14l782t3759r921b3804],
11	J	NNP	PERSON	J	appos	5	SENT_312	[p14l951t3763r984b3814],
12	,	,	O	,	_	0	SENT_312	[p14l951t3763r984b3814],
13	Esteve	NNP	PERSON	Esteve	nn	14	SENT_312	[p14l1021t3763r1185b3804],
14	J	NNP	PERSON	J	appos	5	SENT_312	[p14l1215t3763r1248b3814],
15	,	,	O	,	_	0	SENT_312	[p14l1215t3763r1248b3814],
16	Aymerich	NNP	PERSON	Aymerich	nn	17	SENT_312	[p14l1282t3760r1533b3814],
17	M	NNP	O	M	appos	5	SENT_312	[p14l1569t3763r1630b3810],
18	,	,	O	,	_	0	SENT_312	[p14l1569t3763r1630b3810],
19	Rozman	NNP	PERSON	Rozman	nn	20	SENT_312	[p14l1667t3763r1874b3804],
20	M	NNP	O	M	appos	5	SENT_312	[p14l1911t3763r1972b3810],
21	,	,	O	,	_	0	SENT_312	[p14l1911t3763r1972b3810],
22	et	FW	O	et	nn	23	SENT_312	[p14l2009t3766r2057b3804],
23	al.	FW	O	al.	appos	5	SENT_312	[p14l2092t3760r2147b3804],
24	.	.	O	.	_	0	SENT_312	[p14l2092t3760r2147b3804],

1	Extramedullary	JJ	O	extramedullary	amod	3	SENT_313	[p15l138t12r539b67],
2	multiple	JJ	O	multiple	amod	3	SENT_313	[p15l558t12r775b67],
3	myeloma	NN	O	myeloma	nsubj	4	SENT_313	[p15l795t13r1035b67],
4	escapes	VBZ	O	escape	_	0	SENT_313	[p15l1055t25r1250b67],
5	the	DT	O	the	det	6	SENT_313	[p15l1270t12r1351b56],
6	effect	NN	O	effect	dobj	4	SENT_313	[p15l1372t12r1514b56],
7	of	IN	O	of	_	0	SENT_313	[p15l1533t12r1586b56],
8	thalidomide	NN	O	thalidomide	prep_of	6	SENT_313	[p15l1599t12r1925b56],
9	.	.	O	.	_	0	SENT_313	[p15l1599t12r1925b56],

1	Haematologica	NNP	O	Haematologica	_	0	SENT_314	[p15l1946t15r2147b56, p15l137t79r340b133],
2	2004	CD	DATE	2004	num	1	SENT_314	[p15l358t81r765b129],
3	;	:	O	;	_	0	SENT_314	[p15l358t81r765b129],
4	89:832	CD	NUMBER	89:832	number	5	SENT_314	[p15l358t81r765b129],
5	—	CD	NUMBER	—	dep	1	SENT_314	[p15l358t81r765b129],
6	6	CD	NUMBER	6	dep	5	SENT_314	[p15l358t81r765b129],
7	.	.	O	.	_	0	SENT_314	[p15l358t81r765b129],

1	[	RB	O	[	advmod	3	SENT_315	[p15l7t145r103b200],
2	20	CD	NUMBER	20	number	3	SENT_315	[p15l7t145r103b200],
3	]	CD	NUMBER	]	_	0	SENT_315	[p15l7t145r103b200],
4	Martin	NNP	ORGANIZATION	Martin	nn	5	SENT_315	[p15l138t146r312b189],
5	LP	NN	ORGANIZATION	lp	dep	3	SENT_315	[p15l327t148r395b196],
6	,	,	O	,	_	0	SENT_315	[p15l327t148r395b196],
7	Hamilton	NNP	ORGANIZATION	Hamilton	nn	8	SENT_315	[p15l411t145r652b189],
8	TC	NNP	ORGANIZATION	TC	appos	3	SENT_315	[p15l664t147r740b195],
9	,	,	O	,	_	0	SENT_315	[p15l664t147r740b195],
10	Schilder	NNP	PERSON	Schilder	nn	12	SENT_315	[p15l756t145r965b189],
11	R	NNP	O	R	nn	12	SENT_315	[p15l979t148r1039b200],
12	]	NN	O	]	appos	8	SENT_315	[p15l979t148r1039b200],
13	.	.	O	.	_	0	SENT_315	[p15l979t148r1039b200],

1	Platinum	NN	O	platinum	nn	2	SENT_316	[p15l1055t145r1288b189],
2	resistance	NN	O	resistance	_	0	SENT_316	[p15l1303t146r1576b189],
3	:	:	O	:	_	0	SENT_316	[p15l1303t146r1576b189],
4	the	DT	O	the	det	5	SENT_316	[p15l1594t145r1676b189],
5	role	NN	O	role	dep	2	SENT_316	[p15l1691t145r1788b189],
6	of	IN	O	of	_	0	SENT_316	[p15l1803t145r1857b189],
7	DNA	NN	O	dna	nn	9	SENT_316	[p15l1866t147r1983b188],
8	repair	NN	O	repair	nn	9	SENT_316	[p15l1996t146r2149b200],
9	pathways	NNS	O	pathway	prep_of	5	SENT_316	[p15l138t211r399b265],
10	.	.	O	.	_	0	SENT_316	[p15l138t211r399b265],

1	Clin	NNP	O	Clin	nn	3	SENT_317	[p15l418t211r516b254],
2	Cancer	NNP	O	Cancer	nn	3	SENT_317	[p15l534t213r709b254],
3	Res	NNP	O	Res	_	0	SENT_317	[p15l725t213r810b254],
4	2008	CD	DATE	2008	num	3	SENT_317	[p15l829t213r1269b261],
5	;	:	O	;	_	0	SENT_317	[p15l829t213r1269b261],
6	14:1291	CD	NUMBER	14:1291	number	7	SENT_317	[p15l829t213r1269b261],
7	—	CD	NUMBER	—	dep	3	SENT_317	[p15l829t213r1269b261],
8	5	CD	NUMBER	5	dep	7	SENT_317	[p15l829t213r1269b261],
9	.	.	O	.	_	0	SENT_317	[p15l829t213r1269b261],

1	[	NN	O	[	nn	5	SENT_318	[p15l7t277r103b332],
2	21	CD	NUMBER	21	num	5	SENT_318	[p15l7t277r103b332],
3	]	CD	NUMBER	]	num	5	SENT_318	[p15l7t277r103b332],
4	Thacker	NNP	PERSON	Thacker	nn	5	SENT_318	[p15l136t277r342b321],
5	]	NNP	O	]	_	0	SENT_318	[p15l357t280r390b332],
6	,	,	O	,	_	0	SENT_318	[p15l357t280r390b332],
7	Zdzienicka	NNP	O	Zdzienicka	appos	5	SENT_318	[p15l414t277r691b321],
8	MZ	JJ	O	mz	dep	7	SENT_318	[p15l715t280r807b321],
9	.	.	O	.	_	0	SENT_318	[p15l715t280r807b321],

1	The	DT	O	the	det	3	SENT_319	[p15l830t277r924b321],
2	XRCC	NN	O	xrcc	nn	3	SENT_319	[p15l946t279r1085b321],
3	genes	NNS	O	gene	_	0	SENT_319	[p15l1108t290r1270b332],
4	:	:	O	:	_	0	SENT_319	[p15l1108t290r1270b332],
5	expanding	VBG	O	expand	dep	3	SENT_319	[p15l1298t277r1569b332],
6	roles	NNS	O	role	dobj	5	SENT_319	[p15l1592t277r1714b321],
7	in	IN	O	in	_	0	SENT_319	[p15l1739t278r1787b320],
8	DNA	NN	O	dna	nn	9	SENT_319	[p15l1810t279r1928b321],
9	doublestrand	NN	O	doublestrand	prep_in	5	SENT_319	[p15l1950t277r2147b321, p15l139t343r300b386],

1	break	NN	O	break	_	0	SENT_320	[p15l318t343r462b386],
2	repair	NN	O	repair	dep	1	SENT_320	[p15l479t343r643b397],
3	.	.	O	.	_	0	SENT_320	[p15l479t343r643b397],

1	DNA	NN	MISC	dna	nn	2	SENT_321	[p15l663t345r780b386],
2	Repair	NN	MISC	repair	_	0	SENT_321	[p15l796t343r961b397],
3	2004	CD	DATE	2004	dep	2	SENT_321	[p15l978t345r1300b393],
4	;	:	O	;	_	0	SENT_321	[p15l978t345r1300b393],
5	3:1081	CD	NUMBER	3:1081	num	6	SENT_321	[p15l978t345r1300b393],
6	-90	CD	NUMBER	-90	dep	2	SENT_321	[p15l1312t345r1417b387],
7	.	.	O	.	_	0	SENT_321	[p15l1312t345r1417b387],

1	[	NN	O	[	nn	4	SENT_322	[p15l6t409r103b463],
2	22	CD	NUMBER	22	num	4	SENT_322	[p15l6t409r103b463],
3	]	NN	O	]	nn	4	SENT_322	[p15l6t409r103b463],
4	Monzo	NN	O	monzo	_	0	SENT_322	[p15l138t412r313b453],
5	M	NN	O	m	dep	4	SENT_322	[p15l351t412r412b459],
6	,	,	O	,	_	0	SENT_322	[p15l351t412r412b459],
7	Moreno	NNP	PERSON	Moreno	nn	11	SENT_322	[p15l450t412r650b453],
8	I	PRP	O	I	dep	11	SENT_322	[p15l688t412r714b459],
9	,	,	O	,	_	0	SENT_322	[p15l688t412r714b459],
10	Navarro	NNP	PERSON	Navarro	dep	11	SENT_322	[p15l753t412r957b453],
11	A	NNP	O	A	appos	5	SENT_322	[p15l993t411r1041b459],
12	,	,	O	,	_	0	SENT_322	[p15l993t411r1041b459],
13	Ibeas	NNP	O	Ibeas	nn	14	SENT_322	[p15l1080t409r1209b453],
14	R	NNP	O	R	appos	5	SENT_322	[p15l1247t412r1291b459],
15	,	,	O	,	_	0	SENT_322	[p15l1247t412r1291b459],
16	Artells	NNP	O	Artells	nn	17	SENT_322	[p15l1327t409r1495b453],
17	R	NNP	O	R	appos	5	SENT_322	[p15l1533t412r1577b459],
18	,	,	O	,	_	0	SENT_322	[p15l1533t412r1577b459],
19	Gel	NN	O	gel	nn	20	SENT_322	[p15l1615t409r1697b453],
20	B	NN	O	b	appos	5	SENT_322	[p15l1735t412r1777b459],
21	,	,	O	,	_	0	SENT_322	[p15l1735t412r1777b459],
22	et	FW	O	et	nn	23	SENT_322	[p15l1816t415r1864b453],
23	al.	FW	O	al.	appos	5	SENT_322	[p15l1900t409r1955b453],
24	.	.	O	.	_	0	SENT_322	[p15l1900t409r1955b453],

1	Single	JJ	O	single	amod	3	SENT_323	[p15l1994t409r2147b463],
2	nucleotide	NN	O	nucleotide	nn	3	SENT_323	[p15l138t474r409b518],
3	polymorphisms	NNS	O	polymorphism	nsubj	21	SENT_323	[p15l428t474r832b529],
4	in	IN	O	in	_	0	SENT_323	[p15l852t475r899b518],
5	nucleotide	NN	O	nucleotide	nn	8	SENT_323	[p15l917t474r1188b518],
6	excision	NN	O	excision	nn	8	SENT_323	[p15l1207t475r1417b518],
7	repair	NN	O	repair	nn	8	SENT_323	[p15l1435t475r1589b529],
8	genes	NNS	O	gene	prep_in	3	SENT_323	[p15l1604t487r1750b529],
9	XPA	NNP	O	XPA	dep	8	SENT_323	[p15l1768t476r1885b525],
10	,	,	O	,	_	0	SENT_323	[p15l1768t476r1885b525],
11	XPD	NNP	O	XPD	dep	8	SENT_323	[p15l1902t477r2023b525],
12	,	,	O	,	_	0	SENT_323	[p15l1902t477r2023b525],
13	XPG	NNP	O	XPG	dep	8	SENT_323	[p15l2040t477r2148b518],
14	and	CC	O	and	_	0	SENT_323	[p15l138t541r231b584],
15	ERCC1	NNP	O	ERCC1	dep	8	SENT_323	[p15l248t543r405b584],
16	in	IN	O	in	_	0	SENT_323	[p15l429t542r476b584],
17	advanced	JJ	O	advanced	amod	18	SENT_323	[p15l493t541r736b584],
18	colorectal	JJ	O	colorectal	amod	20	SENT_323	[p15l753t541r1004b584],
19	cancer	NN	O	cancer	nn	20	SENT_323	[p15l1022t553r1190b584],
20	patients	NNS	O	patient	prep_in	8	SENT_323	[p15l1205t542r1411b595],
21	treated	VBN	O	treat	_	0	SENT_323	[p15l1428t541r1612b584],
22	with	IN	O	with	_	0	SENT_323	[p15l1628t541r1747b584],
23	ﬁrst	NN	O	ﬁrst	nn	26	SENT_323	[p15l1763t541r1985b584],
24	—	CD	NUMBER	—	num	26	SENT_323	[p15l1763t541r1985b584],
25	line	NN	O	line	nn	26	SENT_323	[p15l1763t541r1985b584],
26	oxaliplatin	NN	O	oxaliplatin	prep_with	21	SENT_323	[p15l2002t541r2147b584, p15l138t607r763b662],
27	/	:	O	/	punct	28	SENT_323	[p15l2002t541r2147b584, p15l138t607r763b662],
28	ﬂuoropyrimidine	NN	O	ﬂuoropyrimidine	dep	26	SENT_323	[p15l2002t541r2147b584, p15l138t607r763b662],
29	.	.	O	.	_	0	SENT_323	[p15l2002t541r2147b584, p15l138t607r763b662],

1	Oncology	NNP	O	Oncology	_	0	SENT_324	[p15l782t607r1024b662],
2	2007	CD	DATE	2007	num	1	SENT_324	[p15l1040t609r1481b658],
3	;	:	O	;	_	0	SENT_324	[p15l1040t609r1481b658],
4	72:364	CD	NUMBER	72:364	number	5	SENT_324	[p15l1040t609r1481b658],
5	—	CD	NUMBER	—	dep	1	SENT_324	[p15l1040t609r1481b658],
6	70	CD	NUMBER	70	dep	5	SENT_324	[p15l1040t609r1481b658],
7	.	.	O	.	_	0	SENT_324	[p15l1040t609r1481b658],

1	[	NN	O	[	nn	5	SENT_325	[p15l6t672r103b727],
2	23	CD	NUMBER	23	num	5	SENT_325	[p15l6t672r103b727],
3	]	CD	NUMBER	]	num	5	SENT_325	[p15l6t672r103b727],
4	Guillem	NNP	O	Guillem	nn	5	SENT_325	[p15l138t673r341b716],
5	VM	NNP	O	VM	_	0	SENT_325	[p15l361t675r462b723],
6	,	,	O	,	_	0	SENT_325	[p15l361t675r462b723],
7	Cervantes	NNP	PERSON	Cervantes	nn	8	SENT_325	[p15l485t675r737b716],
8	F	NN	PERSON	f	appos	5	SENT_325	[p15l761t675r797b723],
9	,	,	O	,	_	0	SENT_325	[p15l761t675r797b723],
10	Martinez	NNP	PERSON	Martinez	nn	11	SENT_325	[p15l821t671r1101b727],
11	]	NNP	O	]	appos	8	SENT_325	[p15l821t671r1101b727],
12	,	,	O	,	_	0	SENT_325	[p15l821t671r1101b727],
13	Alvarez-Larran	NNP	O	Alvarez-Larran	nn	14	SENT_325	[p15l1122t671r1506b716],
14	A	NNP	O	A	appos	8	SENT_325	[p15l1526t674r1574b723],
15	,	,	O	,	_	0	SENT_325	[p15l1526t674r1574b723],
16	Collado	NNP	PERSON	Collado	nn	17	SENT_325	[p15l1597t673r1787b716],
17	M	NNP	O	M	appos	8	SENT_325	[p15l1810t675r1871b723],
18	,	,	O	,	_	0	SENT_325	[p15l1810t675r1871b723],
19	Camos	NNP	O	Camos	nn	20	SENT_325	[p15l1894t671r2062b716],
20	M	NNP	O	M	appos	8	SENT_325	[p15l2086t675r2147b723],
21	,	,	O	,	_	0	SENT_325	[p15l2086t675r2147b723],
22	et	FW	O	et	nn	23	SENT_325	[p15l138t745r186b783],
23	al.	FW	O	al.	appos	8	SENT_325	[p15l199t739r253b783],
24	.	.	O	.	_	0	SENT_325	[p15l199t739r253b783],

1	XPC	NN	O	xpc	nn	3	SENT_326	[p15l266t741r369b783],
2	genetic	JJ	O	genetic	amod	3	SENT_326	[p15l381t740r568b793],
3	polymorphisms	NNS	O	polymorphism	nsubj	4	SENT_326	[p15l581t739r985b793],
4	correlate	VBP	O	correlate	_	0	SENT_326	[p15l1000t739r1228b783],
5	with	IN	O	with	_	0	SENT_326	[p15l1240t739r1359b783],
6	the	DT	O	the	det	7	SENT_326	[p15l1372t739r1453b783],
7	response	NN	O	response	prep_with	4	SENT_326	[p15l1468t752r1696b793],
8	to	TO	O	to	_	0	SENT_326	[p15l1710t745r1760b783],
9	imatinib	NN	O	imatinib	nn	10	SENT_326	[p15l1774t739r1990b783],
10	treatment	NN	O	treatment	prep_to	4	SENT_326	[p15l2004t745r2147b783, p15l138t811r273b848],
11	in	IN	O	in	_	0	SENT_326	[p15l290t805r337b848],
12	patients	NNS	O	patient	prep_in	10	SENT_326	[p15l355t805r561b859],
13	with	IN	O	with	_	0	SENT_326	[p15l578t805r697b848],
14	chronic	JJ	O	chronic	amod	15	SENT_326	[p15l715t804r906b848],
15	phase	NN	O	phase	prep_with	12	SENT_326	[p15l924t805r1072b859],
16	chronic	JJ	O	chronic	amod	18	SENT_326	[p15l1090t804r1281b848],
17	myeloid	JJ	O	myeloid	amod	18	SENT_326	[p15l1299t804r1507b859],
18	leukemia	NN	O	leukemia	dep	15	SENT_326	[p15l1525t805r1774b848],
19	.	.	O	.	_	0	SENT_326	[p15l1525t805r1774b848],

1	Am	VBP	O	be	cop	2	SENT_327	[p15l1790t806r1910b859],
2	]	CD	NUMBER	]	_	0	SENT_327	[p15l1790t806r1910b859],
3	Hematol	JJ	O	hematol	amod	4	SENT_327	[p15l1929t804r2147b848],
4	2010	CD	DATE	2010	dep	2	SENT_327	[p15l138t873r546b921],
5	;	:	O	;	_	0	SENT_327	[p15l138t873r546b921],
6	85:482	CD	NUMBER	85:482	number	7	SENT_327	[p15l138t873r546b921],
7	—	CD	NUMBER	—	dep	2	SENT_327	[p15l138t873r546b921],
8	6	CD	NUMBER	6	dep	7	SENT_327	[p15l138t873r546b921],
9	.	.	O	.	_	0	SENT_327	[p15l138t873r546b921],

1	[	NN	O	[	nn	5	SENT_328	[p15l7t937r103b992],
2	24	CD	NUMBER	24	num	5	SENT_328	[p15l7t937r103b992],
3	]	CD	NUMBER	]	num	5	SENT_328	[p15l7t937r103b992],
4	Vangsted	NNP	O	Vangsted	nn	5	SENT_328	[p15l136t937r375b992],
5	A	NNP	O	A	_	0	SENT_328	[p15l400t939r448b987],
6	,	,	O	,	_	0	SENT_328	[p15l400t939r448b987],
7	Gimsing	NNP	PERSON	Gimsing	nn	8	SENT_328	[p15l476t938r689b992],
8	P	NN	PERSON	p	appos	5	SENT_328	[p15l716t940r756b988],
9	,	,	O	,	_	0	SENT_328	[p15l716t940r756b988],
10	Klausen	NNP	ORGANIZATION	Klausen	nn	11	SENT_328	[p15l784t937r986b981],
11	TW	NNP	ORGANIZATION	TW	appos	8	SENT_328	[p15l1010t940r1111b987],
12	,	,	O	,	_	0	SENT_328	[p15l1010t940r1111b987],
13	Nexo	NNP	O	Nexo	nn	14	SENT_328	[p15l1140t940r1270b982],
14	BA	NN	O	ba	appos	8	SENT_328	[p15l1297t939r1377b987],
15	,	,	O	,	_	0	SENT_328	[p15l1297t939r1377b987],
16	Wallin	NNP	PERSON	Wallin	nn	17	SENT_328	[p15l1403t937r1575b981],
17	H	NNP	O	H	appos	8	SENT_328	[p15l1602t940r1652b988],
18	,	,	O	,	_	0	SENT_328	[p15l1602t940r1652b988],
19	Andersen	NNP	PERSON	Andersen	nn	20	SENT_328	[p15l1678t937r1923b981],
20	P	NN	O	p	appos	8	SENT_328	[p15l1950t940r1990b987],
21	,	,	O	,	_	0	SENT_328	[p15l1950t940r1990b987],
22	et	FW	O	et	nn	23	SENT_328	[p15l2018t944r2066b981],
23	al.	FW	O	al.	appos	8	SENT_328	[p15l2092t937r2147b981],
24	.	.	O	.	_	0	SENT_328	[p15l2092t937r2147b981],

1	Polymorphisms	NNS	O	polymorphism	_	0	SENT_329	[p15l138t1003r540b1057],
2	in	IN	O	in	_	0	SENT_329	[p15l563t1004r610b1046],
3	the	DT	O	the	det	5	SENT_329	[p15l631t1003r712b1046],
4	genes	NNS	O	gene	nn	5	SENT_329	[p15l733t1015r879b1057],
5	ERCC2	NN	O	ercc2	prep_in	1	SENT_329	[p15l902t1005r1077b1053],
6	,	,	O	,	_	0	SENT_329	[p15l902t1005r1077b1053],
7	XRCC3	NN	O	xrcc3	prep_in	1	SENT_329	[p15l1098t1005r1267b1046],
8	and	CC	O	and	_	0	SENT_329	[p15l1290t1003r1384b1046],
9	CD3EAP	NN	O	cd3eap	nn	12	SENT_329	[p15l1406t1005r1611b1046],
10	inﬂuence	NN	O	inﬂuence	nn	12	SENT_329	[p15l1632t1003r1868b1046],
11	treatment	NN	O	treatment	nn	12	SENT_329	[p15l1889t1009r2149b1046],
12	outcome	NN	O	outcome	conj_and	5	SENT_329	[p15l138t1076r362b1113],
13	in	IN	O	in	_	0	SENT_329	[p15l383t1070r431b1112],
14	multiple	JJ	O	multiple	amod	16	SENT_329	[p15l451t1069r668b1124],
15	myeloma	NN	O	myeloma	nn	16	SENT_329	[p15l690t1069r929b1124],
16	patients	NNS	O	patient	prep_in	1	SENT_329	[p15l950t1070r1156b1124],
17	undergoing	VBG	O	undergo	partmod	1	SENT_329	[p15l1178t1069r1474b1124],
18	autologous	JJ	O	autologous	amod	21	SENT_329	[p15l1494t1069r1776b1124],
19	bone	NN	O	bone	nn	21	SENT_329	[p15l1797t1069r1922b1113],
20	marrow	NN	O	marrow	nn	21	SENT_329	[p15l1944t1082r2149b1113],
21	transplantation	NN	O	transplantation	dobj	17	SENT_329	[p15l138t1135r548b1189],
22	.	.	O	.	_	0	SENT_329	[p15l138t1135r548b1189],

1	Int	NN	O	int	_	0	SENT_330	[p15l567t1137r667b1189],
2	]	CD	NUMBER	]	num	1	SENT_330	[p15l567t1137r667b1189],
3	Cancer	NN	O	cancer	dep	1	SENT_330	[p15l685t1137r861b1178],
4	2007	CD	DATE	2007	num	3	SENT_330	[p15l877t1137r1019b1185],
5	;	:	O	;	_	0	SENT_330	[p15l877t1137r1019b1185],
6	1	CD	NUMBER	1	number	7	SENT_330	[p15l1030t1137r1049b1178],
7	20	CD	NUMBER	20	dep	1	SENT_330	[p15l1060t1137r1137b1179],
8	:	:	O	:	_	0	SENT_330	[p15l1060t1137r1137b1179],
9	1	CD	NUMBER	1	dep	7	SENT_330	[p15l1148t1137r1167b1178],
10	036-45	CD	NUMBER	036-45	dep	9	SENT_330	[p15l1178t1137r1382b1179],
11	.	.	O	.	_	0	SENT_330	[p15l1178t1137r1382b1179],

1	[	NN	O	[	nn	4	SENT_331	[p15l6t1201r103b1255],
2	25	CD	NUMBER	25	num	4	SENT_331	[p15l6t1201r103b1255],
3	]	NN	O	]	nn	4	SENT_331	[p15l6t1201r103b1255],
4	Neben	NN	O	neben	_	0	SENT_331	[p15l138t1201r302b1245],
5	K	NN	O	k	dep	4	SENT_331	[p15l319t1204r364b1251],
6	,	,	O	,	_	0	SENT_331	[p15l319t1204r364b1251],
7	Mytilineos	NNP	ORGANIZATION	Mytilineos	nn	8	SENT_331	[p15l381t1201r653b1255],
8	]	NNP	O	]	appos	5	SENT_331	[p15l664t1204r697b1255],
9	,	,	O	,	_	0	SENT_331	[p15l664t1204r697b1255],
10	Moehler	NNP	PERSON	Moehler	nn	11	SENT_331	[p15l714t1201r930b1245],
11	TM	NNP	MISC	TM	appos	5	SENT_331	[p15l943t1204r1038b1251],
12	,	,	O	,	_	0	SENT_331	[p15l943t1204r1038b1251],
13	Preiss	NNP	PERSON	Preiss	nn	14	SENT_331	[p15l1055t1202r1203b1245],
14	A	NNP	O	A	appos	5	SENT_331	[p15l1218t1203r1266b1251],
15	,	,	O	,	_	0	SENT_331	[p15l1218t1203r1266b1251],
16	Kraemer	NNP	PERSON	Kraemer	nn	17	SENT_331	[p15l1283t1204r1505b1245],
17	A	NNP	O	A	appos	5	SENT_331	[p15l1517t1203r1566b1251],
18	,	,	O	,	_	0	SENT_331	[p15l1517t1203r1566b1251],
19	Ho	NNP	O	Ho	nn	20	SENT_331	[p15l1583t1204r1653b1245],
20	AD	NN	O	ad	appos	5	SENT_331	[p15l1667t1203r1756b1251],
21	,	,	O	,	_	0	SENT_331	[p15l1667t1203r1756b1251],
22	et	FW	O	et	nn	23	SENT_331	[p15l1774t1207r1822b1245],
23	al.	FW	O	al.	appos	5	SENT_331	[p15l1837t1201r1892b1245],
24	.	.	O	.	_	0	SENT_331	[p15l1837t1201r1892b1245],

1	Polymorphisms	NNS	O	polymorphism	nsubj	11	SENT_332	[p15l1910t1201r2147b1255, p15l138t1266r321b1321],
2	of	IN	O	of	_	0	SENT_332	[p15l339t1266r392b1310],
3	the	DT	O	the	det	10	SENT_332	[p15l403t1266r484b1310],
4	tumor	NN	O	tumor	nn	10	SENT_332	[p15l502t1273r663b1310],
5	necrosis	NN	O	necrosis	nn	10	SENT_332	[p15l679t1267r888b1310],
6	factor	NN	O	factor	nn	10	SENT_332	[p15l906t1266r1220b1321],
7	—	NN	O	—	nn	10	SENT_332	[p15l906t1266r1220b1321],
8	alpha	NN	O	alpha	nn	10	SENT_332	[p15l906t1266r1220b1321],
9	gene	NN	O	gene	nn	10	SENT_332	[p15l1237t1279r1358b1321],
10	promoter	NN	O	promoter	prep_of	1	SENT_332	[p15l1376t1273r1621b1321],
11	predict	VBP	O	predict	_	0	SENT_332	[p15l1637t1266r1819b1321],
12	for	IN	O	for	_	0	SENT_332	[p15l1836t1266r1908b1310],
13	outcome	NN	O	outcome	prep_for	11	SENT_332	[p15l1924t1273r2147b1310],
14	after	IN	O	after	_	0	SENT_332	[p15l138t1333r258b1376],
15	thalidomide	NN	O	thalidomide	nn	16	SENT_332	[p15l273t1333r586b1376],
16	therapy	NN	O	therapy	prep_after	11	SENT_332	[p15l602t1333r802b1387],
17	in	IN	O	in	_	0	SENT_332	[p15l818t1334r866b1376],
18	relapsed	VBN	O	relapse	prep_in	16	SENT_332	[p15l883t1333r1099b1387],
19	and	CC	O	and	_	0	SENT_332	[p15l1117t1333r1210b1376],
20	refractory	JJ	O	refractory	amod	22	SENT_332	[p15l1227t1333r1483b1387],
21	multiple	JJ	O	multiple	amod	22	SENT_332	[p15l1499t1333r1716b1387],
22	myeloma	NN	O	myeloma	prep_in	16	SENT_332	[p15l1734t1333r1985b1387],
23	.	.	O	.	_	0	SENT_332	[p15l1734t1333r1985b1387],

1	Blood	NN	O	blood	_	0	SENT_333	[p15l2003t1333r2147b1376],
2	2002	CD	DATE	2002	num	1	SENT_333	[p15l138t1401r611b1450],
3	;	:	O	;	_	0	SENT_333	[p15l138t1401r611b1450],
4	100:2263	CD	NUMBER	100:2263	number	5	SENT_333	[p15l138t1401r611b1450],
5	—	CD	NUMBER	—	dep	1	SENT_333	[p15l138t1401r611b1450],
6	5	CD	NUMBER	5	dep	5	SENT_333	[p15l138t1401r611b1450],
7	.	.	O	.	_	0	SENT_333	[p15l138t1401r611b1450],

1	[	NN	O	[	nn	5	SENT_334	[p15l6t1464r103b1519],
2	26	CD	NUMBER	26	num	5	SENT_334	[p15l6t1464r103b1519],
3	]	CD	NUMBER	]	num	5	SENT_334	[p15l6t1464r103b1519],
4	Du	NNP	O	Du	nn	5	SENT_334	[p15l138t1467r247b1519],
5	]	NNP	O	]	_	0	SENT_334	[p15l138t1467r247b1519],
6	,	,	O	,	_	0	SENT_334	[p15l138t1467r247b1519],
7	Yuan	NNP	O	Yuan	nn	8	SENT_334	[p15l258t1467r389b1508],
8	Z	NNP	O	Z	appos	5	SENT_334	[p15l399t1467r441b1515],
9	,	,	O	,	_	0	SENT_334	[p15l399t1467r441b1515],
10	Zhang	NNP	PERSON	Zhang	nn	11	SENT_334	[p15l453t1465r612b1519],
11	C	NNP	PERSON	C	appos	8	SENT_334	[p15l623t1467r665b1515],
12	,	,	O	,	_	0	SENT_334	[p15l623t1467r665b1515],
13	Fu	NNP	O	Fu	nn	14	SENT_334	[p15l678t1467r737b1508],
14	W	NNP	O	W	appos	8	SENT_334	[p15l747t1465r956b1519],
15	,	,	O	,	_	0	SENT_334	[p15l747t1465r956b1519],
16	]	CD	NUMBER	]	num	18	SENT_334	[p15l747t1465r956b1519],
17	iang	NN	O	iang	nn	18	SENT_334	[p15l747t1465r956b1519],
18	H	NN	O	h	appos	8	SENT_334	[p15l967t1467r1017b1515],
19	,	,	O	,	_	0	SENT_334	[p15l967t1467r1017b1515],
20	Chen	NNP	PERSON	Chen	nn	21	SENT_334	[p15l1030t1465r1159b1508],
21	B	NNP	PERSON	B	appos	8	SENT_334	[p15l1171t1467r1213b1515],
22	,	,	O	,	_	0	SENT_334	[p15l1171t1467r1213b1515],
23	et	FW	O	et	nn	24	SENT_334	[p15l1226t1471r1274b1508],
24	al.	FW	O	al.	appos	8	SENT_334	[p15l1285t1465r1340b1509],
25	.	.	O	.	_	0	SENT_334	[p15l1285t1465r1340b1509],

1	Role	NN	O	role	_	0	SENT_335	[p15l1354t1465r1462b1508],
2	of	IN	O	of	_	0	SENT_335	[p15l1475t1465r1529b1508],
3	the	DT	O	the	det	7	SENT_335	[p15l1534t1465r1615b1508],
4	T	NN	O	t	nn	7	SENT_335	[p15l1625t1467r1657b1508],
5	NF-alpha	NN	O	nf-alpha	nn	7	SENT_335	[p15l1659t1465r1893b1519],
6	promoter	NN	O	promoter	nn	7	SENT_335	[p15l1905t1471r2150b1519],
7	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_335	[p15l138t1531r542b1585],
8	for	IN	O	for	_	0	SENT_335	[p15l559t1531r631b1575],
9	development	NN	O	development	prep_for	7	SENT_335	[p15l645t1531r986b1585],
10	of	IN	O	of	_	0	SENT_335	[p15l1001t1531r1054b1575],
11	multiple	JJ	O	multiple	amod	12	SENT_335	[p15l1064t1531r1281b1585],
12	myeloma	NN	O	myeloma	prep_of	9	SENT_335	[p15l1298t1531r1538b1585],
13	and	CC	O	and	_	0	SENT_335	[p15l1553t1531r1646b1575],
14	clinical	JJ	O	clinical	amod	15	SENT_335	[p15l1663t1531r1844b1575],
15	outcome	NN	O	outcome	prep_for	7	SENT_335	[p15l1860t1537r2084b1575],
16	in	IN	O	in	_	0	SENT_335	[p15l2101t1532r2148b1574],
17	thalidomide	NN	O	thalidomide	prep_in	15	SENT_335	[p15l138t1596r450b1640],
18	plus	CC	O	plus	prep	1	SENT_335	[p15l469t1596r573b1651],
19	dexamethasone	NN	O	dexamethasone	dep	18	SENT_335	[p15l593t1596r1013b1640],
20	.	.	O	.	_	0	SENT_335	[p15l593t1596r1013b1640],

1	Leuk	NNP	O	Leuk	nn	2	SENT_336	[p15l1032t1596r1153b1640],
2	Res	NNP	O	Res	_	0	SENT_336	[p15l1169t1599r1254b1640],
3	2010	CD	DATE	2010	num	2	SENT_336	[p15l1273t1599r1713b1647],
4	;	:	O	;	_	0	SENT_336	[p15l1273t1599r1713b1647],
5	34:1453	CD	NUMBER	34:1453	number	6	SENT_336	[p15l1273t1599r1713b1647],
6	—	CD	NUMBER	—	dep	2	SENT_336	[p15l1273t1599r1713b1647],
7	8	CD	NUMBER	8	dep	6	SENT_336	[p15l1273t1599r1713b1647],
8	.	.	O	.	_	0	SENT_336	[p15l1273t1599r1713b1647],

1	[	NN	O	[	_	0	SENT_337	[p15l6t1663r103b1717],
2	27	CD	NUMBER	27	number	3	SENT_337	[p15l6t1663r103b1717],
3	]	CD	NUMBER	]	num	9	SENT_337	[p15l6t1663r103b1717],
4	Parman	NN	ORGANIZATION	parman	nn	9	SENT_337	[p15l138t1666r334b1706],
5	T	NN	ORGANIZATION	t	nn	9	SENT_337	[p15l353t1666r396b1713],
6	,	,	O	,	_	0	SENT_337	[p15l353t1666r396b1713],
7	Wiley	NN	PERSON	wiley	dep	9	SENT_337	[p15l416t1663r569b1717],
8	M	NN	O	m	nn	9	SENT_337	[p15l589t1666r668b1717],
9	]	NN	O	]	dep	1	SENT_337	[p15l589t1666r668b1717],
10	,	,	O	,	_	0	SENT_337	[p15l589t1666r668b1717],
11	Wells	NNP	ORGANIZATION	Wells	nn	12	SENT_337	[p15l688t1663r833b1706],
12	PG	NNP	ORGANIZATION	PG	appos	9	SENT_337	[p15l856t1665r936b1707],
13	.	.	O	.	_	0	SENT_337	[p15l856t1665r936b1707],

1	Free	NNP	O	Free	nn	3	SENT_338	[p15l958t1666r1065b1706],
2	radical	JJ	O	radical	amod	3	SENT_338	[p15l1088t1663r1529b1706],
3	—	NN	O	—	nsubj	4	SENT_338	[p15l1088t1663r1529b1706],
4	mediated	VBN	O	mediate	_	0	SENT_338	[p15l1088t1663r1529b1706],
5	oxidative	JJ	O	oxidative	amod	7	SENT_338	[p15l1551t1663r1788b1706],
6	DNA	NN	O	dna	nn	7	SENT_338	[p15l1810t1665r1927b1706],
7	damage	NN	O	damage	dobj	4	SENT_338	[p15l1947t1663r2147b1717],
8	in	IN	O	in	_	0	SENT_338	[p15l138t1729r186b1772],
9	the	DT	O	the	det	10	SENT_338	[p15l203t1728r284b1772],
10	mechanism	NN	O	mechanism	prep_in	7	SENT_338	[p15l302t1728r600b1772],
11	of	IN	O	of	_	0	SENT_338	[p15l618t1728r671b1772],
12	thalidomide	NN	O	thalidomide	nn	13	SENT_338	[p15l682t1728r995b1772],
13	teratogenicity	NN	O	teratogenicity	prep_of	10	SENT_338	[p15l1013t1729r1386b1783],
14	.	.	O	.	_	0	SENT_338	[p15l1013t1729r1386b1783],

1	Nat	NNP	O	Nat	nn	2	SENT_339	[p15l1405t1731r1494b1772],
2	Med	NNP	O	Med	_	0	SENT_339	[p15l1511t1728r1622b1772],
3	1999	CD	DATE	1999	num	2	SENT_339	[p15l1643t1731r2016b1779],
4	;	:	O	;	_	0	SENT_339	[p15l1643t1731r2016b1779],
5	5:582	CD	NUMBER	5:582	number	6	SENT_339	[p15l1643t1731r2016b1779],
6	—	CD	NUMBER	—	dep	2	SENT_339	[p15l1643t1731r2016b1779],
7	5	CD	NUMBER	5	dep	6	SENT_339	[p15l1643t1731r2016b1779],
8	.	.	O	.	_	0	SENT_339	[p15l1643t1731r2016b1779],

1	[	NN	O	[	_	0	SENT_340	[p15l6t1795r103b1849],
2	28	CD	NUMBER	28	num	1	SENT_340	[p15l6t1795r103b1849],
3	]	CD	NUMBER	]	num	5	SENT_340	[p15l6t1795r103b1849],
4	Hideshima	NNP	LOCATION	Hideshima	nn	5	SENT_340	[p15l138t1795r415b1838],
5	T	NN	O	t	dep	1	SENT_340	[p15l430t1798r472b1845],
6	,	,	O	,	_	0	SENT_340	[p15l430t1798r472b1845],
7	Chauhan	NN	PERSON	chauhan	nn	8	SENT_340	[p15l490t1795r715b1838],
8	D	NN	PERSON	d	appos	5	SENT_340	[p15l733t1798r782b1845],
9	,	,	O	,	_	0	SENT_340	[p15l733t1798r782b1845],
10	Shima	NNP	PERSON	Shima	nn	11	SENT_340	[p15l800t1795r959b1838],
11	Y	NN	PERSON	y	appos	5	SENT_340	[p15l973t1798r1019b1845],
12	,	,	O	,	_	0	SENT_340	[p15l973t1798r1019b1845],
13	Raje	NNP	PERSON	Raje	nn	14	SENT_340	[p15l1037t1796r1144b1849],
14	N	NNP	O	N	appos	5	SENT_340	[p15l1162t1798r1212b1845],
15	,	,	O	,	_	0	SENT_340	[p15l1162t1798r1212b1845],
16	Davies	NNP	PERSON	Davies	nn	17	SENT_340	[p15l1230t1796r1398b1838],
17	FE	NNP	O	FE	appos	5	SENT_340	[p15l1416t1798r1485b1845],
18	,	,	O	,	_	0	SENT_340	[p15l1416t1798r1485b1845],
19	Tai	NNP	PERSON	Tai	nn	20	SENT_340	[p15l1501t1796r1577b1838],
20	YT	NNP	PERSON	YT	appos	5	SENT_340	[p15l1592t1798r1669b1845],
21	,	,	O	,	_	0	SENT_340	[p15l1592t1798r1669b1845],
22	et	FW	O	et	nn	23	SENT_340	[p15l1688t1801r1735b1838],
23	al.	FW	O	al.	appos	5	SENT_340	[p15l1751t1795r1807b1839],
24	.	.	O	.	_	0	SENT_340	[p15l1751t1795r1807b1839],

1	Thalidomide	NNP	O	Thalidomide	nsubj	5	SENT_341	[p15l1822t1795r2147b1838],
2	and	CC	O	and	_	0	SENT_341	[p15l138t1861r231b1905],
3	its	PRP$	O	its	poss	4	SENT_341	[p15l249t1862r307b1905],
4	analogs	NNS	O	analog	conj_and	1	SENT_341	[p15l325t1861r518b1916],
5	overcome	VBP	O	overcome	_	0	SENT_341	[p15l536t1874r788b1905],
6	drug	NN	O	drug	nn	7	SENT_341	[p15l806t1861r925b1916],
7	resistance	NN	O	resistance	dobj	5	SENT_341	[p15l941t1862r1198b1905],
8	of	IN	O	of	_	0	SENT_341	[p15l1216t1861r1269b1905],
9	human	JJ	O	human	amod	12	SENT_341	[p15l1280t1861r1460b1905],
10	multiple	JJ	O	multiple	amod	12	SENT_341	[p15l1478t1861r1695b1916],
11	myeloma	NN	O	myeloma	nn	12	SENT_341	[p15l1713t1861r1952b1916],
12	cells	NNS	O	cell	prep_of	7	SENT_341	[p15l1969t1861r2080b1905],
13	to	TO	O	to	_	0	SENT_341	[p15l2098t1868r2147b1905],
14	conventional	JJ	O	conventional	amod	15	SENT_341	[p15l138t1927r472b1970],
15	therapy	NN	O	therapy	prep_to	5	SENT_341	[p15l490t1927r701b1981],
16	.	.	O	.	_	0	SENT_341	[p15l490t1927r701b1981],

1	Blood	NN	O	blood	_	0	SENT_342	[p15l720t1927r864b1970],
2	2000	CD	DATE	2000	num	1	SENT_342	[p15l882t1929r1355b1977],
3	;	:	O	;	_	0	SENT_342	[p15l882t1929r1355b1977],
4	96:2943	CD	NUMBER	96:2943	number	5	SENT_342	[p15l882t1929r1355b1977],
5	—	CD	NUMBER	—	dep	1	SENT_342	[p15l882t1929r1355b1977],
6	50	CD	NUMBER	50	dep	5	SENT_342	[p15l882t1929r1355b1977],
7	.	.	O	.	_	0	SENT_342	[p15l882t1929r1355b1977],

1	[	NN	O	[	_	0	SENT_343	[p15l6t1993r103b2047],
2	29	CD	NUMBER	29	num	1	SENT_343	[p15l6t1993r103b2047],
3	]	CD	NUMBER	]	num	6	SENT_343	[p15l6t1993r103b2047],
4	Park	NN	O	park	nn	6	SENT_343	[p15l138t1993r251b2037],
5	D	NN	O	d	nn	6	SENT_343	[p15l272t1996r339b2047],
6	]	NN	O	]	dep	1	SENT_343	[p15l272t1996r339b2047],
7	,	,	O	,	_	0	SENT_343	[p15l272t1996r339b2047],
8	Zhang	NNP	PERSON	Zhang	nn	9	SENT_343	[p15l361t1993r520b2047],
9	W	NNP	PERSON	W	appos	6	SENT_343	[p15l539t1996r608b2043],
10	,	,	O	,	_	0	SENT_343	[p15l539t1996r608b2043],
11	Stoehlmacher	NNP	O	Stoehlmacher	nn	12	SENT_343	[p15l632t1993r989b2037],
12	]	NNP	O	]	appos	6	SENT_343	[p15l1003t1996r1036b2047],
13	,	,	O	,	_	0	SENT_343	[p15l1003t1996r1036b2047],
14	Tsao-Wei	NNP	PERSON	Tsao-Wei	nn	15	SENT_343	[p15l1057t1994r1301b2037],
15	D	NNP	PERSON	D	appos	6	SENT_343	[p15l1325t1996r1373b2043],
16	,	,	O	,	_	0	SENT_343	[p15l1325t1996r1373b2043],
17	Groshen	NNP	PERSON	Groshen	nn	18	SENT_343	[p15l1397t1993r1612b2037],
18	S	NNP	O	S	appos	6	SENT_343	[p15l1634t1995r1672b2043],
19	,	,	O	,	_	0	SENT_343	[p15l1634t1995r1672b2043],
20	Gil	NNP	PERSON	Gil	nn	21	SENT_343	[p15l1695t1993r1814b2047],
21	]	NNP	O	]	appos	6	SENT_343	[p15l1695t1993r1814b2047],
22	,	,	O	,	_	0	SENT_343	[p15l1695t1993r1814b2047],
23	et	FW	O	et	nn	24	SENT_343	[p15l1837t1999r1885b2037],
24	al.	FW	O	al.	appos	6	SENT_343	[p15l1906t1993r1961b2037],
25	.	.	O	.	_	0	SENT_343	[p15l1906t1993r1961b2037],

1	ERCC1	NN	O	ercc1	nn	3	SENT_344	[p15l1984t1995r2141b2037],
2	gene	NN	O	gene	nn	3	SENT_344	[p15l137t2071r258b2113],
3	polymorphism	NN	O	polymorphism	nsubj	15	SENT_344	[p15l277t2058r656b2113],
4	as	IN	O	as	_	0	SENT_344	[p15l674t2071r724b2102],
5	a	DT	O	a	det	6	SENT_344	[p15l742t2071r768b2102],
6	predictor	NN	O	predictor	prep_as	3	SENT_344	[p15l786t2058r1024b2113],
7	for	IN	O	for	_	0	SENT_344	[p15l1041t2058r1112b2102],
8	clinical	JJ	O	clinical	amod	9	SENT_344	[p15l1128t2058r1309b2102],
9	outcome	NN	O	outcome	prep_for	6	SENT_344	[p15l1328t2065r1552b2102],
10	in	IN	O	in	_	0	SENT_344	[p15l1570t2059r1618b2102],
11	advanced	JJ	O	advanced	amod	14	SENT_344	[p15l1635t2058r1878b2102],
12	colorectal	JJ	O	colorectal	amod	14	SENT_344	[p15l1896t2058r2147b2102],
13	cancer	NN	O	cancer	nn	14	SENT_344	[p15l138t2137r306b2168],
14	patients	NNS	O	patient	prep_in	9	SENT_344	[p15l320t2126r526b2179],
15	treated	VBN	O	treat	_	0	SENT_344	[p15l542t2125r726b2168],
16	with	IN	O	with	_	0	SENT_344	[p15l741t2125r859b2168],
17	platinum-based	JJ	O	platinum-based	amod	18	SENT_344	[p15l875t2125r1283b2179],
18	chemotherapy	NN	O	chemotherapy	prep_with	15	SENT_344	[p15l1299t2125r1684b2179],
19	.	.	O	.	_	0	SENT_344	[p15l1299t2125r1684b2179],

1	Clin	NNP	O	Clin	nn	4	SENT_345	[p15l1701t2125r1800b2168],
2	Adv	NNP	O	Adv	nn	4	SENT_345	[p15l1813t2125r1914b2168],
3	Hematol	NNP	O	Hematol	nn	4	SENT_345	[p15l1929t2125r2147b2168],
4	Oncol	NNP	O	Oncol	_	0	SENT_345	[p15l138t2191r284b2235],
5	2003	CD	DATE	2003	num	4	SENT_345	[p15l302t2193r678b2241],
6	;	:	O	;	_	0	SENT_345	[p15l302t2193r678b2241],
7	1:162	CD	NUMBER	1:162	number	8	SENT_345	[p15l302t2193r678b2241],
8	—	CD	NUMBER	—	dep	4	SENT_345	[p15l302t2193r678b2241],
9	6	CD	NUMBER	6	dep	8	SENT_345	[p15l302t2193r678b2241],
10	.	.	O	.	_	0	SENT_345	[p15l302t2193r678b2241],

1	[	RB	O	[	advmod	2	SENT_346	[p15l7t2256r103b2311],
2	30	CD	NUMBER	30	_	0	SENT_346	[p15l7t2256r103b2311],
3	]	CD	NUMBER	]	num	6	SENT_346	[p15l7t2256r103b2311],
4	Hayden	NNP	PERSON	Hayden	nn	6	SENT_346	[p15l138t2257r334b2311],
5	P	NN	O	p	nn	6	SENT_346	[p15l349t2259r406b2311],
6	]	NN	O	]	dep	2	SENT_346	[p15l349t2259r406b2311],
7	,	,	O	,	_	0	SENT_346	[p15l349t2259r406b2311],
8	Tewari	NNP	ORGANIZATION	Tewari	nn	9	SENT_346	[p15l419t2257r596b2300],
9	P	NN	ORGANIZATION	p	appos	6	SENT_346	[p15l611t2259r651b2307],
10	,	,	O	,	_	0	SENT_346	[p15l611t2259r651b2307],
11	Morris	NNP	ORGANIZATION	Morris	nn	12	SENT_346	[p15l667t2257r835b2300],
12	DW	NNP	ORGANIZATION	DW	appos	6	SENT_346	[p15l851t2259r958b2307],
13	,	,	O	,	_	0	SENT_346	[p15l851t2259r958b2307],
14	Staines	NNP	PERSON	Staines	nn	15	SENT_346	[p15l974t2257r1155b2300],
15	A	NNP	O	A	appos	6	SENT_346	[p15l1168t2259r1216b2307],
16	,	,	O	,	_	0	SENT_346	[p15l1168t2259r1216b2307],
17	Crowley	NNP	PERSON	Crowley	nn	18	SENT_346	[p15l1231t2257r1444b2311],
18	D	NNP	O	D	appos	6	SENT_346	[p15l1457t2259r1506b2307],
19	,	,	O	,	_	0	SENT_346	[p15l1457t2259r1506b2307],
20	Nieters	NNP	O	Nieters	nn	21	SENT_346	[p15l1521t2257r1704b2300],
21	A	NNP	O	A	appos	6	SENT_346	[p15l1717t2258r1765b2307],
22	,	,	O	,	_	0	SENT_346	[p15l1717t2258r1765b2307],
23	et	FW	O	et	nn	24	SENT_346	[p15l1780t2263r1828b2300],
24	al.	FW	O	al.	appos	6	SENT_346	[p15l1841t2257r1896b2301],
25	.	.	O	.	_	0	SENT_346	[p15l1841t2257r1896b2301],

1	Variation	NN	O	variation	_	0	SENT_347	[p15l1909t2257r2148b2300],
2	in	IN	O	in	_	0	SENT_347	[p15l138t2324r186b2366],
3	DNA	NN	MISC	dna	nn	5	SENT_347	[p15l199t2325r317b2366],
4	repair	NN	O	repair	nn	5	SENT_347	[p15l328t2324r482b2377],
5	genes	NNS	O	gene	prep_in	1	SENT_347	[p15l493t2336r639b2377],
6	XRCC3	NN	O	xrcc3	dep	1	SENT_347	[p15l651t2325r835b2373],
7	,	,	O	,	_	0	SENT_347	[p15l651t2325r835b2373],
8	XRCC4	NN	O	xrcc4	dep	1	SENT_347	[p15l847t2325r1031b2373],
9	,	,	O	,	_	0	SENT_347	[p15l847t2325r1031b2373],
10	XRCC5	NN	O	xrcc5	conj_and	6	SENT_347	[p15l1044t2325r1213b2367],
11	and	CC	O	and	_	0	SENT_347	[p15l1228t2323r1321b2367],
12	susceptibility	NN	O	susceptibility	dep	1	SENT_347	[p15l1336t2323r1681b2377],
13	to	TO	O	to	_	0	SENT_347	[p15l1693t2329r1742b2367],
14	myeloma	NN	O	myeloma	prep_to	6	SENT_347	[p15l1757t2323r2009b2377],
15	.	.	O	.	_	0	SENT_347	[p15l1757t2323r2009b2377],

1	Hum	NNP	O	Hum	nn	3	SENT_348	[p15l2023t2326r2148b2367],
2	Mol	NNP	ORGANIZATION	Mol	nn	3	SENT_348	[p15l138t2388r235b2432],
3	Genet	NNP	O	Genet	_	0	SENT_348	[p15l254t2391r406b2432],
4	2007	CD	DATE	2007	num	3	SENT_348	[p15l422t2391r595b2439],
5	;	:	O	;	_	0	SENT_348	[p15l422t2391r595b2439],
6	1	CD	NUMBER	1	number	7	SENT_348	[p15l422t2391r595b2439],
7	623117-27	CD	NUMBER	623117-27	dep	3	SENT_348	[p15l606t2391r895b2432],
8	.	.	O	.	_	0	SENT_348	[p15l606t2391r895b2432],

1	[	NN	O	[	nsubj	26	SENT_349	[p15l6t2455r103b2509],
2	31	CD	NUMBER	31	num	1	SENT_349	[p15l6t2455r103b2509],
3	]	CD	NUMBER	]	num	5	SENT_349	[p15l6t2455r103b2509],
4	Tewari	NNP	PERSON	Tewari	nn	5	SENT_349	[p15l136t2456r313b2498],
5	P	NN	PERSON	p	rcmod	1	SENT_349	[p15l331t2458r371b2505],
6	,	,	O	,	_	0	SENT_349	[p15l331t2458r371b2505],
7	Kenny	NNP	PERSON	Kenny	nn	8	SENT_349	[p15l390t2458r553b2509],
8	E	NNP	PERSON	E	appos	5	SENT_349	[p15l570t2458r610b2505],
9	,	,	O	,	_	0	SENT_349	[p15l570t2458r610b2505],
10	Staines	NNP	PERSON	Staines	nn	11	SENT_349	[p15l629t2456r810b2498],
11	A	NNP	O	A	appos	5	SENT_349	[p15l826t2457r874b2505],
12	,	,	O	,	_	0	SENT_349	[p15l826t2457r874b2505],
13	Chanock	NNP	O	Chanock	nn	14	SENT_349	[p15l893t2455r1113b2498],
14	S	NNP	O	S	appos	5	SENT_349	[p15l1129t2457r1167b2505],
15	,	,	O	,	_	0	SENT_349	[p15l1129t2457r1167b2505],
16	Browne	NNP	PERSON	Browne	nn	17	SENT_349	[p15l1186t2458r1383b2498],
17	P	NN	PERSON	p	appos	5	SENT_349	[p15l1402t2458r1442b2505],
18	,	,	O	,	_	0	SENT_349	[p15l1402t2458r1442b2505],
19	Lawler	NNP	PERSON	Lawler	nn	22	SENT_349	[p15l1460t2455r1634b2498],
20	M.	NNP	PERSON	M.	nn	22	SENT_349	[p15l1650t2458r1711b2499],
21	Genetic	NNP	PERSON	Genetic	nn	22	SENT_349	[p15l1730t2456r1925b2498],
22	variants	NNS	O	variant	appos	5	SENT_349	[p15l1940t2456r2147b2498],
23	in	IN	O	in	dep	5	SENT_349	[p15l138t2521r186b2564],
24	XRRC5	NN	O	xrrc5	pobj	23	SENT_349	[p15l202t2523r373b2564],
25	may	MD	O	may	aux	26	SENT_349	[p15l394t2533r504b2575],
26	predict	VB	O	predict	_	0	SENT_349	[p15l522t2520r704b2575],
27	development	NN	O	development	dobj	26	SENT_349	[p15l722t2520r1063b2575],
28	of	IN	O	of	_	0	SENT_349	[p15l1081t2520r1134b2564],
29	venous	JJ	O	venous	amod	31	SENT_349	[p15l1145t2533r1328b2564],
30	thrombotic	JJ	O	thrombotic	amod	31	SENT_349	[p15l1348t2520r1637b2564],
31	events	NNS	O	event	prep_of	27	SENT_349	[p15l1656t2527r1822b2564],
32	in	IN	O	in	_	0	SENT_349	[p15l1842t2521r1890b2564],
33	myeloma	NN	O	myeloma	nn	34	SENT_349	[p15l1909t2520r2148b2575],
34	patients	NNS	O	patient	prep_in	31	SENT_349	[p15l138t2588r344b2641],
35	on	IN	O	on	_	0	SENT_349	[p15l363t2599r426b2630],
36	thalidomide	NN	O	thalidomide	prep_on	26	SENT_349	[p15l443t2587r769b2631],
37	.	.	O	.	_	0	SENT_349	[p15l443t2587r769b2631],

1	Blood	NN	O	blood	_	0	SENT_350	[p15l788t2587r932b2630],
2	2009	CD	DATE	2009	num	1	SENT_350	[p15l950t2589r1123b2637],
3	;	:	O	;	_	0	SENT_350	[p15l950t2589r1123b2637],
4	1	CD	NUMBER	1	number	5	SENT_350	[p15l950t2589r1123b2637],
5	13:5691	CD	NUMBER	13:5691	dep	1	SENT_350	[p15l1136t2589r1423b2631],
6	—	NN	O	—	dep	5	SENT_350	[p15l1136t2589r1423b2631],
7	2	CD	NUMBER	2	num	6	SENT_350	[p15l1136t2589r1423b2631],
8	.	.	O	.	_	0	SENT_350	[p15l1136t2589r1423b2631],

1	[	NN	O	[	nn	5	SENT_351	[p15l7t2653r103b2708],
2	32	CD	NUMBER	32	num	5	SENT_351	[p15l7t2653r103b2708],
3	]	CD	NUMBER	]	num	5	SENT_351	[p15l7t2653r103b2708],
4	Thompson	NNP	PERSON	Thompson	nn	5	SENT_351	[p15l136t2653r410b2708],
5	MA	NNP	PERSON	MA	_	0	SENT_351	[p15l441t2655r540b2703],
6	,	,	O	,	_	0	SENT_351	[p15l441t2655r540b2703],
7	Witzig	NNP	ORGANIZATION	Witzig	nn	8	SENT_351	[p15l570t2654r742b2708],
8	TE	NNP	ORGANIZATION	TE	appos	5	SENT_351	[p15l771t2656r845b2704],
9	,	,	O	,	_	0	SENT_351	[p15l771t2656r845b2704],
10	Kumar	NNP	PERSON	Kumar	nn	11	SENT_351	[p15l878t2656r1051b2697],
11	S	NNP	PERSON	S	appos	8	SENT_351	[p15l1081t2655r1119b2703],
12	,	,	O	,	_	0	SENT_351	[p15l1081t2655r1119b2703],
13	Timm	NNP	PERSON	Timm	nn	14	SENT_351	[p15l1150t2654r1302b2696],
14	MM	NN	O	mm	appos	8	SENT_351	[p15l1333t2656r1447b2703],
15	,	,	O	,	_	0	SENT_351	[p15l1333t2656r1447b2703],
16	Haug	NNP	PERSON	Haug	nn	17	SENT_351	[p15l1480t2656r1614b2708],
17	]	NNP	O	]	appos	8	SENT_351	[p15l1638t2656r1670b2708],
18	,	,	O	,	_	0	SENT_351	[p15l1638t2656r1670b2708],
19	Fonseca	NNP	PERSON	Fonseca	nn	20	SENT_351	[p15l1703t2656r1906b2697],
20	R	NNP	PERSON	R	appos	8	SENT_351	[p15l1937t2656r1981b2704],
21	,	,	O	,	_	0	SENT_351	[p15l1937t2656r1981b2704],
22	et	FW	O	et	nn	23	SENT_351	[p15l2014t2660r2061b2697],
23	al.	FW	O	al.	appos	8	SENT_351	[p15l2092t2653r2147b2697],
24	.	.	O	.	_	0	SENT_351	[p15l2092t2653r2147b2697],

1	Plasma	NN	O	plasma	nn	2	SENT_352	[p15l138t2719r319b2762],
2	levels	NNS	O	level	nsubj	10	SENT_352	[p15l356t2719r500b2762],
3	of	IN	O	of	_	0	SENT_352	[p15l538t2718r591b2762],
4	tumour	NN	O	tumour	nn	6	SENT_352	[p15l622t2725r816b2762],
5	necrosis	NN	O	necrosis	nn	6	SENT_352	[p15l852t2719r1060b2762],
6	factor	NN	O	factor	prep_of	2	SENT_352	[p15l1098t2718r1247b2762],
7	alpha	NN	O	alpha	amod	6	SENT_352	[p15l1282t2719r1422b2773],
8	and	CC	O	and	_	0	SENT_352	[p15l1459t2719r1552b2762],
9	interleukin-6	NN	O	interleukin-6	amod	6	SENT_352	[p15l1590t2719r1929b2762],
10	predict	VBP	O	predict	_	0	SENT_352	[p15l1967t2719r2149b2773],
11	progression-free	JJ	O	progression-free	amod	12	SENT_352	[p15l138t2785r564b2839],
12	survival	NN	O	survival	dobj	10	SENT_352	[p15l584t2785r786b2829],
13	following	VBG	O	follow	_	0	SENT_352	[p15l805t2785r1049b2839],
14	thalidomide	NN	O	thalidomide	nn	15	SENT_352	[p15l1066t2785r1379b2829],
15	therapy	NN	O	therapy	prep_following	12	SENT_352	[p15l1397t2785r1597b2839],
16	in	IN	O	in	_	0	SENT_352	[p15l1615t2786r1662b2828],
17	patients	NNS	O	patient	prep_in	15	SENT_352	[p15l1681t2786r1887b2839],
18	with	IN	O	with	_	0	SENT_352	[p15l1905t2785r2023b2829],
19	previously	RB	DATE	previously	advmod	20	SENT_352	[p15l2042t2798r2147b2839, p15l136t2850r322b2905],
20	untreated	JJ	O	untreated	amod	22	SENT_352	[p15l339t2850r590b2894],
21	multiple	JJ	O	multiple	amod	22	SENT_352	[p15l609t2850r826b2905],
22	myeloma	NN	O	myeloma	prep_with	17	SENT_352	[p15l845t2851r1096b2905],
23	.	.	O	.	_	0	SENT_352	[p15l845t2851r1096b2905],

1	Br	NN	O	br	_	0	SENT_353	[p15l1115t2853r1200b2905],
2	]	CD	NUMBER	]	num	1	SENT_353	[p15l1115t2853r1200b2905],
3	Haematol	NNP	O	Haematol	dep	1	SENT_353	[p15l1219t2850r1466b2894],
4	2003	CD	DATE	2003	num	3	SENT_353	[p15l1485t2853r1925b2901],
5	;	:	O	;	_	0	SENT_353	[p15l1485t2853r1925b2901],
6	123:305	CD	NUMBER	123:305	number	7	SENT_353	[p15l1485t2853r1925b2901],
7	—	CD	NUMBER	—	dep	1	SENT_353	[p15l1485t2853r1925b2901],
8	8	CD	NUMBER	8	dep	7	SENT_353	[p15l1485t2853r1925b2901],
9	.	.	O	.	_	0	SENT_353	[p15l1485t2853r1925b2901],

1	[	NN	O	[	_	0	SENT_354	[p15l6t2917r103b2971],
2	33	CD	NUMBER	33	number	3	SENT_354	[p15l6t2917r103b2971],
3	]	CD	NUMBER	]	dep	1	SENT_354	[p15l6t2917r103b2971],
4	Vangsted	VBN	O	vangst	partmod	1	SENT_354	[p15l136t2917r375b2971],
5	A	DT	O	a	det	6	SENT_354	[p15l397t2919r463b2971],
6	]	NN	O	]	dobj	4	SENT_354	[p15l397t2919r463b2971],
7	,	,	O	,	_	0	SENT_354	[p15l397t2919r463b2971],
8	Klausen	NNP	ORGANIZATION	Klausen	nn	9	SENT_354	[p15l487t2917r690b2960],
9	TW	NNP	ORGANIZATION	TW	appos	6	SENT_354	[p15l711t2920r812b2967],
10	,	,	O	,	_	0	SENT_354	[p15l711t2920r812b2967],
11	Gimsing	NNP	O	Gimsing	nn	12	SENT_354	[p15l837t2918r1050b2971],
12	P	NN	O	p	appos	6	SENT_354	[p15l1073t2920r1113b2967],
13	,	,	O	,	_	0	SENT_354	[p15l1073t2920r1113b2967],
14	Andersen	NNP	ORGANIZATION	Andersen	nn	15	SENT_354	[p15l1135t2917r1381b2960],
15	NF	NN	ORGANIZATION	nf	appos	6	SENT_354	[p15l1405t2920r1484b2967],
16	,	,	O	,	_	0	SENT_354	[p15l1405t2920r1484b2967],
17	Abildgaard	NN	ORGANIZATION	abildgaard	nn	18	SENT_354	[p15l1506t2917r1787b2971],
18	N	NN	ORGANIZATION	n	appos	6	SENT_354	[p15l1812t2920r1862b2967],
19	,	,	O	,	_	0	SENT_354	[p15l1812t2920r1862b2967],
20	Gregersen	NNP	PERSON	Gregersen	nn	21	SENT_354	[p15l1887t2919r2148b2971],
21	H	NNP	O	H	appos	6	SENT_354	[p15l138t2986r188b3033],
22	,	,	O	,	_	0	SENT_354	[p15l138t2986r188b3033],
23	et	FW	O	et	nn	24	SENT_354	[p15l227t2990r275b3027],
24	al.	FW	O	al.	appos	6	SENT_354	[p15l312t2983r367b3027],
25	.	.	O	.	_	0	SENT_354	[p15l312t2983r367b3027],

1	A	DT	O	a	det	2	SENT_355	[p15l403t2985r441b3026],
2	polymorphism	NN	O	polymorphism	nsubjpass	6	SENT_355	[p15l477t2983r856b3038],
3	in	IN	O	in	_	0	SENT_355	[p15l894t2984r941b3026],
4	NFKB1	NN	O	nfkb1	prep_in	2	SENT_355	[p15l979t2986r1142b3027],
5	is	VBZ	O	be	auxpass	6	SENT_355	[p15l1187t2984r1224b3027],
6	associated	VBN	O	associate	_	0	SENT_355	[p15l1263t2983r1528b3027],
7	with	IN	O	with	_	0	SENT_355	[p15l1564t2983r1683b3027],
8	improved	JJ	O	improved	amod	9	SENT_355	[p15l1721t2983r1968b3038],
9	effect	NN	O	effect	prep_with	6	SENT_355	[p15l2007t2983r2149b3027],
10	of	IN	O	of	_	0	SENT_355	[p15l138t3048r191b3092],
11	interferon	NN	O	interferon	prep_of	9	SENT_355	[p15l229t3049r706b3105],
12	-	:	O	-	_	0	SENT_355	[p15l229t3049r706b3105],
13	{	NN	O	{	nn	14	SENT_355	[p15l229t3049r706b3105],
14	alpha	NN	O	alpha	dep	9	SENT_355	[p15l229t3049r706b3105],
15	}	CD	NUMBER	}	num	17	SENT_355	[p15l229t3049r706b3105],
16	maintenance	NN	O	maintenance	nn	17	SENT_355	[p15l752t3049r1085b3092],
17	treatment	NN	O	treatment	dep	14	SENT_355	[p15l1128t3055r1388b3092],
18	of	IN	O	of	_	0	SENT_355	[p15l1429t3049r1483b3092],
19	patients	NNS	O	patient	prep_of	17	SENT_355	[p15l1520t3049r1726b3103],
20	with	IN	O	with	_	0	SENT_355	[p15l1769t3049r1887b3092],
21	multiple	JJ	O	multiple	amod	22	SENT_355	[p15l1930t3049r2147b3103],
22	myeloma	NN	O	myeloma	prep_with	19	SENT_355	[p15l138t3115r378b3169],
23	after	IN	O	after	_	0	SENT_355	[p15l404t3115r524b3159],
24	high-dose	JJ	O	high-dose	amod	25	SENT_355	[p15l549t3115r804b3169],
25	treatment	NN	O	treatment	prep_after	6	SENT_355	[p15l831t3121r1090b3159],
26	with	IN	O	with	_	0	SENT_355	[p15l1115t3115r1233b3159],
27	stem	NN	O	stem	nn	29	SENT_355	[p15l1260t3121r1385b3159],
28	cell	NN	O	cell	nn	29	SENT_355	[p15l1411t3115r1497b3159],
29	support	NN	O	support	prep_with	6	SENT_355	[p15l1524t3121r1735b3169],
30	.	.	O	.	_	0	SENT_355	[p15l1524t3121r1735b3169],

1	Haematologica	NNP	O	Haematologica	_	0	SENT_356	[p15l1763t3115r2148b3169],
2	2009	CD	DATE	2009	num	1	SENT_356	[p15l138t3183r611b3230],
3	;	:	O	;	_	0	SENT_356	[p15l138t3183r611b3230],
4	94:1274	CD	NUMBER	94:1274	number	5	SENT_356	[p15l138t3183r611b3230],
5	—	CD	NUMBER	—	dep	1	SENT_356	[p15l138t3183r611b3230],
6	81	CD	NUMBER	81	dep	5	SENT_356	[p15l138t3183r611b3230],
7	.	.	O	.	_	0	SENT_356	[p15l138t3183r611b3230],

1	M.T.	NNP	PERSON	M.T.	nn	2	SENT_357	[p15l353t3306r403b3327],
2	Cibeira	NNP	PERSON	Cibeira	_	0	SENT_357	[p15l413t3305r496b3327],
3	et	FW	O	et	nn	4	SENT_357	[p15l505t3308r528b3327],
4	al.	FW	O	al.	dep	2	SENT_357	[p15l535t3305r561b3327],
5	/	:	O	/	punct	2	SENT_357	[p15l567t3305r579b3332],
6	Leukemia	NNP	ORGANIZATION	Leukemia	nn	7	SENT_357	[p15l585t3305r701b3327],
7	Research	NNP	ORGANIZATION	Research	dep	2	SENT_357	[p15l709t3305r815b3327],
8	35	CD	NUMBER	35	number	9	SENT_357	[p15l823t3306r853b3327],
9	(	CD	NUMBER	(	num	10	SENT_357	[p15l861t3305r942b3332],
10	2011	CD	DATE	2011	dep	7	SENT_357	[p15l861t3305r942b3332],
11	)	CD	NUMBER	)	number	12	SENT_357	[p15l861t3305r942b3332],
12	1178-1183 1183	CD	DURATION	1178-1183 1183	num	10	SENT_357	[p15l1748t3306r1807b3327],[p15l953t3306r1086b3327],

1	Rosiﬁol	NN	PERSON	rosiﬁol	nn	2	SENT_358	[p16l139t68r327b112],
2	L	NN	PERSON	l	_	0	SENT_358	[p16l344t71r381b118],
3	,	,	O	,	_	0	SENT_358	[p16l344t71r381b118],
4	Cibeira	NNP	O	Cibeira	nn	5	SENT_358	[p16l398t68r577b112],
5	MT	NNP	O	MT	appos	2	SENT_358	[p16l594t71r687b118],
6	,	,	O	,	_	0	SENT_358	[p16l594t71r687b118],
7	Segarra	NNP	PERSON	Segarra	nn	8	SENT_358	[p16l704t70r895b122],
8	M	NNP	O	M	appos	5	SENT_358	[p16l912t71r973b118],
9	,	,	O	,	_	0	SENT_358	[p16l912t71r973b118],
10	Cid	NNP	O	Cid	nn	11	SENT_358	[p16l990t68r1070b112],
11	MC	NNP	O	MC	appos	5	SENT_358	[p16l1087t70r1183b118],
12	,	,	O	,	_	0	SENT_358	[p16l1087t70r1183b118],
13	Filella	NNP	O	Filella	nn	14	SENT_358	[p16l1200t68r1352b112],
14	X	NNP	O	X	appos	5	SENT_358	[p16l1366t71r1414b118],
15	,	,	O	,	_	0	SENT_358	[p16l1366t71r1414b118],
16	Aymerich	NNP	PERSON	Aymerich	nn	17	SENT_358	[p16l1429t68r1680b122],
17	M	NNP	O	M	appos	5	SENT_358	[p16l1697t71r1757b118],
18	,	,	O	,	_	0	SENT_358	[p16l1697t71r1757b118],
19	et	FW	O	et	nn	20	SENT_358	[p16l1775t74r1823b112],
20	al.	FW	O	al.	appos	5	SENT_358	[p16l1838t68r1893b112],
21	.	.	O	.	_	0	SENT_358	[p16l1838t68r1893b112],

1	Response	NN	O	response	_	0	SENT_359	[p16l1911t71r2151b122],
2	to	TO	O	to	_	0	SENT_359	[p16l139t140r188b177],
3	thalidomide	NN	O	thalidomide	prep_to	1	SENT_359	[p16l211t133r524b177],
4	in	IN	O	in	_	0	SENT_359	[p16l548t134r596b177],
5	multiple	JJ	O	multiple	amod	6	SENT_359	[p16l619t133r836b188],
6	myeloma	NN	O	myeloma	prep_in	3	SENT_359	[p16l860t133r1116b188],
7	:	:	O	:	_	0	SENT_359	[p16l860t133r1116b188],
8	impact	NN	O	impact	dep	1	SENT_359	[p16l1144t134r1321b188],
9	of	IN	O	of	_	0	SENT_359	[p16l1344t133r1397b177],
10	angiogenic	JJ	O	angiogenic	amod	11	SENT_359	[p16l1414t134r1693b188],
11	factors	NNS	O	factor	prep_of	8	SENT_359	[p16l1716t133r1901b177],
12	.	.	O	.	_	0	SENT_359	[p16l1716t133r1901b177],

1	Cytokine	NN	O	cytokine	_	0	SENT_360	[p16l1925t134r2151b188],
2	2004	CD	DATE	2004	num	1	SENT_360	[p16l139t202r547b250],
3	;	:	O	;	_	0	SENT_360	[p16l139t202r547b250],
4	26:145	CD	NUMBER	26:145	number	5	SENT_360	[p16l139t202r547b250],
5	—	CD	NUMBER	—	dep	1	SENT_360	[p16l139t202r547b250],
6	8	CD	NUMBER	8	dep	5	SENT_360	[p16l139t202r547b250],
7	.	.	O	.	_	0	SENT_360	[p16l139t202r547b250],

1	Cavo	NNP	O	Cavo	nn	2	SENT_361	[p16l139t268r261b310],
2	M	NNP	O	M	_	0	SENT_361	[p16l277t269r338b316],
3	,	,	O	,	_	0	SENT_361	[p16l277t269r338b316],
4	Tacchetti	NNP	PERSON	Tacchetti	nn	5	SENT_361	[p16l352t266r588b310],
5	P	NN	PERSON	p	appos	2	SENT_361	[p16l604t269r644b316],
6	,	,	O	,	_	0	SENT_361	[p16l604t269r644b316],
7	Patriarca	NNP	ORGANIZATION	Patriarca	nn	8	SENT_361	[p16l660t267r888b310],
8	F	NN	ORGANIZATION	f	appos	5	SENT_361	[p16l903t269r940b317],
9	,	,	O	,	_	0	SENT_361	[p16l903t269r940b317],
10	Petrucci	NNP	PERSON	Petrucci	nn	11	SENT_361	[p16l956t267r1163b310],
11	MT	NNP	O	MT	appos	5	SENT_361	[p16l1179t269r1271b317],
12	,	,	O	,	_	0	SENT_361	[p16l1179t269r1271b317],
13	Pantani	NNP	PERSON	Pantani	nn	14	SENT_361	[p16l1288t267r1480b310],
14	L	NNP	O	L	appos	5	SENT_361	[p16l1496t269r1533b316],
15	,	,	O	,	_	0	SENT_361	[p16l1496t269r1533b316],
16	Galli	NNP	PERSON	Galli	nn	17	SENT_361	[p16l1549t266r1664b310],
17	M	NNP	O	M	appos	5	SENT_361	[p16l1680t269r1742b316],
18	,	,	O	,	_	0	SENT_361	[p16l1680t269r1742b316],
19	et	FW	O	et	nn	20	SENT_361	[p16l1758t273r1805b310],
20	al.	FW	O	al.	appos	5	SENT_361	[p16l1819t266r1875b310],
21	.	.	O	.	_	0	SENT_361	[p16l1819t266r1875b310],

1	A	DT	O	a	det	4	SENT_362	[p16l1889t268r1926b309],
2	phase	NN	O	phase	nn	4	SENT_362	[p16l1940t266r2088b321],
3	III	CD	NUMBER	iii	num	4	SENT_362	[p16l2104t269r2151b309],
4	study	NN	O	study	_	0	SENT_362	[p16l140t332r281b386],
5	of	IN	O	of	_	0	SENT_362	[p16l299t332r352b375],
6	double	JJ	O	double	amod	7	SENT_362	[p16l364t332r539b375],
7	autotransplantation	JJ	O	autotransplantation	prep_of	4	SENT_362	[p16l557t332r1073b386],
8	incorporating	VBG	O	incorporate	partmod	4	SENT_362	[p16l1091t332r1443b386],
9	Bortezomib	NNP	O	Bortezomib	dobj	8	SENT_362	[p16l1460t332r2151b375],
10	.	.	O	.	_	0	SENT_362	[p16l1460t332r2151b375],

1	—	NN	O	—	_	0	SENT_363	[p16l1460t332r2151b375],
2	.	.	O	.	_	0	SENT_363	[p16l1460t332r2151b375],

1	Thalidomide	NNP	O	Thalidomide	nn	4	SENT_364	[p16l1460t332r2151b375],
2	Dexamethasone	NN	O	dexamethasone	nn	4	SENT_364	[p16l139t398r554b442],
3	(	NN	O	(	nn	4	SENT_364	[p16l591t398r739b452],
4	VTD	NN	O	vtd	_	0	SENT_364	[p16l591t398r739b452],
5	)	CD	NUMBER	)	dep	4	SENT_364	[p16l591t398r739b452],
6	or	CC	O	or	_	0	SENT_364	[p16l777t411r830b442],
7	Thalidomide	NNP	O	Thalidomide	dep	4	SENT_364	[p16l863t398r1641b442],
8	.	.	O	.	_	0	SENT_364	[p16l863t398r1641b442],

1	—	NN	O	—	_	0	SENT_365	[p16l863t398r1641b442],
2	.	.	O	.	_	0	SENT_365	[p16l863t398r1641b442],

1	Dexamethasone	NN	O	dexamethasone	nn	4	SENT_366	[p16l863t398r1641b442],
2	(	CD	NUMBER	(	num	4	SENT_366	[p16l1679t398r1788b452],
3	TD	NN	O	td	nn	4	SENT_366	[p16l1679t398r1788b452],
4	)	NN	O	)	_	0	SENT_366	[p16l1679t398r1788b452],
5	for	IN	O	for	_	0	SENT_366	[p16l1826t398r1898b442],
6	multiple	JJ	O	multiple	amod	7	SENT_366	[p16l1934t398r2151b452],
7	myeloma	NN	O	myeloma	prep_for	4	SENT_366	[p16l139t463r395b518],
8	:	:	O	:	_	0	SENT_366	[p16l139t463r395b518],
9	superior	JJ	O	superior	amod	11	SENT_366	[p16l439t464r654b518],
10	clinical	JJ	O	clinical	amod	11	SENT_366	[p16l691t463r872b507],
11	outcomes	NNS	O	outcome	dep	4	SENT_366	[p16l912t470r1161b507],
12	with	IN	O	with	_	0	SENT_366	[p16l1199t464r1318b507],
13	VTD	NN	O	vtd	prep_with	11	SENT_366	[p16l1355t466r1462b507],
14	compared	VBN	O	compare	_	0	SENT_366	[p16l1501t463r1758b518],
15	to	TO	O	to	prepc_compared_to	13	SENT_366	[p16l1798t470r1847b507],
16	TD	NN	O	td	pobj	13	SENT_366	[p16l1884t466r1967b507],
17	.	.	O	.	_	0	SENT_366	[p16l1884t466r1967b507],

1	Blood	NN	O	blood	_	0	SENT_367	[p16l2007t463r2151b507],
2	2009	CD	DATE	2009	num	1	SENT_367	[p16l139t532r495b580],
3	;	:	O	;	_	0	SENT_367	[p16l139t532r495b580],
4	114:351	CD	NUMBER	114:351	number	5	SENT_367	[p16l139t532r495b580],
5	[	CD	NUMBER	[	num	6	SENT_367	[p16l523t530r747b584],
6	abstract	JJ	O	abstract	dep	1	SENT_367	[p16l523t530r747b584],
7	351	CD	NUMBER	351	num	8	SENT_367	[p16l762t530r890b584],
8	]	NN	O	]	dep	6	SENT_367	[p16l762t530r890b584],
9	.	.	O	.	_	0	SENT_367	[p16l762t530r890b584],

1	Rosiﬁol	NN	PERSON	rosiﬁol	nn	2	SENT_368	[p16l139t596r327b639],
2	L	NN	PERSON	l	_	0	SENT_368	[p16l395t598r431b646],
3	,	,	O	,	_	0	SENT_368	[p16l395t598r431b646],
4	Cibeira	NNP	O	Cibeira	nn	5	SENT_368	[p16l499t595r678b639],
5	MT	NNP	O	MT	appos	2	SENT_368	[p16l745t598r837b646],
6	,	,	O	,	_	0	SENT_368	[p16l745t598r837b646],
7	Martinez	NNP	PERSON	Martinez	nn	8	SENT_368	[p16l905t596r1136b639],
8	J	NNP	PERSON	J	appos	5	SENT_368	[p16l1197t598r1229b650],
9	,	,	O	,	_	0	SENT_368	[p16l1197t598r1229b650],
10	Mateos	NNP	PERSON	Mateos	nn	11	SENT_368	[p16l1297t598r1482b639],
11	MV	NNP	O	MV	appos	5	SENT_368	[p16l1550t598r1649b646],
12	,	,	O	,	_	0	SENT_368	[p16l1550t598r1649b646],
13	Oriol	NNP	ORGANIZATION	Oriol	nn	14	SENT_368	[p16l1717t595r1842b639],
14	A	NNP	ORGANIZATION	A	appos	5	SENT_368	[p16l1907t597r1955b646],
15	,	,	O	,	_	0	SENT_368	[p16l1907t597r1955b646],
16	Terol	NNP	O	Terol	nn	18	SENT_368	[p16l2020t595r2151b639],
17	M	NNP	O	M	nn	18	SENT_368	[p16l139t665r218b716],
18	]	NN	O	]	appos	5	SENT_368	[p16l139t665r218b716],
19	,	,	O	,	_	0	SENT_368	[p16l139t665r218b716],
20	et	FW	O	et	nn	21	SENT_368	[p16l285t668r333b705],
21	al.	FW	O	al.	appos	5	SENT_368	[p16l398t662r452b706],
22	.	.	O	.	_	0	SENT_368	[p16l398t662r452b706],

1	Thalidomide/Dexamethasone	NN	O	thalidomide/dexamethasone	dep	6	SENT_369	[p16l517t662r1282b716],
2	(	CD	NUMBER	(	dep	1	SENT_369	[p16l1348t662r1458b716],
3	TD	NN	O	td	dep	6	SENT_369	[p16l1348t662r1458b716],
4	)	CD	NUMBER	)	num	3	SENT_369	[p16l1348t662r1458b716],
5	Vs.	NNP	O	Vs.	nn	6	SENT_369	[p16l1522t665r1595b706],
6	Bortezomib	NNP	O	Bortezomib	dep	9	SENT_369	[p16l1663t662r1961b705],
7	(	CD	NUMBER	(	num	8	SENT_369	[p16l2027t662r2151b716, p16l139t728r1062b783],
8	Velcade	NNP	O	Velcade	dep	6	SENT_369	[p16l2027t662r2151b716, p16l139t728r1062b783],
9	)	CD	NUMBER	)	_	0	SENT_369	[p16l2027t662r2151b716, p16l139t728r1062b783],
10	/	:	O	/	punct	9	SENT_369	[p16l2027t662r2151b716, p16l139t728r1062b783],
11	Thalidomide/Dexamethasone	NN	O	thalidomide/dexamethasone	dep	16	SENT_369	[p16l2027t662r2151b716, p16l139t728r1062b783],
12	(	CD	NUMBER	(	dep	11	SENT_369	[p16l1122t728r1269b782],
13	VTD	NN	O	vtd	dep	16	SENT_369	[p16l1122t728r1269b782],
14	)	CD	NUMBER	)	num	13	SENT_369	[p16l1122t728r1269b782],
15	Vs.	NNP	O	Vs.	nn	16	SENT_369	[p16l1327t731r1401b772],
16	VBMCP/VBAD/Velcade	NNP	O	VBMCP/VBAD/Velcade	dep	41	SENT_369	[p16l1459t728r2041b783],
17	as	IN	O	as	_	0	SENT_369	[p16l2101t741r2151b772],
18	induction	NN	O	induction	nn	19	SENT_369	[p16l139t794r386b837],
19	regimens	NNS	O	regimen	prep_as	16	SENT_369	[p16l422t794r659b848],
20	prior	RB	O	prior	prep	19	SENT_369	[p16l697t794r824b848],
21	autologous	JJ	O	autologous	amod	27	SENT_369	[p16l858t794r1141b848],
22	stem	NN	O	stem	nn	27	SENT_369	[p16l1179t800r1303b837],
23	cell	NN	O	cell	nn	27	SENT_369	[p16l1339t794r1426b837],
24	transplantation	NN	O	transplantation	nn	27	SENT_369	[p16l1462t794r1861b848],
25	(	CD	NUMBER	(	num	27	SENT_369	[p16l1897t794r2067b848],
26	ASCT	NN	O	asct	nn	27	SENT_369	[p16l1897t794r2067b848],
27	)	NN	O	)	pobj	20	SENT_369	[p16l1897t794r2067b848],
28	in	IN	O	in	_	0	SENT_369	[p16l2105t794r2152b837],
29	multiple	JJ	O	multiple	amod	30	SENT_369	[p16l139t860r356b914],
30	myeloma	NN	O	myeloma	prep_in	27	SENT_369	[p16l386t860r626b914],
31	(	CD	NUMBER	(	num	33	SENT_369	[p16l655t860r814b914],
32	MM	NN	O	mm	nn	33	SENT_369	[p16l655t860r814b914],
33	)	NN	O	)	dep	30	SENT_369	[p16l655t860r814b914],
34	:	:	O	:	_	0	SENT_369	[p16l655t860r814b914],
35	results	NNS	O	result	dep	30	SENT_369	[p16l847t860r1017b904],
36	of	IN	O	of	_	0	SENT_369	[p16l1047t860r1101b904],
37	a	DT	O	a	det	40	SENT_369	[p16l1123t873r1149b904],
38	phase	NN	O	phase	nn	40	SENT_369	[p16l1178t860r1325b914],
39	III	CD	NUMBER	iii	num	40	SENT_369	[p16l1355t863r1403b903],
40	PETHEMA/GEM	NN	O	pethema/gem	prep_of	35	SENT_369	[p16l1432t860r1832b914],
41	trial	NN	O	trial	dep	9	SENT_369	[p16l1860t860r1977b904],
42	.	.	O	.	_	0	SENT_369	[p16l1860t860r1977b904],

1	Blood	NN	O	blood	_	0	SENT_370	[p16l2007t860r2151b904],
2	2009	CD	DATE	2009	num	1	SENT_370	[p16l139t928r502b976],
3	;	:	O	;	_	0	SENT_370	[p16l139t928r502b976],
4	114:130	CD	NUMBER	114:130	number	5	SENT_370	[p16l139t928r502b976],
5	[	CD	NUMBER	[	num	6	SENT_370	[p16l523t925r747b980],
6	abstract	JJ	O	abstract	dep	1	SENT_370	[p16l523t925r747b980],
7	130	CD	NUMBER	130	num	8	SENT_370	[p16l766t925r890b980],
8	]	NN	O	]	dep	6	SENT_370	[p16l766t925r890b980],
9	.	.	O	.	_	0	SENT_370	[p16l766t925r890b980],

1	Attal	JJ	PERSON	attal	amod	2	SENT_371	[p16l137t992r260b1035],
2	M	NN	O	m	_	0	SENT_371	[p16l290t995r351b1042],
3	,	,	O	,	_	0	SENT_371	[p16l290t995r351b1042],
4	Cristini	NNP	PERSON	Cristini	nn	5	SENT_371	[p16l380t993r565b1035],
5	C	NNP	O	C	appos	2	SENT_371	[p16l594t994r636b1042],
6	,	,	O	,	_	0	SENT_371	[p16l594t994r636b1042],
7	Marit	NNP	PERSON	Marit	nn	8	SENT_371	[p16l666t993r806b1035],
8	G	NNP	PERSON	G	appos	5	SENT_371	[p16l834t994r882b1042],
9	,	,	O	,	_	0	SENT_371	[p16l834t994r882b1042],
10	Caillot	NNP	PERSON	Caillot	nn	11	SENT_371	[p16l912t992r1077b1035],
11	D	NNP	O	D	appos	5	SENT_371	[p16l1104t995r1153b1042],
12	,	,	O	,	_	0	SENT_371	[p16l1104t995r1153b1042],
13	Facon	NNP	ORGANIZATION	Facon	nn	14	SENT_371	[p16l1183t995r1330b1035],
14	T	NN	ORGANIZATION	t	appos	5	SENT_371	[p16l1357t994r1399b1042],
15	,	,	O	,	_	0	SENT_371	[p16l1357t994r1399b1042],
16	Hullin	NNP	PERSON	Hullin	nn	17	SENT_371	[p16l1428t992r1586b1035],
17	C	NNP	O	C	appos	5	SENT_371	[p16l1615t994r1657b1042],
18	,	,	O	,	_	0	SENT_371	[p16l1615t994r1657b1042],
19	et	FW	O	et	nn	20	SENT_371	[p16l1686t998r1735b1035],
20	al.	FW	O	al.	appos	5	SENT_371	[p16l1762t992r1817b1036],
21	.	.	O	.	_	0	SENT_371	[p16l1762t992r1817b1036],

1	Intergroupe	NNP	O	Intergroupe	nn	4	SENT_372	[p16l1847t995r2151b1046],
2	Francophone	NNP	O	Francophone	nn	4	SENT_372	[p16l139t1058r474b1113],
3	du	NNP	O	du	nn	4	SENT_372	[p16l500t1058r564b1102],
4	Myelome	NNP	O	Myelome	_	0	SENT_372	[p16l591t1058r844b1113],
5	.	.	O	.	_	0	SENT_372	[p16l591t1058r844b1113],

1	Lenalidomide	NNP	O	Lenalidomide	_	0	SENT_373	[p16l872t1058r1221b1102],
2	maintenance	NN	O	maintenance	dep	1	SENT_373	[p16l1248t1059r1582b1102],
3	after	IN	O	after	_	0	SENT_373	[p16l1608t1058r1729b1102],
4	transplantation	NN	O	transplantation	prep_after	2	SENT_373	[p16l1753t1058r2152b1113],
5	for	IN	O	for	prep	2	SENT_373	[p16l139t1123r211b1167],
6	myeloma	NN	O	myeloma	dep	5	SENT_373	[p16l228t1124r512b1178],
7	.	.	O	.	_	0	SENT_373	[p16l228t1124r512b1178],
8	]	SYM	O	]	dep	2	SENT_373	[p16l228t1124r512b1178],

1	Clin	NNP	O	Clin	nn	2	SENT_374	[p16l530t1124r629b1167],
2	Oncol	NNP	O	Oncol	_	0	SENT_374	[p16l647t1124r793b1167],
3	2010	CD	DATE	2010	num	2	SENT_374	[p16l811t1126r1173b1174],
4	;	:	O	;	_	0	SENT_374	[p16l811t1126r1173b1174],
5	28:8018	CD	NUMBER	28:8018	num	6	SENT_374	[p16l811t1126r1173b1174],
6	[	CD	NUMBER	[	dep	2	SENT_374	[p16l1195t1123r1419b1178],
7	abstract	JJ	O	abstract	amod	6	SENT_374	[p16l1195t1123r1419b1178],
8	8018	CD	NUMBER	8018	number	9	SENT_374	[p16l1436t1123r1596b1178],
9	]	CD	NUMBER	]	dep	7	SENT_374	[p16l1436t1123r1596b1178],
10	.	.	O	.	_	0	SENT_374	[p16l1436t1123r1596b1178],

1	Palumbo	NNP	PERSON	Palumbo	nn	2	SENT_375	[p16l139t1190r364b1234],
2	A	NNP	O	A	_	0	SENT_375	[p16l384t1192r432b1240],
3	,	,	O	,	_	0	SENT_375	[p16l384t1192r432b1240],
4	Bringhen	NNP	O	Bringhen	nn	5	SENT_375	[p16l454t1190r688b1244],
5	S	NNP	O	S	appos	2	SENT_375	[p16l710t1192r748b1240],
6	,	,	O	,	_	0	SENT_375	[p16l710t1192r748b1240],
7	Caravita	NNP	ORGANIZATION	Caravita	nn	8	SENT_375	[p16l770t1191r980b1234],
8	T	NN	ORGANIZATION	t	appos	5	SENT_375	[p16l999t1193r1042b1240],
9	,	,	O	,	_	0	SENT_375	[p16l999t1193r1042b1240],
10	Merla	NNP	PERSON	Merla	nn	11	SENT_375	[p16l1064t1190r1213b1234],
11	E	NNP	O	E	appos	5	SENT_375	[p16l1234t1193r1274b1240],
12	,	,	O	,	_	0	SENT_375	[p16l1234t1193r1274b1240],
13	Capparella	NNP	O	Capparella	nn	14	SENT_375	[p16l1297t1190r1570b1244],
14	V	NNP	O	V	appos	5	SENT_375	[p16l1589t1193r1637b1240],
15	,	,	O	,	_	0	SENT_375	[p16l1589t1193r1637b1240],
16	Callea	NNP	PERSON	Callea	nn	17	SENT_375	[p16l1660t1190r1812b1234],
17	V	NNP	PERSON	V	appos	5	SENT_375	[p16l1831t1193r1879b1240],
18	,	,	O	,	_	0	SENT_375	[p16l1831t1193r1879b1240],
19	et	FW	O	et	nn	20	SENT_375	[p16l1902t1196r1950b1234],
20	al.	FW	O	al.	appos	5	SENT_375	[p16l1970t1190r2025b1234],
21	.	.	O	.	_	0	SENT_375	[p16l1970t1190r2025b1234],

1	Italian	JJ	MISC	italian	amod	3	SENT_376	[p16l2048t1190r2151b1234, p16l139t1256r216b1299],
2	Multiple	JJ	MISC	multiple	amod	3	SENT_376	[p16l246t1256r463b1310],
3	Myeloma	NN	MISC	myeloma	_	0	SENT_376	[p16l494t1256r734b1310],
4	Network	NNP	MISC	Network	nn	6	SENT_376	[p16l764t1256r1000b1306],
5	,	,	O	,	_	0	SENT_376	[p16l764t1256r1000b1306],
6	GIMEMA	NNP	O	GIMEMA	dep	3	SENT_376	[p16l1030t1258r1271b1300],
7	.	.	O	.	_	0	SENT_376	[p16l1030t1258r1271b1300],

1	Oral	JJ	O	oral	amod	2	SENT_377	[p16l1301t1256r1407b1299],
2	melphalan	NN	O	melphalan	nsubj	21	SENT_377	[p16l1437t1256r1710b1310],
3	and	CC	O	and	_	0	SENT_377	[p16l1739t1256r1833b1299],
4	prednisone	NN	O	prednisone	nn	5	SENT_377	[p16l1863t1256r2151b1310],
5	chemotherapy	NN	O	chemotherapy	nsubj	21	SENT_377	[p16l139t1322r514b1376],
6	plus	CC	O	plus	prep	2	SENT_377	[p16l540t1322r645b1376],
7	thalidomide	NN	O	thalidomide	dep	6	SENT_377	[p16l673t1322r986b1366],
8	compared	VBN	O	compare	_	0	SENT_377	[p16l1013t1322r1270b1376],
9	with	IN	O	with	prepc_compared_with	7	SENT_377	[p16l1296t1322r1415b1366],
10	melphalan	NN	O	melphalan	pobj	7	SENT_377	[p16l1442t1322r1715b1376],
11	and	CC	O	and	_	0	SENT_377	[p16l1742t1322r1835b1366],
12	prednisone	NN	O	prednisone	conj_and	10	SENT_377	[p16l1862t1322r2151b1376],
13	alone	RB	O	alone	advmod	21	SENT_377	[p16l139t1387r277b1431],
14	in	IN	O	in	dep	16	SENT_377	[p16l295t1388r342b1431],
15	elderly	JJ	O	elderly	amod	16	SENT_377	[p16l360t1387r538b1442],
16	patients	NNS	O	patient	dep	21	SENT_377	[p16l555t1388r761b1442],
17	with	IN	O	with	_	0	SENT_377	[p16l778t1387r897b1431],
18	multiple	JJ	O	multiple	amod	19	SENT_377	[p16l914t1387r1132b1442],
19	myeloma	NN	O	myeloma	prep_with	16	SENT_377	[p16l1150t1387r1405b1442],
20	:	:	O	:	_	0	SENT_377	[p16l1150t1387r1405b1442],
21	randomized	VBN	O	randomize	_	0	SENT_377	[p16l1427t1387r1736b1431],
22	controlled	JJ	O	controlled	amod	23	SENT_377	[p16l1754t1387r2017b1431],
23	trial	NN	O	trial	dobj	21	SENT_377	[p16l2034t1388r2151b1431],
24	.	.	O	.	_	0	SENT_377	[p16l2034t1388r2151b1431],

1	Lancet	NNP	O	Lancet	_	0	SENT_378	[p16l139t1457r306b1497],
2	2006	CD	DATE	2006	num	1	SENT_378	[p16l322t1456r763b1504],
3	;	:	O	;	_	0	SENT_378	[p16l322t1456r763b1504],
4	36:825	CD	NUMBER	36:825	number	5	SENT_378	[p16l322t1456r763b1504],
5	—	CD	NUMBER	—	dep	1	SENT_378	[p16l322t1456r763b1504],
6	31	CD	NUMBER	31	dep	5	SENT_378	[p16l322t1456r763b1504],
7	.	.	O	.	_	0	SENT_378	[p16l322t1456r763b1504],

1	Facon	NNP	ORGANIZATION	Facon	nn	2	SENT_379	[p16l139t1523r287b1564],
2	T	NN	ORGANIZATION	t	_	0	SENT_379	[p16l313t1523r355b1570],
3	,	,	O	,	_	0	SENT_379	[p16l313t1523r355b1570],
4	Mary	NNP	PERSON	Mary	nn	5	SENT_379	[p16l384t1523r518b1575],
5	JY	NN	PERSON	jy	appos	2	SENT_379	[p16l538t1523r606b1575],
6	,	,	O	,	_	0	SENT_379	[p16l538t1523r606b1575],
7	Hulin	NNP	ORGANIZATION	Hulin	nn	8	SENT_379	[p16l636t1520r776b1564],
8	C	NNP	ORGANIZATION	C	appos	5	SENT_379	[p16l805t1522r847b1570],
9	,	,	O	,	_	0	SENT_379	[p16l805t1522r847b1570],
10	Benboubker	NNP	PERSON	Benboubker	nn	11	SENT_379	[p16l877t1520r1188b1564],
11	L	NNP	PERSON	L	appos	5	SENT_379	[p16l1215t1523r1252b1571],
12	,	,	O	,	_	0	SENT_379	[p16l1215t1523r1252b1571],
13	Attal	NNP	PERSON	Attal	nn	14	SENT_379	[p16l1279t1520r1402b1564],
14	M	NN	O	m	appos	5	SENT_379	[p16l1432t1523r1492b1570],
15	,	,	O	,	_	0	SENT_379	[p16l1432t1523r1492b1570],
16	Pegourie	NN	O	pegourie	nn	17	SENT_379	[p16l1522t1521r1746b1575],
17	B	NN	O	b	appos	5	SENT_379	[p16l1775t1523r1818b1571],
18	,	,	O	,	_	0	SENT_379	[p16l1775t1523r1818b1571],
19	et	FW	O	et	nn	20	SENT_379	[p16l1847t1527r1895b1564],
20	al.	FW	O	al.	appos	5	SENT_379	[p16l1922t1520r1977b1564],
21	.	.	O	.	_	0	SENT_379	[p16l1922t1520r1977b1564],

1	Intergroupe	NNP	O	Intergroupe	nn	4	SENT_380	[p16l2007t1523r2151b1564, p16l138t1598r318b1640],
2	Francophone	NNP	O	Francophone	nn	4	SENT_380	[p16l332t1586r666b1640],
3	du	NNP	O	du	nn	4	SENT_380	[p16l680t1586r743b1629],
4	Myélome	NNP	O	Myélome	_	0	SENT_380	[p16l757t1584r1010b1640],
5	.	.	O	.	_	0	SENT_380	[p16l757t1584r1010b1640],

1	Melphalan	NNP	O	Melphalan	dep	24	SENT_381	[p16l1024t1586r1298b1640],
2	and	CC	O	and	_	0	SENT_381	[p16l1310t1586r1403b1629],
3	prednisone	NN	O	prednisone	conj_and	1	SENT_381	[p16l1417t1586r1706b1640],
4	plus	CC	O	plus	_	0	SENT_381	[p16l1719t1586r1824b1640],
5	thalidomide	NN	O	thalidomide	conj_plus	1	SENT_381	[p16l1838t1586r2151b1629],
6	versus	CC	O	versus	prep	5	SENT_381	[p16l137t1665r302b1696],
7	melphalan	NN	O	melphalan	dep	6	SENT_381	[p16l320t1652r593b1706],
8	and	CC	O	and	_	0	SENT_381	[p16l609t1652r702b1696],
9	prednisone	NN	O	prednisone	dep	6	SENT_381	[p16l720t1652r1008b1706],
10	alone	RB	O	alone	advmod	7	SENT_381	[p16l1025t1652r1164b1696],
11	or	CC	O	or	_	0	SENT_381	[p16l1181t1665r1234b1696],
12	reduced-intensity	JJ	O	reduced-intensity	amod	16	SENT_381	[p16l1249t1652r1711b1706],
13	autologous	JJ	O	autologous	amod	16	SENT_381	[p16l1726t1652r2009b1706],
14	stem	NN	O	stem	nn	16	SENT_381	[p16l2027t1658r2152b1696],
15	cell	NN	O	cell	nn	16	SENT_381	[p16l139t1717r225b1761],
16	transplantation	NN	O	transplantation	conj_or	1	SENT_381	[p16l244t1717r643b1772],
17	in	IN	O	in	_	0	SENT_381	[p16l662t1718r709b1761],
18	elderly	JJ	O	elderly	amod	19	SENT_381	[p16l727t1717r906b1772],
19	patients	NNS	O	patient	prep_in	16	SENT_381	[p16l924t1718r1130b1772],
20	with	IN	O	with	_	0	SENT_381	[p16l1149t1718r1267b1761],
21	multiple	JJ	O	multiple	amod	22	SENT_381	[p16l1286t1717r1503b1772],
22	myeloma	NN	O	myeloma	prep_with	19	SENT_381	[p16l1523t1718r1763b1772],
23	(	CD	NUMBER	(	dep	24	SENT_381	[p16l1781t1718r1897b1772],
24	IFM	NNP	O	IFM	dep	30	SENT_381	[p16l1781t1718r1897b1772],
25	99-06	CD	NUMBER	99-06	num	24	SENT_381	[p16l1916t1718r2103b1771],
26	)	CD	NUMBER	)	dep	24	SENT_381	[p16l1916t1718r2103b1771],
27	:	:	O	:	_	0	SENT_381	[p16l1916t1718r2103b1771],
28	a	DT	O	a	det	30	SENT_381	[p16l2126t1730r2152b1761],
29	randomised	JJ	O	randomised	amod	30	SENT_381	[p16l139t1784r445b1828],
30	trial	NN	O	trial	_	0	SENT_381	[p16l463t1784r579b1828],
31	.	.	O	.	_	0	SENT_381	[p16l463t1784r579b1828],

1	Lancet	NNP	O	Lancet	_	0	SENT_382	[p16l598t1787r765b1828],
2	2007	CD	DATE	2007	num	1	SENT_382	[p16l782t1786r1288b1834],
3	;	:	O	;	_	0	SENT_382	[p16l782t1786r1288b1834],
4	370:1209	CD	NUMBER	370:1209	number	5	SENT_382	[p16l782t1786r1288b1834],
5	—	CD	NUMBER	—	dep	1	SENT_382	[p16l782t1786r1288b1834],
6	18	CD	NUMBER	18	dep	5	SENT_382	[p16l782t1786r1288b1834],
7	.	.	O	.	_	0	SENT_382	[p16l782t1786r1288b1834],

1	Palumbo	NNP	PERSON	Palumbo	nn	2	SENT_383	[p16l139t1849r364b1893],
2	A	NNP	O	A	_	0	SENT_383	[p16l399t1851r447b1900],
3	,	,	O	,	_	0	SENT_383	[p16l399t1851r447b1900],
4	Falco	NNP	PERSON	Falco	nn	5	SENT_383	[p16l485t1850r614b1893],
5	P	NN	PERSON	p	appos	2	SENT_383	[p16l652t1852r692b1900],
6	,	,	O	,	_	0	SENT_383	[p16l652t1852r692b1900],
7	Corradini	NNP	PERSON	Corradini	nn	8	SENT_383	[p16l729t1849r969b1893],
8	P	NN	PERSON	p	appos	5	SENT_383	[p16l1006t1852r1046b1900],
9	,	,	O	,	_	0	SENT_383	[p16l1006t1852r1046b1900],
10	Falcone	NNP	PERSON	Falcone	nn	11	SENT_383	[p16l1084t1849r1278b1893],
11	A	NNP	O	A	appos	5	SENT_383	[p16l1313t1851r1361b1900],
12	,	,	O	,	_	0	SENT_383	[p16l1313t1851r1361b1900],
13	Di	NNP	PERSON	Di	nn	15	SENT_383	[p16l1399t1850r1451b1893],
14	Raimondo	NNP	PERSON	Raimondo	nn	15	SENT_383	[p16l1489t1849r1750b1893],
15	F	NN	PERSON	f	appos	5	SENT_383	[p16l1788t1852r1825b1900],
16	,	,	O	,	_	0	SENT_383	[p16l1788t1852r1825b1900],
17	Giuliani	NNP	PERSON	Giuliani	nn	18	SENT_383	[p16l1862t1850r2063b1893],
18	N	NNP	O	N	appos	5	SENT_383	[p16l2101t1852r2151b1900],
19	,	,	O	,	_	0	SENT_383	[p16l2101t1852r2151b1900],
20	et	FW	O	et	nn	21	SENT_383	[p16l139t1922r187b1959],
21	al.	FW	O	al.	appos	5	SENT_383	[p16l212t1916r267b1960],
22	.	.	O	.	_	0	SENT_383	[p16l212t1916r267b1960],

1	GIMEMA	NNP	O	GIMEMA	_	0	SENT_384	[p16l294t1916r735b1959],
2	.	.	O	.	_	0	SENT_384	[p16l294t1916r735b1959],

1	—	NN	O	—	_	0	SENT_385	[p16l294t1916r735b1959],
2	.	.	O	.	_	0	SENT_385	[p16l294t1916r735b1959],

1	Italian	JJ	MISC	italian	amod	6	SENT_386	[p16l294t1916r735b1959],
2	Multiple	JJ	MISC	multiple	amod	6	SENT_386	[p16l761t1916r979b1970],
3	Myeloma	NN	MISC	myeloma	nn	6	SENT_386	[p16l1006t1916r1246b1970],
4	Network	NNP	MISC	Network	nn	6	SENT_386	[p16l1273t1916r1509b1966],
5	,	,	O	,	_	0	SENT_386	[p16l1273t1916r1509b1966],
6	Melphalan	NNP	O	Melphalan	_	0	SENT_386	[p16l1536t1916r1822b1970],
7	,	,	O	,	_	0	SENT_386	[p16l1536t1916r1822b1970],
8	prednisone	NN	O	prednisone	conj_and	6	SENT_386	[p16l1849t1916r2151b1970],
9	,	,	O	,	_	0	SENT_386	[p16l1849t1916r2151b1970],
10	and	CC	O	and	_	0	SENT_386	[p16l139t1982r232b2026],
11	lenalidomide	NN	O	lenalidomide	nn	12	SENT_386	[p16l262t1982r600b2026],
12	treatment	NN	O	treatment	conj_and	6	SENT_386	[p16l630t1989r889b2026],
13	for	IN	O	for	_	0	SENT_386	[p16l918t1982r990b2026],
14	newly	RB	O	newly	advmod	15	SENT_386	[p16l1018t1982r1176b2037],
15	diagnosed	VBN	O	diagnose	amod	16	SENT_386	[p16l1204t1982r1465b2037],
16	myeloma	NN	O	myeloma	prep_for	12	SENT_386	[p16l1496t1982r1751b2037],
17	:	:	O	:	_	0	SENT_386	[p16l1496t1982r1751b2037],
18	a	DT	O	a	det	19	SENT_386	[p16l1785t1995r1811b2026],
19	report	NN	O	report	dep	6	SENT_386	[p16l1840t1989r2001b2037],
20	from	IN	O	from	_	0	SENT_386	[p16l2029t1982r2152b2026],
21	the	DT	O	the	det	22	SENT_386	[p16l138t2048r220b2091],
22	GlMEMA	NN	O	glmema	prep_from	19	SENT_386	[p16l258t2048r698b2091],
23	.	.	O	.	_	0	SENT_386	[p16l258t2048r698b2091],

1	—	NN	O	—	_	0	SENT_387	[p16l258t2048r698b2091],
2	.	.	O	.	_	0	SENT_387	[p16l258t2048r698b2091],

1	Italian	JJ	O	italian	amod	3	SENT_388	[p16l258t2048r698b2091],
2	Multiple	JJ	O	multiple	amod	3	SENT_388	[p16l736t2048r954b2102],
3	Myeloma	NN	O	myeloma	_	0	SENT_388	[p16l993t2048r1233b2102],
4	Network	NNP	O	Network	dep	3	SENT_388	[p16l1271t2048r1507b2092],
5	.	.	O	.	_	0	SENT_388	[p16l1271t2048r1507b2092],

1	J	NNP	O	J	nn	3	SENT_389	[p16l1540t2050r1560b2102],
2	Clin	NNP	O	Clin	nn	3	SENT_389	[p16l1598t2048r1697b2091],
3	Oncol	NNP	O	Oncol	_	0	SENT_389	[p16l1734t2048r1881b2091],
4	2007	CD	DATE	2007	num	3	SENT_389	[p16l1919t2050r2147b2098],
5	;	:	O	;	_	0	SENT_389	[p16l1919t2050r2147b2098],
6	25	CD	NUMBER	25	num	8	SENT_389	[p16l1919t2050r2147b2098],
7	:	:	O	:	_	0	SENT_389	[p16l1919t2050r2147b2098],
8	4459-65	CD	NUMBER	4459-65	dep	3	SENT_389	[p16l137t2117r377b2159],
9	.	.	O	.	_	0	SENT_389	[p16l137t2117r377b2159],

1	Lacy	NNP	ORGANIZATION	Lacy	nn	2	SENT_390	[p16l139t2183r252b2235],
2	MQ	NNP	ORGANIZATION	MQ	_	0	SENT_390	[p16l273t2183r374b2233],
3	,	,	O	,	_	0	SENT_390	[p16l273t2183r374b2233],
4	Gertz	NNP	PERSON	Gertz	nn	5	SENT_390	[p16l397t2183r535b2224],
5	MA	NNP	PERSON	MA	appos	2	SENT_390	[p16l558t2182r656b2231],
6	,	,	O	,	_	0	SENT_390	[p16l558t2182r656b2231],
7	Dispenzieri	NNP	O	Dispenzieri	nn	8	SENT_390	[p16l679t2181r970b2235],
8	A	NNP	O	A	appos	5	SENT_390	[p16l990t2182r1039b2231],
9	,	,	O	,	_	0	SENT_390	[p16l990t2182r1039b2231],
10	Hayman	NNP	PERSON	Hayman	nn	11	SENT_390	[p16l1062t2183r1276b2235],
11	SR	NN	O	sr	appos	5	SENT_390	[p16l1298t2183r1371b2231],
12	,	,	O	,	_	0	SENT_390	[p16l1298t2183r1371b2231],
13	Geyer	NNP	PERSON	Geyer	nn	14	SENT_390	[p16l1395t2183r1546b2235],
14	S	NNP	O	S	appos	5	SENT_390	[p16l1566t2183r1604b2231],
15	,	,	O	,	_	0	SENT_390	[p16l1566t2183r1604b2231],
16	Kabat	NNP	PERSON	Kabat	nn	17	SENT_390	[p16l1628t2180r1774b2224],
17	B	NNP	PERSON	B	appos	5	SENT_390	[p16l1795t2183r1837b2231],
18	,	,	O	,	_	0	SENT_390	[p16l1795t2183r1837b2231],
19	et	FW	O	et	nn	20	SENT_390	[p16l1860t2187r1908b2224],
20	al.	FW	O	al.	appos	5	SENT_390	[p16l1929t2180r1984b2224],
21	.	.	O	.	_	0	SENT_390	[p16l1929t2180r1984b2224],

1	Longterm	JJ	O	longterm	amod	2	SENT_391	[p16l2007t2183r2151b2235, p16l138t2253r262b2290],
2	results	NNS	O	result	_	0	SENT_391	[p16l287t2247r458b2290],
3	of	IN	O	of	_	0	SENT_391	[p16l485t2247r538b2290],
4	response	NN	O	response	prep_of	2	SENT_391	[p16l558t2259r787b2301],
5	to	TO	O	to	_	0	SENT_391	[p16l813t2253r862b2290],
6	therapy	NN	O	therapy	prep_to	4	SENT_391	[p16l888t2247r1099b2301],
7	,	,	O	,	_	0	SENT_391	[p16l888t2247r1099b2301],
8	time	NN	O	time	conj_and	4	SENT_391	[p16l1126t2248r1242b2290],
9	to	TO	O	to	_	0	SENT_391	[p16l1268t2253r1318b2290],
10	progression	NN	O	progression	prep_to	8	SENT_391	[p16l1344t2248r1659b2301],
11	,	,	O	,	_	0	SENT_391	[p16l1344t2248r1659b2301],
12	and	CC	O	and	_	0	SENT_391	[p16l1686t2247r1779b2290],
13	survival	NN	O	survival	conj_and	4	SENT_391	[p16l1806t2247r2008b2290],
14	with	IN	O	with	_	0	SENT_391	[p16l2033t2247r2152b2290],
15	lenalidomide	NN	O	lenalidomide	prep_with	13	SENT_391	[p16l139t2313r477b2357],
16	plus	CC	O	plus	_	0	SENT_391	[p16l503t2313r608b2368],
17	dexamethasone	NN	O	dexamethasone	conj_and	4	SENT_391	[p16l634t2313r1042b2357],
18	in	IN	O	in	_	0	SENT_391	[p16l1068t2314r1115b2356],
19	newly	RB	O	newly	advmod	20	SENT_391	[p16l1140t2313r1298b2368],
20	diagnosed	VBN	O	diagnose	amod	21	SENT_391	[p16l1322t2313r1583b2368],
21	myeloma	NN	O	myeloma	prep_in	17	SENT_391	[p16l1608t2313r1861b2368],
22	.	.	O	.	_	0	SENT_391	[p16l1608t2313r1861b2368],

1	Mayo	NNP	ORGANIZATION	Mayo	nn	3	SENT_392	[p16l1887t2316r2027b2368],
2	Clin	NNP	ORGANIZATION	Clin	nn	3	SENT_392	[p16l2053t2313r2152b2357],
3	Proc	NNP	ORGANIZATION	Proc	_	0	SENT_392	[p16l139t2381r250b2422],
4	2007	CD	DATE	2007	num	3	SENT_392	[p16l267t2381r558b2428],
5	;	:	O	;	_	0	SENT_392	[p16l267t2381r558b2428],
6	82:11	CD	NUMBER	82:11	number	7	SENT_392	[p16l267t2381r558b2428],
7	79-84	CD	NUMBER	79-84	dep	3	SENT_392	[p16l570t2381r741b2423],
8	.	.	O	.	_	0	SENT_392	[p16l570t2381r741b2423],

